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The role of halogens in the 5-endo-trig cyclizations of radicals derived from N-cyclohexenyl--
haloacetamides on the product distribution has been thoroughly investigated.  Under reductive 
radical conditions, -chloroamides produce octahydroindolones, while -iodoamides primarily 
give a mixture of hexahydroindolones and N-cyclohexenylacetamides.  Kinetic studies showed 
the rate constants of cyclization are not critically halogen-dependent, but the ratio of cyclized to 
oxidized products is dependent on the halogen used in the radical precursor.  When the starting 
halide is easily reducible, a single electron transfer from cyclized intermediates to starting 
material overrides the normal reductive chain process.  This process spurs an ionic, acid-driven 
reductive halogenation process, which disrupts the anticipated radical chain mechanism.  
Addition of excess base suppresses the reductive dehalogenation pathway.  
Enantioenriched derivatives of N-allyl-o-iodoarylcarbamates undergo radical cyclizations 
to give enantioenriched dihydroindoles in 87-100% yields and 83-92% chirality transfers.  
Anionic cyclizations of these substrates proceed in 58-74% yields and 84-99% chirality transfers.  
N-Aryl barriers to rotation were measured and found to be comparable to similar o-
iodoacetanilides.  The radical and anionic cyclizations proceed with the same sense of chirality. 
Radical cyclizations of N-cyclohexenyl-o-iodoanilides may only occur through the syn 
atropisomer when an additional ortho substituent is present on the aromatic ring.  When a second 
ortho substituent is not present, N-aryl rotation of the intermediate radical is faster than all 
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  iv 
competing processes.  Heck cyclizations on these substrates proceed through the anti 
atropisomer, requiring simultaneous N-aryl and N-cyclohexenyl rotations to achieve the 
necessary transition state.  The -elimination step of these Heck reactions occurs with complete 
syn selectivity. 
Radical cyclizations of axially chiral -haloacetanilides which contain an ortho-radical acceptor 
produce dihydroquinolin-2-ones in high yields and with high levels of chirality transfer (80-
100%).  A model of chirality transfer has been determined by absolute configuration 
determination of a substrate / product pair by X-ray crystallography.  Secondary -haloamides 
faithfully cyclize with exclusive trans selectivity.  This methodology has been applied to a 
tandem 6-exo-trig/5-exo-trig radical cyclization, which proceeds with good diastereo- and 
enantioselectivity.  
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1.0  EFFECT OF THE HALOGEN ATOM IN 5-ENDO-TRIG RADICAL 
CYCLIZATIONS OF -HALOENAMIDES 
1.1 INTRODUCTION 
1.1.1 5-Endo-trig Radical Cyclizations in Organic Synthesis 
A relatively new addition to the family of radical cyclizations, the 5-endo-trig ring closure is 
both an unusual and useful process.
1-17
  A 4-pentenyl radical 1.1 can react in a 5-endo-trig 
fashion to produce a cyclopentyl radical 1.2, or it can cyclize in a 4-exo-trig manner to produce a 
cyclobutylcarbinyl radical 1.3 (Scheme 1.1).  Due to the ring strain present in 1.3, 4-exo-trig 
processes are often reversible with the equilibrium greatly favoring the ring-opened form 1.1,
4,17
 
except in special cases where R is a radical stabilizing group.
18
  In contrast, the 5-endo-trig 
process is much less reversible due to the thermodynamic stability of cyclopentyl radical 1.2.
3
 
However, formation of 1.2 is disfavored by Baldwin’s rules because of the failure of 1.1 to meet 
the stereoelectronic requirements for cyclization.
19,20
 
R
R
R5-endo-
trig
4-exo-
trig
1.11.2 1.3  
Scheme 1.1  Cyclization Routes for a 4-Pentenyl Radical 
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Despite the inherently unfavorable nature of the 5-endo-trig process, addition of a high 
degree of substitution around the ring being formed can result in a beneficial Thorpe-Ingold 
effect,
21,22
 accelerating cyclization.  Malacria used this advantageous factor in the cascade radical 
cyclization of 1.4 to 1.5, shown in Scheme 1.2.  This is one of the first examples of formation of 
an all-carbon ring through a 5-endo-trig radical process.
1
  The fused silacycle also assists in the 
final ring closure process by conformational fixation of the radical intermediate, an effect which 
has been observed in other, similar reactions.
23
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Scheme 1.2  Tandem Sequence Including an All-Carbon 5-Endo-trig Cyclization 
 
The majority of effective 5-endo-trig cyclizations take advantage of a highly stabilized 
cyclized radical.  Early studies toward the synthesis of fredericamycin A employed such an 
effect
14
 by cyclizing the radical derived from 1.6 to form benzyl radical 1.7, which abstracts a 
hydrogen atom from Ph3SnH to give the 5-endo-trig product 1.8 in very high yield (Scheme 1.3).  
The synthetic tactic used on model compound 1.6 was successfully applied to a synthesis of the 
natural product.
13
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Scheme 1.3  5-Endo-trig Cyclization in Fredericamycin Model System 
 
Radical 5-endo-trig cyclizations have also found widespread use in the formation of -
lactam containing alkaloids and related compounds.
2,5-9,11,12,15,16,24-26
  The Bu3SnH-mediated 
cyclization of -halo enamides is a useful way to form five-membered nitrogen-containing 
heterocycles.  The precursors for these cyclizations contain four sp
2
 carbons in the ring being 
formed, assisting in cyclization, and the resulting cyclized radical is heteroatom-stabilized.  This 
methodology has been successfully applied to the synthesis of 4-arylglutamic acid 1.10 from -
chloroenamide 1.9,
24
 as seen in Scheme 1.4. 
NO
PMB
CO2Me
Ph Cl
Bu3SnH, AIBN
toluene,  N
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Scheme 1.4  Cyclization of -Halo Enamide Towards Amino Acids 
 
Radical cyclizations of -halo enamides have been frequently used to construct fused 
ring systems found in natural alkaloids.
5-7,9,11,16
  For example, chloride 1.11a in Scheme 1.5 
cyclizes under Bu3SnH-mediated conditions to produce a mixture of lactams 1.13 and 1.14 in 
77% total yield; the iodo congener 1.11b gives similar results, cyclizing in 81% overall yield 
(Scheme 1.5).
5
  The incorporation of the hydroxyl group in compound 1.14 is rationalized by 
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reaction of cyclized radical 1.12 with molecular oxygen, followed by reduction of the resulting 
peroxyl radical with Bu3SnH.
27
  The ability of intermediate 1.12 to react with adventitious 
oxygen, rather than Bu3SnH, has been attributed to its relatively long-lived nature.  Due to 
captodative stabilization
17,28,29
 by the flanking nitrogen and carbonyl moieties, intermediate 1.12 
reacts slowly with Bu3SnH, and has ample lifetime to capture dissolved oxygen. 
O
N
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O
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27%
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Scheme 1.5  Cyclization of -Haloenamides to Produce Fused Lactams 
1.1.2 Role of the Halogen Atom in 5-Endo-trig Cyclizations of -Haloenamides 
Recently, Ishibashi and co-workers reported anomalous results dealing with the Bu3SnH-
mediated radical cyclizations of substrates 1.15a-c,
16
 as summarized in Table 1.1.  Chloride 
1.15a cyclized cleanly and efficiently to give octahydroindolone 1.16 as the sole product in 92% 
yield.  Iodide 1.15c, on the other hand, gave the product of direct reduction 1.19 in 68% yield, 
along with minor amounts of oxidized cyclized products 1.17 and 1.18.  Bromide 1.15b gave a 
product distribution intermediate between the other two halides, producing 1.16 in a moderate 
yield of 55%, with small amounts of the oxidized cyclized compounds.  These results were 
puzzling, as halogen abstraction from any substrate 1.15a-c results in the same radical 
intermediate regardless of the identity of the halogen.  A previous study on the N-methyl 
congeners of 1.15a and 1.15c showed a qualitatively similar trend in reactivity; only the chloride 
was able to cyclize, while the iodide was simply reduced.
8
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Table 1.1  Selected Examples of Halogen Effect in Ishibashi’s Cyclizations of -Haloenamides 
N
CH2Ph
O
X
N
O
CH2Ph
N
O
CH2Ph
N
O
CH2Ph
N
CH2Ph
O
Bu3SnH
AIBN
PhMe

1.15a X = Cl
1.15b X = Br
1.15c X = I
1.16 1.17 1.18 1.19
H
H
 
   % yield of product
b
  
entry
a
 amide X 1.16 1.17 1.18 1.19 total cyc:red
c 
1 1.15a Cl 92 0 0 0 92 > 99:1 
2 1.15b Br 55 11 11 0 77 > 99:1 
3 1.15c I 0 13 11 68 92 26:74 
a
 conditions: Bu3SnH (1.2 equiv) and AIBN (0.1 equiv) in toluene (12 mM in Bu3SnH) was added via syringe pump 
to a refluxing mixture of the amide in toluene (10 mM) over 3 h.  
b
 Isolated yield after aq. KF workup and column 
chromatography.  
c
 Ratio of (1.16 + 1.17 + 1.18) to 1.19. 
 
Ishibashi postulated that steric differences among the different halogen atoms in 1.15a-c 
were responsible for fixing the precursor in different Z/E amide rotamers as in Figure 1.1, 
consequently affecting the overall cyclization/reduction ratio of the products.  It was proposed 
that, due to the greater internal steric hindrance caused by a shorter carbon-halogen bond 
length,
22
 the -chloro group (C−Cl = 1.78 Å) would have a significant repulsion by the N-benzyl 
group, forcing the molecule into rotamer (E)-1.15a (KX < 1).  The iodide, with a longer carbon-
halogen bond length (2.14 Å), could preferentially populate the (Z)-1.15c rotamer (KX > 1).  The 
bromide (C−Br = 1.94 Å) would be expected to have an intermediate Z/E ratio. 
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Figure 1.1  Postulated Rotamer Roles in Reactions of 11a-c 
 
Upon halogen abstraction, rotamer (E)-1.15 initially produces carbamoylmethyl radical 
(E)-1.20, which is in position to cyclize; similarly, halide rotamer (Z)-1.15 would produce (Z)-
1.20 after halogen abstraction.  Ishibashi postulated -amide radical rotation rates kR/k-R to be 
slower than either intramolecular cyclization or reduction by Bu3SnH.  In this scenario, the fate 
of a given radical depends directly on the initial rotamer geometry of the starting material, which 
in turn is dependent on the identity of the halide used. 
Rotamer geometry plays a vital role in the radical cyclization of various carbamoylmethyl 
radicals.
15,30-33
  Previous studies by Curran
30,32
 showed that, at ambient temperature, the 5-exo-
trig atom-transfer cyclization of various -halo amides gave a product distribution that reflected 
the starting Z/E amide rotamer ratio.  Cyclization yields were increased by heating the reaction 
mixture, allowing the unreactive Z--amide radical intermediate to overcome the amide rotation 
barrier and isomerize to the reactive E-rotamer. 
By using laser flash photolytic methods, Newcomb was able to determine absolute rate 
constants for the rotation of simple N,N-disubstituted -amide radicals.34  For primary -amide 
radical 1.21, carbonyl−N rotation rate constants of krot = 5.1 x 10
5
 s
-1
 at 20 °C, and krot = 1.5 x 
  7 
10
7
 at 110 °C are derived from the experimentally determined Arrhenius equation.  In 
comparison, Chatgilialoglu has determined absolute rate constants
3
 for the 5-endo-trig 
cyclization of -amide radical 1.22 to 1.23 as kC = 1.9 x 10
4
 s
-1
 at 20 °C, and kC = 5.1 x 10
5
 s
-1
 at 
110 °C.  Because krot of 1.22 is 25-30 times faster than kC of 1.22 in this temperature range, the 
starting rotamer population is likely irrelevant, which makes Ishibashi’s hypothesis flawed from 
a kinetic standpoint. 
N
n-Bu
O
Ph
Ph
(E)-1.21
N
CH3
O
1.22
krot
N
n-Bu
O
Ph
Ph
(Z)-1.21
kC
N
CH3
O
1.23  
Figure 1.2  Previously Investigated -Amide Radicals 
1.1.3 Lewis Acids as Cyclization-Promoting Additives 
In further studies of the reactions of 1.15c with Bu3SnH, Ishibashi also discovered that 
when 1 equiv of Bu3SnCl was added to the reaction mixture, the ratio of cyclized products to 
directly reduced 1.19 was significantly increased, as seen in Table 1.2 (Entry 2).
16
  Addition of 5 
equiv of Bu3SnCl resulted in an 88:12 cyclization:reduction ratio, albeit with a 17% decrease in 
total mass recovery (Entry 3).  Interestingly, addition of Bu3SnI had no effect on the product 
distribution, even though it should also behave as a Lewis acid (Entry 1). 
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Table 1.2  Representative Cyclizations of 1.15c With Tributyltin Additives 
   % yield of product
b
  
entry
a 
additive equiv. 1.16 1.17 1.18 1.19 total cyc:red
c 
control
d
 -- -- 0 13 11 68 92 26:74 
1 Bu3SnI 1 0 14 12 71 97 27:73 
2 Bu3SnCl 1 11 13 14 30 68 56:44 
3 Bu3SnCl 5 18 20 28 9 75 88:12 
a
 conditions: Bu3SnH (1.2 equiv) and AIBN (0.1 equiv) in toluene (12 mM in Bu3SnH) was added via syringe 
pump to a refluxing mixture of the amide in toluene (10 mM) and additive over 3 h.  
b
 Isolated yield after aq. 
KF workup and column chromatography.  
c
 Ratio of (1.16 + 1.17 + 1.18) to 1.19.  
d 
From Table 1.1, Entry 3. 
 
Ishibashi proposed that Bu3SnCl could act as a Lewis acid in this reaction by 
coordinating to the carbonyl oxygen of 1.15c, greatly increasing the steric bulk around this center 
and forcing the amide bond to populate the E-rotamer.
16
  This would result in nearly exclusive 
production of radical intermediate (E)-1.20-Sn, which is in position to cyclize, as shown in 
Scheme 1.8.  It was also proposed that the coordinated Lewis acid could block any attempts by 
tin hydride to reduce the minor radical intermediate (Z)-1.20-Sn. 
N
CH2Ph
O
X
N
CH2Ph
O
X
KX
N
CH2Ph
O N
CH2Ph
O
Bu3Sn Bu3Sn
SnBu3Cl
SnBu3Cl
SnBu3Cl
SnBu3Cl
H SnBu3
(E)-1.15-Sn (Z)-1.15-Sn
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Figure 1.3  Postulated Role of Lewis Acids in Cyclization Behavior of 1.15c 
 
Sibi and co-workers have used tributyltin halides
35
 to fix the geometries of N-
enoyloxazolidinones through bidentate chelation of the two carbonyl groups.  Bu3SnCl 
  9 
presumably has a greater effect than Bu3SnI, because it is a stronger Lewis acid.
36
  However, it is 
curious that such a large excess of additive is needed to produce a relatively moderate increase in 
yields of the cyclized products.  Lewis acids are known to significantly weaken the carbon-
halogen bonds of -halocarbonyl compounds, making them more susceptible to homolytic 
cleavage.
37,38
  This implies that the complexed substrate (E)-1.15-Sn would be significantly more 
reactive towards halogen abstraction than uncomplexed 1.15, resulting in preferential formation 
of complexed radical intermediate (E)-1.20-Sn (vs. uncomplexed 1.20) even with 
substoichiometric Lewis acid additive. 
1.1.4 Formation of Oxidized Cyclized Products by Single Electron Transfer 
Under standard Bu3SnH-mediated reaction conditions, no formal oxidants are present in the 
reaction mixture.  However, the formation of oxidation products derived from intermediate 
cyclized -amidoyl radicals is common nonetheless.8,9,12,16,39  To justify the formation of 
oxidized cyclized products 1.17 and 1.18, Ishibashi proposed
16
 reaction of cyclized -amidoyl 
radical 1.24 with starting material 1.15 via one of two routes, as shown in Scheme 1.6.  A single 
electron transfer (SET) from 1.24 to halide 1.15 through an outer-sphere process
2,39-41
 produces 
acyliminium ion 1.25, which can deprotonate to give products 1.17 and 1.18.  The radical anion 
1.26 produced by the SET will fragment extremely quickly to give iodide ion and -amide 
radical 1.20.  Another viable pathway for oxidation of 1.24 is an inner-sphere halogen atom 
transfer,
30,42-44
 where 1.24 is converted to halide 1.27, which may then eliminate hydrogen halide 
to give the oxidized products 1.17 and 1.18. 
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Scheme 1.6  Oxidative Mechanisms for Formation of Products 1.17-1.18 
 
Bowman has previously found evidence for SET from cyclized radical intermediates to 
starting material
39
 in cyclizations of alkyl radicals onto imidazole rings, where phenylselenides 
are the radical precursors.  SET has also been implicated in reactions with easily reduced halides 
in the starting material,
40,41
 but evidence for halogen atom transfer has been observed by Savéant 
in the electrochemical reduction of various -halocarbonyl compounds.42  Both mechanisms 
shown in Scheme 1.6 produce the same result: formation of oxidized products 1.17/1.18, 
consumption of starting material 1.15 to give -amide radical 1.20, and release of hydrogen 
halide.  Without a detailed kinetic analysis, these processes are practically indistinguishable from 
one another,
41,45
 and for our purposes may be treated as similar.  For simplicity, the remainder of 
this chapter will refer to these collective processes as “SET,” though either mechanism outlined 
in Scheme 1.6 may actually be occurring. 
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The literature is filled with oxidative versions of 5-endo-trig cyclizations of enamide 
systems,
2,6,9,11,12
 most of which take advantage of the easily oxidized -amidoyl radical 
intermediates.  Miranda and co-workers recently exploited the ease of oxidation of radical 
intermediate 1.20 by developing methodology
6
 in which organic peroxides act as both chain 
initiators and single electron oxidants.  Upon addition of 2 equiv of dibenzoyl peroxide to 1.15a 
in toluene at 95 °C, the oxidized cyclized compounds 1.17 and 1.18 were isolated in 5% and 
89% yield, respectively. 
The proposed mechanism of this oxidative 5-endo-trig radical cyclization is shown in 
Scheme 1.7.  Chlorine atom abstraction from 1.15a by phenyl radical results in chlorobenzene 
and carbamoylmethyl radical 1.20, which cyclizes in a typical fashion to give tertiary -amidoyl 
radical 1.24.  A SET to dibenzoyl peroxide occurs, producing acyliminium ion 1.25.  The 
resulting peroxyl radical anion may then fragment to produce phenyl radical, carbon dioxide, and 
benzoate anion, the latter of which may assist in deprotonating 1.25.  A benzoic acid-catalyzed 
equilibrium can account for the product distribution between 1.17 and 1.18. 
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Scheme 1.7  Miranda's Oxidative 5-Endo-trig Cyclization Pathway 
  12 
Despite the apparent ease of oxidation of intermediate 1.24 to 1.25, Bu3SnH-mediated 
conditions allow few reasonable mechanisms for this process.  It has been proposed that AIBN
46
 
and various other azoalkanes
47
 can act as oxidants by H-atom abstraction of a radical 
intermediate, a process that has been observed in reactions such as heterolytic aromatic 
substitution.
48
  However, this requires a stoichiometric amount of AIBN.  Because only catalytic 
amounts are used in Ishibashi’s reaction conditions,16 oxidation by AIBN cannot totally account 
for the formation of products 1.17 and 1.18. 
With this backdrop, we set out to investigate the halogen-dependent cyclization ability of 
-haloenamides 1.15a-c, specifically examining the roles of SET processes and amide rotamer 
behavior on the product distribution. 
1.2 RESULTS AND DISCUSSION 
1.2.1 Conformational Analysis of N-Benzyl -Haloenamides 
Ishibashi originally postulated that halides 1.15a and 1.15c had different rotamer ratios, but 
provided no experimental evidence to support this conclusion.  Hence, we first turned our 
attention toward determining the syn/anti amide geometry of these substrates by dynamic 
1
H 
NMR spectroscopic analysis.  Previous studies
49
 in this area have determined the barrier to 
amide rotation for -chloroacetamide 1.28a (Figure 1.4) in chlorobenzene to be G
‡
298 = 16.4 
kcal/mol, while the -bromo congener 1.28b has a slightly lower G
‡
298 = 15.8 kcal/mol in 
chlorobenzene.  These are within the range of typical amide rotation barriers
22
 (15-17 kcal/mol), 
and the nonequivalent N-methyl groups in 1.28a-b are well-defined in the 
1
H NMR spectra.  
  13 
Because 1.15a-c contain an N-cyclohexenyl group, -chloroacetanilide 1.29 is likely a better 
comparison due to the sp
2
 carbon bonded to the amidic nitrogen.  Unfortunately, the barrier to 
amide rotation of 1.28 cannot be determined, because the population of the minor rotamer is too 
small to measure by 
1
H NMR spectroscopy.
50
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Figure 1.4  Previously Studied -Haloamides 
 
To begin our conformational analysis, 1.15c was dissolved in CDCl3 with a small amount 
of tetramethylsilane to be used as a line width standard.  
1
H NMR spectra were recorded at 
various temperatures in the range of 297 K – 215 K, and portions of these spectra are shown in 
Figure 1.5. 
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Figure 1.5  300 MHz 
1
H NMR Spectra of 1.15c in CDCl3 (297 K – 215 K) 
 
The NMR spectrum of 1.15c at 297 K shows one singlet apiece for the benzyl and  
protons, suggesting either the presence of one major rotamer,
50
 or the existence of an abnormally 
low barrier to rotation about the C–N bond resulting in a coalescence of the rotamer signals.51  
As the sample was cooled, decoalescence of the  protons and benzyl protons occurred.  At 215 
K, the benzyl protons give rise to mutually coupled doublets (J = 14.6 Hz) at 5.04 and 4.22 ppm; 
the  signal shows similar behavior, producing geminally coupled doublets (J = 9.3 Hz) at 3.99 
and 3.79 ppm. 
N P h 
O 
I 
1 . 1 5 c v i n y l 
b e n z y l 
 
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The spectroscopic behavior observed in Figure 1.5 is not consistent with locking out Z/E 
amide rotamers.
52
  This process would result in a doubling of all signals near the C-N amide 
bond, which was not observed at any temperature.  Furthermore, the Z/E rotamers would be 
expected to have homotopic methylene groups at the - and benzyl positions.  These results 
suggested that 1.15c exists as a single amide rotamer in solution, and another rotational process 
causes both sets of protons to become diastereotopic.
53,54
  The variable-temperature 
1
H NMR 
spectra of chloride 1.15a are not shown, but displayed temperature-dependent decoalescences 
and couplings similar to 1.15c.  At 212 K, the benzyl signal decoalesced into two doublets (J = 
13.6 Hz) at 5.08 and 4.18 ppm.  The  protons were partially obscured by one of the benzyl 
signals, but line-shape analysis with WINDNMR software
55
 revealed two doublets (J = 12.4 Hz) 
at 4.30 and 4.18 ppm. 
The low temperature NMR data strongly suggests that cooling the substrate slows the N-
cyclohexenyl bond rotation, as shown in Figure 1.6.  Slowing this rotation allows the element of 
asymmetry within the molecule to become visible on the NMR timescale.  In this sense, 
compounds 1.15a-c behave similarly to axially chiral anilides,
56
 in which an asymmetrically 
substituted N-aryl group serves as a source of chirality.  Mannschreck and coworkers were the 
first to recognize the axial chirality of enamides,
57
 and used the coalescence temperature of 
diastereotopic protons in NMR spectra to determine the N-vinyl barrier to rotation for several 
enamides.
58
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Figure 1.6  Rotational Dynamics of 1.15a-c 
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Using the WINDNMR 7.1 line-shape analysis program
55
 to analyze the benzyl peaks of 
1.15a,c,
59
 we determined the rotational rate constant krot at each temperature T.  The G
‡
 at any 
temperature can be calculated from the experimentally determined rate using the Arrhenius 
equation (Equation 1.1), where h is Planck’s constant and kB is Boltzmann’s constant.
60
  The data 
was graphed in an Eyring plot (Figure 1.8) for further kinetic analysis.  The plots for chloride 
1.15a and iodide 1.15c nearly coincide, suggesting that their dynamics are similar. 

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Figure 1.7  Eyring Plot of Chloride 1.15a (♦) and Iodide 1.15c (○) 
 
Using equation 1.2
60
 and the slope and intercept from the Eyring plot, we calculated 
thermodynamic values for the bond rotations.  Chloride 1.15a exhibited a H
‡
 of 8.9 kcal/mol 
for the N-cyclohexenyl rotation, and a significant S
‡
 of −10.6 cal/(mol K).  The iodide 1.15c 
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gave similar results, with H
‡
 = 9.3 kcal/mol and S
‡
 = −9.0 cal/(mol K).  The Gibbs energies of 
activation for the rotations at room temperature were calculated, and were found to be G
‡
298 = 
12.1 kcal/mol for chloride 1.15a and G
‡
298 = 11.9 kcal/mol for iodide 1.15c. 
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  (Equation 1.2) 
The measured G
‡
298 values are much too small to represent amide bond rotation, but are 
reasonable for the N-cyclohexenyl bond rotation, a theory that was supported by the crystal 
structure of 1.15a.  X-ray quality crystals were grown by a vapor diffusion technique
61
 in an 
ethyl acetate/hexanes solvent system, and an enantiopure single crystal of (P)-1.15a was 
deposited. The crystal structure in Figure 1.8 shows that the N-cyclohexenyl bond prefers to exist 
orthogonal to the plane of the N-C amide bond, with a torsional angle of 74°.  Furthermore, the 
amide bond nitrogen clearly exhibits typical sp
2
 character, with practically no pyramidalization: 
the sum of the bond angles to nitrogen is 359.9
o
.  As expected, the amide exists as the (E)-1.15 
rotamer, extending the structural similarities between -haloenamides and -haloacetamides. 
  
Figure 1.8  ORTEP Crystal Structure of 1.15a 
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We then extended our rotational studies to several other -haloenamides, in collaboration 
with Dr. Andrew Clark at the University of Warwick.  -Bromo-,-dimethylenamides 1.30-
1.33 (Figure 1.9) were synthesized in the laboratories of Dr. Clark.  Samples of these compounds 
were dissolved in toluene-d8 and analyzed with variable temperature 
1
H NMR.  In each case, 
coalescence and decoalescence of the benzyl proton signals was the focal point of analysis.  At 
room temperature, 1.30a and 1.31 displayed sharp singlets for the benzylic protons.  Enamide 
1.32 showed geminally coupled doublets for the benzylic protons in its room temperature 
spectrum.  All other compounds displayed a very broad benzylic signal at room temperature, in 
some cases completely disappearing into the baseline. 
N O
Br
n
Ph
1.30a-e
N O
Br
Ph
1.31
N O
Br
Ph
1.32
N O
Br
Ph
1.33
1.30a
1.30b
1.30c
1.30d
1.30e
n = 1
n = 2
n = 3
n = 4
n = 8
 
Figure 1.9  -Haloenamides Used in Rotational Studies 
 
Line-shape analysis was again performed with NUTS
62
 and WINDNMR
55
 programs.  
The rate of rotation at each temperature was calculated, and Eyring plots for each substrate 
afforded thermodynamic data (Table 1.3).  Varying the size of the cycloalkenyl ring in the 6-12 
carbon range did little to change the barriers to rotation among 1.30b-e, with a narrow range of 
G
‡
298 = 12.4–13.3 kcal/mol (Entries 4-7).  However, a sharp decrease in rotational barrier was 
seen with cyclopentenyl substrate 1.30a, with G
‡
298 = 9.95 kcal/mol (Entry 3).  Enamide 1.31, a 
derivative of 2-tetralone, had a barrier of G
‡
298 = 11.7 kcal/mol.  In sharp contrast, 1-tetralone 
derivative 1.32 had a much higher barrier to rotation of G
‡
298 = 18.0 kcal/mol, which can be 
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attributed to the additional substitution on the enamide double bond (Entry 9).  Upon cooling, 
1.33 decoalesced to a 2:1 mixture of diastereomers with two separate barriers to rotation (Entry 
10); compared to 1.30b, the barrier increase induced by the -methyl group was about 1 
kcal/mol. 
 
Table 1.3  Barriers to Rotation of -Haloenamides in Toluene-d8 
entry
 
substrate temp. range  
k298 
(s
-1
) 
H
‡
 
(kcal/mol) 
S
‡
 
(cal/mol K) 
G
‡
298 
(kcal/mol) 
1
a 
1.15a
 297 – 215 K  8.49 x 103 8.9 −10.6 12.1 
2
a 
1.15c 270 – 216 K  1.12 x 10
4
 9.2 −9.0 11.9 
3 1.30a 290 – 186 K  3.11 x 10
5 
8.0 −6.6 9.95 
4 1.30b 311 – 233 K  1.06 x 10
3
 11.3 −6.6 13.3 
5 1.30c 350 – 250 K  7.35 x 10
2
 11.8 −5.7 13.5 
6 1.30d 341 – 230 K  3.09 x 10
3
 11.4 −4.3 12.7 
7 1.30e 341 – 230 K  4.88 x 10
3
 11.4 −3.5 12.4 
8 1.31 311 – 220 K  1.59 x 10
4
 9.7 −6.7 11.7 
9 1.32 379 – 341 K  4.08 x 10
-1
 11.9 −20.4 18.0 
10
b 
1.33 350 – 271 K { 
1.83 x 10
2 
12.7 −5.4 14.4 
3.64 x 10
2 
12.7 −4.0 14.0 
a
 CDCl3 was used as the solvent.  
b
 Forward and reverse rates for diastereomer interconversion were determined. 
 
None of the -haloenamides in this study had barriers to rotation high enough to allow 
for resolution of enantiomers at room temperature.  Substitution on the carbons  to the carbonyl 
or  to the nitrogen did little to increase the barrier.  In the case of 1.32, however, substitution at 
the vinylic carbon brought the barrier close to a useful range for resolution.  Further studies on 
developing resolvable -haloenamides should, therefore, focus on substitution at the vinylic and 
allylic
58
 position of the olefin to increase the barrier. 
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1.2.2 Rate Constant Determinations of 5-Endo-trig Cyclizations  
Having eliminated amide rotamer behavior as the source of the halogen-dependent 
cyclization results, we next turned our attention to studying the radical cyclization kinetics of 
1.15a-c.  A series of competition experiments were performed, measuring the ratio of direct 
reduction product 1.19 to the sum of cyclization products 1.16-1.18 as a function of Bu3SnH 
concentration.
63
  Because the Bu3SnH trapping agent is added at the start (as opposed to by 
syringe pump), its initial concentration is known, and the relative cyclization rate can be 
determined.  For an accurate determination of the product distribution, GC analysis was used for 
these reactions. 
Substrates 1.15a-c and authentic products 1.16-1.19 were synthesized as shown in 
Scheme 1.8.  Literature procedures
16
 were followed to make 1.15a-c in 23-97% yields.  Catalytic 
hydrogenation of 2-oxindole to produce octahydroindolone 1.34, followed by N-benzylation, 
afforded an authentic sample of cyclized product 1.16 in 45% overall yield.  Condensation of 
cyclohexanone and benzylamine, followed by N-acetylation, produced reduction product 1.19 in 
66% yield.   Basic hydrolysis of ester 1.35 and coupling of the resulting acid with benzylamine 
produced amide 1.36 in 80% yield over two steps.  Acid-catalyzed intramolecular condensation 
of 1.36 afforded products 1.17 and 1.18.  While compound 1.18 was isolable as a stable 
compound by flash chromatography, 1.17 was extremely sensitive to isomerization.  Even 
though it exhibited two spots on TLC, it was always recovered as a 2.3:1 mixture of the 7,7a and 
7a,3a isomers after flash chromatography.  A 2D TLC experiment showed that this isomerization 
occurs on silica gel on the timescale of flash chromatography (< 15 min). 
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Scheme 1.8  Synthesis of Substrates 1.15a-c and Authentic Products 1.16-1.19 
 
Competition experiments were conducted by heating an -halo enamide 1.15a-c (0.025 
mmol), Bu3SnH (1.2 equiv), and AIBN (0.2 equiv) in toluene at 110 °C in a sealed tube for 3 h.  
Reaction mixtures contained octadecane as an internal standard, and were analyzed by GC; the 
results are summarized in Table 2.1.  Response factors of 1.15-1.19 versus octadecane were 
determined so that absolute GC yields could be calculated for each reaction.  Oxidized products 
1.17-1.18 gave a single peak in the GC method used, and authentic 1.18 was used to calculate the 
response factor for this peak.  All reactions were clean; product peaks were well-defined and no 
significant side product peaks formed, even when mass balances were low. 
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The kinetic competition reactions of 1.15a-c gave standard, highly reproducible results 
(Table 1.4).  As the Bu3SnH concentration was increased, the ratio of reduced 1.19 to cyclized 
1.16-1.18 increased accordingly for all substrates.  The mass balances were moderate to high 
(60-87%), and generally increased as the Bu3SnH concentration was increased.  Even at lower 
Bu3SnH concentrations, only small amounts of unreacted starting material were present in the 
case of the chloride 1.15a and bromide 1.15b.  Interestingly, the ratio of cyclized 1.16 to 
oxidized products 1.17/1.18 showed a halogen dependence, in qualitative agreement with 
Ishibashi’s results.8,16  Regardless of the tin hydride concentration, chloride 1.15a yielded an 
average of 15:1 cyclized:oxidized in the product distribution.  Cyclization of 1.15b gave a ratio 
of about 8:1, and the iodide 1.15c equalized the ratio to 1:1. 
 
Table 1.4 Kinetic Competition Reactions for Substrates 1.15a-c 
  % yield of product
b 
 
substrate [Bu3SnH]i
c 
1.16 1.17+1.18 1.19 total
d
 cyc : red
e 
1.15a 10.0 mM 33 2 15 60 (71) 70 : 30 
 15.0 mM 32 3 22 57 (74) 61 : 39 
 17.8 mM 36 3 29 68 (82) 57 : 43 
 30.0 mM 29 2 39 70 (81) 44 : 66 
 42.9 mM 28 2 56 86 35 : 65 
1.15b 7.5 mM 34 5 18 57 (61) 68 : 32 
 10.0 mM 29 5 22 56 (61) 61 : 39 
 15.0 mM 39 4 38 81 53 : 47 
 17.8 mM 35 4 41 80 49 : 51 
 30.0 mM 27 3 52 82 36 : 64 
 42.9 mM 20 2 55 77 29 : 71 
1.15c 7.5 mM 16 18 31 65 52 : 48 
 10.0 mM 13 14 33 60 45 : 55 
 15.0 mM 12 14 46 72 36 : 64 
 17.8 mM 11 14 55 80 31 : 69 
 30.0 mM 9 10 68 87 22 : 78 
a
 conditions: The appropriate substrate (1.0 equiv), Bu3SnH (1.2 equiv), and AIBN (0.2 equiv) in toluene were 
combined in a sealed tube and heated at 110 °C for 3 h.  
b
 GC yield, using octadecane as an internal standard.  Yields 
are an average of three trials.  
c
 Initial concentration of Bu3SnH.  
d 
Yield in parentheses is based on recovered 
starting material.  
e 
Ratio of (1.16 + 1.17 + 1.18) to 1.19. 
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Relative rates of cyclization for each system were established by a plot of the ratio of 
reduction product 1.19 to combined cyclization products 1.15-1.17, versus the concentration of 
Bu3SnH.  In this plot, the slope is equal to the ratio kH/kc, representing the rate constants of 
competing reduction and unimolecular cyclization shown in Scheme 1.9.  Because the conditions 
were not pseudo-first order in trapping agent, the mean concentration of tributyltin hydride 
[Bu3SnH]c (equation 1.3) was used for the k calculations, as recommended by Newcomb.
63
  The 
kinetic plot is depicted in Figure 1.10. 
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Scheme 1.9  Competing Pathways of -Amidoyl Radical 1.20 
 
 
      
2
33
3
iii
c
RXSnHBuSnHBu
SnHBu

   (Equation 1.3) 
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Figure 1.10  Kinetic Competition Plot of 1.15a (○), 1.15b (▲) and 1.15c (♦) 
 
In principle, the three precursors should give the same radical intermediate 1.20, and the 
plots in Figure 1.11 should overlap.  In actuality, there is a four-fold difference between the 
slopes of the competition plots for chloride 1.15a and iodide 1.15c.  This implies a different rate 
constant of cyclization kc for the common intermediate 1.20, depending on the substrate used. 
Using the relative rate data, absolute rate constants for these cyclizations were 
determined. Absolute rate data for the direct Bu3SnH reduction of carbon-centered alkyl radicals 
is abundant, and Newcomb has shown that -amide radicals are reduced by Bu3SnH at a rate 
comparable to their alkyl counterparts.
64
  With the appropriate Arrhenius equations determined 
by Chatgilialoglu for primary carbon-centered radicals,
65,66
 the kH for -carbamoylmethyl radical 
1.20 can be reasonably approximated as kH = 9.3 x 10
6
 M
-1
s
-1
 at 383 K.  Based on the relative 
rates garnered from Figure 2.9, we can calculate the 5-endo-trig cyclization rate constant of 1.20 
produced by 1.15a to be kc = 1.3 x 10
5
 s
-1
, a value in reasonable agreement with Chatgilialoglu’s 
experimentally determined rate constant of 5.1 x 10
5
 s
-1
 at 383 K for the N-methyl radical 1.22 
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(Chapter 1.1.2).
3
  Our competition results also yielded cyclization rate constants of kc = 9.3 x 10
4
 
s
-1
 for 1.15b and kc = 4.0 x 10
4
 s
-1
 for 1.15c. 
The relatively small difference between kc values, all within a factor of ~5, was 
unexpected given Ishibashi’s previous results.  Because Ishibashi’s optimized conditions for the 
5-endo-trig cyclization utilize a syringe pump, the Bu3SnH concentration is always kept very low 
(<< 1 mM).   At low Bu3SnH concentrations, the competition plots in Figure 1.11 converge, 
theoretically yielding similar reduction/cyclization ratios.  Ishibashi’s preparative results (Table 
1.1), therefore, cannot be explained by our kinetic findings.  Although the kinetic plot slopes for 
1.15a-c are different, there is a common y-intercept value of zero for the competition plots of all 
three substrates.  This rules out reversibility of the cyclization; in this case, the intercept would 
be positive.
63
  Furthermore, the halogen-dependent cyclized:oxidized ratios suggest a 
mechanistic divergence after cyclization in these reactions. 
1.2.3 Effects of Bu3SnX Additives 
We then briefly investigated the effect of the variable tributylstannyl halide byproduct on the 
reaction mixture, which in some cases had been posited to act as a Lewis acid.  A room 
temperature 
1
H NMR spectrum of a 1:1 mixture of Bu3SnCl and 1.15c in CDCl3 produced no 
discernible change in chemical shifts of the substrate.  We took this as evidence that little or no 
coordination was occurring, and Bu3SnCl was not acting as a Lewis acid activator towards 1.15c.  
Nevertheless, we ran several trials to determine if Bu3SnX compounds could play a role in 
increasing the cyclization yield of 1.15c.  The results of some of these trials, which were run 
under the same conditions as the competition reactions (Table 1.4) at 10.0 mM Bu3SnH, are 
outlined in Table 1.5. 
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Table 1.5  Reaction of 1.15c in the Presence of Bu3SnX Additives 
    % yield of products
b
  
entry
a
  additive equiv 1.16 1.17+1.18 1.19 total cyc:red
d 
control
c
  -- -- 13 14 33 60 45 : 55 
1  Bu3SnCl 1.0 10 9 33 52 36 : 64 
2  Bu3SnCl 3.0 3 8 25 36 31 : 69 
3  Bu3SnCl 5.0 9 9 33 51 35 : 65 
4  Bu3SnI 1.0 13 12 34 59 42 : 58 
5  Bu3SnI 2.0 14 9 32 55 42 : 58 
6  Bu3SnI 3.0 13 8 31 52 41 : 59 
a
 conditions: Iodide 1.15c (1.0 equiv), Bu3SnH (1.2 equiv), additive, and AIBN (0.2 equiv) in toluene were 
combined in a sealed tube and heated at 110 °C for 3 h.  
b
 GC yield, using octadecane as an internal standard.  Yields 
are an average of three trials.  
c
 From Table 1.4.  
d
 Ratio of (1.16 + 1.17 + 1.18) to 1.19. 
 
In these trials, no increase in the cyclized:reduced product ratio was seen, regardless of 
the identity or quality of tin halide used.  In fact, a slight decrease in mass balance and 
cyclization ability was noticed when 3 equiv of tributyltin chloride was employed (Entry 2); the 
reason for this is not currently known.  Multiple other trials were run at varying Bu3SnH 
concentrations with different amounts of Bu3SnX (1-5 equiv), but no significant deviations from 
the control experiment (Entry 1) or noticeable trends were observed under any conditions. 
Our results show that Bu3SnX additives do not noticeably assist in cyclization by acting 
as Lewis acids.  However, halogen exchange between trialkyltin halides and alkyl halides is 
known to occur,
67
 resulting in an equilibrium based on the strengths of the carbon-halogen and 
tin-halogen bonds.  This process is greatly accelerated by catalytic amounts of halide anions in 
solution.
67
  Therefore, Bu3SnCl may have been altering the behavior of iodide 1.15c in 
Ishibashi’s syringe pump experiments by a halogen exchange reaction. 
This hypothesis was supported with a control experiment by refluxing 1 equiv of 1.15c 
with 5 equiv of Bu3SnCl in toluene.  After 3 h, a small amount (< 5% by GC) of conversion to 
the chloride 1.15a was seen.  Addition of 5 mol% tetrabutylammonium iodide, however, caused 
the reaction to reach equilibrium (Figure 1.11) within 1 h (further refluxing did not change the 
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GC ratios of 1.15a/1.15c).  A 
1
H NMR spectrum of the final equilibrium mixture in CDCl3 
showed a mixture of 1.15c:1.15a in a 1.4:1.0 ratio (by integration of  proton peaks). 
N
CH2Ph
O
I
Bu3SnCl+
1.15c
N
CH2Ph
O
Cl
Bu3SnI+
1.15a  
Figure 1.11  Halogen Exchange Equilibrium for 1.15 and Tributyltin Halides 
 
The equilibrium constant in Figure 1.11 favors the iodide 1.15c and Bu3SnCl, in keeping 
with other experimentally determined equilibria of this nature.
67
  However, addition of a large 
excess of Bu3SnCl can shift the equilibrium to produce a significant amount of chloride 1.15a.  
Ishibashi observed that addition of Bu3SnCl to iodide 1.15c provided cyclization results similar 
to chloride 1.15a.  We suggest that this is not because Bu3SnCl functions as a Lewis acid, but 
because it partially converts iodide 1.15c to chloride 1.15a under the conditions of the 
experiment, producing “chloride-like” results. 
1.2.4 Preliminary Evidence for SET 
A possible alternate mechanism in the radical reactions of 1.15a-c, hypothesized by 
Ishibashi
16
 but not investigated, involves an SET-type reaction between cyclized intermediate 
1.23 and starting material 1.15 as previously outlined in Scheme 1.6.  This secondary chain 
process can proceed in the absence of tin hydride, but it is not immediately clear how this would 
affect the reduction vs. cyclization product distribution.  
It has previously been established that radical intermediates  to a heteroatom such as 
nitrogen or oxygen
68
 are powerful reducing agents.  This is commonly attributed to a three-
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electron interaction, where the third electron lies in a higher-energy antibonding 
orbital and can thus be easily removed.
69,70
  Yoshida has reported
71
 an 
electrochemical single electron reduction potential of −0.85 V (vs. 
Ag/AgCl(CH3CN)) for acyliminium ion 1.37.  Furthermore, tertiary alkyl radicals tend to have 
an oxidation potential 0.10-0.20 V lower than their secondary counterparts.  These data give a 
good approximation of E1/2
ox = −1.0 V for radical intermediate 1.24, which is comparable to the 
substantial oxidation potential of -aminyl radicals.69 
The reduction potential of -halo carbonyl compounds is known to be much lower than 
most other alkyl halides, such as E1/2
red =  −0.34 V for bromoacetone (vs. SCE, H2O pH 4.6) vs. 
E1/2
red 
= −2.23 V for a typical alkyl bromide (vs. SCE, 75% dioxane/water).72  A better 
comparison to 1.15 is ethyl bromoacetate, which has E1/2
red
 = −0.88 V (vs. SCE) in anhydrous 
DMF.
73
 
The efficiency of SET to the starting material is expected to be highly halogen-dependent 
as well.  Literature trends indicate that alkyl chlorides tend to have a reduction potential 
approximately 0.75-0.85 V higher than bromides, while the easily reduced iodides have a typical 
0.35-0.45 V decrease in reduction potential.
72,74-76
  We can thus estimate a redox potential of 
−0.1 V (−2.3 kcal/mol) for the SET from 1.24 to 1.15b, while SET to the iodide 1.15c occurs at a 
more favorable potential of approximately −0.5 V (−11.5 kcal/mol).  While these values cannot 
be quantitatively applied to our system due to estimations and solvent effects, they do show that 
SET from 1.23 to the starting halide 1.15 is a thermodynamically viable pathway.  Furthermore, 
these values are equally applicable whether the oxidation/reduction is occurring via a stepwise 
(SET) mechanism, or concerted (halogen atom transfer) pathway.
77
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Our preliminary test for this mechanistic pathway was to favor the possible SET by 
adding excess 1.15c substrate.  As the concentration of iodide precursor 1.15c is increased 
relative to that of Bu3SnH, the reaction rate of cyclized radical intermediate 1.24 with starting 
material 1.15c would increase relative to reduction by Bu3SnH.  In these reactions, 1-2 equiv of 
starting material were reacted with 1 equiv of Bu3SnH (0.01 M) under our typical sealed-tube 
conditions, as in Table 1.6. 
We observed an increasing ratio of oxidized cyclized products 1.17/1.18 to cyclized 
product 1.16 (1.1:1, 2.5:1, 4.0:1), as the amount of 1.15c was increased from 1.0 to 1.5 to 2.0 
equiv.  Furthermore, substoichiometric amounts of Bu3SnH were needed to consume 1.15c in 
entries 2-3 of Table 1.6, implying that an SET pathway could be occurring.  As shown 
previously in Scheme 1.6, the SET process regenerates -carbamoylmethylradical 1.20 from 
1.15c.  This allows the iodide precursor to be consumed in a “SET chain” mechanism, where 
Bu3SnH is only involved in the intiation and termination steps.  Control experiments showed that 
1.15c is stable under the reaction conditions, as well as in the presence of AIBN and/or Bu3SnI, 
so simple thermal decomposition of the substrate itself can be effectively ruled out.  Although 
the mass balances of these reactions were low (41-47%), no additional peaks appeared on the 
GC. 
Table 1.6  Promotion of SET by Adding Excess 1.15c 
  % yield of product
b 
   
entry
a
 
equiv 
1.15c 
1.16 1.17+1.18 1.19 total 
recovered 
1.15c (equiv) 
cyc:red
c 
ox:cyc
d 
1 1.0 12 13 21 46 0.00 54 : 46 1.1 : 1 
2 1.5 6 15 26 47 0.15 45 : 55 2.5 : 1 
3 2.0 4 16 28 48 0.46 29 : 71 4.0 : 1 
a
 conditions: Iodide 1.15c, Bu3SnH (1.0 equiv), and AIBN (0.2 equiv) in toluene were combined in a sealed tube and 
heated at 110
o
C for 3h.  
b
 GC yield, using octadecane as an internal standard.  Yields are an average of three trials.  
Bu3SnH was the limiting reagent  
c
 Ratio of (1.16 + 1.17 + 1.18) to 1.19.  
d
 Ratio of (1.17 + 1.18) to 1.16. 
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1.2.5 Attempt to Trap Post-SET Acyliminium Intermediate 
Our next mechanistic probe for SET involved an intramolecular trap to intercept the posited 
acyliminium ion generated during the process.  We envisioned tethering an electron-rich 
aromatic ring near the reactive site as in enamide 1.38 (Scheme 1.10).  A 5-endo-trig cyclization 
of this substrate to give radical 1.39, followed by SET, would produce acyliminium ion 1.40, 
which could act as an electrophile in a Friedel-Crafts alkylation, producing alkaloid 1.41. The 
cyclization of acyliminium ions such as 1.40 is well-known
78
 and is a commonly used route to 
the Erythrina alkaloids.
6,11
  -Amidoyl radical 1.39 would not be expected to cyclize onto the 
aromatic ring,
11
 allowing a differentiation between possible trapped intermediates. 
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Scheme 1.10  Proposed Trapping of the Post-SET Acyliminium Intermediate 
 
Substrates 1.38a-c were synthesized according to Scheme 1.11.  Condensation of 3-
methoxyphenethylamine with cyclohexanone, followed by N-acylation with chloroacetyl 
chloride, afforded -chloroenamide 1.38a in 80% yield.  Xanthate 1.38b was synthesized from 
1.38a and potassium O-ethylxanthate in 96% yield, while treatment with NaI under Finkelstein 
conditions produced the -iodide 1.38c.  An authentic sample of the expected Friedel-Crafts 
product 1.41 was made by condensation of 3-methoxyphenethylamine with ester 1.35, followed 
by treatment with concentrated hydroiodic acid, in 73% yield over two steps.
10
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Scheme 1.11  Synthesis of Iminium “Trap” Substrates and Authentic Trapped Product 
 
Initial testing on the Bu3SnH-mediated cyclization yielded results similar to Ishibashi’s 
results with the N-benzyl congeners.
16
  A toluene solution of Bu3SnH (1.2 equiv) and catalytic 
AIBN (0.1 equiv) was added over 2 h via syringe pump to a refluxing solution of precursors 
1.38a-c in toluene (2.0 mM).  The mixtures were subjected to an aqueous KF workup
16
 followed 
by flash chromatography to isolate the products shown in Scheme 1.12.  Chloride 1.38a required 
2.4 equiv of Bu3SnH to fully react, but afforded cyclization product 1.42 in 75% yield, along 
with 10% of reduced product 1.45.  Xanthate 1.38b reacted similarly, producing 1.42 in 62% 
yield and 1.45 in 13% yield.  In contrast, iodide 1.38c gave a mixture of oxidized cyclized 
products 1.43 and 1.44 (9% and 43% yields, respectively), as well as ~12% of 1.45 
(contaminated with tin byproducts).  No evidence of the expected Friedel-Crafts product
10
 1.41 
was seen in any reaction mixture. 
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Scheme 1.12  Bu3SnH-Mediated Cyclization of 1.38a-c 
 
The absence of alkaloid 1.41 suggested either that acyliminium ion 1.40 was not being 
formed under our conditions, or that it was forming and its deprotonation was faster than the 
cyclization.  Therefore, we tested the feasibility of cyclization onto the hypothesized 
acyliminium ion under various reaction conditions (Scheme 1.13).  Xanthate 1.38b was cyclized 
under oxidative radical conditions with dilauroyl peroxide,
6
 followed by addition of catalytic p-
toluenesulfonic acid in benzene.  Surprisingly, compound 1.44 was the only compound isolated 
after column chromatography, in 67% yield.  A literature search established that cyclizations 
onto an acyliminium ion which do not occur in nonpolar aprotic solvents proceed cleanly in 
more polar aprotic solvents.
79
  Therefore, we resubmitted 1.44 to acidic conditions in 1,2-
dichloroethane (DCE) to regenerate the acyliminium ion, shown in Scheme.  This produced an 
inseparable mixture of alkaloid 1.41 in 81% yield along with 12% recovered starting material.  
Drawing on these results, iodide 1.38c was subjected once again to Bu3SnH-mediated radical 
cyclization, this time in DCE.  No evidence of 1.41 was seen by NMR analysis of the crude 
reaction mixture, and only 1.44 (45%) and 1.45 (15%) were isolated by column chromatography. 
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Scheme 1.13  Further Attempts to Trap Acyliminium Ion 1.40 
 
At this point, the inability of the aromatic substituents to trap the postulated acyliminium 
ion was recognized, and this mechanistic probe was abandoned.  While these experiments were 
unable to confirm the existence of acyliminium 1.40, the results strongly suggest that if 1.40 does 
exist as an intermediate, the rate of its deprotonation is very fast.  However, the complete 
isomerization from 1.43 to the thermodynamically favored 1.44 in some of our trials implies that 
residual acid was present in the reaction mixture.  In these cases, a trapped iminium may not 
have come directly from the SET, but rather from reprotonation of 1.43/1.44.  The possibility of 
acid within the reaction is important, and will be discussed further in Chapter 1.2.7. 
1.2.6 Attempts to Discourage SET by Substrate Control 
We then turned our attention towards trapping an intermediate -amidoyl radical in a 
tandem intramolecular cyclization before it could be oxidized.  Ishibashi has previously shown 
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that chloride 1.46a cyclizes under Bu3SnH-mediated conditions in a predominant 5-endo-trig 
manner
26
 as shown in Scheme 1.14, giving minor amounts of the 6-exo-trig product 1.49 (8%).  
Moreover, the intermediate 1.47 from initial cyclization react further via 5-exo-trig to give 1.51 
(32% yield), or 6-endo-trig to produce 1.52 (27% yield).  Small amounts of products from 
premature reduction are also formed: 1.48 in 6% yield, and 1.50 in 7% yield. 
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Scheme 1.14  Routes for Tandem Cyclization After a 5-Endo-trig Step 
 
We hypothesized that the -iodo congener 1.46b would produce similar results as the 
chloride 1.46a, cyclizing in a tandem fashion before SET could occur.  Chloride 1.46a was 
synthesized as shown in Scheme 1.15;
26
 allyl cyanide was reduced to the corresponding amine, 
condensed with cyclohexanone, and acylated with chloroacetyl chloride in a three-step sequence 
(15% overall yield).  Iodide 1.46b was then made in 83% yield by treatment of 1.46a with NaI in 
acetone.  With both substrates in hand, radical cyclizations were performed under several 
conditions.  Either Bu3SnH or tris(trimethylsilyl)silane (TTMSS) with catalytic AIBN (0.1 
equiv) in toluene was added via syringe pump to 1.46 in a refluxing toluene solution.  After 
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removing the solvent, the crude mixture was directly chromatographed using 10% w/w KF/silica 
gel as the stationary phase to remove the tributyltin residues.
80
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Scheme 1.15  Synthesis of Tandem Cyclization Substrates 
 
The Bu3SnH-mediated cyclization of 1.46a went in general accordance with literature 
results, giving good yields of tandem cyclization products 1.51 (14%) and 1.52 (51%), along 
with minor amounts of premature reduction product 1.48 and initial 6-exo-trig cyclization onto 
the terminal olefin to give 1.49 (Table 1.7, Entry 1).  However, the -iodo congener 1.46b, under 
the same conditions, produced only reduction product 1.48 in excellent yield (83%), with trace 
amounts of cyclization product visible in the crude NMR spectrum (Entry 2).  Lengthening the 
addition time of Bu3SnH to 1.46b had little effect on the product distribution (Entry 3), so 
TTMSS was considered as an alternative hydride source.  TTMSS delivers hydrogen at a rate 
about one order of magnitude slower than tin hydride,
17,65
 which in some cases may allow slower 
cyclizations to proceed more efficiently.  Reaction of TTMSS with chloride 1.46a resulted in 
recovered starting material, which was attributed to the inability of TTMSS to begin an efficient 
chain with the chloride (Entry 4).  Reaction with iodide 1.46b, however, immediately resulted in 
a persistent, dark red-colored reaction mixture that was highly acidic (pH approx. 1-3) to pH 
paper.  The reaction mixture was exceedingly difficult to purify directly, and even after basic 
workup, column chromatography produced only 1.48, contaminated with silicon-containing 
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byproducts, in less than 26% yield (Entry 5).  Octahydroindolone 1.50 was not isolated in any of 
the reactions. 
 
Table 1.7  Cyclization Reactions of 1.46a-b 
N O
X
N O N
O
N
O
N
O
1.46 1.48
Hydride source
cat. AIBN
PhMe, 
syringe pump
1.49 1.51 1.52  
    % yield of product
b
 
entry
a
 substrate hydride addn time 1.48 1.49 1.51 1.52 
control
26
 1.46a Bu3SnH 1 h 6 8 32 27 
1 1.46a Bu3SnH 3 h 9 < 5 14 51 
2 1.46b Bu3SnH 3 h 83 trace trace trace 
3 1.46b Bu3SnH 6 h 75 trace trace trace 
4 1.46a TTMSS 2 h Recovered 1.46a 
5 1.46b TTMSS 3 h < 26 0 0 0 
a
 conditions: hydride (1.2 equiv) and AIBN (0.1 equiv) in toluene (24 mM in hydride) was added via syringe pump 
to a refluxing mixture of the amide in toluene (20 mM).  
b
 Isolated yield after 10% KF/silica gel column 
chromatography. 
 
Iodide 1.46b was unable to achieve the desired tandem cyclization, but its inability to 
form isolable amounts of any cyclized product is very interesting.  An analogous reaction of the 
trichloroacetamide 1.53 has also failed to complete the tandem cyclization shown in Scheme 
1.16.
2
  Zard and coworkers observed that, after 5-endo-trig cyclization under Ni/AcOH 
conditions, intermediate 1.54 was oxidized by the easily-reduced starting material to eventually 
produce 1.55 in 51% yield.  This astonishing result suggests that SET from the -amidoyl radical 
1.54 is faster than the possible cyclizations onto the available olefin, and is the favored pathway 
when a good oxidant is present.  Furthermore, our results indicate that even a small amount of 
SET under typical Bu3SnH-mediated conditions may be enough to terminate the radical chain 
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process, and initiate a competing mechanism to form reduced 1.48.  This possibility is explored 
further in Chapter 1.2.7. 
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Scheme 1.16  SET Under Oxidative Radical Conditions 
1.2.7 Ionic Reductive Dehalogenation and Base Additive Studies 
The presence of iodine and HI in the reaction of TTMSS with 1.46b caused us to reevaluate the 
origin of reduced product 1.48.  Silyl iodides are known to perform reductive dehalogenations on 
-halocarbonyl compounds.81-84  It is possible that TTMSS iodide formed in the reaction of 
1.46b with TTMSS (Table 1.7, Entry 5) could react in this manner with starting material, as 
shown in Scheme 1.17.  TTMSS also reacts with the necessary byproduct of I2 to form 
(TMS)3Si• which propagates the radical chain, and hydrogen iodide
85
 which consumes TTMSS 
to release more iodine.  So, in the presence of HI or I2, this ionic sequence is self-propagating 
upon addition of further TTMSS.  Ishibashi’s reaction of 1.15c with TTMSS resulted in 
recovering 1.19 as the sole product in 76% yield.
16
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Scheme 1.17  Proposed TTMSI-Mediated Reductive Dehalogenation of 1.46b 
 
Without a silyl iodide to begin this process, though, how does reductive dehalogenation 
occur in Bu3SnH-mediated processes?  Bearing in mind that the SET process occurring in 
Scheme 1.6 results in the overall elimination of HI, it is plausible that this Brønsted acid would 
react with an -iodo substrate86,87 like 1.15c, as shown in Scheme 1.18.  Furthermore, the 
distinctive color of molecular iodine, the necessary byproduct of this reaction, had been observed 
in all syringe pump additions involving -iodo compounds thus far. 
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Scheme 1.18  Proposed Mechanism of Non-Radical Reductive Dehalogenation of 1.15c 
 
To test the ability of an -iodo enamide to undergo acidic reductive dehalogenation, we 
submitted substrate 1.15c to several reaction conditions in refluxing toluene as shown in Table 
1.8, and monitored for the formation of reduced compound 1.19.  A control experiment using 
Bu4NI as an iodide source showed no reaction (Entry 1), and an attempt to generate HI in situ 
using iodine and alumina
88
 led to complete decomposition (Entry 3).  Refluxing with 1 equiv 
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camphorsulfonic acid (CSA) delivered 1.19 in 53% yield, albeit with a rather long reaction time 
(Entry 4).  When 2 equiv each of CSA and Bu4NI were used, however, the reaction proceeded 
cleanly and efficiently, giving 1.19 in 68% yield (Entry 5).  Interestingly, extensive refluxing 
with CSA and Bu3SnI showed no reaction (Entry 2), suggesting that Bu3SnI does not act as 
source of iodide ion.  No products of cyclization 1.16-1.18 were formed under any of these 
conditions. 
 
Table 1.8  Non-Radical Reductive Dehalogenation of 1.15c 
entry
a
 conditions time 1.19 (% yield) 
1 1.0 equiv Bu4NI 2 h --
 
2 1.0 equiv CSA, 1.0 equiv Bu3SnI 24 h --
 
3 4.0 equiv I2, alumina 5 h Decomposition 
4 1.0 equiv CSA 24 h 53 
5 2.0 equiv CSA, 2.0 equiv Bu4NI 2 h 68 
a
 conditions: 1.15c (0.01 M) and additive in toluene were refluxed under Ar.  
 
The presence of iodide in an acidic medium not only promotes the formation of 1.19 via 
reductive dehalogenation, but it can also halt the radical chain.  Past studies have shown that 
Bu3SnH can be consumed by protic acids such as in Equation 1.4, disrupting the normal chain 
process.
17
  The molecular iodine produced by the SET process also rapidly converts trialkyltin 
hydrides to their iodide counterparts as shown in Equation 1.5, releasing further protic acid. 
Bu3SnH + HI   Bu3SnI + H2   (Equation 1.4) 
Bu3SnH + I2   Bu3SnI + HI   (Equation 1.5) 
With an eye towards removing the interfering HI being produced by SET, cyclization 
reactions were run on iodide 1.15c with a variety of base additives.  The use of bases, both 
homogeneous and heterogeneous, has been shown to increase the efficiency of other radical 
reactions involving the release of protic acid.
43
  Typical syringe pump conditions were used: 
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Bu3SnH (1.2 equiv) and AIBN (0.1 equiv) in toluene were added over 3 h to a refluxing solution 
of substrate 1.15c and the appropriate base additive in toluene.  After filtering the mixtures 
(when solid bases were used) and removing solvent, the crude reaction mixtures were directly 
chromatographed on a 10% w/w KF/silica column.
89
  The results are summarized in Table 1.9. 
 
Table 1.9  Bu3SnH-Mediated Cyclization of 1.15c With Base Additives 
   % yield of product
b
  
entry
a 
additive equiv 1.16 1.17 1.18 1.19 total cyc:red
c 
control
16
 -- -- 0 13 11 68 92 26 : 74 
1 -- -- 4 13 21 35 73 52 : 48 
2 pyridine 5 13 60 3 5 81 94 : 6 
3 2,6-lutidine 5 4 45 22 5 76 93 : 7 
4 Cs2CO3 5 4 44 5 0 53 > 100 : 1 
5 K2CO3 10 10 41 20 0 71 > 100 : 1 
6 Proton Sponge 
®
 5 0 32 0 0 32 > 100 : 1 
a
 conditions: Bu3SnH (1.2 equiv) and AIBN (.1 equiv) in toluene (12 mM in Bu3SnH) was added via syringe pump 
to a refluxing mixture of the amide 1.15c in toluene (10 mM) and additive over 3 h.  
b
 Isolated yield after 10% 
KF/silica column chromatography.  
c
 Ratio of (1.16 + 1.17 + 1.18) to 1.19. 
 
The base additives had the predicted effect on the product distribution: the normal radical 
chain and SET mechanisms were unhindered by competing acid-driven processes.  The 
distinctive red color of iodine was not observed in any of the reactions with additives, suggesting 
that the pathway in Scheme 1.18 had been shut down.  Under basic conditions, the total yield of 
cyclized products 1.16-1.18 could be increased to 76% in some cases, while only trace amounts 
of directly reduced products were observed in any of the reactions.  Heterogeneous bases seemed 
to work as well as the soluble organic bases, though cesium carbonate produced a lower mass 
recovery (Entry 4).  The use of Proton Sponge
®
 resulted in a large amount of decomposition 
(Entry 6), which is likely due to its high basicity. 
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1.2.8 Conclusions 
The role of halogens in the 5-endo-trig cyclization of -haloenamides has been thoroughly 
investigated.
90
  Low-temperature NMR analysis has shown that N-cyclohexenyl rotation, not 
amide rotation, is the major conformational process in these molecules.  Kinetic studies showed 
the rate constants of cyclization are not critically halogen-dependent, but the ratio of cyclized to 
oxidized products is dependent on the halogen used in the radical precursor.  Control 
experiments with Bu3SnX additives showed no distinctive Lewis acid activity, but halogen 
exchange occurs under the reaction conditions.  SET plays a substantial role as a competing 
mechanism when the starting halide is easily reducible.  This process also spurs an ionic, acid-
driven reductive halogenation process, which disrupts the anticipated radical chain mechanism.  
Addition of excess base to the reaction mixture suppresses the reductive dehalogenation 
pathway. 
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2.0  AN INTRODUCTION TO AXIALLY CHIRAL ANILIDES 
2.1 AXIALLY CHIRAL AMIDES 
2.1.1 Axial Chirality 
Once a mere curiosity, axial chirality has become a major focal point of research in the last two 
decades.
54,91-139
  Axially chiral compounds do not necessarily contain a stereogenic center, yet 
nevertheless possess an element of asymmetry.  Eliel defines axial chirality as four substituents 
held in a non-planar arrangement around an axis, such that the molecule is not superimposable 
on its mirror image.
140,141
  Like stereogenic centers, axes of chirality have two possible spatial 
arrangements that are mirror images of one another.  Throughout the remainder of this document, 
the Cahn-Ingold-Prelog notation of M/P will be used to describe the absolute stereochemistry of 
chiral axes.
142
 
Axial chirality is exemplified by allenes such as 2.1, cumulated dienes which contain two 
orthogonal -bonds (Figure 2.1).  Biaryls such as 2.2 are also common, and their enantiomeric 
forms may interconvert by a 180° rotation about the aryl-aryl bond.  In recent years, axially 
chiral natural products (Figure 2.2) have also been identified and synthesized.  These include 
murrastifoline F,
95
 which possesses an N-aryl axis, and the biaryl natural product kotanin.
114
  The 
potent antibiotic vancomycin
129
 also contains an axis of chirality, highlighted in Figure 2.2. 
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Figure 2.1  Axially Chiral Allenes and Biphenyls 
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Figure 2.2  Representative Axially Chiral Natural Products 
 
Axially chiral compounds have also enjoyed great synthetic utility, particularly as 
transition metal ligands for asymmetric synthesis.  In 2001, Noyori shared the Nobel Prize in 
Chemistry for his accomplishments in asymmetric catalysis, specifically the use of axially chiral 
diphosphine ligands.  Most notable is the industrial synthesis of menthol, which relies on a 
ruthenium-catalyzed asymmetric olefin isomerization with BINAP as a chiral ligand (Scheme 
2.1).  Isomerization of 2.3 is catalyzed by the (S)-BINAP-Rh
I
 complex formed in situ, producing 
intermediate 2.4 in 96-99% ee on a 9 ton scale.
130
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Scheme 2.1  Asymmetric Catalysis With an Axially Chiral Ligand 
2.1.2 Atropisomerism 
Axially chiral compounds that emanate from restricted rotation about a single bond are 
racemized through thermal, not chemical, means.  While tetrahedral stereocenters require a 
bond-breaking event and subsequent bond forming to change configuration, an axially chiral 
compound needs only to overcome an energy barrier to undergo a 180° rotation about its axis.  If 
this barrier is high enough, then the axially chiral enantiomers are classified as “atropisomers.”  
Ōki defined an atropisomer54 as a conformer which can retain its axial chirality with a half-life of 
racemization of t1/2 ≥ 1000 s.  This definition is temperature-dependent, however, as the half-life 
of racemization of an axially chiral compound will decrease with increasing temperature. By 
Ōki’s definition, a compound at 25 °C requires a barrier to rotation of at least 22.2 kcal/mol to be 
considered atropisomeric, while a barrier of 26.4 kcal/mol is required at 80 °C.  We propose a 
more practical definition of atropisomers as compounds whose axial chirality can be observed by 
spectroscopic means.  Stable atropisomers, then, have a barrier high enough that they can be 
resolved by laboratory methods. 
The first stable atropisomer to be isolated was 6,6′-dinitro-2,2′-diphenic acid 2.5 (Figure 
2.3), which was resolved by cocrystallization with a chiral amine in 1922.
143
  Since then, 
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thousands of atropisomeric compounds have been identified and resolved by numerous methods, 
including 2,2′-diiodobiphenyl 2.6.139  Biaryl 2.6 possesses an aryl-aryl rotation barrier of 23.1 
kcal/mol, giving it a half-life to racemization of 80 min at room temperature.   
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Figure 2.3  Atropisomerism in Biaryl Compounds 
2.1.3 Configurational and Rotational Behavior of Amides 
The amide functional group contains a planar, sp
2
-hybridized nitrogen resulting from conjugation 
of the nitrogen lone pair with the adjacent carbonyl functionality (Figure 2.4),
22,144
 granting the 
carbonyl-nitrogen bond a partial double bond character.  Unsymmetrically N,N-disubstituted 
amides 2.7 have two possible ground states that interconvert by a single rotation of the N-
carbonyl bond.  Because of the partial double bond character of the rotating bond, we refer to 
these two states as “Z” and “E” by analogy to the nomenclature rules for olefins.  Tertiary N,N-
dialkylamides nearly always prefer the (Z) configuration at equilibrium, because the larger N-
substituent R
3
 is cis to the smaller carbonyl oxygen.
145
 
  46 
R1 N
O
R1 N
O
R3 > R2
(E )-2.7 (Z)-2.7
R2
R3
R3
R2
R1 N
O
R3
R2
R1 N
O
R2
R3  
Figure 2.4  Rotation and Resonance of a Generic Tertiary Amide 
 
The barrier to amide rotation is typically in the range of 15-20 kcal/mol,
22
 and is subject 
to both steric and electronic effects of substituents.  Sample barriers to amide N-carbonyl rotation 
are shown in Figure 2.5.  Increasing the steric bulk of carbonyl substituent R
1
 or N-substituents 
R
2
 and R
3
 leads to a decrease in the rotational barrier, as seen in comparisons of 2.8 to more 
highly substituted amides 2.9-2.11.
49,146
  In the ground state, all substituents are coplanar and 
thus have the most steric interaction with one another.  Therefore, greater steric hindrance leads 
to a destabilization of the ground state energy.  Substitution with multiple -halogen atoms, as in 
2.12, raises the rotational barrier by withdrawing electron density from the carbonyl group, 
thereby stabilizing the ground state and offsetting the steric factor.
49
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Figure 2.5  Representative Carbonyl-N Amide Barriers to Rotation 
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ortho-Substituted benzamides 2.13, as in Figure 2.6, add a second element of 
stereochemistry to the amide.
147,148
  The steric effect of o-substituents X and Y twists the 
aromatic ring out of planarity with the amide group, creating an axis of chirality.  If R
2
 and R
3
 
are non-equivalent, equilibrium favors the E-amide rotamer,
92
 in contrast to the preferred Z-
configuration of o-unsubstituted benzamides (X = Y = H).  If alkyl groups R
2
 and R
3
 contain no 
additional stereocenters, then interconverting enantiomers (M)-2.13 and (P)-2.13 are formed.  
Some examples of experimentally determined barriers to rotation are shown in Figure 2.6.
92
  
When only one ortho substituent is present (Y = H), the barrier to carbonyl-aryl rotation is low 
enough that the amides cannot be resolved as stable atropisomers (for example, 2.14 and 2.15).
54
  
However, a second substituent increases the barrier to rotation as in the cases of 2.16 and 2.17, 
slowing interconversion to a rate that allows for resolution of the enantiomers under ambient 
conditions.
149,150
  The rotational dynamics
91,92,94,97-101,104,151
 and asymmetric reactions
94,97-101
 of 
this class of compounds have been thoroughly studied by Clayden and coworkers.   
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Figure 2.6  Rotational Dynamics and Barriers of Axially Chiral Benzamides 
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Aryl groups positioned on the amide nitrogen are also twisted out of planarity.  An early 
crystal structure of N-methylacetanilide 2.18 showed that the amide and aryl planes were roughly 
perpendicular to one another (Figure 2.7).
152
  Because the aryl group twists to avoid steric 
interactions, tertiary anilides prefer the E-configuration in solution, and most are able to readily 
equilibrate at room temperature with typical barriers to carbonyl-N rotation.
107
  In one case, 2.18 
has a 200:1 E:Z ratio in pyridine solution; in most systems, ratios of 10:1 E:Z or greater are 
typical.
48,105,107,109,127,132,133
  In a rare example, extremely hindered system 2.19 is locked in either 
a Z- or E-configuration, only able to isomerize under prolonged heating.
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Figure 2.7  E/Z Configuration in Twisted Anilides 
 
Substitution at the ortho position of an aryl group forms an axis of chirality along the 
aryl-N bond, producing stable atropisomers if steric hindrance is significant.  The first axially 
chiral anilide 2.20 was discovered in 1937 by optical resolution of its brucine salt (Figure 2.8).
154
  
Since then, many other chiral anilides have been developed, each with a single large ortho 
substituent such as t-Bu (2.21, 2.22) or I (2.23) to slow N-aryl rotation and allow for resolution.  
Addition of a second ortho substituent further increases the barrier (2.24), resulting in 
compounds that are atropisomerically stable for years, if not centuries, at ambient temperature.  
In general, greater steric hindrance on the N substituent, at either of the ortho positions, or alpha 
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to the carbonyl increases the barrier to rotation, as seen by the examples in Figure 2.8.  Benzoyl 
and acryloyl anilides tend to have lower barriers than acetanilides, as observed in the 3.2 
kcal/mol difference between the rotation of 2.21 and 2.22.  Unlike alkyl groups, aryl and vinyl 
groups may twist out of planarity with the carbonyl, thereby avoiding hindrance with o-
substituents in the rotation transition state.
107
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Figure 2.8  Barriers to Rotation and Approximate Half-Lives of Selected Axially Chiral Anilides 
2.1.4 Preparation of Enantioenriched Axially Chiral Anilides 
The first synthesis of an enantioenriched axially chiral anilide was achieved by the chemical 
resolution of diastereomeric atropisomers.
120
  EDCI-mediated coupling of N-allylaniline 2.25 
with (S)-O-acetyl lactic acid produced 2.26 as a 3:1 mixture of diastereomers.  These compounds 
were separable by column chromatography, and their relative configurations were identified by 
X-ray crystallography.  The major diastereomer, (S,P)-2.26, was subjected to saponification, 
followed by formation of the mesylate and substitution to provide -selenide 2.27.  This 
compound was oxidized to the selenoxide, and spontaneous -elimination produced anilide (P)-
2.28 in 81% yield over 4 steps with 97% ee.  This process
119,120,122
 has also been applied to the 
preparation of enantioenriched o-iodoanilides,
132
 but is somewhat limited in substrate scope. 
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Scheme 2.2  Preparation of Enantioenriched Anilide via Chemical Resolution 
 
To date, the most general access to enantioenriched axially chiral anilides is resolution of 
racemates by semipreparative chiral HPLC.  Axially chiral benzamides with an aryl-carbonyl 
axis of chirality were among the first amides to be resolved by this method.
92,149,150
  This 
chromatographic technique was first applied to anilides in 1997,
96,107
 and has proven itself to be 
highly useful in the resolution of numerous anilides ever since.
105,108,128,132,133,155
  Two columns 
are particularly efficient for resolution of anilides (Figure 2.9):  the Chiralcel OD column, which 
has a cellulose-based coating on silica gel, and the (S,S)-Whelk O1 column, which contains a 
chiral amide-containing group covalently tethered to the silica.  Both stationary phases possess 
chiral functionalities that act as hydrogen bond donors for axially chiral amide substrates.  
Additionally, the -acidic dinitrobenzamide group and the -basic naphthyl group in the Whelk 
column recognize aromatic analytes through - face-to-face as well as face-to-edge 
interactions.
156
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Figure 2.9  Chiral HPLC Stationary Phases 
 
Recently, enantioselective syntheses of axially chiral anilides have also been developed. 
Uemura has developed a general procedure for the desymmetrization of 2,6-dimethylanilides by 
asymmetric deprotonation of tricarbonylchromium complexes such as 2.29, followed by 
alkylation to give 2.30 in 97% ee.
112,113,125,126
  Curran
137
 and Taguchi
121
 simultaneously disclosed 
methods for the asymmetric allylation of achiral anilides possessing an ortho t-butyl substituent 
(Scheme 2.3).  In the allylation of 2.31, Curran’s procedure gave allylated product (P)-2.32 in 
27% yield and 43% ee, while Taguchi’s conditions produce (P)-2.32 in 94% yield and 40% ee.  
This strategy has been extended to catalytic asymmetric N-arylation, with significantly higher 
enantioselectivities (88-96% ee).
123,124
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Scheme 2.3  Enantioselective Syntheses of Axially Chiral Anilides 
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While enantioselective synthesis is a promising route toward enantioenriched axially 
chiral anilides, the aforementioned methods in Scheme 2.3 are limited in scope.  Presently, the 
most general means to efficiently access a variety of enantioenriched anilides is through 
resolution by chiral HPLC. 
2.1.5 Asymmetric Induction by Axially Chiral Anilides 
Many asymmetric reactions of atropisomeric anilides take advantage of the bulky ortho 
substituent as a stereodirecting group, preferentially shielding one face of the reactive site.
109
  In 
an early example, the 1,3-dipolar cycloaddition of racemic 2.33 with benzonitrile oxide 
generated in situ gave cycloadducts 2.34a and 2.34b in a 92/8 dr (Scheme 2.4).
157
  Because 2.33 
exists primarily in the E-amide configuration, the o-t-butyl group effectively shields one face of 
the alkene, allowing cycloaddition to occur selectively from the back side to give 2.34a as the 
primary product.  Facial selectivity has also been observed in other nitrile oxide 
cycloadditions,
107
 as well as iodine-mediated Diels-Alder reactions
119,120
 and [2+2] 
photocycloadditions
158
 of axially chiral anilides. 
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Scheme 2.4  Atroposelective Cycloaddition with Benzonitrile Oxide 
 
Enolates of axially chiral amides undergo nucleophilic reactions with facial control 
imparted by the bulky ortho substituent (Scheme 2.5).  The lithium enolate 2.36 is prepared by 
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treatment of 2.35 with LDA.
115
  The N-methoxymethyl group is thought to fix the configuration 
of the amide N-carbonyl bond in enolate 2.36 by lithium coordination, as shown in Scheme 2.5.  
Treating 2.36 with BnBr gives alkylated product 2.37 in 83% yield and 25:1 dr.
115-117
  This 
method has recently been extended to atropisomeric N-phenyl anilides with excellent 
diastereoselection (23:1 to 46:1 dr).
124
  Alternatively, treating enolate 2.36 with benzaldehyde 
results in a 87% yield of syn-aldol product 2.38 as a single diastereomer.
115,116
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Scheme 2.5  Atroposelective Alkylation and Aldol Reaction 
2.2 CHIRALITY TRANSFER OF AXIALLY CHIRAL O-IODOANILIDES 
2.2.1 Chirality Transfer 
“Memory of chirality” occurs when the reaction of a chiral starting material results in a chiral 
product, despite proceeding through a configurationally labile intermediate containing no 
permanent chiral features.
118,159-161
  Chirality transfer is a subset of “memory of chirality” 
reactions, in which the element of stereochemistry in the product is at a different location than in 
the starting material.
160
  An excellent example of chirality transfer was recently put forth by 
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Rychnovsky in the transannular radical cyclization of 2.39 (Scheme 2.6).
162
  When 
enantioenriched oxalate 2.39 (94/6 er) was exposed to light at –15 °C, cyclization and 
thiopyridyl trapping produced 2.40 in 51% yield and 84/16 er (major enantiomer 2.40a). 
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Scheme 2.6  Chirality Transfer in a Radical Transannulation 
 
Cyclodecenyl radical 2.41a is initially produced by deoxygenation of 2.39.  Radical 2.41a 
may cyclize to give major enantiomer 2.40a, or interconvert by a ring flip to radical 2.41b, which 
cyclizes to minor enantiomer 2.40b.  Radical 2.41 is configurationally labile and lacks permanent 
chiral features, but the cyclization is faster than ring interconversion, and chirality transfer 
results.  At higher temperatures, the yield of the reaction increased but the chirality transfer 
decreased, implying that conformational interconversion gradually becomes competitive with 
cyclization. 
Chirality transfer is usually quantified by dividing the proportion of the major enantiomer 
in the product by the proportion of the major enantiomer in the starting material.  This is a 
measurement of what percentage of the conformationally labile intermediate reacted while 
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retaining its memory of chirality.  In the example above (Scheme 2.6), the chirality transfer is 
(84/94) x 100% = 89%.  This value represents the percentage of the major enantiomer one would 
expect from reaction of enantiopure starting material.  By definition, chirality transfer values 
range from 50% (racemization, complete loss of stereochemical information) to 100% (complete 
chirality transfer). 
2.2.2 Chirality Transfer in Intramolecular Radical Reactions 
Chirality transfer in radical cyclizations of o-iodoanilides was discovered by the Curran 
group in 1999.
108
  Enantioenriched (P)-2.42 was treated with Bu3SnH and Et3B in benzene at 
room temperature, producing dihydroindolone (S)-2.43 in 86% yield and 90% chirality transfer 
(Scheme 2.7).  Similarly, (M)-2.42 gave (R)-2.43 in 93% yield with 90% chirality transfer (not 
shown).  Cyclizations of related substrates proceeded with 50-94% chirality transfer.
108,127
 
N
O
I
N
O
(P)-2.42
(S)-2.43, 86%
90% chiral trans.
Bu3SnH (0.01 M)
Et3B
PhH, rt
 
Scheme 2.7  Chirality Transfer in a 5-exo Radical Cyclization 
 
Substrate (P)-2.42 exists as a stable atropisomer at room temperature (G
‡
rot ≈ 30.8 
kcal/mol),
108
 but iodine atom abstraction produces an aryl radical 2.44a whose barrier to rotation 
is significantly lower (Scheme 2.8).  Radical 2.44a is a labile intermediate that can rotate to 
2.44b, which destroys the chiral information in the starting material, or cyclize to 2.45a, which 
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retains the memory of chirality.  The transition state model for this class of cyclizations has the 
olefin twisting towards the incoming radical.
106,108,127,163
   
N
O
I Bu3SnH
Et3B
N
O
N
O
N
O
N
O
H
N
O
N
O
kC
kC Bu3SnH
(P)-2.42 2.44a
2.44b
2.45a
2.45b
Bu3SnH
(S)-2.43
k rotk rot'
(R)-2.43
cyc
rot
rot
cyc
H
 
Scheme 2.8  Model for Chirality Transfer in Cyclizations of Acryloyl Anilides 
 
The stereoselectivity of the radical cyclization depends on two factors: the facial 
selectivity of the attacking radical, and the ability of the intermediate radical 2.44 to cyclize 
before N-aryl rotation.  The cyclization rate constant kC of radical 2.44 has been estimated as kC 
= 7.8 x 10
7
 s
-1
 at room temperature.
133,155
  The high values of chirality transfer for this cyclization 
imply that, for the most part, cyclization events proceed before a rotation can occur (kC > krot).  
The reaction also proceeds with moderate to excellent facial selectivity, preferring to react with 
one face of the olefin radical acceptor. 
Chirality transfer has also been observed in radical cyclizations of N-allyl-o-iodoanilides.  
In a typical example, enantioenriched 2.46a (99.5/0.5 er) was subjected to room temperature 
radical cyclization conditions with Bu3SnH and Et3B (Scheme 2.9).
105,127
  After purification, 
dihydroindolone 2.47a was obtained in 95% yield and in a 93/7 er, a chirality transfer of 93%.  
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The general model for chirality transfer was deduced by X-ray crystallographic analysis of a 
substrate-product pair.  Iodine abstraction from 2.46a produces aryl radical 2.48a, and the N-allyl 
group twists towards the radical center.  Attack of the radical on the bottom face of the alkene 
results in intermediate 2.49a, which is reduced by Bu3SnH to produce 2.47a.  According to this 
model, P-iodoanilides are expected to give R-indolines, and M-iodoanilides give S-indolines. 
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Scheme 2.9  Chirality Transfer in Cyclizations onto N-Allyl Groups 
 
Chirality transfer in this class of cyclization is dependent upon both cyclization outpacing 
competitive N-aryl rotation, and facial selectivity in reaction with the olefin.  The rate constant of 
cyclization kC of radical 2.48b, produced by halogen abstraction from racemic 2.46b, was 
measured as kC = 3.0 x 10
9
 s
-1
.  Given that chirality transfer values for this class of reactions were 
moderate to high (74-95%),
105
 cyclization must be significantly faster than rotation about the N-
aryl bond, and facial selectivity must be high. 
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3.0  CHIRALITY TRANSFER IN RADICAL AND ANIONIC CYCLIZATIONS OF 
AXIALLY CHIRAL CARBAMATES 
3.1 INTRODUCTION 
3.1.1 Axially Chiral Carbamates 
Axially chiral amides are among the most widely studied types of N-aryl atropisomeric 
compounds, particularly o-iodoanilides which undergo cyclizations with chirality 
transfer.
105,108,127,128,132,133
  While axially chiral o-iodoanilides are useful substrates for forming 
indolines, a common subunit of alkaloids, the residual amide moiety in the product can be 
difficult to remove.  Therefore, a more synthetically useful alternative to amides would be highly 
valuable.  Among the reported yet little-studied classes of compounds possessing an N-aryl axis 
of chirality (Figure 3.1) are thiazolin-2-thiones,
138
 thiazolin-2-ones,
138
 iminothiazolines,
134
 
thioureas,
164
 ureas,
102,103
 thioamides,
110
 and carbamates.
91
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Figure 3.1  Some Axially Chiral Compounds with a C−N Axis 
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Surprisingly, axially chiral carbamates have received little attention, despite the vast 
synthetic utility of carbamates as easily removable protecting groups.
165
  Like amides, 
carbamates (Figure 3.2) contain an sp
2
-hybridized nitrogen atom whose lone pair is delocalized 
into the adjacent carbonyl, resulting in planarity of the functional group.  Also like amides, 
carbamates are resistant to hydrolysis and nucleophilic attack.  But unlike amides, carbamates 
undergo facile C−N bond cleavage under conditions dictated by the oxygen substituent R3.  In 
two examples of particular relevance to peptide chemistry, the t-butoxycarbonyl (Boc) group 
suffers deprotection under anhydrous acidic conditions, and the carbonylbenzyloxy (Cbz) group 
is susceptible to hydrogenolysis.
165
 
O
N OR3
R1
R2
O
N O
R1
R2
N -Boc
O
N O
R1
R2
Ph
N -Cbz
O
N O
R1
R2
N -Alloc
O
N O
R1
R2
N -MeocTertiary carbamate  
Figure 3.2  Representative Carbamate Structures 
 
The radical cyclizations of o-iodoarylcarbamates have been used in syntheses of analogs 
of antitumor agents duocarmycin,
166-174
 CC-1065,
167-169,171,174-176
 and yatakemycin.
172
  An 
example of this cyclization is shown in Scheme 3.1; aryl iodide 3.1 was treated with Bu3SnH, 
cyclizing to give racemic indoline rac-3.2 in 87% yield.
172
  The product was then resolved by 
chiral HPLC to give enantiomerically pure (S)-3.2, which is carried forward in the synthesis.  
Because 3.1 only contains a single o-iodine substituent, its N-aryl barrier to rotation is estimated 
to be G
‡
rot = 19.2 kcal/mol,
91
 making resolution of the enantiomers impossible under ambient 
laboratory conditions (t1/2 for racemization = 15 s). 
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Scheme 3.1  Racemic Radical Cyclization of an o-Iodoarylcarbamate 
 
The N-aryl barriers to rotation of N-aryl-N-benzyl carbamates containing various ortho-
substituents have previously been measured by Annunziata and co-workers (Figure 3.3).
177
  
Predictably, increasing the steric bulk of the o-substituent leads to a gradual rise in barrier to 
rotation, as exemplified by substrates 3.3-3.5.  However, increasing the sterics of the O-
substituent in the carbamate group does not noticeably affect the barrier, as seen by comparing o-
Cl substrates 3.6-3.8.  None of the o-monosubstituted N-arylcarbamates studied possessed a 
barrier high enough to allow for resolution. 
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Figure 3.3  N-Aryl Barriers to Rotation of o-Monosubstituted Carbamates 
 
N-Aryl carbamates containing two ortho substituents have a much higher N-aryl barrier 
to rotation, and therefore display atropisomeric behavior.  Tanaka’s group has recently reported 
the enantioselective synthesis of an axially chiral carbamate 3.11, using an asymmetric Rh-
catalyzed [2+2+2] cycloaddition of ynamide 3.9 and diyne 3.10 (Scheme 3.2).
136
  Carbamate (P)-
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3.11 was isolated in 69% yield and 98% ee, with a syn/anti rotamer ratio of 86/14.  Hsung 
expanded upon this reaction by reacting aryl-substituted ynamide 3.12 and diyne 3.13 to produce 
diastereomeric biphenyls (M,P)-3.14 and (P,P)-3.14 in a 6:1 dr, containing both a C−C and a 
C−N axis of chirality.131  These oxazolidinones, which are cyclic carbamates, are also 
configurationally stable.  When (M,P)-3.14 was heated to 85 °C in toluene-d8 for 24 h, no N-aryl 
bond rotation was observed, implying a high barrier to rotation.  When analogs of 3.14 
containing only one ortho group were synthesized, C−N rotation was observed on the NMR 
timescale.
131
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Scheme 3.2  Asymmetric Syntheses of Axially Chiral Carbamates 
3.1.2 Intramolecular Conjugate Addition of Aryllithiums 
Lithium-halogen (Li-X) exchange is an indispensable tool for creating a nucleophilic 
organolithium within a molecule, which can then undergo intramolecular conjugate addition.  In 
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particular, conjugate additions of aryllithiums generated by Li-X exchange typically proceed 
without significant side reactions.
178,179
  At low temperatures, Li-X exchange between 
alkyllithium reagents and aryl halides proceeds much more quickly than competing 
deprotonation or intermolecular addition processes.
180
  The cyclizations themselves also tend to 
be very rapid for most medium-sized ring formations,
178
 an effect of conformational control by 
the sp
2
 carbons in the aromatic ring.
180
  An example of efficient intramolecular aryllithium 
addition was recently developed by Piers (Scheme 3.3).
181
  Lithium-iodine exchange with aryl 
iodide 3.15 was triggered at –78 °C by t-BuLi in the presence of TMSCl and HMPA in THF.  
Subsequent conjugate addition onto the enone produced racemic 3.16 in 80% yield.  No 
complications from the potential aforementioned side reactions were observed. 
MeO O
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H
OMeO I
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2.5 equiv HMPA
THF, -78 oC to rt, 80%
rac-3.15 rac-3.16  
Scheme 3.3  Intramolecular Conjugate Addition of an Aryllithium 
 
Rodrigo and coworkers reported that fumaric ester amide 3.17 easily underwent anionic 
cyclization after lithium-halogen exchange, to give dihydroindol-2-one 3.18 in 85% yield 
(Scheme 3.4).
182
  The optimal conditions involved addition of BuLi in a 4:1:1 THF : Et2O : 
hexane solvent mixture, more commonly known as the Trapp solvent mixture,
183
 at –100 °C.  
The presence of TMSCl was required to avoid polymerization of the cyclized enolate ester 
intermediate.  Despite the excess of TMSCl present in the reaction, no o-silylation was observed, 
leading to the conclusion that the lifetime of the aryllithium intermediate is short indeed.  A 
crystal structure of 3.17 revealed that the planes of the aromatic ring and amide groups are 
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perpendicular to one another, resulting in axial chirality about the N-aryl bond.  We hypothesized 
that if compounds similar to 3.17 could be resolved, then the anionic cyclization would proceed 
with chirality transfer. 
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Scheme 3.4  Intramolecular Anionic Conjugate Addition of an Axially Chiral Anilide 
 
Rodrigo’s substrate 3.17 is unfit for chirality transfer experiments in anionic cyclizations 
for two reasons.  First, the presence of only one ortho substituent implies the barrier to rotation 
of 3.17 is too low for convenient resolution (< 22 kcal/mol).  Second, the pKa of the proton at the 
newly formed stereocenter in 3.18 is expected to be less than 18.5,
184
 and its removal by BuLi 
during the reaction results in destruction of the product’s chirality.  To address these problems, 
we developed N-arylcarbamates 3.19 (Scheme 3.5) as substrates which contain a second o-
substituent to facilitate resolution, and produce a non-epimerizable stereocenter upon cyclization 
to 3.20.  Our studies focused especially on the role of carbamate identity (R
1
) and additional 
aromatic substituents (R
2
, R
3
) on reactivity, barriers to rotation, and chirality transfer. 

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Scheme 3.5  Proposed Anionic Cyclization of Axially Chiral Carbamates 
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3.2 RESULTS AND DISCUSSION 
3.2.1 Synthesis of Starting Materials 
The preparation of carbamates 3.19 began with the synthesis of various o-iodoanilines with 
different substitution patterns (Scheme 3.6).  Compound 3.21 was made in 68% yield by treating 
2,4-dimethylaniline with BnNEt3•ICl2 and solid base in the presence of MeOH.
185
  Similarly, o-
bromo analog 3.22
132
 was prepared in 91% yield from 2-bromo-4-methylaniline and  iodinating 
reagent BnNMe3•ICl2.  The iodinations of 4-bromo-2-methylaniline and 2,4-dibromoaniline were 
effected with I2 and Ag2SO4 in EtOH to furnish 3.23
128
 (65%) and 3.24
186
 (33%), respectively.  
The preparation of o-silylated 3.27 was accomplished by a three-step sequence.  bis-Iodination of 
p-toluidine with ICl provided 3.25
132
 in 77% yield, followed by bis-TMS protection by two 
treatments with LDA and TMSCl to give 3.26
132
 in 87% yield.  A lithium-halogen exchange with 
s-BuLi, followed by a C to N silyl migration
187
 and hydrolysis of the remaining N-TMS group, 
furnished aniline 3.27 in 82% yield. 
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Scheme 3.6  Preparation of o-Iodoanilines 
 
Next, various carbamate groups were installed on the nitrogen atoms of the o-
iodoanilines (Scheme 3.7).  Boc groups were easily installed by deprotonation of the appropriate 
aniline with NaHMDS at low temperatures, followed by treatment with di-t-butyldicarbonate, 
producing 3.28-3.33 in 62-94% yields.  Alloc and methoxycarbonyl (Meoc) groups were 
installed on 3.21 by treatment with the appropriate chloroformate reagent in pyridine, to give 
3.34 (93% yield) and 3.35 (92% yield), respectively.  Treatment of 3.21 with 
benzyloxychloroformate under biphasic Schotten-Baumann conditions provided Cbz-protected 
3.36 in 93% yield. 
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Scheme 3.7  Formation of Carbamates from o-Iodoanilines 
 
Finally, the preparation of substrates 3.19a-i was completed by installing the olefinic 
acceptor via N-alkylation (Table 3.1).  We initially attempted deprotonation of carbamate 3.36 
with NaHMDS followed by alkylation with methyl 4-bromocrotonate (Entry 1), but this led to 
incomplete reaction, low yield of 3.19c (47%) and difficult purification.  Changing the base to 
K2CO3 led to complete consumption of carbamates 3.28 and 3.36 (Entries 2-3), though multiple 
additions of base and alkylating agent were required, and numerous side products led to low 
isolated yields of 3.19a (52%) and 3.19b (67%).  Use of Cs2CO3 as a base for 3.28 (Entry 4) 
accelerated the reaction, but side products were still a problem, increasing the yield of 3.19a by 
only a small amount (68%).  Alkylation of 3.28 with methyl 4-iodocrotonate eliminated the 
formation of side products, accelerated the reaction, and increased the yield of 3.19a to 72% 
(Entry 5).  Compounds 3.29-3.36 were alkylated with these conditions, furnishing 3.19b-i in a 
range of 63 – 99% yields (Entries 6-13).  Allyl ester 3.19j was also prepared by hydrolysis of 
methyl ester 3.19a, followed by DCC-mediated coupling of crude acid 3.37 with allyl alcohol 
(Scheme 3.8).  Carbamate 3.19j was isolated in 62% yield over two steps.   
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Table 3.1  Alkylation of N-Carbamate Protected Anilines 
NH
R2
R3
I
R1O
O
Base, DMF
CO2MeX
N
R2
R3
I
R1O
O
CO2Me
 
  
entry substrate R
1
 R
2 
R
3 
X
 
base product % yield
a 
1 3.36 Bn Me Me Br NaHMDS
b
 3.19c 47 
2 3.28 t-Bu Me Me Br K2CO3 3.19a 52 
3 3.36 Bn Me Me Br K2CO3 3.19c 67 
4 3.28 t-Bu Me Me Br Cs2CO3 3.19a 68 
5 3.28 t-Bu Me Me I Cs2CO3 3.19a 72 
6 3.34 Allyl Me Me I Cs2CO3 3.19b 99 
7 3.36 Bn Me Me I Cs2CO3 3.19c 94 
8 3.29 t-Bu Me Br I Cs2CO3 3.19d 63 
9 3.30 t-Bu H H I Cs2CO3 3.19e 91 
10 3.35 Me Me Me I Cs2CO3 3.19f 77 
11 3.31 t-Bu TMS Me I Cs2CO3 3.19g 57 
12 3.32 t-Bu Br Me I Cs2CO3 3.19h 65 
13 3.33 t-Bu Br Br I Cs2CO3 3.19i 86 
a
 Isolated by column chromatography.  
b
 THF was used as solvent. 
 
N
I
t-BuO
O
CO2Me
3.19a
NaOH
THF/H2O
0 oC to rt
quant.
N
I
t-BuO
O
CO2H
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CH2Cl2, rt
62% over 2 steps
N
I
t-BuO
O
O
O
3.19j3.37  
Scheme 3.8  Synthesis of Allyl Ester Substrate 3.19j 
 
In contrast to N-allyl o-iodoanilides, which exist largely or exclusively as E-amide 
rotamers in solution,
105,155
 carbamates 3.19a-j exist as two rotamers in CDCl3 as determined by 
1
H NMR spectroscopy.  Whereas Z/E nomenclature is typically used to describe amide rotamers, 
syn/anti designations are used for carbamates.
188
  The rotamer ratios in 3.19a-j range from 2:1 to 
5:1, depending on the identity of the carbamate group R
1
 as well as the ortho substituent R
2
 (see 
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Chapter 6.3).  Tertiary N-aryl carbamates containing at least one o-aryl substituent display a 
moderate preference for the syn rotamer (Figure 3.4),
136
 so we determined that the major rotamer 
of substrates 3.19a-j in solution was syn.  For simplicity, only the syn isomer of substrates 3.19a-
j are depicted in future schemes.  Both rotamers of 3.19a-j are able to undergo cyclization. 
The carbonyl-N barrier to rotation of N-aryl-N-alkyl carbamates is typically G
‡
rot = 
10.7-13.2 kcal/mol when no ortho substituent is present on the aromatic ring.
189,190
  The 
appearance of well-defined signals for two rotamers in the 
1
H NMR spectra of 3.19a-j suggest a 
minimum value of G
‡
rot > 16 kcal/mol, which is comparable to N,N-dialkylcarbamates
189,191,192
 
and o-monosubstituted N-alkyl-N-aryl carbamates.
177
 
N
R2
R3
I
R1O
O
syn-3.19
OR4
O
N
R2
R3
I
O
OR1
OR4
O
ant i-3.19  
Figure 3.4  Rotamer Behavior of Axially Chiral Carbamates 3.19a-j 
3.2.2 Reaction Optimization and Substrate Screening 
We began the studies by optimizing the anionic cyclization conditions on racemic 3.19a-j (Table 
3.2).  t-BuLi was slowly added to a solution of iodide 3.19a and excess TMSCl in an 
HMPA/THF solvent mixture at –78 °C (Conditions “A3”).181  These conditions provided 3.20a 
in 56% yield, along with numerous side products (Entry 1).  The same conditions were applied to 
N-Cbz congener 3.19c, producing 3.20c in only 10% isolable yield (Entry 2).  When 
BuLi/TMSCl was used in the reaction of 3.19a in the Trapp solvent mixture
183
 at –98 °C 
(Conditions “A”), the reaction proceeded much more cleanly and efficiently to give 3.20a in 
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79% isolated yield (Entry 3).  Similarly, the yield of 3.20c was increased to 76% by cyclizing 
3.19c under these conditions (Entry 5).  Application of these optimized conditions to iodides 
3.19b,e,f,g,j gave similar results, with yields ranging from 67-82% and no formation of major 
side products (Entries 4, 6-9).  The lithium-halogen exchange therefore occurs more rapidly than 
the intermolecular conjugate addition of BuLi.
179
  As in Rodrigo’s findings,182 no direct 
silylation of the intermediate aryllithium by TMSCl was observed, implying a rapid cyclization. 
 
Table 3.2  Anionic and Radical Cyclizations of Racemic Carbamates 
N
R2
R3
I
OR4
O
O
R1O
N
R2
R3
OR4
O
rac-3.19a-j rac-3.20a-j
anionic (A)
or
radical (R)
conditions
O
R1O
 
  
entry substrate
 
R
1
 R
2 
R
3
 R
4
 cond.
a 
prod. % yield
b 
1 3.19a t-Bu Me Me Me A3 3.20a 56 
2 3.19c Bn Me Me Me A3 3.20c 10 
3 3.19a t-Bu Me Me Me A 3.20a 79 
4 3.19b Allyl Me Me Me A 3.20b 82 
5 3.19c Bn Me Me Me A 3.20c 76 
6 3.19e t-Bu H H Me A 3.20e 67 
7 3.19f Me Me Me Me A 3.20f 79 
8 3.19g t-Bu TMS Me Me A 3.20g 76 
9 3.19j t-Bu Me Me Allyl A 3.20j 76 
10 3.19h t-Bu Br Me Me A 3.20h 18 
11 3.19h t-Bu Br Me Me A2 3.20h 59 
12 3.19d t-Bu Me Br Me A2 3.20d 51 
13 3.19i t-Bu Br Br Me A2 3.20i 42 
14 3.19a t-Bu Me Me Me R 3.20a 96 
15 3.19b Allyl Me Me Me R 3.20b 99 
16 3.19c Bn Me Me Me R 3.20c 96 
17 3.19d t-Bu Me Br Me R2 3.20d 99 
b
 Conditions A: 1.2 equiv BuLi, 5.0 equiv TMSCl, Trapp solvent mix, –98 °C.  A2: 1.2 equiv BuLi, 5.0 equiv 
TMSCl, PhMe, –91 °C.  A3: 2.2 equiv t-BuLi, 5.0 equiv TMSCl, THF/HMPA, –78 °C.  R: 1.5 equiv Bu3SnH, Et3B, 
PhH, rt.  R2: 1.1 equiv Bu3SnH, Et3B, PhH, rt.  
b
 Isolated by column chromatography. 
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Bromide 3.19h was reacted under the optimized conditions, but produced desired 3.20h 
in only 18% yield (Entry 10).  The multiple products seen in the reaction mixture, as well as the 
incomplete consumption of starting material, implied a competitive lithium-halogen exchange 
with the aryl bromide.  Taking a cue from Fukuyama’s previous work,193,194 we curtailed the 
undesired Li-Br exchange by switching the reaction solvent to toluene at –91 °C (Conditions 
“A2”).  These conditions led to a much cleaner reaction of 3.19h, albeit with a modest 59% yield 
of 3.20h (Entry 11).  Brominated substrates 3.19d and 3.19i reacted cleanly under these 
conditions as well, producing 3.20d in 51% yield and 3.20i in 42% yield (Entries 12-13). 
Racemic iodides 3.19a-d were also subjected to radical cyclization reactions.  In a typical 
experiment, Et3B initiator was added to a stirred PhH solution of iodide 3.19a and 1.5 equiv 
Bu3SnH (10 mM) at room temperature (Conditions “R”).  The iodide was consumed within 5 
min, the solvent was removed, and the cyclized product 3.20a was isolated by flash 
chromatography on 10% w/w KF/silica gel in 96% yield (Entry 14).
80
  Iodides 3.19b-d were 
reacted in the same fashion (Entries 15-17), and consistently gave nearly quantitative yields of 
3.20b-d (96-99%).  Only 1.1 equiv Bu3SnH was used in the reaction of 3.19d to avoid over-
reduction of the bromide (Conditions “R2”). 
3.2.3 Resolution of Substrates 3.19a-d 
Substrates 3.19a-d were resolved by dissolution in i-PrOH and injection onto the appropriate 
semipreparative HPLC column, eluting with the appropriate ratio of hexanes and i-PrOH (flow 
rate 10 mL/min).  In this study, either an (S,S)-Whelk O1 (25 cm x 21.1 mm ID) or a Chiralcel 
OD (25 cm x 20.0 mm ID) column was used, depending on which gave the best separation.  
Typically, 40 mg of racemate were injected at once, and several injections were performed per 
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compound.  After resolution, the solvent was removed from combined enantioenriched fractions, 
and the er was determined by analytical chiral HPLC – either on an (S,S)-Whelk O1 (250 mm x 
4.6 mm ID) or Chiralcel OD (250 mm x 4.6 mm ID) column.  The first eluting enantiomers of 
3.19a-d were recovered in 96-98% ee, but partial peak overlap led to poorer resolution of second 
eluting enantiomers (74-98% ee).  The resolved compounds are quite stable to racemization at 
room temperature (see Chapter 3.2.4), but were generally stored in the freezer.  The attempted 
resolutions of 3.19e-j failed due to poor recognition by the chiral stationary phases; HPLC 
analysis showed either a single peak or nearly complete peak overlap of the two enantiomers. 
3.2.4 Studies of N-Aryl Rotational Barriers 
The barriers to rotation of the N-aryl bonds in 3.19a-c were measured by thermally racemizing 
enantioenriched samples, and following the loss of enantiopurity by HPLC.  In a typical 
procedure, a sample of the second eluting enantiomer of 3.19b was dissolved in 9:1 hexanes:i-
PrOH to make a ~2 mg/mL solution in a pressure tube.  The tube was sealed and placed in a 
preheated oil bath at 115 °C with an electronic temperature controller.  At various time intervals, 
the sealed tube was removed briefly (1-2 min) from the bath, unsealed, and a 10 L aliquot was 
removed via syringe.  The tube was resealed and replaced into the bath, and the aliquot was 
injected onto the Chiralcel OD column to measure the enantiomeric ratio (Table 3.3). 
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Table 3.3  Thermal Racemization Data for 3.19b 
Time (min) er 
NO
O
CO2Me
I
NO
O
CO2Me
I115 °C
 
0 83.3/16.7 
20 82.4/17.6 
93 81.3/18.7 
171 79.7/20.3 
254 78.2/21.8 
388 76.8/23.2 
519 74.7/25.3 
596 73.2/26.8 
 
The decreasing ee of 3.19b over time is a first-order process, and can therefore be 
quantified by the left-hand term in Equation 3.1.
141
  Here, “F3.19b” denotes the mol % fraction 
of the first eluting enantiomer, and “S3.19b” denotes the fraction of the second eluting 
enantiomer at a given time t.  The value of the left-hand side of the equation is plotted on the y-
axis against time t on the x-axis as in Figure 3.5.  In this plot, the slope is equal to the rate of 
racemization krac. 
ctkrac 







]S3.19b/[]F3.19b[1
S3.19b]/[]F3.19b[1
ln
   (Equation 3.1)
 
 
Figure 3.5  Thermal Racemization of 3.19b 
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From Figure 3.5, the slope is equal to the rate of racemization krac = 9.53 x 10
-6
 s
-1
.  
However, the rate of racemization is equivalent to twice the rate of the rotation from one 
enantiomer to another.
141
  Therefore, a “corrected” value of krot = 4.77 x 10
-6
 s
-1
 was used for the 
calculations.  This value was entered into the Arrhenius equation
60
 (Equation 3.2), and a G
‡
rot = 
32.4 kcal/mol was obtained for 3.19b at 388 K.   







Tk
hk
RTG
B
rot
rot ln
‡
   (Equation 3.2) 
 The half-life to racemization at room temperature can be approximated by using the 
G
‡
rot value and Equation 3.2 to calculate krac at 298 K.  With this value in hand, the half-life can 
be determined using Equation 3.3.  At room temperature, 3.19b has an approximate half-life to 
racemization of t1/2 = 960 years. 
rack
t
2ln
2/1      (Equation 3.3) 
  N-Boc congener 3.19a had a barrier of G
‡
rot = 32.2 kcal/mol at 115 °C, and N-Cbz 
compound 3.19c was measured at G
‡
rot = 32.1 kcal/mol at 114 °C (Figure 3.6).  These barriers 
are all high enough that the half-life for racemization is greater than t1/2 = 600 years at ambient 
temperature.  Changing the identity of the carbamate did not appreciably affect the barrier to 
rotation.  We were pleased to see that the barriers to rotation are comparable to those of axially 
chiral amides 3.38a-c.  This implies that axially chiral carbamates will retain their configuration 
just as well as amides in reactions with chirality transfer, but will have the added feature of a 
removable exocyclic group after undergoing cyclization. 
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Figure 3.6  N-Aryl Rotational Barriers of Carbamates and Amides 
3.2.5 Chirality Transfer in Cyclizations 
After resolution of substrates 3.19a-d, chirality transfer in both the optimized radical and anionic 
reactions was examined (Table 3.4).  Radical cyclization of (+)-3.19a (99/1 er) under the 
optimized conditions produced (+)-3.20a in 87% yield and 86/14 er, a chirality transfer of 87% 
(Entry 1).  Lithium-halogen exchange with (+)-3.19a effected anionic cyclization, producing (+)-
3.20a in a slightly lower yield of 72%, but with 90/10 er, a higher chirality transfer of 91% 
(Entry 3). 
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Table 3.4  Chirality Transfer in Cyclizations of Axially Chiral Carbamates 

N
R3
I
OMe
O
O
R1O

N
R3
OMe
O
3.19a-d 3.20a-d
anionic (A)
or
radical (R)
conditions
O
R1O
 
  
entry substrate
a 
R
1
 R
3 
er cond.
b 
prod.
a 
% yield
c
 er % ct
d
 
1 (P)-(+)-3.19a t-Bu Me 99/1 R (S)-(+)-3.20a 87 86/14 87 
2 (M)-(–)-3.19a   90/10 R (R)-(–)-3.20a 91 82/18 91 
3 (P)-(+)-3.19a   99/1 A (S)-(+)-3.20a 72 90/10 91 
4 (M)-(–)-3.19a   87/13 A (R)-(–)-3.20a 72 81/19 93 
5 (P)-(–)-3.19b Allyl Me 99/1 R (S)-(+)-3.20b 97 92/8 93 
6 (M)-(+)-3.19b   87/13 R (R)-(–)-3.20b 100 75/25 86 
7 (P)-(–)-3.19b   99/1 A (S)-(+)-3.20b 67 98/2 99 
8 (M)-(+)-3.19b   87/13 A (R)-(–)-3.20b 70 82/18 94 
9 (P)-(+)-3.19c Bn Me 99/1 R (S)-(+)-3.20c 93 91/9 92 
10 (M)-(–)-3.19c   89/11 R (R)-(–)-3.20c 97 77/23 87 
11 (P)-(+)-3.19c   99/1 A (S)-(+)-3.20c 74 97/3 98 
12 (M)-(–)-3.19c   89/11 A (R)-(–)-3.20c 71 82/18 92 
13 (+)-3.19d t-Bu Br 98/2 R2 (+)-3.20d 97 81/19 83 
14 (–)-3.19d   97/3 R2 (–)-3.20d 100 85/15 88 
15 (+)-3.19d   98/2 A2 (+)-3.20d 63 82/18 84 
16 (–)-3.19d   97/3 A2 (–)-3.20d 58 87/13 90 
a
 Absolute stereochemical assignments are discussed in Section 3.2.6.  
b
 Conditions R: 1.5 equiv Bu3SnH, Et3B, 
PhH, rt.  A: 1.2 equiv BuLi, 5.0 equiv TMSCl, Trapp solvent mix, –98 °C.  R2: 1.1 equiv Bu3SnH, Et3B, PhH, rt.  
A2: 1.2 equiv BuLi, 5.0 equiv TMSCl, PhMe, –91 °C.  c  Isolated by column chromatography.  d  Chirality transfer. 
 
The remaining radical reactions of enantioenriched 3.19a-d (Entries 2, 5/6, 9/10, 13/14) 
proceeded in excellent yields (87-100%) of 3.20a-d with chirality transfers in the range of 83-
93%, which are comparable to values seen in the radical cyclizations of o-iodo-N-
allylanilides.
127,133
  Iodides 3.19a-c gave lower yields of 3.20a-c (67-74%) under anionic 
conditions, but proceeded with higher chirality transfers (91-99%) than radical conditions 
(Entries 3/4, 7/8, 11/12).  This is undoubtedly partially due to the much lower temperature used 
for the Li-I exchange.  Bromine-containing 3.19d, which was subjected to anionic cyclization in 
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toluene (Entries 15/16), gave lower yields (58-63%) and chirality transfers (84-90%) only 
slightly better than those produced by radical reactions.  The excellent chirality transfers in all 
cases show that both the radical and anionic ring closures are much faster than rotation of the N-
aryl bond of the intermediate aryl radical or aryllithium.  The assignment of absolute 
stereochemistries in the case of 3.19a-c and 3.20a-c is discussed in Section 3.2.6. 
3.2.6 Determination of Absolute Configurations 
The elution orders and signs of optical rotation of enantioenriched precursors 3.19a-d and their 
products of cyclization 3.20a-d are listed in Table 3.5.  Unlike our previous work with axially 
chiral amides,
105,155
 there was no correlation between the HPLC elution order or signs of optical 
rotation between substrates 3.19a-d and their products 3.20a-d.  Matters were further 
complicated by the use of two HPLC columns with different chiral stationary phases, precluding 
correlations.  Our attempts at crystallizing a precursor/product pair failed, so comparison of the 
absolute stereochemistry of indolines 3.20a-c required derivatization.  The first step in this 
process was to convert an enantioenriched cyclized product to a compound with a known 
absolute configuration. 
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Table 3.5  Chiral HPLC Analysis of Substrate/Product Pairs 

N
R3
I
OMe
O
O
R1O

N
R3
OMe
O
3.19a-d 3.20a-d
anionic (A)
or
radical (R)
conditions
O
R1O
 
  
iodide R
1 
R
3
 column
 
elution rot.
 
prod.
 
column elution rot. 
3.19a t-Bu Me Whelk FEE
a 
+ 3.20a Whelk FEE + 
    SEE
b –   SEE – 
3.19b Allyl Me Chiralcel FEE – 3.20b Whelk FEE + 
    SEE +   SEE – 
3.19c Bn Me Chiralcel FEE + 3.20c Chiralcel SEE + 
    SEE –   FEE – 
3.19d t-Bu Br Whelk FEE + 3.20d Whelk FEE + 
    SEE –   SEE – 
a
 FEE: first eluting enantiomer.  
b
 SEE: second eluting enantiomer. 
 
Racemic 3.20b was resolved using semipreparative HPLC on the (S,S)-Whelk O1 column 
(97:3 hexanes:i-PrOH, 10 mL/min).  Enantioenriched (+)-3.20b (99/1 er) was hydrolyzed with 
aqueous NaOH in THF to produce the crude acid 3.39 in 89% yield (Scheme 3.9).  The acid was 
converted to the acid chloride, and 2-mercaptopyridine N-oxide was added with exclusion of 
light to form the crude thiohydroxamate ester.  This compound was immediately subjected to 
Barton radical decarboxylation
195
 with Bu3SnH to afford (+)-3.40 in 47% yield over 3 steps from 
(+)-3.20b.  Deprotection of the N-Alloc group with Pd(PPh3)4 and NaBH4 proceeded efficiently 
to produce (+)-3.41 in 80% yield.  Finally, acylation with benzoyl chloride produced 
enantioenriched (+)-3.42 in 61% yield.  The 
1
H NMR spectrum and optical rotation ([D
23
 +3.0, 
c 6.0 mg/mL, CHCl3) were identical with the previously reported enantioenriched compound 
([D
23
 +3.0, c 6.2 mg/mL, CHCl3).
105,127
  Comparison to an authentic sample, synthesized by Dr. 
Andre Lapierre, by analytical HPLC ((S,S)-Whelk O1, 85:15 hexane:i-PrOH, 1 mL/min) 
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confirmed the stereochemistry as (S)-3.42.  The stereochemistry of (+)-3.42 was originally 
assigned by comparison to a closely related analog whose absolute configuration was determined 
by X-ray crystallography.
105,127
    The stereochemistry of (+)-3.20b can thus be assigned as (S). 
N
CO2Me
Alloc
N
Alloc
HN N
O
PhPhCOCl
pyridine
cat. DMAP
CH2Cl2
61%
10 mol% Pd(PPh3)4
NaBH4
MeOH, 0 oC
80%
NaOH
H2O/THF
(+)-3.20b (+)-3.40
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N
CO2H
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Scheme 3.9  Absolute Configuration of (+)-3.20b by Derivatization 
 
Having determined the absolute configuration of (+)-3.20b, we performed N- 
deprotections to compare the configurations of (+)-3.20a-c (Scheme 3.10).  The carbamate group 
was removed from each of the enantioenriched cyclized products, and the resulting compounds 
were compared by analytical HPLC.  N-Boc derivative (+)-3.20a was treated with TFA to 
produce (+)-3.43 in 75% yield.  N-Cbz congener (+)-3.20c was deprotected by catalytic 
hydrogenation, giving (+)-3.43 in 80% yield.  N-Alloc derivative (+)-3.20b was treated with 
Pd(PPh3)4 and NaBH4 to produce a reasonably pure sample of (+)-3.43 which was analyzed by 
HPLC without further purification.  Each compound (+)-3.20a-c gave the same enantiomer (+)-
3.43 as determined by chiral HPLC.  Because (+)-3.20b was determined to be the (S) 
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enantiomer, all three indolines (+)-3.20a-c must be (S) as well.  The experiments shown in 
Scheme 3.10 also demonstrate the ease of carbamate deprotection from cyclized indolines. 
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Scheme 3.10  Comparison of Product Configurations by Deprotection 
 
In all cyclizations, a given enantiomer of 3.19a-d resulted in the same enantiomer of 
3.20a-d whether radical or anionic conditions were used, implying similar transition states.  By 
analogy to cyclizations of N-allyl-o-iodoanilines (see Chapter 2.2.2),
105,155
 we propose a likely 
model of chirality transfer for this system (Scheme 3.11).  When the aryl radical or aryllithium is 
formed from (M)-3.19, N-aryl bond rotation towards the alkene allows it to attack one of two 
diastereotopic faces of the olefin acceptor.  Based on the previously accepted model for 
anilides,
105
 the alkene preferentially rotates away from the incoming radical (3.44a) rather than 
towards it (3.44b), ultimately resulting in (R)-3.20.  Our results shown in Table 3 imply that the 
anionic and radical reactions likely proceed through similar transition states, though the anionic 
transition state is simplified by omitting the lithium ion. 
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Scheme 3.11  Transition State Model for Chirality Transfer 
 
Working backwards using the model of chirality transfer shown in Scheme 3.11, we 
identified the configuration of precursors to (S)-(+)-3.20a-c as (P)-3.19a-c.  Consequently, the 
(M)-atropisomer of 3.19a-c gives (R)-(–)-3.20a-c upon cyclization.  Testing on additional 
substrates would be required to determine if the correlation between (+) and (S) in cyclized 
carbamates is a trend that can be used for predictive purposes. 
3.2.7 Conclusions 
We have developed the first anionic and radical cyclizations of enantiomerically enriched axially 
chiral carbamates.  The radical cyclizations of o-iodoarylcarbamates 3.19a-d proceed in 87-
100% yield and 83-92% chirality transfer, while anionic reaction conditions on 3.19a-d proceed 
in 58-74% yield and 84-99% chirality transfer.  Chemoselective conditions for the Li-I exchange 
have been developed for bromine-containing compounds.  The N-aryl barriers to rotation were 
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measured and found to be comparable to similar o-iodoacetanilides (~ 32 kcal/mol).  Finally, the 
absolute configurations of three products were determined by derivatization and comparison to a 
compound of known stereochemistry. 
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4.0  RADICAL AND HECK CYCLIZATIONS OF DIASTEREOMERIC O-
HALOANILIDE ATROPISOMERS 
4.1 INTRODUCTION 
4.1.1 Radical Cyclizations of Axially Diastereomeric o-Iodoanilides 
Most stereoselective radical cyclizations rely on existing stereocenters in the chain between the 
radical and the olefin acceptor (“intraannular” stereocenters).  By comparison, few reactions use 
a remote, or “extraannular,” stereocenter to influence the stereochemical outcome.4,196  The 
presence of such a stereocenter creates an energy difference between two or more transition 
states of the intermediate radical.  Alternatively, extraannular stereocenters may fix the radical 
precursor in a specific conformation, leading to the generation of a radical intermediate which 
cyclizes before adopting a different conformation. 
Recent work in the Curran group has focused on the latter strategy in cyclizations of o-
iodoanilides (Scheme 4.1),
133
 based on Jones’ work.197  An equilibrium mixture of 68/32 
(M,S)/(P,S)-4.1 was resolved by preparative HPLC to obtain (M,S)-4.1 enriched to a 99/1 dr, and 
(P,S)-4.1 in a 97/3 dr.  Iodide (M,S)-4.1 was then subjected to room temperature radical 
cyclization to obtain 4.2 as a mixture of diastereomers in 73% yield.  The excellent 
diastereoselectivity of 94/6 (R,S)-4.2/(S,S)-4.2 shows that the radical initially formed from (M,S)-
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4.1 cyclizes faster than it interconverts.  Similarly, (P,S)-4.1 selectively produces (S,S)-4.2 in 
79% yield and 91/9 dr.  In these reactions, the function of the extraannular stereocenter is not to 
create a significant energy difference between two configurationally labile intermediate radicals.  
Instead, it allows for the separation of two atropisomeric precursors, leading to the preferential 
generation of only one diastereomeric radical which cyclizes with good chirality transfer. 
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Scheme 4.1  Diastereoselective Radical Cyclizations at Room Temperature 
4.1.2 Axially Chiral Anilides with Branching Near the Radical Acceptor 
The effect of stereocenters within the forming ring of axially chiral o-haloanilide radical 
cyclizations has not been studied in depth.  In one of the few existing examples, -lactam 4.3 
was reacted with Bu3SnH to produce benzocarbanepam 4.4 as a single diastereomer in 65% yield 
(Scheme 4.2).
198,199
  The reported 
1
H NMR spectrum of 4.3 does not show discrete signals for the 
two diastereomeric atropisomers 4.3a and 4.3b, which suggests rapid N-aryl rotation at room 
temperature.  Abstraction of the bromine atom by tributyltin radical produces aryl radicals 4.5a 
and 4.5b, which probably interconvert; however, only 4.5b is predisposed to cyclize.  Two 
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transition states are available for cyclization, but 4.6a is the favored one, in which the olefin 
acceptor is held away from the incoming radical.  This exclusively leads to 4.4 after Bu3SnH 
reduction.  In this case, the preexisting stereocenter controls the selectivity. 
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Scheme 4.2  Diastereoselectivity in Cyclizations of 2-Azetidinone 4.3 
 
In another interesting example,
200
 diazonium salt 4.7 cyclized under radical conditions to 
produce tricycle 4.8 in 65% yield (Scheme 4.3).  SET from tetrathiafulvalene (TTF) produces the 
radical cation TTF
+•
, nitrogen gas, and aryl radical 4.9.  Cyclization onto the N-cyclohexenyl 
group gives alkyl radical 4.10, which is trapped by TTF
+•
 to give sulfonium intermediate 4.11.
201
  
Solvolysis by water produces alcohol 4.8 as a single diastereomer and regenerates TTF.  The 
complete selectivity for cis-ring fusion suggests a favored transition state through a single axial 
diastereomer of radical 4.9.  Although diazonium 4.7 undoubtedly contains an element of axial 
chirality, the authors did not investigate this molecular feature.  Because the conformation of 4.7 
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and its resultant radical are unknown, they are drawn without explicit axial chirality in Scheme 
4.3. 
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Scheme 4.3  Radical-Polar Crossover Cyclization of a Diazonium Salt 
 
We envisioned using an ortho iodine atom in N-cyclohexenyl radical precursors similar 
to 4.7.  By increasing the steric bulk of the o-substituent, the barrier to rotation could be 
increased, allowing for isolation of the diastereomeric atropisomers at room temperature.
91,133
  
Furthermore, by adding a second o-substituent, the barriers to rotation of the atropisomers could 
be increased.  Reaction of these compounds could give insight to both the cyclization transition 
states of radicals like 4.9, as well as the rates of N-aryl bond rotation of the intermediate aryl 
radicals. 
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4.2 RESULTS AND DISCUSSION 
4.2.1 Synthesis and Configuration of Diastereomeric o-Iodoanilides 
The first series of diastereomeric anilides 4.13 was prepared as shown in Scheme 4.4.  First, 2-
iodoaniline was alkylated to produce N-cyclohexenyl aniline 4.12 in 87% yield.  This compound 
was then acylated with acetyl chloride to produce a mixture of atropisomers 4.13.  The two 
diastereomers were partially separable by column chromatography; the first eluting compound, 
anti-4.13, was isolated in 58% yield in a 95/5 dr.  The second eluting compound, syn-4.13, was 
collected in 22% yield in an 82/18 dr.  A set of o-methylated substrates was made in the same 
fashion: alkylation of 3.21 with 3-bromocyclohexene afforded 4.14 in 61% yield.  Acylation with 
acetyl chloride produced two stereopure diastereomers of 4.15 which were separable by flash 
chromatography.  The first eluting diastereomer, pure anti-4.15, was collected in 45% yield, 
followed by pure syn-4.15, which was isolated in 40% yield. 
NH2
R
R
I
K2CO3
MeCN, rt
HN
R
R
I
AcCl, K2CO3
acetone, rt
N
O
I R
R
H
N
O
R I
R
H
2-iodoaniline (R = H)
3.21 (R = Me)
4.12 (R = H)
4.14 (R = Me)
87%
61%
+
anti-4.13 (R = H)
58%, 95:5 dr
ant i-4.15 (R = Me)
45%
syn-4.13 (R = H)
22%, 82:18 dr
syn-4.15 (R = Me)
40%
Br
 
Scheme 4.4  Synthesis of Diastereomeric o-Iodoanilides 
 
The relative configurations of the atropisomers of 4.15 were determined by X-ray 
crystallography.  Single crystals of both syn- and anti-4.15 were grown by slow evaporation from 
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a 3:1 hexane:CH2Cl2 solvent mixture, and the crystal structures were solved by Dr. Steven Geib.  
Anti-4.15 crystallized with a pair of enantiomers in the unit cell; for clarity, only the (P,R) 
structure is shown in Figure 4.1.  In this structure, the planes of the amide group and the aromatic 
ring are nearly perpendicular, with a dihedral angle of 84.1°.  The N-cyclohexenyl bond is 
rotated such that the hydrogen  to the amide nitrogen is pointing toward the o-iodine.  The 
dihedral angle between this C-H bond and the N-carbonyl amide bond is 46.6°.  As expected, the 
cyclohexene ring exists in a half-chair conformation, with the amide group at the pseudoaxial 
position.  The (M,S) structure, which is also contained in the unit cell, possesses a very similar 
structure, with differences in dihedral angles of less than 2° in all instances.  In this structure, the 
iodine atom is held far from the olefin, implying that the radical derived from anti-4.15 is not 
predisposed for cyclization. 
  
N
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I
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Figure 4.1  ORTEP Representation of anti-4.15 
 
Slow evaporation of a solution containing racemic syn-4.15 deposited several crystals, 
and the one chosen for analysis consisted of only the (M,R) enantiomer, containing two unique 
structures in the unit cell (Figure 4.2).  As expected, both structures contained an N-aryl axis of 
chirality nearly perpendicular to the plane of the amide, with similar dihedral angles of 84.8° and 
85.6°.  However, the two structures differ in the orientation of the N-cyclohexenyl group.  In the 
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left structure of Figure 4.2, the allylic hydrogen alpha to nitrogen is pointed toward the o-methyl 
group, with a dihedral C-H / N-carbonyl angle of 48.5°.  In the other unique structure, the -
hydrogen is oriented towards the o-iodine, and the dihedral angle between the C-H bond and 
carbonyl-N bond is –41.5°.  This molecule showed only one set of resonances in 1H NMR 
spectra, so it is likely that these conformations rapidly interconvert in solution.  Importantly, the 
o-iodine radical precursor is in proximity to the double bond, making the radical derived from 
syn-4.15 predisposed to cyclize. 
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Figure 4.2  ORTEP Representations of syn-4.15 
 
 Chromatographic and spectroscopic behavior of syn- and anti-4.15 allowed us to 
characterize atropisomeric compounds 4.13 as anti or syn by analogy.  During column 
chromatography on silica gel, anti-4.15 was less polar than syn-4.15.  Furthermore, 
1
H NMR 
spectroscopy showed that the olefinic and allylic ( to N) protons of anti-4.15 were shifted 
downfield relative to those of syn-4.15.  After separation of the atropisomers of 4.13, the first 
eluting atropisomer indeed showed a downfield shift for the three diagnostic signals, making its 
assignment syn-4.13.  This pattern held true for all N-cyclohexenyl-o-iodoanilides prepared for 
our studies. 
  89 
4.2.2 Determination of N-Aryl Barriers To Rotation 
Because anti-4.13 and syn-4.13 are diastereomers, interconversion by rotation of the N-aryl bond 
occurs with two different barriers to rotation if Keq ≠ 1.  To determine the barriers, a sample of 
syn-4.13 (72/28 dr) was first dissolved in a 9:1 hexanes:EtOAc solvent mixture (~2 mg/mL 
concentration) in a sealable tube.  The cap was affixed, and the tube was placed in a pre-heated 
oil bath at 36 °C with digital temperature control.  At various times, the cap was removed, and a 
10 L aliquot was collected and injected onto an analytical Waters NovaPak silica HPLC 
column (90:10 hexane:EtOAc, 1 mL/min).  The ratio of diastereomers was measured over time 
until equilibrium was reached, and the final composition of the equilibrium mixture was 
confirmed by 
1
H NMR to be 65/35 anti/syn.  The first-order isomerization of syn-4.13 to anti-
4.13 was plotted against time (Figure 4.3). 
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Figure 4.3  Equilibration Plot of syn-4.13 to anti-4.13 Conversion 
 
The slope of the graph in Figure 4.3 corresponds to the rate constant of rotation from syn-
4.13 to anti-4.13 (Figure 4.4) at 36 °C, k1 = 5.16 x 10
-4
 s
-1
.  From the equilibrium values, the rate 
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constant for the reverse rotation is k-1 = 2.80 x 10
-4
 s
-1
.  By the Eyring equation,
60
 the barriers to 
rotation for these two processes at 36 °C are G
‡
rot = 22.8 kcal/mol and G
‡
rot = 23.1 kcal/mol, 
respectively.  These values are in line with the experimentally determined barrier to rotation for 
N-cyclohexyl o-iodoanilide 4.16 (Figure 4.4), which has G
‡
rot = 25.1 kcal/mol at 40 °C.
91
  The 
barriers to rotation for 4.15 were determined in the same manner as for 4.13, although heating to 
153 °C was necessary to effect rotation on a practical timescale (data can be found in Chapter 
6.6).  The rotation of syn-4.15 to anti-4.15 has a barrier of G
‡
rot = 36.0 kcal/mol, and the reverse 
process has G
‡
rot = 36.6 kcal/mol. 
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Figure 4.4  Barriers to Rotation for N-Cyclohexenyl Compounds 
4.2.3 Radical Reactions of N-Cyclohexenyl Atropisomers 
Having assigned the relative stereochemistry of the atropisomers of 4.15, we subjected both 
compounds to radical conditions (Scheme 4.5).  First, syn-4.15 was reacted with Bu3SnH (0.10 
M) and Et3B at rt, resulting in two products.  Cyclized 4.18 was isolated as the major product in 
92% yield.  A minor product consisted of directly reduced 4.17 (4%) as an inseparable mixture 
of atropisomers in a 2/1 ratio – the configurations of the atropisomers were not assigned.  To 
unambiguously confirm the identity of 4.17, catalytic hydrogenation over Pd/C produced N-
cyclohexylanilide 4.19, a racemic compound with a simpler spectrum.  Upon reacting anti-4.15 
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under radical cyclization conditions, 4.17 was obtained in 71% yield, again as a 2/1 mixture of 
atropisomers.  Decreasing the Bu3SnH concentration 100-fold at room temperature to [Bu3SnH]i 
= 1.0 mM led to partial decomposition; crude NMR analysis showed significant formation of 
4.17, but no cyclized 4.18.  A radical reaction in refluxing benzene, initiated by AIBN, gave 
similar results to this room temperature experiment. 
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Scheme 4.5  Radical Reactions of syn- and anti-4.15 
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The preference for syn-4.15 to cyclize can be explained by analogy to radical cyclizations 
of N-allyl-o-iodoacetamides,
105
 discussed in Chapter 2.2.2.  When radical 4.20 is formed 
(Scheme 4.6), the preferred conformation of the allyl group holds the olefin acceptor away from 
the radical center.  This results in cyclization to 4.21, which is eventually reduced by Bu3SnH.  
The N-cyclohexenyl system likely goes through a similar transition state, except that the 
conformation of the olefin acceptor in radical 4.22a is fixed.  Cyclization to 4.23 can only occur 
from the “bottom” face of the olefin, accounting for the cis ring fusion in the product.  The 
failure of anti-4.13 to cyclize implies that the aryl radical 4.22b generated by iodine abstraction 
cannot undergo N-aryl bond rotation to 4.22a before undergoing some other process.  Therefore, 
N-aryl rotation of the intermediate aryl radical must be slow relative to reduction, due to the 
steric hindrance of the o-methyl group. 
N
O H
H
H
H
H
N
O H
H H
O
N
H
H
H
H
H
O
N
H
H
H
4.20 4.21
4.22a 4.23
N
O H
H H
I
syn-4.15
Bu3Sn
N
O H
H H
ant i-4.15
Bu3Sn
N
O H
H H
4.22b
Bu3SnH
4.18
Bu3SnH 4.17
or side reactions
I
 
Scheme 4.6  Transition State Analysis for Cyclizations Onto N-Cyclohexenyl Group 
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The Bu3SnH-mediated radical reactions of atropisomerically enriched 4.13 gave 
strikingly different results than those of 4.15.  A 12:82 anti:syn mixture of 4.13 was dissolved in 
a minimal amount of benzene with Bu3SnH, and Et3B initiator was added extremely rapidly to 
the stirred solution (Scheme 4.7).  Despite the high initial concentration of hydride ([Bu3SnH]i = 
0.83 M), cyclization predominated, giving 4.23 in 81% yield and the product of direct reduction, 
4.24, in 6% isolated yield.  When a 95:5 syn:anti mixture was reacted under the same conditions, 
similar results were obtained.  Cyclized 4.23 was isolated in 76% yield, and directly reduced 
4.24 was collected in 10% yield. 
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Scheme 4.7  Radical Reactions of syn- and anti-4.13 
 
From our studies on 4.15, we know that cyclization only occurs when the aryl radical 
formed is syn to the double bond in the cyclohexene group.  Therefore, cyclization must occur 
via radical 4.25a, which can be produced directly from syn-4.13, or by an N-aryl bond rotation of 
radical 4.25b (Scheme 4.8).  Because anti-4.13 and syn-4.13 give similar results at high 
[Bu3SnH], this rotation kr must be rapid.  In the reaction of 95/5 anti/syn-4.13, at least 75% of 
radical 4.25b formed from anti-4.13 must have undergone rotation to 4.25a to account for the 
total yield of 4.23.  This implies that the rotation process is at least three times faster than the 
competing reduction by Bu3SnH. 
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Scheme 4.8  Mechanism of Formation of 4.23 and 4.24 
 
The rate constant kH for reduction of the phenyl radical is 5.2 x 10
8 
M
-1
s
-1
 at room 
temperature.
202
 In the experiments shown in Scheme 2.7, the mean tributyltin hydride 
concentration
63
 [Bu3SnH]c = 0.55 M allows us to estimate the rate of reduction of 4.25 as 2.9 x 
10
8
 s
-1
 in both reactions.  We can therefore identify a lower limit for the rotational rate constant 
of 4.25b to 4.25a of kr = 8.7 x 10
8
 s
-1
. 
4.2.4 Radical Reactions of Diastereomeric Atropisomers with Two Acceptors 
We extended our studies on the kinetics of N-aryl bond rotation by developing substrates with a 
second radical acceptor.  Work in the Jones
203
 and Curran
105,127
 groups has illustrated a 
regioselectivity effect in the cyclizations of compounds such as 4.26 and 4.27 (Scheme 4.9).  
When no second ortho substituent is present, as in 4.26, cyclization occurs exclusively onto the 
acryloyl group to give 4.28, with no trace of 4.29 in the product mixture.  When an o-methyl 
group is present, however, 4.27 cyclizes preferentially onto the N-allyl group to give 4.31, with 
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no 4.30 detected.  This difference was attributed to steric hindrance between the second o-
substituent and the N-allyl moiety, which slows the cyclization onto the crotonyl group.
105,127
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Scheme 4.9  Regioselective Cyclizations Dependent on o-Substituent 
 
Substrates 4.32 and 4.33 were designed with an additional olefin acceptor at the amide carbonyl 
(Scheme 4.10).  Acylation of 4.12 with trans-crotonyl chloride produced 4.32 in 49% yield as an 
inseparable mixture of anti/syn diastereomers in a 64/36 ratio.  While both atropisomers were 
visible by TLC analysis, N-aryl bond rotation on the flash chromatography timescale made 
separation at room temperature impossible by this method.  o-Methylated aniline 4.14 was also 
acylated with trans-crotonyl chloride to produce stable atropisomers of 4.33, which were 
separable by column chromatography.  The first eluting diastereomer, anti-4.33, was collected in 
38% yield, followed by syn-4.33, which was isolated in 29% yield. 
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Scheme 4.10  Synthesis of Competition Substrates 
  96 
These substrates were then reacted under radical conditions as shown in Scheme 4.11.  
Substrate syn-4.33 was reacted with Bu3SnH (0.01 M) and Et3B at room temperature in benzene.  
Although the initially formed radical has two 5-exo-trig pathways available, 4.34 was obtained in 
81% yield as the sole product, denoting exclusive cyclization onto the N-cyclohexenyl moiety.  
The reaction of anti-4.33 under similar conditions gave decomposition to multiple inseparable 
products in poor mass balance.  In both of these reactions, severe steric hindrance between the o-
methyl group and branched N-cyclohexenyl group likely disfavors the transition state for 
cyclization onto the crotonyl olefin, in accordance with Curran’s and Jones’ work.105,127,203 
When a 64/36 anti/syn mixture of 4.32 was treated with Bu3SnH at room temperature, a 
mixture of products was obtained.  The first eluting N-cyclohexenylindolone 4.35 was obtained 
in 46% yield as an inseparable 5:1 mixture of diastereomers.  Tricyclic 4.36 was also collected in 
53% yield. 
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Scheme 4.11  Radical Reactions of Competition Substrates 
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The pathways for formation of 4.35 and 4.36 from 4.32 are shown in Scheme 4.12.  
Radical 4.37a, formed directly from anti-4.32, can only cyclize onto the crotonyl group, 
preferentially giving cyclized radical 4.38a according to the previously discussed transition state 
model (see Chapter 2.2.2).  Bu3SnH reduction of 4.38a leads to product 4.35a.  Aryl radical 
4.37b, produced by iodine atom abstraction from syn-4.32, has two cyclization pathways 
available.  Cyclization onto the crotonyl group gives radical 4.38b, leading to product 4.35b.  
Alternatively, cyclization of 4.37b onto the cyclohexenyl group produces radical 4.39, which 
leads to product 4.36.  Aryl radicals 4.37a and 4.37b may also interconvert by an N-aryl bond 
rotation, shown by the immediately preceding work (Section 4.2.3). 
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Scheme 4.12  Mechanistic Analysis for Radical Reaction of 4.32 
 
If N-aryl rotation processes of 4.37a and 4.37b (kr, kr’) are significantly slower than 
cyclization processes (kc1, kc2, kc3) then the ratio of products 4.35a/(4.35b + 4.36) should reflect 
the starting anti/syn ratio.  However, this is not the case, and therefore 4.37a and 4.37b must 
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equilibrate to some degree before cyclizing at room temperature.  Our inability to unambiguously 
identify the major diastereomer of 4.35 precludes comparison of the rate constants of cyclization  
(kc1, kc2, kc3) to one another. 
4.2.5 Heck Reactions of Axially Chiral Diastereomers 
The Curran group has previously investigated chirality transfer in room temperature Heck 
reactions of axially chiral o-iodoanilide 4.40 (Scheme 4.13).
128
  In these reactions, the axis of 
chirality of the substrates dictated the stereochemistry of the product 4.41.  After oxidative 
insertion, the arylpalladium intermediate was able to selectively coordinate with one face of a 
freely rotating olefin, leading to chirality transfers of 86-91%.  
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Scheme 4.13  Asymmetric Room Temperature Heck Reactions 
  
Because substrates 4.15 have restricted rotation about both the N-aryl and N-
cyclohexenyl bonds, we surmised that one atropisomer would cyclize under Heck conditions, 
while the other would fail to react.  We subjected both diastereomers of 4.15 to room 
temperature Heck conditions (Scheme 4.14), which were developed by Hartwig,
204
 in order to 
minimize rotational processes in the substrates and intermediates.  Surprisingly, when syn-4.15 
was treated with catalytic Pd2(dba)3 and P(t-Bu)3 ligand with Et3N base, no cyclization to 4.42 
occurred.  When the same conditions were applied to syn-4.15 in the presence of excess t-butyl 
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acrylate, intramolecular coupling product 4.43 was obtained in 69% yield.  The room 
temperature Heck reaction of anti-4.15 effected intramolecular cyclization, producing 74% of 
4.42a/b as an inseparable mixture of olefin isomers in a 55:45 ratio.  Performing the Heck 
reaction of anti-4.15 in the presence of 4.0 equiv t-butyl acrylate formed t-butyl adduct 4.44 in 
31% yield, and 4.42a/b was isolated as a 25:75 mixture in 68% yield. 
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Scheme 4.14  Room-Temperature Heck Reactions of 4.15 
 
In contrast to the radical reactions of 4.15, in which only the syn atropisomer can cyclize, 
only anti-4.15 is predisposed to cyclize under room-temperature Heck conditions.  Based on 
these results, a transition state model for the Heck cyclization of anti-4.15 was developed as 
shown in Scheme 4.15.  Oxidative addition of the palladium catalyst into the carbon-iodine bond 
of anti-4.15 produces arylpalladium intermediate 4.45.  N-Aryl rotation, concomitant with N-
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cyclohexenyl bond rotation, allows for coordination between the palladium and the olefin on the 
concave face of the cyclohexene ring, as in 4.46.  Migratory insertion from this face results in the 
cis ring fusion observed in the product, and gives intermediate 4.47.  Only one hydrogen is 
available for syn -hydride elimination, initially producing 4.42a.  Rapid palladium hydride 
reinsertion and elimination can migrate the double bond to the 2,3 position205,206 to produce 
4.42b.  The Pd
II
 species is then reduced to the active Pd
0
 by the Et3N base in solution. 
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Scheme 4.15  Transition State Model for Heck Reaction 
4.2.6 Synthesis of N-Cyclohexenyl Allylic Acetates 
In the final step of the Heck reaction, the -elimination of a heteroatomic leaving group (e.g.,     
–Cl, –OAc, –OCH3) typically proceeds more quickly than competing -hydride elimination 
when both pathways are available.
207
  Recently, Lautens and coworkers developed a procedure 
for the efficient Heck coupling of aryl iodides and allylic acetates.
208,209
  The final step of the 
reaction presumably involved a chemoselective -acetoxy elimination.  Strikingly, very little 
isomerization of the double bond was seen in most products.  We hypothesized that judicious 
placement of an acetoxy group in our substrates could avoid a palladium hydride intermediate, 
thereby circumventing isomerization. 
With this in mind, disubstituted cyclohexenes 4.51-4.52 were prepared, containing a cis-
acetoxy group relative to the anilide group (Scheme 4.16).  First, 2-iodoaniline was oxidized to a 
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nitrosoarene using m-CPBA, and the crude nitroso compound was subjected to [4 + 2] 
cycloaddition with 1,3-cyclohexadiene to produce bicyclic oxazine 4.48.  The N-O bond of 
impure 4.48 was then reductively cleaved
210,211
 using Mo(CO)6 and NaBH4 to produce pure 
alcohol 4.49 in 40% yield over three steps.  bis-Acetylation of 4.49 gave desired 4.52 in 76% 
yield as a 3:2 mixture of anti:syn atropisomers.  o-Methyl congeners 4.53 were prepared in the 
same fashion, beginning with oxidation of 3.21 to the nitroso compound followed by 
cycloaddition with 1,3-cyclohexadiene to produce impure oxazine 4.50.  Treatment of 4.50 with 
Mo(CO)6/NaBH4 failed to produce alcohol 4.51; this is likely due to the additional steric 
hindrance near the nitrogen imposed by the o-methyl group.
210,211
  The N-O bond cleavage was 
effected by reaction with TMSI in wet acetonitrile, producing pure 4.51 in 39% over three steps 
from 3.21.  bis-Acetylation of 4.51, followed by careful column chromatography, yielded anti-
4.53 (32%) and syn-4.53 (26%) as atropisomerically stable compounds. 
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Scheme 4.16  Preparation of cis-Cyclohexenyl Acetate Substrates 
 
Upon standing at room temperature, a sample of neat oil 4.52 (3:2 anti:syn) 
spontaneously formed crystals possessing an anti configuration (Figure 4.5).  The selective 
crystallization of one diastereomeric atropisomer, a dynamic thermodynamic resolution, has been 
performed previously in our group
133
 to produce diastereoenriched anilides from an equilibrium 
mixture.  The torsion angle between the amide and aromatic planes is 83.8°, essentially 
perpendicular as expected.  The cyclohexene ring exists in a half-chair conformation, with the 
bulkier amide group pseudo-equatorial and the acetate pseudo-axial.  
1
H NMR analysis of a 
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crystal fragment confirmed that anti-4.52 is the major atropisomer in CDCl3 solution after 
equilibrium is reached. 
   
N
I
O H
H
O
O
 
Figure 4.5  Crystal Structure of anti-4.52 
 
Substrates 4.56 and 4.57, possessing an acetoxy substituent trans relative to the anilide, 
were also prepared (Scheme 4.17).  Anilide 4.54
48
 was deprotonated with NaH and alkylated 
with cis-4-chlorocyclohex-2-enyl acetate,
212
 producing 4.56 in 76% yield as a 2:1 mixture of 
anti:syn atropisomers.  The N-alkylation of anilide 4.55
93,105
 met with less success due to the 
steric hindrance imparted by the o-methyl group.  The two atropisomers anti-4.57 (17%) and 
syn-4.57 (11%) were separable by column chromatography, and 42% of 4.55 was recovered. 
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Scheme 4.17  Preparation of trans-Cyclohexenyl Acetate Substrates 
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4.2.7 Radical and Heck Reactions of N-Cyclohexenyl Allylic Acetates 
Under radical conditions (Scheme 4.18), all compounds containing an allylic acetate 
group behaved similarly to unsubstituted analogs 4.13 and 4.15.  trans-Disubstituted 4.56 (3:2 
anti:syn) was treated with Bu3SnH and Et3B at room temperature and cyclized to 4.58 in 89% 
yield.  Similarly, cis-acetoxy compound 4.52 (3:2 anti:syn) efficiently cyclized to 4.59 in 92% 
yield without a trace of premature reduction.  o-Methyl substrates syn-4.57 and syn-4.53 also 
underwent cyclization under these conditions, producing 4.60 (77% yield) and 4.61 (71% yield), 
respectively.  When anti-4.57 was treated with Bu3SnH at an initial hydride concentration of 
0.01 M, multiple inseparable products were formed.  Increasing the [Bu3SnH]i to 0.21 M avoided 
the formation of these compounds and produced 4.62 in 96% yield in a 2:1 ratio of atropisomers.  
Similarly, the radical reaction of anti-4.53 afforded directly reduced 4.63 (96% yield) as a 2:1 
mixture of atropisomers. 
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Scheme 4.18  Radical Reactions of Cyclohexenyl Acetates 
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 The substrates were then subjected to Heck conditions according to a procedure 
developed by Lautens (Scheme 4.19).
208,209
  Based on our results with 4.15, the syn substrates 
were expected to be unreactive towards Heck cyclizations, and were not thoroughly examined.  
In a 10:1 MeCN:H2O solvent system, 4.52 (3:2 anti:syn) was combined with BuNMe2 base and 
catalytic Pd2(dba)3•CHCl3 along with P(o-tol)3 ligand.  The mixture was placed in a sealed tube 
and heated at 80 °C until the reaction was complete, at which point Pd black precipitated from 
the mixture.  After purification, 4.64 was obtained in 47% yield as a single olefin isomer.  Under 
the same reaction conditions, anti-4.53 produced 4.42a in 73% yield as a single olefin isomer.  
The behavior of trans-disubstituted cyclohexene systems under these conditions was studied as 
well.  Under Heck conditions, 4.56 (3:2 anti:syn) gave vinyl acetate 4.65 in 82% yield as the sole 
product.  Similarly, anti-4.57 produced vinyl acetate 4.66 in 73% yield. 
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Scheme 4.19  Heck Reactions of Cyclohexenyl Acetates 
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The mechanistic rationale for these results is shown in Scheme 4.20, using substrates 
anti-4.53 and anti-4.57 as examples.  Oxidative addition of the Pd
0
 catalyst occurs to give aryl-
Pd
II
 intermediate 4.67, followed by concomitant N-aryl and N-cyclohexenyl rotation to allow 
coordination to the olefin (4.68).  Insertion gives alkylpalladium intermediate 4.69, which 
necessarily undergoes -elimination with syn substituent R2.  In the reaction of anti-4.53, R2 is 
an acetate group; IPd
II
OAc is eliminated and is subsequently reduced by tertiary amine base.
208
  
When anti-4.57 is the substrate, R
2
 is H, and -hydride elimination occurs to give vinyl acetate 
4.66. 
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Scheme 4.20  Mechanism of Heck Reaction with Chemoselective -Elimination 
 
The ability of 4.69 to undergo -acetoxy elimination when R2 = OAc is unusual.  
Previous studies have shown that -elimination of heteroatom substituents during the Heck 
reaction proceeds with the leaving group anti-periplanar to the palladium.
207,213
  However, those 
studies were performed under acidic reaction conditions, with Pd(OAc)2 catalyst in AcOH 
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solution.  Both anti- and syn-eliminations of aryloxy groups have been observed during Heck 
reactions in the presence of trialkylamine base.
214
  The propensity for our system to undergo syn-
acetoxy elimination is indicative of a change in mechanism when switching to basic conditions.   
4.2.8 Conclusions 
The radical and Heck reactions of N-cyclohexenyl-o-iodoanilides were investigated.  Radical 
cyclizations may only occur through the syn atropisomer when an additional ortho substituent is 
present on the aromatic ring.  Heck cyclizations may only proceed through the anti isomer, 
requiring simultaneous N-aryl and N-cyclohexenyl rotation to achieve the necessary transition 
state.  The -elimination step of these Heck reactions occurs with complete syn selectivity. 
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5.0  CHIRALITY TRANSFER IN 6-EXO-TRIG CYCLIZATIONS OF -HALO-(2-
ALKENYL)ANILIDES 
5.1 INTRODUCTION 
5.1.1 Stereoselective Preparations of Dihydroquinolin-2-ones 
The dihydroquinolin-2-one moiety is rarely present in natural products.  Most of these natural 
compounds, such as pinolinone
215
 and the penigequinolines,
216
 display little to no biological 
activity.  Exploration of non-natural dihydroquinolin-2-ones, however, has revealed structures 
with great medicinal potential.  Recently, cyclopropanated quinolinones have shown promise as 
HIV-1 inhibitors.
217,218
  Other compounds being developed include selective 3 integrin 
antagonists, which may provide a treatment for osteoporosis or the angiogenesis phase of 
cancer.
219
  Despite the recent advances made with this class of molecules, relatively few methods 
exist to synthesize substituted derivatives in a stereoselective fashion. 
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Figure 5.1  Representative Natural (Left) and Non-Natural (Right) Dihydroquinolin-2-ones 
 
One of the first enantioselective routes towards dihydroquinolin-2-ones was introduced 
by Alper, who developed an asymmetric version of his palladium-catalyzed 
cyclocarbonylation.
220
  By treating 2-vinylanilines with catalytic amounts of Pd(OAc)2 and a 
chiral bidentate biphosphine ligand under a CO/H2 atmosphere, enantioenriched 
dihydroquinolin-2-ones can be obtained in excellent yields and with varying substitution 
patterns.
221,222
  However, this method is impractical for general use due to the high pressures and 
temperatures (> 40 atm, > 100 °C) required, as well as the modest and substrate-dependent 
enantioselectivities (0 – 84% ee). 
More recently, new entries to dihydroquinolin-2-ones have been developed (Scheme 5.1), 
each with its own strengths and limitations.  In the first example, dioxolanone 5.1, derived from 
readily available mandelic acid, undergoes highly diastereoselective alkylation to produce 5.2.  A 
one-pot nitro group reduction and aminolysis affords enantiopure products 5.3 in excellent 
yields.
223
  Despite the efficiency of this sequence, the scope is limited; the phenyl and hydroxy 
substituents at the 3-position are both derived from the mandelic acid starting material, and thus 
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must appear in the product.  Procter’s solid-phase approach to these systems holds more promise 
for molecular diversity.
224,225
  A three-step procedure attaches -bromoacetanilide 5.4 to solid 
support via a sulfonyl linker, and installs a Michael acceptor.  Base-induced cyclization of 5.5, 
followed by -allylation and cleavage of the linker with SmI2, produces disubstituted 
dihydroquinolinone 5.6.  This general procedure allows for alkyl substitution at the 3- and 4-
positions. However, little to no diastereoselectivity is observed, and the method cannot be 
extended to enantioselective preparations.  Harmata and co-workers have developed a more 
selective method, using chiral sulfoximines to effect diastereoselective cyclizations.
226
  Coupling 
of aryl bromide 5.7 and sulfoximine 5.8, followed by deprotonation and Michael addition, 
produces benzothiazine 5.9 as a single diastereomer.  Subsequent alkylation of 5.9, followed by 
reductive desulfurization and lactamization, affords enantiopure products 5.10 in good yields.  
This procedure allows introduction of a variety of functional groups at the 4-position of the 
dihydroquinolinone system, but does not tolerate substitution at the 3-position.  While these 
approaches are useful, they are limited in scope and selectivity, and a need still exists for more 
general methods of enantioselective dihydroquinolin-2-one production. 
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Scheme 5.1  Stereoselective Syntheses of Dihydroquinolin-2-ones 
5.1.2 Dihydroquinolin-2-ones Via 6-Exo-Trig Radical Cyclizations 
6-Exo-trig
227
 and 6-endo-trig
228
 radical cyclizations of o-iodoanilides have been used to 
construct dihydroquinolin-2-ones, but these reactions suffered from poor yields and 
regioselectivities.  In these approaches, halogen abstraction at the ortho position generates an 
aryl radical, which cyclizes onto an olefin acceptor within the amide group.  Greater success has 
been found in “reversed” systems, in which the ortho substituent is the radical acceptor group, 
and the radical is generated within the amide functionality.  In the first examples of this type, 
Ikeda and co-workers reacted ,-dichloroacetanilides 5.11a-d with Bu3SnH and catalytic AIBN 
in refluxing toluene, to cleanly produce cyclized products 5.12a-d (Scheme 5.2).
229
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Regioselectivity for 6-exo-trig cyclization was typically excellent in these systems; no 7-endo-
trig products were observed.  
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Scheme 5.2  First Radical Cyclizations of N-(o-Alkenylphenyl)--Haloacetamides 
 
More recently, Parsons and coworkers reported an undesired 6-exo-trig cyclization 
during their efforts to construct mitomycin systems by tandem radical cyclizations (Scheme 
5.3).
230
  When -chloroamide 5.13 was subjected to Ph3SnH and catalytic AIBN in refluxing 
toluene, 6-exo product 5.14 was obtained in 63% yield, along with tandem cyclization products 
5.15 and target molecule 5.16 in 16% and 12% yields, respectively.  The formation of 5.14 as the 
major product further supports the notion that this mode of cyclization is an efficient method of 
synthesizing dihydroquinolinones.  However, the competitive formation of 5.15 and 5.16, whose 
formations begin with a usually disfavored 5-endo-trig cyclization,
231
 indicates that the 6-exo-
trig cyclization is rather slow, despite the presence of the activating terminal ester substituent. 
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Scheme 5.3  Competing 5-Endo-Trig and 6-Exo-Trig Radical Cyclizations 
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In the examples discussed in Schemes 5.2 and 5.3, the -haloanilide precursors contain 
an element of N-aryl axial chirality.
50,152,232
  Because 5.11a-d and 5.13 do not possess a second 
ortho substituent, it is likely that their N-aryl barriers to rotation are low, precluding resolution.  
We envisioned a series of anilide precursors 5.17 (Scheme 5.4) with an additional ortho 
substituent to decrease the rate of racemization.  We set out to learn whether substrates 5.17 
could be resolved, and to determine whether radical cyclizations of enantioenriched 5.17 would 
proceed with chirality transfer to give enantioenriched cyclized products 5.18. 
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Scheme 5.4  Proposed 6-Exo-Trig Cyclization with Chirality Transfer 
5.2 RESULTS AND DISCUSSION 
5.2.1 Synthesis of Starting Materials 
Preparation of substrates 5.17 began with the installation of a variety of N-substituents on an 
array of o-iodoanilines (Scheme 5.5).  Deprotonation of 3.21 with LDA, followed by alkylation 
with methyl iodide, provided N-methylated 5.19 in 84% yield.  Alternatively, N-PMB congener 
5.20 was prepared in 83% yield from 3.21 by reductive amination at room temperature with p-
anisaldehyde and NaBH(OAc)3.
233
  Boc-deprotection of 5.21
234
 with TFA, followed by reductive 
amination to install the N-PMB group, provided 5.22 (76% yield) in a simple one-pot operation.  
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Treatment of 3.21 with tosyl chloride in pyridine readily provided 5.23 in 90% yield.  Synthesis 
of 5.24 via acid-mediated reductive amination failed, owing to the sensitivity of the o-TMS 
group to TFA.  Success was achieved by deprotonation of 3.27 with LiHMDS and alkylation 
with p-methoxybenzyl bromide (81% yield).  Condensation of 3.23 with p-anisaldehyde did not 
proceed at room temperature, but refluxing these compounds in toluene with azeotropic removal 
of water effected the transformation.  Reduction of the resulting imine with TFA/NaBH(OAc)3 
cleanly provided 5.25 in 72% yield. 
NH
MeO
Boc
I
NH
MeO
PMB
I
1. TFA, CH2Cl2
0 °C to rt
2. p-anisaldehyde
NaBH(OAc)3, rt
76%
NH2
I
NH2
I
TMS
NH2
I
LDA, MeI, THF
-78 °C to rt
84%
I
NH p-anisaldehyde
TFA, NaBH(OAc)3
EtOAc, rt
83%
NH
I
PMB
5.19 5.20
Br
NH2
I
1. p-anisaldehyde
cat. TFA, PhMe, 
2. TFA, NaBH(OAc)3
EtOAc, rt
72%
Br
NH
I
PMB
5.25
NH2
I
TsCl
pyridine, rt
90%
NH
I
Ts
5.235.22
LiHMDS, PMBBr
THF, -78 °C to rt
81%
TMS
NH
I
PMB
5.24
5.21
3.21 3.21
3.21
3.27 3.23  
Scheme 5.5  Preparation of N-Substituted Anilines 
 
Next, the aryl iodide was used as a handle to install various olefinic radical acceptors by 
palladium-mediated methods (Scheme 5.6).  Ligand-free Heck reactions
235
 coupled 5.19-5.24 
with tert-butyl acrylate to cleanly produce 5.26a-e (77-92% yields).  With o-bromo compound 
5.25, the Jeffery-Larock protocol
236
 effected chemoselective
237,238
 coupling with t-butyl acrylate 
to furnish 5.26f in 81% yield at room temperature.  These conditions were also used to couple 
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5.20 with acrylonitrile; however, higher temperatures were required for reaction, and ,-
unsaturated nitrile 5.26g was obtained in 45% yield.  The ligand-free Heck conditions were 
applied to coupling with 4-bromostyrene; however, the reaction was not clean, and 5.26h was 
only produced in 29% yield.  Finally, a geminal-dimethyl olefin acceptor was installed through a 
Negishi coupling
239
 of 5.20 and (2-methylprop-1-enyl)zinc halide formed from the 
corresponding Grignard reagent, producing 5.26i in 98% yield. 
NH
R1
R2
R3
I
t-butyl acrylate
K2CO3
3.5 mol% Pd/C
DMF, 130-140 °C
NH
R1
R2
R3
Ot -Bu
O
5.19-5.24 5.26a-e
Product
5.26a
5.26b
5.26c
5.26d
5.26e
R1 R2 R3 % yield
Me
PMB
PMB
Ts
PMB
Me
Me
OMe
Me
TMS
Me
Me
H
Me
Me
92%
82%
85%
90%
77%
NH
PMB
I
4-bromostyrene
K2CO3
3.5 mol% Pd/C
DMF, 130-140 °C
29%
NH
PMB Br
NH
PMB
Br I
t-butyl acrylate
Bu4NBr, KOAc
20 mol% Pd(OAc)2
4Å MS, DMF, rt
81%
NH
PMB
Br
Ot -Bu
O NH
PMB
I
acrylonitrile
Bu4NBr, KOAc
10 mol% Pd(OAc)2
4Å MS, DMF, 80 °C
45%
NH
PMB
CN
NH
PMB
I
NH
PMB
BrMg
ZnCl2
5 mol% Pd(dppf)Cl2
THF, rt, 98%
5.26f 5.26g
5.26h 5.26i
5.25 5.20
5.20 5.20  
Scheme 5.6  Installation of Radical Acceptor Groups 
 
With 5.26a-i in hand, a general two-step sequence gave access to racemic -iodide 
precursors 5.17a-i as depicted in Table 5.1.  N-Acetylation of 5.26a-i with chloroacetyl chloride 
provided -chloroamides 5.27a-i (74 – 98% yields) as racemates.  These -chloramides 
underwent halogen exchange under typical room temperature Finkelstein conditions to produce 
-iodoamide substrates 5.17a-i (78 – 96% yields).  The reactions proceeded uneventfully in all 
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cases, except for the transformation of 5.27e to 5.17e, which required prolonged refluxing.  It is 
likely that the o-TMS group of 5.27e sterically hinders the reaction site, slowing the backside 
attack of iodide. 
 
Table 5.1  Preparation of -Haloacetamide Substrates 
NH
R1
R2
R3
R4
R5 Et3N
CH2Cl2, 0 °C
Cl
O
Cl N
R1
R2
R3
R4
R5
Cl
O
NaI
acetone, rt
N
R1
R2
R3
R4
R5
I
O
5.27a-i 5.17a-i5.26a-i  
 
substrate R
1
 R
2 
R
3 
R
4 
R
5 -Cl 
amide 
% yield
a -I 
amide 
% yield
a 
5.26a Me Me Me CO2t-Bu H 5.27a 90 5.17a 93 
5.26b PMB Me Me CO2t-Bu H 5.27b 97 5.17b 92 
5.26c PMB OMe H CO2t-Bu H 5.27c 85 5.17c 98 
5.26d Ts Me Me CO2t-Bu H 5.27d 89 5.17d 78 
5.26e PMB TMS Me CO2t-Bu H 5.27e 99 5.17e 96
b 
5.26f PMB Br Me CO2t-Bu H 5.27f 90 5.17f 91 
5.26g PMB Me Me 4-BrC6H4 H 5.27g 89 5.17g 86 
5.26h PMB Me Me CN H 5.27h 74 5.17h 86 
5.26i PMB Me Me Me Me 5.27i 98 5.17i 88 
a
 Yield of racemate after isolation by column chromatography.  
b
 The reaction mixture was refluxed for 40 h and 
reaction progress was monitored by GC. 
5.2.2 Reaction Optimization and Substrate Screening 
With -iodides 5.17a-i in hand, we set out to determine optimal cyclization conditions on 
racemic compounds, while also probing the scope of the reaction.  To a solution of 5.17a and 
Bu3SnH (10 mM) in PhH at rt was added Et3B initiator.  After 5 min, TLC analysis of the 
reaction mixture showed complete consumption of 5.17a.  The solvent was removed, and the 
crude mixture was directly chromatographed on 10% w/w KF/silica gel
80
 to efficiently remove 
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tributyltin byproducts.  This reaction provided cyclized product 5.18a in 55% yield, but 
purification was complicated by the presence of small amounts of directly reduced 5.28a.  The 
reaction of 5.17b under similar conditions produced 5.18b in 72% yield, along with small 
amounts of 5.28b.  To minimize premature reduction, we employed syringe pump conditions.  
Bu3SnH and Et3B initiator were dissolved in rigorously degassed PhH, and this solution was 
added dropwise over 2 h to a non-degassed PhH solution of substrates 5.17a-b at room 
temperature.  We were pleased to see that these conditions both increased the yields of 5.18a and 
5.18b to 83% and 85%, respectively (Table 5.2, Entries 2 and 4), and no 5.28a-b was observed 
in the product mixture. 
Substrates 5.17c,e,f behaved similarly, cyclizing in 61-97% yields (Entries 5, 7, 8).  
Especially notable is the surprising stability of o-silylated 5.18e (Entry 7) to the chromatography 
conditions; no desilylation was observed despite the KF treatment.  Unsaturated nitrile 5.17h 
cyclized to 5.18h under syringe pump conditions, but coeluted with numerous impurities that 
made purification impossible (Entry 11).  Adding all Bu3SnH at the outset of the reaction 
suppressed most of the side products, and allowed 5.18h to be formed in 70% yield in ~ 95% 
purity.  A lower yield in the cyclization of 5.17i to 5.18i (51%) was not surprising, as 
cyclizations onto olefins with terminal alkyl substituents are approximately 700 times slower
18,59
 
than those with terminal ester substituents.  A small amount of the sole side product was isolated 
during purification and identified as the product of premature reduction 5.28i. 
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Table 5.2  Cyclizations of Racemic -Iodoamides 5.17a-i 
N
R1
R2
R3
R4
R5
I
O
rac-5.17a-i
1.2 equiv Bu3SnH
1.0 equiv Et3B
conditions
PhH, rt
N
R1
R2
R3
R4
R5
O
rac-5.18a-i
+
N
R1
R2
R3
R4
R5
O
rac-5.28a-i  
   
entry -I R
1
 R
2 
R
3 
R
4 
R
5
 cond.
a cyc. 
product 
% yield
b 
1 5.17a Me Me Me CO2t-Bu H B 5.18a 55
d 
2 5.17a Me Me Me CO2t-Bu H A 5.18a 83 
3 5.17b PMB Me Me CO2t-Bu H B 5.18b 72
d 
4 5.17b PMB Me Me CO2t-Bu H A 5.18b 85 
5 5.17c PMB OMe H CO2t-Bu H A 5.18c 97 
6 5.17d Ts Me Me CO2t-Bu H A 5.18d nd
c,d 
7 5.17e PMB TMS Me CO2t-Bu H A 5.18e 93 
8 5.17f PMB Br Me CO2t-Bu H A 5.18f 61 
9 5.17g PMB Me Me 4-BrC6H4 H B 5.18g nd
c 
10 5.17g PMB Me Me 4-BrC6H4 H A 5.18g nd
c 
11 5.17h PMB Me Me CN H A 5.18h < 71 
12 5.17h PMB Me Me CN H C 5.18h 70 
13 5.17i PMB Me Me Me Me A 5.18i 51
d 
a
 Conditions A: Bu3SnH and Et3B in 20 mL PhH were added over 2 h via syringe pump to a stirred 10 mM PhH 
solution of iodide.  B: neat Bu3SnH and Et3B were added sequentially in one portion to a stirred PhH solution of 
iodide with [Bu3SnH]i = 10 mM.  C: Same as B with [Bu3SnH]i = 5 mM.  
b
 Yield of racemic 5.18a-i after isolation 
by column chromatography on 10% w/w KF/silica gel.  
c
 nd = not determined.  
d
 Directly reduced 5.28 was detected 
in crude reaction mixture by TLC or 
1
H NMR. 
 
Not all substrates were able to cyclize in an efficient manner.  The reaction of N-tosyl 
compound 5.17d gave an inseparable mixture of products in 90% mass balance after 
chromatography (Entry 6).  Synthesis of the product of direct reduction 5.28d
240
 and comparison 
of 
1
H NMR spectra showed that 5.28d made up approximately 80% of the product mixture; little 
or no cyclization product was observed.  The reaction of substrate 5.17g, containing an aromatic 
olefin substituent, resulted in decomposition (Entry 9) with no major product identifiable by TLC 
or 
1
H NMR analysis of the reaction mixture.  Adding all Bu3SnH reducing reagent at 10 mM 
concentration before Et3B initiation led to similar results (Entry 10).  It is likely that reduction of 
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the cyclized benzylic radical by Bu3SnH is slow enough (kH = 3.6 x 10
4
 M
-1
 s
-1
 at 298 K)
241
 that, 
under the low Bu3SnH concentrations employed in this reaction, side reactions of the radical 
occur before reduction. 
5.2.3 Rate Constant Measurements 
The necessity of syringe pump conditions to avoid premature reduction in reactions of 
compounds 5.17a-i implies a small rate constant of 6-exo-trig cyclization.  The rate constant of 
6-exo-trig cyclization of the parent 6-heptenyl radical
4,17,63
 is kC = 5.0 x 10
3
 s
-1
.  However, 
because all atoms connecting the radical precursor and radical acceptor are sp
2
-hybridized in 
5.17a-i, no direct comparison to the all-sp
3
 6-heptenyl system can be made.  Therefore, kinetic 
competition experiments
63
 were undertaken to determine the cyclization rate constant kC for the 
reaction of a representative compound 5.17b, using GC analysis as described in Chapter 1.2.2. 
An authentic sample of 5.28b was prepared in 92% yield by treating 5.26b with acetyl 
chloride.
240
  The GC retention times of 5.18b and 5.28b were then determined with respect to 
eicosane, which was used as an internal standard in competition experiments.  This allowed for 
determination of absolute yields in each reaction. 
The competition experiments were performed by mixing stock PhH (non-degassed) 
solutions of 5.17b (0.025 mmol), Bu3SnH (0.030 mmol), and eicosane internal standard in round 
bottom flasks open to the atmosphere.  A hexanes solution of Et3B (0.010 mmol) was added all 
at once.  The initiator solution was included in the total volume during calculations, but 
accounted for no more than 2.5% of the total reaction volume in any experiment.  The reaction 
mixtures were stirred for 10 min, and were then injected onto the GC without workup or dilution.  
Three trials were performed at each concentration, and the results of these reactions are 
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summarized in Table 5.3.  Reactions were very clean and went to completion in all cases, and no 
significant side peaks were observed in GC analysis. 
 
Table 5.3  Kinetic Competition Experiments for 5.17b 
N
PMB
CO2t-Bu
I
O
Bu3SnH
Et3B
PhH, rt
5.17b
N
PMB
CO2t-Bu
O
5.28b
N
PMB
CO2t-Bu
O
5.18b
+
 
 
   products (% yield)
a
   
 
[Bu3SnH]i
b
 [Bu3SnH]c
c
 5.18b
 
5.28b total
 
red : cyc
d 
14.9 mM 8.7 mM 67 21 89 24 : 76 
19.9 mM 11.6 mM 64 25 89 28 : 72 
27.0 mM 15.8 mM 59 30 88 33 : 67 
37.0 mM 21.6 mM 58 39 97 40 : 60 
49.2 mM 28.7 mM 50 46 95 48 : 52 
58.8 mM 34.3 mM 45 45 90 50 : 50 
73.2 mM 42.7 mM 33 43 76 57 : 43 
a
 GC yield, using eicosane as an internal standard.  Yields are an average of three trials.  
b
 Initial concentration of 
Bu3SnH.  
c
 Average concentration of Bu3SnH during consumption of starting material.  
d
 The ratio of reduced 5.18b 
to cyclized 5.28b. 
 
The reactions of 5.17b gave highly reproducible results at all concentrations, with 
excellent mass balances (76-95%) throughout.  As expected, the ratio of reduced product 5.28b 
increased with respect to 5.18b as the concentration of tin hydride reducing agent increased.  As 
seen in Scheme 5.7, initially formed -amide radical 5.29 may cyclize to -ester radical 5.30 
with rate constant kC, eventually producing cyclized 5.18b.  Alternately, 5.29 may be directly 
reduced to 5.28b in a process whose rate depends on Bu3SnH concentration.  The 
reduction:cyclization ratio was plotted against the mean tributyltin hydride concentration 
[Bu3SnH]c as shown in Figure 5.2, in which the slope of the resulting line is equal to kH/kC. 
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O
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N
PMB
CO2t-Bu
O
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O
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Scheme 5.7  Competing Reactions of Radical 5.29 
 
Figure 5.2  Kinetic Competition Plot of 5.17b 
 
We calculated the cyclization rate constant kC from the data in the kinetic plot.  Because 
primary -amidoyl radicals undergo reduction by Bu3SnH at the same rate as primary alkyl 
radicals,
242
 the rate constant for reduction of 5.29 at room temperature was taken to be kH = 2.31 
y = 28.88x + 0.057
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x 10
6
 M
-1
s
-1
 based on existing rate data.
65,66
  From this value and the slope of the kinetic plot, the 
rate constant for cyclization of radical 5.29 was calculated to be kC = 8.0 x 10
4
 s
-1
.  This 
cyclization is over an order of magnitude faster than the all-carbon 6-exo-trig cyclization of the 
6-heptenyl radical (kC = 5.0 x 10
3
 s
-1
 at 298 K),
4,17,243
 and is slightly faster than the 5-endo-trig 
cyclization of 1.22 from Chapter 1.1.2 (kC = 1.9 x 10
4
 s
-1
 at 298 K).
3
  These findings are in line 
with the 5-endo / 6-exo competition experiments of Parsons (Scheme 5.3).
230
 
The slightly positive value of the intercept in the kinetic plot raises the possibility that the 
cyclization may be reversible.  The value of the intercept
63
 in Figure 5.2 is equal to (kH·k–
C)/(kC·kH') where k–C is the rate constant of ring opening of 5.30 and kH' is the rate constant for 
Bu3SnH reduction of 5.30, which is taken to be kH' = 1.47 x 10
6
 s
-1
 based on measurements by 
Chatgilialoglu.
65,66
  Using these values, we calculated a ring opening rate constant for 5.30 of k–C 
= 2.9 x 10
3
 s
-1
, almost 30 times slower than cyclization.  Further experiments would be needed to 
verify the reversibility of 6-exo-trig cyclization in the reaction of 5.17b. 
5.2.4 Resolution of Substrates 
In order to perform chirality transfer experiments, enantioenriched samples of 5.17a-c,e-f,h-i 
were obtained by resolution on semipreparative chiral HPLC.  Typically, samples of 5.17 were 
dissolved in i-PrOH, and injected onto either a Chiralcel OD or (S,S)-Whelk-O 1 column (25.0 
cm x 21.1 mm ID) eluting with a hexane:i-PrOH solvent mixture.  A hexane:EtOAc solvent 
system was used for 5.17h because of complete insolubility in i-PrOH.  Depending on the ease of 
separation, a 40–120 mg sample of racemic 5.17 was resolved per injection.  After fraction 
collection and solvent removal, the enantiomeric ratios of the resolved compounds were 
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measured by analytical chiral HPLC.  Most compounds were recovered in > 97% ee, and all 
resolved compounds were stored in a freezer to avoid racemization. 
Most compounds were resolved without difficulty; however, the rotational dynamics of 
N-methyl congener 5.17a led to complications.  Iodide 5.17a exists as a 14:1 E:Z ratio of amide 
rotamers which are visible by TLC analysis but not isolable under ambient laboratory conditions.  
Analytical HPLC (Whelk, 80:20 hexanes:i-PrOH, 1 mL/min) showed a small peak at 10.5 min, 
followed by two large peaks at 14.5 min and 18.5 min that were nearly equal in area.  HPLC 
analysis of the resolved fractions allowed us to interpret the chromatogram of racemic 5.17a.  
The peak at 10.5 min is the minor amide rotamer of (–)-5.17a, and the major amide rotamer of 
(+)-5.17a elutes at 14.5 min.  The minor amide rotamer of (+)-5.17a and the major amide 
rotamer of (–)-5.17a overlap at 18.1 min.  A plateau between the minor and major amide rotamer 
peaks of each enantiomer indicates slow interconversion at room temperature, and therefore a 
larger barrier to amide rotation than is typical (G‡rot ≈ 22-23 kcal/mol).
50
  While this introduced 
difficulties into determining the er of resolved 5.17a, the relatively small proportion of the minor 
rotamer (6.7%) should keep the error at a reasonable amount. 
After resolution, four substrates (5.17b, 5.17c, 5.17f, 5.27c) were chosen for racemization 
studies to measure their respective barriers to N-aryl bond rotation.  As described in Chapter 
3.2.4, enantioenriched samples were dissolved in a 90:10 hexane:i-PrOH solvent mixture, and 
heated in a sealed tube at an appropriate temperature.  The racemization was monitored by 
periodically measuring the er of aliquots of the solution by analytical chiral HPLC.  
Racemization data is available in the Experimental section (Chapter 6.6). 
The barrier to rotation of o-methyl substrate 5.17b was surprisingly high, with a G‡rot = 
34.3 kcal/mol (143.7 kJ/mol).  The o-Br substrate 5.17f had an essentially similar barrier of 34.2 
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kcal/mol (142.9 kJ/mol), a result in line with previous observations.
108,132
  The barrier to rotation 
of o-methoxy substrate 5.17c was rather low, with G‡rot = 26.3 kcal/mol (109.9 kJ/mol).  The 
experimental 8.0 kcal/mol barrier difference between 5.17b and 5.17c is significantly larger than 
that predicted by Sternhell’s biphenyl model,244 which predicts a 2.3 – 3.8 kcal/mol difference.  
Finally, replacing the -iodine atom with a chlorine atom in 5.27c led to only a 1.0 kcal/mol 
lowering of the barrier (Figure 5.3).  The barriers to rotation are high enough that the 
enantioenriched iodides can all be handled at ambient temperature without rapid racemization; o-
methoxy substrate 5.17c, however, is much less stable and should be kept from sources of heat to 
avoid loss of enantiopurity. 
R
N
PMB
O
I
CO2t-Bu MeO
N
PMB
O
X
CO2t-Bu
5.17b (R = Me)
34.3 kcal/mol at 140 oC
t1/2 at 25
oC = 25,200 years
5.17f (R = Br)
34.2 kcal/mol at 143 oC
t1/2 at 25
oC = 21,400 years
5.17c (X = I)
26.3 kcal/mol at 55 oC
t1/2 at 25
oC = 12 days
5.27c (X = Cl)
25.3 kcal/mol at 52 oC
t1/2 at 25
oC = 2.4 days  
Figure 5.3  Barriers to Rotation and Half-Lives of Racemization for -Haloacetamides 
5.2.5 Chirality Transfer in 6-Exo-trig Cyclizations 
Enantioenriched samples of 5.17a-c,e-f,h-i were subjected to optimized reaction 
conditions for reductive cyclization.  The cyclized products were isolated by column 
chromatography, and enantiopurities were determined by analytical chiral HPLC with 
comparison to racemic material.  The results of this series of experiments are shown in Table 5.4.  
Both enantiomers of each substrate were tested, and resulted in similar chirality transfers within 
experimental error.  Isolated yields of each reaction were comparable to yields of reactions with 
racemic substrate (Table 5.2) in each case.  N-Methyl substrate 5.17a cyclized with 92-99% 
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chirality transfer (Entries 1-2).  N-PMB substrates 5.17b-f with a terminal ester acceptor 
consistently cyclized to 5.18b-f with chirality transfers of 94-96% (Entries 3-10) regardless of 
ortho substituent.  Substrate 5.17h, containing a terminal nitrile substituent, also cyclized to 
5.18h with excellent chirality transfer of 93-97% (Entries 11-12).  Compound 5.17i gave 5.18i in 
modest chirality transfer of 80-81% (Entries 13-14), likely reflecting a longer time for the 
intermediate radical to racemize before the slower cyclization occurs.  These values of chirality 
transfer are comparable to those observed in room temperature cyclizations of N-allyl-o-
iodoacetamides (74-97%)
105
 and N-acryloyl-o-iodoanilides (49-94%).
108
 
 
Table 5.4  Chirality Transfer in Cyclizations of 5.17a-i 

N
R1
R2
R3
R4
R5
I
O
5.17a-i
N
R1
R2
R3
 R4
R5
O
5.18a-i
1.2 equiv Bu3SnH
1.0 equiv Et3B
PhH, rt
 
 
entry precursor R
1 
R
2 
R
3 
R
4 
R
5 
er cond.
a 
product % yield
b 
er % ct
d
 
1 (+)-5.17a Me Me Me CO2t-Bu H 98.5/1.5 A (–)-5.18a 79 91/9 92 
2 (–)-5.17a Me Me Me CO2t-Bu H 85/15 A (+)-5.18a 81 84/16 99 
3 (+)-5.17b PMB Me Me CO2t-Bu H 100/0 A (–)-5.18b 87 95/5 95 
4 (–)-5.17b PMB Me Me CO2t-Bu H 100/0 A (+)-5.18b 85 96/4 96 
5 (+)-5.17c PMB OMe H CO2t-Bu H 99/1 A (–)-5.18c 94 93/7 94 
6 (–)-5.17c PMB OMe H CO2t-Bu H 99/1 A (+)-5.18c 96 93/7 94 
7 (+)-5.17e PMB TMS Me CO2t-Bu H 100/0 A (+)-5.18e 95 95/5 95 
8 (–)-5.17e PMB TMS Me CO2t-Bu H 100/0 A (–)-5.18e 93 94/6 96 
9 (P)-5.17f
c 
PMB Br Me CO2t-Bu H 99/1 A
 
(S)-5.18f
c
 63 95/5 96 
10 (M)-5.17f
c 
PMB Br Me CO2t-Bu H 0/100 A
 
(R)-5.18f
c
 66 94/6 94 
11 (+)-5.17h PMB Me Me CN H 99.5/0.5 C
 
(–)-5.18h 71 93/7 93 
12 (–)-5.17h PMB Me Me CN H 99/1 C (+)-5.18h 68 96/4 97 
13 (+)-5.17i PMB Me Me Me Me 99/1 A (+)-5.18i 57 80/20 81 
14 (–)-5.17i PMB Me Me Me Me 0/100 A (–)-5.18i 55 80/20 80 
a
 Conditions A: Bu3SnH and Et3B in 20 mL PhH were added over 2 h via syringe pump to a stirred 10 mM PhH 
solution of iodide.  C: neat Bu3SnH and Et3B were added sequentially in one portion to a stirred PhH solution of 
iodide with [Bu3SnH]i = 5 mM.  
b
 Yield of 5.18 after isolation by column chromatography on 10% w/w KF/silica 
gel.  
c
 Absolute stereochemistry determined by X-ray crystallography.  
d
 Percent chirality transfer. 
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5.2.6 Crystal Structures of a Precursor / Product Pair and Model of Chirality Transfer 
To propose a model for chirality transfer, the absolute configurations of an enantioenriched 
precursor 5.17f and its product 5.18f were determined.  Because 5.17f exists as a non-
crystallizable semisolid as either a racemate or a single atropisomer, conversion to a suitable 
derivative was necessary.  To this end, a sample of (+)-5.17f (99/1 er) was treated with TFA in 
CH2Cl2 to cleave the t-butyl ester, producing solid ,-unsaturated acid (+)-5.31 in 71% yield 
(Figure 5.4).
240
  This acid was crystallized by the slow vapor diffusion method, by first 
dissolving (+)-5.31 in ethyl acetate and allowing hexanes to diffuse into this solution.  The 
crystal structure was solved by Dr. Steven Geib, and the absolute configuration was determined 
by using the anomalous scattering method.
245,246
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Figure 5.4  ORTEP Diagram of (P)-5.31 
 
Acid (+)-5.31 crystallized with four unique molecules in the unit cell, as two pairs of 
dimers displaying hydrogen bonding between the carboxylic acid groups.  The differences in 
geometries between the four structures are small, and consist of different dihedral angles 
between either the PMB methoxy group and the aromatic ring, or the carbon-iodine single bond 
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with the double bond of the carbonyl group.  For simplicity, only one of the four molecules is 
shown in Figure 5.4. 
In this structure, the plane of the aromatic ring is almost completely orthogonal to the 
plane of the amide, with a torsion angle of 83.4°.  The olefin acceptor exists in the s-trans 
conformation, and is twisted slightly out of planarity with the aromatic ring (torsion angle = 
156.2°).  Interestingly, the N-PMB group is twisted to the same side of the molecule as the ,-
unsaturated carboxylic acid function, with their planes nearly parallel.  This can possibly be 
attributed to - stacking247 between the electron-rich aromatic ring and the electron-deficient 
olefin.  The 3.32–3.86 Å distance range between the two quasi-parallel planes is ideal for this 
interaction.
248
  The other three unique structures in the crystal lattice displayed similar 
characteristics for these molecular features, and most importantly, all possess the same absolute 
configuration, allowing us to assign (+)-5.17f as (P). 
Although racemic and enantioenriched 5.18f were originally isolated as oils, (+)-5.18f 
(Table 5.4, Entry 9) spontaneously solidified upon standing.  Slow vapor-phase diffusion in a 
CHCl3 / hexane solvent system produced crystals of 5.18f suitable for X-ray crystallography.  
This structure was also solved by Dr. Geib, and is shown in Figure 5.5.  Due to the presence of 
the bromine heavy atom, the anomalous scattering method allowed us to determine the absolute 
stereochemistry of (+)-5.18f as (S). 
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R = -CH2CO2t-Bu  
Figure 5.5  ORTEP Diagram of (S)-5.18f 
 
Based on these results, a model of chirality transfer for the formation of (S)-5.18f from 
(P)-5.17f was put forth, shown in Scheme 5.8.  Iodine abstraction by a tributyltin radical 
produces -amidoyl radical 5.32.  While the N-aryl bond rotates to bring the olefin acceptor into 
proximity with the radical, a slight aryl-olefin bond rotation allows the double bond to twist 
towards the radical, resulting in cyclized intermediate 5.33.  Reduction of 5.33 produces cyclized 
product (S)-5.18f. 
N
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t-BuO2CH
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O
t-BuO2C Br Bu3SnH
(P)-5.17f 5.32 5.33 (S)-5.18f  
Scheme 5.8  Model of Chirality Transfer for 6-Exo-trig Cyclizations 
 
Unfortunately, there is no correlation between the optical rotation sign or HPLC elution 
order of substrates 5.17a-i and the respective products of cyclization 5.18a-i.  Because no clear 
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pattern exists, the absolute configuration of the remaining precursor/product pairs cannot 
currently be determined. 
5.2.7 Preparation and Chirality Transfer of a Secondary Radical Precursor 
Encouraged by the excellent chirality transfer seen in cyclizations of primary -iodoanilides, we 
extended our efforts toward secondary radical precursors to explore the potential for 
diastereoselectivity.  Substrates 5.34a-b were prepared by treating 5.26c with 2-bromopropionyl 
bromide and Et3N, producing two diastereomers 5.34a (less polar) and 5.34b (more polar) which 
were separable by column chromatography (Scheme 5.9).  Attempts to convert these compounds 
to suitable crystalline derivatives were unsuccessful, and NMR spectroscopy was not informative 
enough to unambiguously assign the relative stereochemistry.  Because halogen abstraction from 
5.34a-b destroys the -stereocenter,4,17 leaving only the N-aryl axis to influence chirality 
transfer, further examination of the relative stereochemistry of 5.34a-b was not undertaken. 
MeO
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THF, 0 oC
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+
minor: 5.34a, 33% yield
major: 5.34b, 65% yield
relative stereochemistry unassigned
5.26c
 
Scheme 5.9  Preparation of a Secondary Radical Precursor 
 
Racemic samples of 5.34a-b were reacted with Bu3SnH and Et3B at room temperature, 
according to the optimized syringe pump conditions, as seen in Table 5.5 (Entries 1-2).  Both 
diastereomers gave the same product 5.35 in excellent yield (95-97%), and only one 
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diastereomer of the expected product was isolated.  Samples of 5.34a-b were also resolved by 
chiral HPLC, and the enantioenriched substrates were subjected to the same reaction conditions 
(Entries 3-6).  Yields were reproducibly high (96-98%), and chirality transfers were even higher 
than those observed for the primary -amide radical precursor series, at least 99% in all cases. 
 
Table 5.5  Cyclizations of a Secondary Radical Precursor 
N
PMB
O
Br
MeO CO2t -Bu
1.2 equiv. Bu3SnH
1.0 equiv. Et3B
syringe pump
PhH, rt
N
PMB
O
MeO CO2t -Bu
5.34a-b 5.35  
 
entry substrate er
 
product % yield
a 
er % chirality transfer 
1 rac-5.34a 50/50 rac-5.35 95 50/50 -- 
2 rac-5.34b 50/50 rac-5.35 97 50/50 -- 
3 (+)-5.34a 98/2 (+)-5.35 98 98/2 100 
4 (–)-5.34a 99/1 (–)-5.35 96 98/2 99 
5 (+)-5.34b 100/0 (–)-5.35 98 99/1 99 
6 (–)-5.34b 100/0 (+)-5.35 97 99.5/0.5 99.5 
a
 Yield after isolation by column chromatography on 10% w/w KF/silica gel. 
 
The product 5.35 was assigned with trans stereochemistry based on the transition state 
analysis shown in Scheme 5.10.  Halogen abstraction from either diastereomer of 5.34 produces 
a mixture of -amide radicals s-cis-5.36 and s-trans-5.36, which interconvert by rotation of the 
C-carbonyl single bond.  While s-cis/s-trans interconversion in 5.36 is relatively slow,
249
 with 
krot = 2.0 x 10
4
 s
-1
, the slow rate of 6-exo-trig cyclization may allow time for thermodynamic 
equilibration to the favored s-cis-5.36 conformer.
4
  Cyclization of s-cis-5.36 proceeds through 
transition state 5.37a, which minimizes strain between the substituents and leads to the observed 
product 5.35.  Transition state 5.37b is significantly less favored due to steric hindrance between 
the methyl group and the radical acceptor, and thus cis-disubstituted 5.38 is not formed in 
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appreciable amounts.  The results continue an established trend; preferential-to-exclusive 
formation of trans products has also been observed in 4-exo-trig
250
 and 5-exo-trig
251-253
 
cyclizations of substituted -amidoyl radicals. 
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Scheme 5.10  Assignment of Configuration by Transition State Analysis 
5.2.8 Preparation and Chirality Transfer of a Tandem Cyclization Precursor 
Given our success with the reaction of 5.34, we envisioned incorporating the highly 
diastereoselective 6-exo-trig cyclization into a tandem radical sequence.  Cyclizations often 
proceed with high levels of diastereoselectivity when the radical and alkene acceptor are 
connected by a pre-formed ring.
4
   
Scheme 5.11 illustrates the synthesis of tandem precursors 5.40a-b.  Racemic 2-
aminopentenoic acid underwent diazotization of the amine, followed by bromine substitution, to 
produce -bromoacid 5.39 in 58% yield.  Acid 5.39 was converted to the acid chloride, which 
was added to 5.26c followed by Et3N, producing 5.40a (35% yield) and 5.40b (39% yield) as 
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diastereomers separable by column chromatography.  The order of addition was crucial in this 
reaction:  when Et3N was added to 5.26c before the acid chloride was introduced, the starting 
aniline was recovered unchanged.  As with 5.34a-b, the configurations of 5.40a-b were not 
assigned. 
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Scheme 5.11  Synthesis of a Tandem Precursor 
 
Racemic 5.40a was treated with Bu3SnH under syringe pump conditions at room 
temperature (Table 5.6, Entry 1).  After column chromatography, tricyclic product rac-5.41 was 
isolated in 51% yield as a single diastereomer.  Column fractions containing minor products, 
inseparable from one another, were also collected and comprised 30% of the mass balance.  This 
mixture of side products contained, among other unidentified compounds, two minor 
diastereomers of the 6-endo-trig / 5-exo-trig sequence, as evidenced by two distinct doublets in 
the upfield region denoting the respective methyl signals of the diastereomers.  Enantiopure 
samples of 5.40b were accessed by resolution with chiral HPLC, and were also subjected to the 
reaction conditions (Entries 2-3).  These reactions provided the same diastereomer of 5.41 in 
similar yields and excellent chirality transfer (98-99%).  The final products of these reactions 
were contaminated by small amounts (~5%) of the minor cyclized products after purification as 
determined by 
1
H NMR. 
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Table 5.6  Cyclization of a Tandem Radical Precursor 
N
PMB
O
Br
MeO CO2t -Bu
1.2 equiv. Bu3SnH
1.0 equiv. Et3B
syringe pump
PhH, rt
N
PMB
O
MeO
CO2t -Bu
CH3
H
H
5.40a-b 5.41  
 
entry substrate er
 
product % yield
a 
er % chirality transfer 
1 rac-5.40a 50/50 rac-5.41 51 50/50 -- 
2 (+)-5.40b 100/0 (–)-5.41 51b 99/1 99 
3 (–)-5.40b 100/0 (+)-5.41 49b 98/2 98 
a
 Yield after isolation by column chromatography on 10% w/w KF/silica gel.  
b
 95% diastereomeric purity. 
 
The assignment of the ring fusion 5.41 as trans was based on the 14.1 Hz coupling 
constant between the -lactam and benzylic protons, indicating a nearly 180° dihedral angle 
between these protons.
254
  The remaining stereocenters were unambiguously determined by X-
ray crystallography.  A CDCl3 sample containing racemic 5.41, upon slow evaporation, produced 
single crystals suitable for analysis.  The structure, which was solved by Dr. Steve Geib, is 
shown in Figure 5.6. 
 
Figure 5.6  Crystal Structure of rac-5.41 
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The transition state analysis for formation of 5.41 is shown in Scheme 5.12.  Reaction of 
either diastereomer of 5.40a-b with tributyltin radical produces -amide radical 5.44 in the s-cis 
geometry.  This radical is unlikely to undergo 3-exo-trig cyclization onto the pendant terminal 
olefin.  3-exo-trig cyclization in the parent 3-butenyl system 5.42 is slow (kC  = 9 x 10
3
 s
-1
), and 
the reverse ring opening of the resulting cyclopropylmethyl radical 5.43 is fast enough (kopen > 1 
x 10
8
 s
-1
) that 5.42 exists almost exclusively in the open-chain form.
17,63,255-259
  As discussed in 
Section 5.2.7, 5.44 cyclizes with trans selectivity through transition state 5.45, forming -ester 
radical 5.46. 
The final 5-exo-trig cyclization occurs in accordance with the Beckwith-Houk model; the 
four possible transition states 5.46 are shown in Scheme 5.12.
4,260,261
  The major product 5.41 
arises from chair-equatorial-5.46, which minimizes steric strain.  Because the ester substituent is 
relatively small, eclipsing interactions between it and the olefin are minimal.  Boat-equatorial-
5.46 and chair-axial-5.46 transition states are higher in energy due to unfavorable gauche 
interactions, and produce a trans relationship between the methyl and ester functionalities in the 
product.  The resulting products of these transition states, 5.47 and 5.48, could be the minor 
products seen during purification of the reaction mixture.  Finally, 5.49 could potentially be 
formed through the boat-axial conformation; however, this transition state is high enough in 
energy that 5.49 will likely not be formed. 
  135 
N
t-BuO2C OMe
PMB
O
N
PMB
O
N
OMe
t-BuO2C
H
H
PMB
H
O
t-BuO2C OMe
Br
HBu3Sn
H
N
O
H PMB
OMe
H
t-BuO2C
H
H
N
O
H PMB
OMe
t-BuO2C
H
H
N
O
H PMB
OMe
H
H
t-BuO2C
H
H
N
O
H PMB
OMe
H
t-BuO2C
NH
O
OMet-BuO2C
cyc, then
Bu3SnH
H
cyc, then
Bu3SnH
cyc, then
Bu3SnH
cyc, then
Bu3SnH
N
PMB
O
OMe
H
H
t-BuO2C
N
PMB
O
OMe
H
H
t-BuO2C
N
PMB
O
OMe
H
H
t-BuO2C
N
PMB
O
OMe
H
H
t-BuO2C
5.40a-b 5.44 5.46
chair-eq-5.46 boat-eq-5.46 chair-ax-5.46 boat-ax-5.46
5.41 5.47 5.48 5.49
kC = 9 x 10
3 s-1
kopen > 1 x 10
8 s-1
5.42 5.43
5.45
 
Scheme 5.12  Transition State Analysis of Tandem Cyclization 
 
The excellent enantio- and diastereoselectivities of this tandem reaction hold great 
promise for future exploration.   Further development of this methodology could provide swift 
access to the ring system of the Melodinus alkaloids (Figure 5.7).
262-265
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Figure 5.7  Melodinus Alkaloids 
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5.2.9 Conclusions 
Axially chiral -haloamides in which an ortho-substituent is a radical acceptor are easily 
prepared and resolved.  The radical cyclizations of these -haloamides to dihydroquinolin-2-
ones proceed in high yields and with high levels of chirality transfer (80-100%).  A model of 
chirality transfer has been determined by absolute configuration determination of a substrate / 
product pair by X-ray crystallography.  Secondary -haloamides, upon cyclization, faithfully do 
so with exclusively trans selectivity.  This methodology has been applied to a tandem 6-exo-
trig/5-exo-trig radical cyclization, which proceeds with good diastereo- and enantioselectivity. 
  137 
6.0  EXPERIMENTAL 
6.1 GENERAL INFORMATION AND PROCEDURES 
All reactions were performed in oven-dried glassware under an argon atmosphere, except where 
noted.  Chemicals and solvents were purchased from commercial suppliers and used as received, 
excepting as follows.  Dichloromethane, THF, ether, and toluene were dried by passing through 
an activated alumina column.  When necessary, DMF, MeCN, and H2O were degassed by 
sparging with Ar for at least 2 h.  Benzene was also degassed when necessary by the freeze-
pump-thaw method (at least 5 cycles).  Trimethylsilyl chloride (TMSCl) was distilled over CaH2 
before use.  Solutions of BuLi were titrated regularly against diphenylacetic acid in THF.  
Benzyltriethylammonium dichloroiodate was prepared as described in the literature.
185
 
All reactions were followed by TLC to completion, unless stated otherwise.  TLC 
analysis was performed by illumination with a UV lamp (254 nm) or staining with KMnO4 and 
heating.  All flash chromatography was performed with 230-400 mesh silica gel purchased from 
Sorbent Technologies as the stationary phase.  “Gradient column chromatography” refers to 
packing the column with the initial eluent, and initially filling the solvent reservoir with ~4 
column volumes of the initial eluent.  After elution of one column volume, the solvent reservoir 
is refilled with the second eluent.  This process is continued after every eluted column volume 
until the final compound has completely eluted. 
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1
H NMR spectra were measured on a Bruker Avance 300 MHz instrument in CDCl3, and 
chemical shifts were measured relative to residual solvent peak ( 7.27).  The following 
abbreviations were used to describe coupling: s = singlet, d = doublet, t = triplet, q = quartet, m = 
multiplet, br = broad.  
13
C NMR spectra were measured on Bruker Avance instruments at 75 
MHz with chemical shifts relative to residual solvent peak ( 77.0).  In 13C spectra, a notation of 
(xC) is used to denote x equivalent carbons for a multi-carbon signal.  In some compounds 
containing rotamers, complicated 
13
C spectra were deconvoluted by comparison with DEPT-135 
spectra to determine peaks corresponding to the major and minor rotamers. 
IR spectra were recorded as thin films (CHCl3) or neat on NaCl plates on a Nicolet 
Avatar 360 FTIR spectrometer.  Melting ranges were determined using a Mel-Temp II apparatus 
and are uncorrected.  Compounds listed as having a melting point at a single temperature had a 
sharp melting range of < 0.5 °C.  Optical rotations were measured on a Perkin-Elmer 241 
Polarimeter using a 1 dm cell length.  All quoted optical rotation values are corrected for 100% 
ee samples, and have the units (deg cm
2
 g
-1
).  Mass spectra were obtained on a VG-7070 or 
Fisons Autospec high-resolution magnetic sector mass spectrometer. 
Analytical chiral HPLC analysis was conducted using either an (S,S)-Whelk-O 1 column 
(Pirkle, 250 mm x 4.6 mm ID) or a Chiralcel OD column (Daicel, 250 mm x 4.6 mm ID) 
typically eluting with hexanes:i-PrOH at 1.0 mL/min, 10-20 g per injection.  Analytical normal 
phase HPLC analysis was conducted using a Waters Nova-Pak Silica column (150 mm x 3.9 mm 
ID) eluting with hexanes:EtOAc at 1.0 mL/min, 10-20 g per injection.  Preparatory chiral 
HPLC resolutions were performed on either an (S,S)-Whelk-O 1 column (Pirkle, 25 cm x 21.1 
mm ID) or a Chiralcel OD column (Daicel, 250 mm x 20.0 mm ID) eluting with hexanes:iPrOH 
at 10.0 mL/min, 40-150 mg per injection.  All HPLC injections were monitored with a Waters 
  139 
model 440 UV detector at wavelength 254 nm, when the solvent system was hexane:i-PrOH.  In 
the cases where a hexane:EtOAc solvent system was used, the injections were monitored at 
wavelength 270 nm. 
All gas chromatography analysis was performed with an Agilent 6850 GC under the 
following conditions:  Initial oven temp. 100 °C, first ramp 10 °C/min to 250 °C, second ramp 15 
°C/min to 315 °C, held at this temperature for 8 min.  All GC yields were determined by 
calculation of response factors, using a straight-chain alkane internal standard.  For each 
compound analyzed, three standard mixtures of a measured amount of the compound and a 
known amount of internal standard from a stock solution were analyzed by GC.  Response 
factors were calculated using the equation:
266
 
XIS
XIS
X
MA
AM
RF


  
 
RFX = response factor of compound X 
MIS = moles of internal standard 
MX = moles of compound X 
AIS = area of internal standard GC peak 
AX = area of compound X GC peak 
For each compound X, the three trials were graphed with the MIS/MX value on the y-axis, 
and the corresponding AIS/AX value on the x-axis.  The slope of the line was taken to be the RFX 
value.  All compounds gave excellent linear plots with intercepts ≈ 0, showing that the response 
factor for each compound was consistent over varying molar ratios of compound to internal 
standard.  
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6.2 COMPOUND DATA FOR CHAPTER 1 
Experimental procedures and spectroscopic data have been previously reported in the literature 
for compounds 1.15a-c,
16
 1.16,
8,16
 1.17,
6,16
 1.18,
6,16
 1.19,
8,16
 1.34,
267
 1.35,
268,269
 1.36,
270
 1.41,
10
 
1.46a,
26
 1.48,
26
 1.49,
26
 1.51,
26
 and 1.52.
26
  These procedures were followed, and the products’ 
physical properties and spectroscopic data were consistent with those previously reported, except 
as outlined below.  Compounds 1.29-1.32 were synthesized in the labs of Dr. Andrew Clark at 
the University of Warwick, and were graciously donated to us. 
 
N O
Cl
 
N-Benzyl-2-chloro-N-cyclohex-1-enylacetamide (1.15a):  The literature procedure
16
 was 
followed: benzylamine (3.21 g, 30.0 mmol) and cyclohexanone (2.94 g, 30.0 mmol) were 
condensed in refluxing toluene (150 mL) for 4 h.  The crude imine was N-acylated (again, 
following the literature procedure) using chloroacetyl chloride (6.78 g, 60.0 mmol), and N,N-
diethylaniline (13.43 g, 90.0 mmol) as the base instead of Et3N.  After workup, chromatography 
on silica gel (hexanes:Et2O 5:2) gave the title compound (42%) as a white solid, mp 92-93 °C 
(previously reported as an oil).  Spectroscopic data was consistent with the previously reported 
results.
16
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N O
Br
 
N-Benzyl-2-bromo-N-cyclohex-1-enylacetamide (1.15b):  The literature procedure
16
 was 
followed: benzylamine (1.07 g, 10.0 mmol) and cyclohexanone (0.98 g, 10.0 mmol) were 
condensed in refluxing toluene (50 mL) for 4 h.  The crude imine was N-acylated (again, 
following the literature procedure) with bromoacetyl bromide (2.20 g, 11.0 mmol) and 
triethylamine (2.97 g, 30.0 mmol).  After workup, chromatography on silica gel (hexanes:Et2O 
5:2) gave the title compound (23%) as a white solid, mp 35-36 °C (previously reported as an oil).  
Spectroscopic data was consistent with the previously reported results.
16
 
 
N
O
H
H
 
rac-N-Benzyl-cis-octahydroindol-2-one (1.16):  Solid 95% NaH (29 mg, 1.2 mmol) was 
slurried with THF (1.0 mL) and cooled to 0 °C.  Octahydroindolone 1.34
267
 (139 mg, 1.0 mmol, 
> 95% purity by 
1
H NMR) was dissolved in THF (1.0 mL) and added dropwise to the stirred 
reaction mixture.  Stirring continued for another 30 min, at which point a solution of benzyl 
bromide (205 mg, 1.2 mmol) in THF (1.0 mL) was added dropwise to the reaction mixture.  The 
ice bath was removed, and the mixture was stirred at room temperature for 3 h before being 
quenched with sat. aq. NH4Cl (5 mL).  The mixture was extracted with CH2Cl2 (3 x 10 mL), and 
the combined organic layers were dried over MgSO4, filtered, and solvent was evaporated.  The 
crude residue was chromatographed (2:1 hexanes:EtOAc) to afford 144 mg of the title compound 
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as a colorless oil (45% yield over 2 steps from 2-oxindole).  Spectroscopic data matched 
previously reported results.
16
 
 
N
O
CH2Ph
N
O
CH2Ph  
Intramolecular condensation of 1.36:  In a pressure tube, amide 1.36 (0.245 g, 1.0 mmol) and p-
TsOH (3 mg, 0.016 mmol) were combined with m-xylene (2.0 mL) and a stir bar.  The tube was 
tightly sealed with a screw cap, and heated at 180 °C for 2 h.  The reaction mixture was cooled to 
room temperature, solvent was removed by rotary evaporation, and the crude residue was 
chromatographed (1:1 hexanes:Et2O).  The first eluting product 1.17 was collected as an 
inseparable mixture of olefin isomers (0.076 g, 33%): 1-benzyl-3a,4,5,6-tetrahydro-1H-indol-
2(3H)-one and 1-benzyl-4,5,6,7-tetrahydro-1H-indol-2(3H)-one in a 2.3:1.0 ratio.  These 
compounds were extremely sensitive to isomerization and interconverted rapidly to one another 
on silica gel.  The second eluting compound, 1-benzyl-5,6,7,7a-tetrahydro-1H-indol-2(4H)-
one (1.18) was collected as a light yellow oil (0.119 g, 52% yield).  Spectra were consistent with 
previously reported results.
6,16
 
 
N O
 
N-Benzyl-N-cyclohex-1-enylacetamide (1.19):  Benzylamine (1.07 g, 10.0 mmol) and 
cyclohexanone (0.98 g, 10.0 mmol) were dissolved in toluene (50 mL) in a round-bottomed flask 
fitted with a Dean-Stark apparatus.  The solution was refluxed for 3 h with azeotropic removal of 
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water, cooled to room temperature, and the reaction volume was reduced by half by rotary 
evaporation.  The solution containing the crude imine was cooled to 0 °C, and a solution of 
acetyl chloride (1.18 g, 15.0 mmol) in toluene (50 mL) was added dropwise to the reaction 
mixture.  After stirring for 2 h at this temperature, triethylamine (2.97 g, 30.0 mmol) was added 
dropwise to the reaction mixture, and stirring was continued for another 2 h at 0 °C.  The 
reaction mixture was then washed with saturated NaHCO3 (3 x 100 mL) and brine (3 x 100 mL) 
solutions, dried over MgSO4, and solvent was removed by using rotary evaporation.  
Chromatography on silica gel (3:2 hexanes:Et2O) gave the title compound (1.51 g, 66%) as a 
white solid, mp 50-51 °C (previously reported as an oil).  Spectroscopic data was consistent with 
the previously reported results.
16
 
 
N O
Cl
OMe  
N-Cyclohex-1-enyl-2-chloro-N-(2-(3-methoxyphenyl)ethyl)acetamide (1.38a):  A stirred 
solution of cyclohexanone (0.79 g, 8.0 mmol) and 3-methoxyphenethylamine (1.21 g, 8.0 mmol) 
in toluene (50 mL) was refluxed for 3 h in a round-bottomed flask fitted with a Dean-Stark 
apparatus.  The reaction mixture was then cooled to room temperature, and the solvent volume 
was reduced by half by using rotary evaporation.  The mixture containing the imine was added 
dropwise to a solution of chloroacetyl chloride (1.36 g, 12.0 mmol) in toluene (25 mL) at 0 °C.  
The reaction mixture was stirred for 2 h at 0°C, at which point N,N-diethylaniline (2.39 g, 16.0 
mmol) was added dropwise, and stirring at 0 °C was continued for 2 h.  The reaction was 
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quenched by addition of H2O (100 mL), and the organic layer was washed with saturated aq. 
NaHCO3 (3 x 50 mL) and brine (3 x 50 mL) solutions.  The organic layer was dried over 
MgSO4, concentrated by rotary evaporation, and chromatographed on silica gel (hexanes:EtOAc 
3:1) to give the title compound (1.98 g, 80%) as a yellow oil:  
1
H NMR (300 MHz, CDCl3)  
7.21 (t, J = 7.7 Hz, 1H), 6.83-6.74 (m, 3H), 5.62 (m, 1H), 4.09 (s, 2 H), 3.80 (s, 3H), 3.63 (t, J = 
7.2 Hz, 2H), 2.85 (t, J = 7.9 Hz, 2H), 2.18-2.04 (m, 4H), 1.78-1.67 (m, 2H), 1.66-1.55 (m, 2H); 
13
C NMR (75 MHz, CDCl3)  165.3, 159.4, 140.0, 137.6, 129.1, 128.2, 120.8, 114.0, 111.6, 54.8, 
47.3, 41.5, 33.6, 27.3, 24.4, 22.3, 21.1; FTIR (neat, cm
−1
) 2935, 2837, 1655, 1603, 1402, 1043, 
783; HRMS calcd for C17H22NO2Cl [M]
+
: 307.1339, found: 307.1338. 
 
N O
S
OMe
S
OEt
 
N-Cyclohex-1-enyl-2-(O-ethylxanthate)-N-(2-(3-methoxyphenyl)ethyl)acetamide 
(1.38b):Enamide 1.38a (616 mg, 2.0 mmol) was dissolved in dry MeCN (50 mL), and solid 
potassium O-ethyl xanthate (320 mg, 2.0 mmol) was added portionwise (approximately 0.1 
equiv per addition) over 5 minutes.  The mixture was stirred for 5 h, and then solvent was 
removed by rotary evaporation.  The crude residue was partitioned between ether and water (25 
mL each), and the aqueous layer was extracted with ether (3 x 25 mL).  The combined organic 
layers were dried over MgSO4, the solvent was evaporated, and the crude residue was 
chromatographed on silica gel (hexanes:EtOAc 3:1) to give the title compound (756 mg, 96%) as 
a viscous, light yellow oil:  
1
H NMR (300 MHz, CDCl3)  7.20 (t, J = 7.7 Hz, 1H), 6.83-6.74 (m, 
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3H), 5.66 (m, 1H), 4.65 (q, J = 7.1 Hz, 2H), 4.08 (s, 2H), 3.80 (s, 3H), 3.63 (t, J = 7.5 Hz, 2H), 
2.85 (t, J = 7.8 Hz, 2H), 2.20-2.10 (m, 4H), 1.81-1.73 (m, 2H), 1.68-1.60 (m, 2H), 1.42 (t, J = 7.1 
Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  214.0, 165.6, 159.5, 140.3, 138.2, 129.2, 128.5, 121.0, 
114.2, 111.7, 70.2, 55.0, 47.6, 39.6, 34.0, 27.6, 24.7, 22.6, 21.3, 13.7; FTIR (neat, cm
−1
) 2935, 
1649, 1601, 1055, 783; HRMS calcd for C17H22NO2S [M – CSOEt]
+
: 304.1371, found: 
304.1370. 
 
N O
I
OMe  
N-Cyclohex-1-enyl-2-iodo-N-(2-(3-methoxyphenyl)ethyl)acetamide (1.38c):  Enamide 1.38a 
(616 mg, 2.0 mmol) was dissolved in dry acetone (50 mL) in a round-bottomed flask covered 
with aluminum foil.  Excess sodium iodide (3.00 g, 20.0 mmol) was added, and the mixture was 
stirred for 16 h under argon.  The solvent was removed by rotary evaporation, and the residue 
was partitioned between ether and water (30 mL each).  The organic layer was successively 
washed with 10% aq. Na2S2O3 (2 x 30 mL) and water (2 x 30 mL), and dried over Na2SO4.  The 
resulting mixture was filtered, concentrated by rotary evaporation, and the residue was 
chromatographed on silica gel (hexanes:EtOAc 2:1) to give the title compound (743 mg, 93%) as 
a viscous, bright yellow oil:  
1
H NMR (300 MHz, CDCl3) 7.21 (t, J = 7.7 Hz, 1H), 6.84-6.74 
(m, 3H), 5.73 (m, 1H), 3.82 (s, 2H), 3.81 (s, 3H), 3.61 (br m, 2H), 2.85 (t, J = 7.9 Hz, 2H), 2.21-
2.11 (m, 4H), 1.80-1.71 (m, 2H), 1.67-1.58 (m, 2H);  
13
C NMR (75 MHz, CDCl3)  167.1, 159.6, 
140.3, 138.7, 129.3, 128.0, 121.1, 114.3, 111.8, 55.1, 47.7, 33.7, 27.3, 24.6, 22.7, 21.3, −2.3.  
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FTIR (neat, cm
−1
) 2933, 2834, 1649, 1415, 1039, 783:  HRMS calcd for C17H22NO2 [M – I]
+
: 
272.1651, found: 272.1646. 
 
N
O
MeO
H
 
16-Methoxy-8-oxoerythrinane (1.41):  Ester 1.35 (0.179 g, 0.97 mmol) and 3-
methoxyphenethylamine (0.147 g, 0.97 mmol) were refluxed in toluene (3.0 mL) for 8 h.  The 
reaction mixture was cooled to room temperature, 47% aq. HI (0.70 mL) was added, and the 
mixture was stirred overnight open to the atmosphere.  The mixture was diluted with EtOAc (20 
mL), and washed successively with saturated NaHCO3 (2 x 20 mL) and 10% Na2S2O3 (1 x 20 
mL) solutions.  The organic phase was dried over MgSO4, filtered, and solvent was removed to 
give a pale yellow oil.  Flash chromatography with EtOAc furnished the title compound as a 
white solid (192 mg, 73%), mp 109-110 °C (lit. 109-110.5 °C).
10
  Spectroscopic data agreed with 
the previously reported partial characterization:
10
 
1
H NMR (300 MHz, CDCl3) 7.32 (d, J = 8.6 
Hz, 1H), 6.77 (dd, J = 8.6 Hz, 2.6 Hz, 1H), 6.65 (d, J = 2.5 Hz, 1H), 4.05 (ddd, J = 13.1 Hz, 7.0 
Hz, 4.0 Hz, 1H), 3.79 (s, 3H), 3.28 (ddd, J = 13.1 Hz, 9.4 Hz, 5.8 Hz, 1H), 3.02 (ddd, J = 16.4 
Hz, 9.2 Hz, 7.2 Hz, 1H), 2.78 (ddd, J = 16.4 H, 4.8 Hz, 4.8 Hz, 1H), 2.62-2.54 (m, 1H), 2.36 (d, 
J = 8.4 Hz, 2H), 2.12-2.00 (m, 1H), 1.92-1.47 (m, 7H); 
13
C NMR (75 MHz, CDCl3)  173.9, 
158.0, 135.5, 134.9, 125.6, 113.9, 112.2, 62.1, 55.1, 37.8, 36.4, 36.0, 34.8, 27.9, 26.8, 20.6, 20.1; 
FTIR (thin film, cm
−1
) 3006, 2939, 2862, 1668, 1441, 1041, 667; HRMS calcd for C17H21NO2
 
[M]
+
: 271.1572, found: 271.1570. 
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1-(2-(3-Methoxyphenyl)ethyl)octahydroindol-2-one (1.42):  namide 1.38a (128 mg, 0.416 
mmol) was dissolved in toluene (22 mL) and the solution was brought to reflux.  A solution of 
Bu3SnH (292 mg, 0.500 mmol) and AIBN (6.2 mg, 0.042 mmol) in toluene (22 mL) was added 
to the reaction mixture via syringe pump over 2 h, and the mixture was refluxed an additional 2 
h.  GC analysis showed that approximately half of the starting material remained, so a second 
portion of Bu3SnH (292 mg, 0.500 mmol) and AIBN (6.2 mg, 0.042 mmol) in toluene solution 
(11 mL) was added via syringe pump over 1 h, and reflux was continued for a further 2 h.  The 
mixture was cooled to room temperature, the solvent was removed by rotary evaporation, and the 
residue was partitioned between Et2O (20 mL) and 8% aq. KF (50 mL),
271
 and the mixture was 
stirred for 15 h.  The aqueous layer was removed, and the organic layer was dried over MgSO4, 
filtered through a Celite pad, and solvent was removed.  Gradient column chromatography 
(exhaustive 100% hexane flush to remove tin impurities, followed by 1:1 hexanes:EtOAc) 
furnished the title compound as a light yellow oil (84 mg, 74%):  
1
H NMR (300 MHz, CDCl3)  
7.19 (t, J = 8.1 Hz, 1H), 6.81-6.72 (m, 3H), 3.87 (ddd, J = 14.1 Hz, 9.3 Hz, 6.4 Hz, 1H), 3.78 (s, 
3H), 3.40 (q, J = 5.3 Hz, 1H), 3.05 (ddd, J = 14.0 Hz, 9.1 Hz, 6.1 Hz, 1H), 2.86-2.68 (m, 2H), 
2.32-2.18 (m, 2H), 2.17-2.06 (m, 1H), 1.81-1.67 (m, 1H), 1.64-1.50 (m, 2H), 1.49-1.25 (m, 5H); 
13
C NMR (75 MHz, CDCl3)  175.2, 159.6, 140.5, 129.3, 120.9, 114.2, 111.7, 56.6, 55.1, 41.3, 
36.9, 33.9, 32.3, 27.0, 26.7, 22.3, 21.0; HRMS calcd for C17H23NO2 [M]
+
: 273.1729, found: 
273.1728. 
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N O N
OMe
O
N
OMe
O
OMe  
Cyclization of 1.38c:  Enamide 1.38c (200. mg, 0.50 mmol) was dissolved in toluene (25 mL) 
and the solution was brought to reflux.  A solution of Bu3SnH (175 mg, 0.60 mmol) and AIBN 
(8 mg, 0.05 mmol) in toluene (25 mL) was added to the reaction mixture via syringe pump over 
2.5 h, and the mixture was refluxed an additional 1 h.  The mixture was cooled to room 
temperature, solvent was removed by rotary evaporation, the residue was partitioned between 
Et2O (20 mL) and 8% aq. KF (50 mL), and the mixture was stirred 15 h.  The aqueous layer was 
removed, and the organic layer was dried over MgSO4, filtered through a Celite pad, and solvent 
was removed by rotary evaporation.  Gradient column chromatography (exhaustive hexane flush 
to remove tin impurities, followed by 1:1 hexanes:EtOAc) furnished three products: 
N-Cyclohex-1-enyl-N-(2-(3-methoxyphenyl)ethyl)acetamide (1.45) was the first 
eluting compound, yielding 17 mg (12% yield) as a light yellow oil: 
1
H NMR (300 MHz, CDCl3) 
 7.20 (t, J = 7.8 Hz, 1H), 6.83-6.73 (m, 3H), 5.55 (m, 1H), 3.80 (s, 3H), 3.60 (m, 2H), 2.83 (t, J 
= 8.5 Hz, 2H), 2.15-2.09 (m, 2H), 2.07-2.01 (m, 2H), 2.02 (s, 3H), 1.77-1.69 (m, 2H), 1.64-1.56 
(m, 2H); 
13
C NMR (75 MHz, CDCl3):  169.6, 159.5, 140.7, 139.1, 129.1, 127.3, 121.0, 114.2, 
111.5, 55.0, 46.9, 34.2, 27.6, 24.6, 22.7, 21.7, 21.4; FTIR (neat, cm
−1
) 2933, 2837, 1651, 1398, 
1045; HRMS calcd for C17H23NO2 [M]
+
: 273.1729, found: 273.1727. 
1-(2-(3-Methoxyphenyl)ethyl)-1,3,3a,4,5,6-hexahydroindol-2-one (1.43) eluted second 
and consisted of 12 mg (9% yield) as a bright yellow oil:  
1
H NMR (300 MHz, CDCl3)  7.22 
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(dd, J = 8.9 Hz, 7.5 Hz, 1H), 6.83-6.75 (m, 3H), 4.85 (br m, 1H), 3.85-3.75 (overlapping m with 
clear d, J = 7.1 Hz, 1H), 3.81 (s, 3H), 3.48 (ddd, J = 13.8 Hz, 9.3 Hz, 5.9 Hz, 1H), 2.92-2.84 
(overlapping m with clear dd, J = 13.3 Hz, 5.7 Hz, 1H), 2.85-2.74 (overlapping with clear ddd, J 
= 13.3 Hz, 9.1 Hz, 7.1 Hz, 1H), 2.73-2.60 (m, 1H), 2.53 (dd, J = 16.0 Hz, 8.8 Hz, 1H), 2.30-2.00 
(m, 4H), 1.96-1.84 (br m, 1H), 1.67-1.49 (m, 1H), 1.39-1.27 (m, 1H); 
13
C NMR (75 MHz, 
CDCl3)  173.8, 159.4, 141.6, 139.9, 129.1, 120.8, 114.1, 111.5, 96.5, 54.8, 40.5, 36.5, 34.4, 
32.7, 27.6, 22.9, 22.0; FTIR (thin film, cm
−1
) 2933, 2837, 1721, 1678, 1602, 1454, 1403, 1323, 
1260, 1164.   
1-(2-(3-Methoxyphenyl)ethyl)-1,4,5,6,7,7a-hexahydroindol-2-one (1.44) was the final 
eluting product, collected by an EtOAc flush of the column, and consisted of 58 mg (43% yield) 
of a clear oil:  
1
H NMR (300 MHz, CDCl3)  7.21 (t, J = 8.2 Hz, 1H), 6.83-6.74 (m, 3H), 5.78 (s, 
1H), 3.91 (ddd, J = 14.3 Hz, 8.4 Hz, 6.4 Hz, 1H), 3.80 (s, 3H), 3.54 (dd, J = 11.6 Hz, 6.1 Hz, 
1H), 3.33 (ddd, J = 14.3 Hz, 8.5 Hz, 6.8 Hz, 1H), 2.86 (m, 2H), 2.75-2.70 (m, 1H), 2.39-1.78 (m, 
4H), 1.45-1.21 (m, 2H) 1.05-0.92 (m, 1H); 
13
C NMR (75 MHz, CDCl3)  171.8, 162.1, 160.1, 
141.0, 129.8, 121.4, 118.7, 114.6, 112.3, 62.6, 55.5, 41.7, 35.6, 33.4, 28.6, 27.7, 23.4; FTIR 
(neat, cm
−1) νmax 2933, 2862, 1686, 1500, 1241, 1158, 1040, 751. 
 
N O
I
 
N-(But-3-enyl)-N-cyclohexenyl-2-iodoacetamide (1.46b):  -Chloroenamide 1.46a (454 mg, 
2.0 mmol) was dissolved in dry acetone (20 mL) in a round-bottomed flask covered with 
aluminum foil.  Excess sodium iodide (3.00 g, 20.0 mmol) was added, and the mixture was 
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stirred for 15 h under argon.  The solvent was removed by rotary evaporation, and the residue 
was partitioned between ethyl acetate (100 mL) and 10% aq. Na2S2O3 (50 mL each).  The 
organic layer was successively washed with 10% aq. Na2S2O3 (50 mL) and brine (50 mL), and 
dried over Na2SO4.  The resulting solution was concentrated by rotary evaporation, and the 
residue was chromatographed on silica gel (4:1 hexanes:EtOAc) to give the title compound (530 
mg, 83%) as a viscous, bright yellow oil:  
1
H NMR (300 MHz, CDCl3)  5.84 (m, 1H), 5.78 (ddt, 
J = 17.1 Hz, 10.3 Hz, 6.8 Hz, 1H), 5.11-5.00 (m, 2H), 3.80 (s, 2H), 3.46 (br s, 2H), 2.30 (m with 
clear q, J = 7.0 Hz, 2H), 2.22-2.13 (m, 4H), 1.82-1.71 (m, 2H), 1.68-1.58 (m, 2H); 
13
C NMR (75 
MHz, CDCl3)  167.0, 138.3, 135.0, 128.1, 116.5, 45.1, 31.8, 27.3, 24.6, 22.6, 21.3, −2.4;  FTIR 
(neat, cm
−1
) 2932, 1650. 1416. 1393, 921. 
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6.3 COMPOUND DATA FOR CHAPTER 3 
NH2
I
 
2-Iodo-4,6-dimethylaniline (3.21):  2,4-Dimethylaniline (9.69 g, 80.0 mmol) was dissolved in a 
magnetically stirred mixture of MeOH (80 mL) and CH2Cl2 (80 mL), and solid NaHCO3 (13.44 
g, 160. mmol) was added.  A solution of benzyltriethylammonium dichloroiodate
185
 (31.2 g, 80.0 
mmol) in CH2Cl2 was added dropwise via an addition funnel to the stirred mixture over 30 min 
at room temperature.  After stirring for 1 hour, the mixture was poured into 240 mL water.  The 
organic layer was separated and washed further with water (3 x 160 mL), dried over MgSO4, 
filtered, and concentrated by rotary evaporation.  The resulting semisolid material was stirred in 
200 mL of a 10:1 hexane:EtOAc mixture for 15 minutes, and the resulting supernatant solution 
was decanted away from the insoluble material.  This was repeated a total of four times.  The 
supernatant solutions were combined and concentrated by rotary evaporation, and the resulting 
crude was passed through a plug of silica gel using 25:1 petroleum ether:Et2O to afford the title 
compound
272
 (13.42 g, 68%) as a pink solid, mp 64–65 °C (lit. 66–67 °C):  1H NMR (300 MHz, 
CDCl3)  7.37 (s, 1H), 6.85 (s, 1H), 4.11 (br s, 2H), 2.21 (s, 3H), 2.19 (s, 3H); 
13
C NMR (75 
MHz, CDCl3)  142.1, 136.5, 131.2, 128.8, 122.2, 84.6, 19.7, 18.7; FTIR (thin film, CHCl3, cm
-
1
) 3399, 3307 (broad), 3016, 2918, 1622, 1480, 1287, 1239, 1061, 854, 755, 722; LRMS (EI) m/z 
247 (M
+
, 79), 120 (100), 104 (76), 91 (85), 77 (82); HRMS (EI) calcd for C8H10IN [M]
+
: 
246.9858, found: 246.9863. 
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4-Bromo-2-iodo-6-methylaniline (3.22):  To a magnetically stirred solution of 4-bromo-2-
methylaniline (2.08 g, 11.2 mmol) in EtOH (37 mL) was added I2 (2.83 g, 11.2 mmol) all at 
once.  The mixture was stirred for 5 min, Ag2SO4 (3.49 g, 11.2 mmol) was added in one portion, 
and the mixture was stirred at room temperature for 3 h.  Upon completion of the reaction, solids 
were removed by vacuum filtration, and the filtrate was concentrated by rotary evaporation.  The 
crude mixture was redissolved in CH2Cl2 (30 mL) and washed sequentially with 5% aqueous 
NaOH, water, and brine (25 mL each), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Flash chromatography (10:1 pentane:Et2O) afforded the title compound
128
 (2.26 g, 
65%) as a tan solid, mp 59–60 °C (lit. 55–57 °C):  1H NMR (300 MHz, CDCl3)  7.62 (d, J = 2.1 
Hz, 1H), 7.12 (d, J = 1.5 Hz, 1H), 4.04 (br s, 2H), 2.16 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  
143.9, 137.8, 132.6, 123.6, 109.4, 84.2, 18.6; FTIR (thin film, CHCl3, cm
-1
) 3391, 3303 (broad), 
3221, 2930, 1620, 1462, 1438, 1238, 861, 720, 668; LRMS (EI) m/z 313 (M
+
 (
81
Br), 38), 128 
(50), 83 (56), 69 (95), 55 (100); HRMS (EI) calcd for C7H7
79
BrIN [M]
+
: 310.8807, found: 
310.8812. 
 
NH2
IBr
 
2-Bromo-6-iodo-4-methylaniline (3.23):  To a stirred mixture of 2-bromo-4-methylaniline 
(4.65 g, 25.0 mmol) and CaCO3 (5.00 g, 50.0 mmol) in CH2Cl2 (50 mL) and MeOH (25 mL) was 
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added portionwise BnNMe3•ICl2 (9.57 g, 27.5 mmol) over 5 min.  The reaction was stirred at 
room temperature for 9 h, and was determined to have stalled by TLC analysis.  A second 
portion of BnNMe3•ICl2 (4.35 g, 12.5 mmol) and CaCO3 (2.50 g, 25.0 mmol) were added with 
MeOH (75 mL), and the mixture was stirred overnight (12 h).  The reaction mixture was filtered 
through a pad of Celite and concentrated by rotary evaporation.  The crude was partitioned 
between 5% aqueous NaHSO3 (250 mL) and Et2O (300 mL), the organic layer was removed, and 
the aqueous layer was extracted with Et2O (3 x 300 mL).  The combined organic layers were 
dried over MgSO4, filtered, and concentrated by rotary evaporation.  Flash chromatography of 
the crude residue (25:1 pentane:Et2O) gave the title compound
132
 (7.09 g, 91%) as a white solid, 
mp 91 °C (lit. 85–88 °C):  1H NMR (300 MHz, CDCl3)  7.44 (s, 1H), 7.24 (s, 1H), 4.43 (br s, 
2H), 2.20 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  141.6, 138.5, 133.2, 130.1, 107.0, 83.1, 19.5; 
FTIR (thin film, CHCl3, cm
-1
) 3419, 3321 (broad), 1614, 1575, 1469, 1053, 849, 716, 706; 
LRMS (EI) m/z 313 (M
+
 (
81
Br), 61), 104 (49), 52 (100); HRMS (EI) calcd for C7H7
79
BrIN [M]
+
: 
310.8807, found: 310.8810. 
 
NH2
IBr
Br  
2,4-Dibromo-6-iodoaniline (3.24):  To a magnetically stirred solution of I2 (2.79 g, 11.0 mmol) 
in EtOH (50 mL) was added solid Ag2SO4 (3.43 g, 11.0 mmol) all at once.  The mixture was 
stirred for 5 min at room temperature, 2,4-dibromoaniline (2.51 g, 10.0 mmol) was added all at 
once, and the mixture was stirred for 3 h.  Upon completion of the reaction, the mixture was 
filtered through a Celite pad, the pad was rinsed with EtOH, and the filtrate was concentrated by 
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rotary evaporation.  The residue was dissolved in CH2Cl2 (200 mL), washed once with 10% 
aqueous Na2S2O3 solution (50 mL), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Flash chromatography (97.5:2.5 pentane:Et2O) gave the title compound
186
 (1.23 g, 
33%) as a light pink solid, mp 120-121 °C (lit. 124–125 °C):  1H NMR (300 MHz, CDCl3)  7.71 
(d, J = 2.1 Hz, 1H), 7.54 (d, J = 2.1 Hz, 1H), 4.61 (br s, 1H); 
13
C NMR (75 MHz, CDCl3)  
143.4, 139.8, 134.7, 109.4, 107.1, 82.6; FTIR (thin film, CHCl3, cm
-1
) 3250 (broad), 2949, 1693, 
1514, 1245, 1062, 995, 941, 846, 694; LRMS (EI) m/z 379 (M
+
 (
81
Br, 
81
Br), 88), 252 ((
81
Br, 
81
Br), 56), 168 (74); HRMS (EI) calcd for C6H4
79
Br2IN [M]
+
: 374.7755, found: 374.7748. 
 
NH2
I I
 
2,6-Diiodo-4-methylaniline (3.25):  To a room temperature solution of 37% w/w aq. HCl (250 
mL) and water (1.75 L) in a round bottom flask equipped with a mechanical stirrer was added p-
toluidine (11.50 g, 107.3 mmol) all at once.  After all solid had dissolved, solid ICl (34.84 g, 
214.6 mmol) was added all at once, and the mixture was stirred open to the atmosphere for 20 h.  
The mixture was vacuum filtered, and the solids were washed with water (1.0 L).  The crude wet 
solid was taken up in 300 mL CH2Cl2, the aqueous layer that formed was removed, and the 
organic layer was dried over MgSO4, filtered, and concentrated by rotary evaporation.  The crude 
product was taken up in CH2Cl2, and “short” flash column chromatography (400 g silica, 4:1 
hexanes:EtOAc) afforded the title compound
132
 (29.59 g, 77%) as a yellow-brown solid whose 
spectra matched that previously reported:  
1
H NMR (300 MHz, CDCl3)  7.47 (s, 2H), 4.46 (br s, 
2H), 2.18 (s, 3H). 
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2,6-Diiodo-4-methyl-N,N-bis(trimethylsilyl)aniline (3.26):  To a stirred solution of 3.25 (1.84 
g, 5.13 mmol) in THF (50 mL) at –78 °C was quickly added a heptane/PhEt/THF solution of 
LDA (2.69 mL, 5.39 mmol) via syringe.  The mixture was stirred at this temperature for 15 min, 
TMSCl (0.585 g, 5.39 mmol) was quickly added via syringe, and the mixture was stirred at –78 
°C for 15 min.  In the same fashion, a second portion of LDA solution (2.69 mL, 5.39 mmol) 
was added, followed by stirring 20 min, and a second addition of TMSCl (0.585 g, 5.39 mmol).  
The mixture was allowed to warm to room temperature, was stirred for 30 min, and saturated 
aqueous NH4Cl solution (50 mL) was added.  The mixture was extracted with Et2O (3 x 50 mL), 
and the combined organic layers were washed with brine (2 x 50 mL), dried over MgSO4, 
filtered, and concentrated by rotary evaporation.  The crude product was filtered through a plug 
of silica gel with hexanes to afford the title compound
132
 (2.24 g, 87%) as a white solid, mp 122-
123 °C (lit. 125–128 °C):  1H NMR (300 MHz, CDCl3)  7.69 (s, 2H), 2.20 (s, 3H), 0.27 (s, 
18H); 
13
C NMR (75 MHz, CDCl3)  150.4, 140.6 (2C), 136.6, 103.3 (2C), 19.3, 3.6 (6C); FTIR 
(thin film, CHCl3, cm
-1
) 2954, 1427, 1249, 1232, 910, 837, 821, 758, 703; LRMS (EI) m/z 503 
(M
+
, 7), 488 (60), 361 (100), 73 (90); HRMS (EI) calcd for C13H23I2NSi2 [M]
+
: 502.9459, found: 
502.9458. 
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2-Iodo-4-methyl-6-(trimethylsilyl)aniline (3.27):  To a stirred solution of 3.26 (2.01 g, 4.00 
mmol) in THF (120 mL) at –78 °C was added a solution of s-BuLi in cyclohexane (6.3 mL, 8.80 
mmol) quickly via syringe.  The mixture was stirred at this temperature for 30 min, saturated 
aqueous NH4Cl (40 mL) was added, and the mixture was warmed to rt and stirred 2 h.  The 
mixture was extracted with Et2O (3 x 120 mL), and the combined organic layers were washed 
with brine (2 x 120 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  
Flash chromatography of the crude residue (99:1 hexanes:EtOAc) afforded the title compound 
(0.997 g, 82%) as an orange oil:  
1
H NMR (300 MHz, CDCl3)  7.53 (s, 1H), 7.06 (s, 1H), 4.12 
(br s, 2H), 2.21 (s, 3H), 0.34 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  148.1, 140.6, 135.8, 129.0, 
123.5, 86.8, 19.9, –0.8 (3C); FTIR (neat, cm-1) 3473, 3375, 2954, 1611, 1441, 1250, 1064, 902, 
840, 761; LRMS (EI) m/z 305 (M
+
, 89), 290 (99), 250 (84), 162 (33), 73 (100); HRMS (EI) calcd 
for C10H16INSi [M]
+
: 305.0097, found: 305.0088.  
 
NH
I
Boc
 
tert-Butyl 2-iodo-4,6-dimethylphenylcarbamate (3.28):  To a stirred solution of aniline 3.21 
(3.71 g, 15.0 mmol) in THF (60 mL) at –78 °C was added a solution of NaHMDS in THF (1.0 
M, 30.0 mL) dropwise via syringe.  The mixture was warmed to room temperature over 30 min, 
stirred at room temperature an additional 30 min, and recooled to –78 °C.  A solution of Boc2O 
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(3.60 g, 16.5 mmol) in THF (30 mL) was added dropwise via syringe, and the mixture was 
stirred at –78 °C for 15 min.  The reaction was quenched with sat. aqueous NH4Cl solution (60 
mL), warmed to room temperature, and extracted with EtOAc (3 x 150 mL).  The combined 
organic layers were washed with brine (1 x 150 mL), dried over MgSO4, filtered, and 
concentrated by rotary evaporation.  Flash chromatography (10:1 hexanes:EtOAc) afforded the 
title compound (4.88 g, 94%) as a red viscous oil:  
1
H NMR (300 MHz, CDCl3)  7.52 (s, 1H), 
7.01 (s, 1H), 5.97 (br s, 1H), 2.30 (s, 3H), 2.26 (s, 3H), 1.51 (br s, 9H); 
13
C NMR (75 MHz, 
CDCl3)  153.0, 137.9, 136.9, 136.5, 134.5, 131.1, 100.1, 79.6, 28.0 (3C), 20.0, 19.1; FTIR 
(neat, cm
-1
) 3310 (broad), 2978, 2926, 1706, 1367, 1246, 1167, 1050, 910, 851, 733; HRMS 
(ESI) calcd for C13H18INNaO2 [M + Na]
+
: 370.0280, found: 370.0273. 
 
NH
Br
I
Boc
 
tert-Butyl 4-bromo-2-iodo-6-methylphenylcarbamate (3.29):  To a stirred solution of aniline 
3.22 (1.56 g, 5.00 mmol) in THF (10.0 mL) at –78 °C was added a solution of NaHMDS in THF 
(1.0 M, 10.0 mL) dropwise via syringe.  The mixture was warmed to room temperature over 30 
min, stirred at room temperature an additional 30 min, and recooled to –78 °C.  A solution of 
Boc2O (1.20 g, 5.50 mmol) in THF (10.0 mL) was added dropwise via syringe, and the mixture 
was stirred at –78 °C for 1 h.  Saturated aqueous NH4Cl solution (20 mL) was added, the mixture 
was warmed to room temperature, and extracted with EtOAc (3 x 50 mL).  The combined 
organic layers were washed with brine (1 x 25 mL), dried over MgSO4, filtered, and concentrated 
by rotary evaporation.  Flash chromatography (9:1 pentane:Et2O) afforded the title compound 
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(1.51 g, 73%) as a tan solid, mp 83-84 °C:  
1
H NMR (300 MHz, CDCl3)  7.80 (d, J = 1.8 Hz, 
1H), 7.34 (d, J = 1.8 Hz, 1H), 6.08 (br s, 1H), 2.30 (s, 3H), 1.50 (s, 9H); 
13
C NMR (75 MHz, 
CDCl3)  153.00, 139.2, 138.4, 136.7, 133.6, 120.8, 100.7, 80.7, 28.3 (3C), 19.4; FTIR (thin 
film, CHCl3, cm
-1
) 3284 (broad), 2978, 2929, 1695, 1498, 1391, 1367, 1249, 1153, 1059, 915, 
855, 757, 682; LRMS (EI) m/z 413 (M
+
 (
81
Br), 25), 313 ((
81
Br) 99), 311 ((
79
Br) 100), 230 ((
81
Br) 
69), 104 (91), 77 (93); HRMS (EI) calcd for C12H15
79
BrINO2 [M]
+
: 410.9331, found: 410.9327. 
 
NH
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I
 
tert-Butyl 2-iodophenylcarbamate (3.30):  To a stirred solution of 2-iodoaniline (2.19 g, 10.0 
mmol) in THF (10 mL) at –78 °C was added a solution of NaHMDS in THF (1.0 M, 20.0 mL) 
dropwise via syringe.  The mixture was warmed to room temperature over 30 min, stirred at 
room temperature an additional 30 min, and recooled to –78 °C.  A solution of Boc2O (2.40 g, 
11.0 mmol) in THF (10 mL) was added dropwise via syringe, and the mixture was stirred at –78 
°C for 1 h.  Saturated aqueous NH4Cl solution (40 mL) was added, the mixture was warmed to 
room temperature, and extracted with EtOAc (100 mL).  The combined organic layers were 
washed with brine (1 x 50 mL), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Flash chromatography (20:1 pentane:Et2O) afforded the title compound
273
 (2.14 g, 
67%) as an orange liquid:  
1
H NMR (300 MHz, CDCl3)   8.06 (d, J = 8.1 Hz, 1H), 7.75 (dd, J = 
7.8 Hz, 1.2 Hz, 1H), 7.32 (t, J = 8.1 Hz, 1H), 6.83 (br s, 1H), 6.78 (td, J = 7.8 Hz, 1.2 Hz, 1H), 
1.55 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  152.5, 138.8, 129.1, 124.6, 120.1, 88.7, 81.0, 28.2 
(3C); FTIR (neat, cm
-1
) 3394, 2978, 2931, 1734, 1588, 1516, 1431, 1367, 1298, 1246, 1223, 
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1156, 1011, 898, 830, 749; LRMS (EI) m/z 319 (M
+
, 63), 263 (76), 219 (80), 136 (71), 57 (100); 
HRMS (EI) calcd for C11H14INO2 [M]
+
: 319.0069, found: 319.0077. 
 
NH
TMS I
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tert-Butyl 2-iodo-4-methyl-6-(trimethylsilyl)phenylcarbamate (3.31):  To a stirred solution of 
aniline 3.27 (305 mg, 1.00 mmol) in THF (4.0 mL) at –78 °C was added a solution of NaHMDS 
in THF (1.0 M, 2.00 mL) dropwise via syringe.  The mixture was warmed to room temperature 
over 30 min, stirred at room temperature an additional 30 min, and recooled to –78 °C.  A 
solution of Boc2O (240. mg, 1.10 mmol) in THF (1.00 mL) was added dropwise via syringe, the 
mixture was stirred at –78 °C for 3 h, warmed to room temperature, and stirred overnight (16 h).  
The reaction was quenched with sat. aqueous NH4Cl solution (5 mL), and extracted with EtOAc 
(3 x 10 mL).  The combined organic layers were washed with brine (2 x 10 mL), dried over 
MgSO4, filtered, and concentrated by rotary evaporation.  Flash chromatography (10:1 
hexanes:EtOAc) afforded the title compound (253 mg, 62%) as a cream-colored solid, mp 132-
133 °C, in a 2.2:1 ratio of rotamers:  
1
H NMR (300 MHz, CDCl3)  7.72 (s, 1H), 7.25 (s, 1H), 
6.05 (br s, 1H, major), 5.90 (br s, 1H, minor), 2.30 (s, 3H), 1.53 (s, 9H, major), 1.42 (s, 9H, 
minor), 0.28 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  153.8, 141.2, 140.8, 140.3, 138.5, 135.6, 
102.9, 80.0, 28.4 (3C), 20.4, –0.6 (3C); FTIR (thin film, CHCl3, cm
-1
) 3220, 2976, 1704, 1366, 
1250, 1164, 1086, 887, 840, 757, 627; HRMS (ESI) calcd for C15H20NNaO2SiI [M + Na]
+
: 
428.0157, found: 428.0169. 
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tert-Butyl 2-bromo-6-iodo-4-methylphenylcarbamate (3.32):  To a stirred solution of aniline 
3.23 (0.624 g, 2.00 mmol) in THF (5.0 mL) at –78 °C was added a solution of NaHMDS in THF 
(1.0 M, 4.00 mL) dropwise via syringe.  The mixture was warmed to room temperature over 30 
min, stirred at room temperature an additional 30 min, and recooled to –78 °C.  A solution of 
Boc2O (0.480 g, 2.20 mmol) in THF (3.00 mL) was added dropwise via syringe, the mixture was 
stirred at –78 °C for 1 h, warmed to room temperature, and stirred for 1 h further.  The mixture 
was quenched at 0 °C with sat. aqueous NH4Cl solution (10 mL), warmed to room temperature, 
and extracted with EtOAc (3 x 20 mL).  The combined organic layers were washed with brine (2 
x 20 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Flash 
chromatography (6:1 hexanes:EtOAc) afforded the title compound (0.645 g, 78%) as a tan solid, 
mp 77-79 °C, in an 8:1 ratio of rotamers:  
1
H NMR (300 MHz, CDCl3)  7.64 (s, 1H), 7.42 (s, 
1H), 6.13 (br s, 1H, major), 5.84 (br s, 1H, minor), 2.29 (s, 3H), 1.52 (br s, 9H, major), 1.42 (s, 
1H, minor); 
13
C NMR (75 MHz, CDCl3)  152.7, 140.0, 138.8, 135.0, 133.5, 122.4, 100.4, 80.6, 
28.2 (3C), 20.0; FTIR (thin film, CHCl3, cm
-1
) 3300 (broad), 2977, 2927, 1709, 1483, 1450, 
1367, 1251, 1161, 1072, 1045, 1023, 852, 758, 725; LRMS (EI) m/z 413 (M
+
 (
81
Br), 17), 313 
((
81
Br) 99), 311 ((
79
Br) 100), 184 (35), 77 (65); HRMS (EI) calcd for C12H15
79
BrINO2 [M]
+
: 
410.9331, found: 410.9310. 
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tert-Butyl 2,4-dibromo-6-iodophenylcarbamate (3.33):  To a stirred solution of aniline 3.24 
(1.13 g, 3.00 mmol) in THF (12.0 mL) at –78 °C was added a solution of NaHMDS in THF (1.0 
M, 6.00 mL) dropwise via syringe.  The mixture was warmed to room temperature over 30 min, 
stirred at room temperature an additional 30 min, and recooled to –78 °C.  A solution of Boc2O 
(0.720 g, 3.30 mmol) in THF (6.00 mL) was added dropwise via syringe, the mixture was stirred 
at –78 °C for 2 h, warmed to room temperature, and stirred for 4 h further.  The mixture was 
quenched at 0 °C with sat. aqueous NH4Cl solution (15 mL), warmed to room temperature, and 
extracted with EtOAc (3 x 15 mL).  The combined organic layers were washed with brine (3 x 
15 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Flash 
chromatography (10:1 hexanes:EtOAc) afforded the title compound (0.645 g, 78%) as a pinkish-
orange solid, mp 82 °C:  
1
H NMR (300 MHz, CDCl3) 7.96 (d, J = 2.1 Hz, 1H), 7.77 (d, J = 2.1 
Hz, 1H), 6.12 (br s, 1H), 1.52 (br s, 9H); 
13
C NMR (75 MHz, CDCl3)  152.3, 140.5, 137.2, 
135.4, 123.3, 121.3, 101.0, 81.3, 28.2 (3C); FTIR (thin film, CHCl3, cm
-1
) 3267 (broad), 2979, 
1702, 1498, 1367, 1278, 1253, 1167, 857, 759, 722, 677; LRMS (EI) m/z 479 (M
+
 (
81
Br, 
81
Br), 
3), 379 (
81
Br, 
81
Br) 70), 88 (71), 59 (100); HRMS (EI) calcd for C11H12
79
Br2INO2 [M]
+
: 
474.8280, found: 474.8288. 
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Allyl 2-iodo-4,6-dimethylphenylcarbamate (3.34):  To a stirred solution of aniline 3.21 (0.988 
g, 4.00 mmol) in pyridine (10 mL) at 0 °C was added allyl chloroformate (1.45 g, 12.0 mmol) 
dropwise via syringe over 5 min.  The mixture was warmed to room temperature, stirred 
overnight (16 h), and poured into water (40 mL).  The mixture was extracted with EtOAc (3 x 40 
mL), and the combined organic layers were washed sequentially with water, sat. CuSO4 solution, 
0.20 M HCl, and brine (1 x 40 mL each), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Flash chromatography (6:1 hexanes:EtOAc) afforded the title compound (1.23 g, 
93%) as a cream-colored solid, mp 77–78 °C:  1H NMR (300 MHz, CDCl3)  7.53 (s, 1H), 7.03 
(s, 1H), 6.28-5.79 (m, 2H), 5.50-5.15 (m, 2H), 4.68 (br s, 2H), 2.31 (s, 3H), 2.28 (s, 3H); 
13
C 
NMR (75 MHz, CDCl3)  153.8, 138.9, 137.2, 137.0, 134.1, 132.5, 131.6, 117.7, 99.8, 65.9, 
20.3, 19.3; FTIR (thin film, CHCl3, cm
-1
) 3270 (broad), 2921, 1707, 1508, 1232, 1056, 994, 936, 
847, 771; HRMS (ESI) calcd for C12H14INNaO2 [M + Na]
+
: 353.9967, found: 353.9964. 
 
NH
I
O
O
 
Methyl 2-iodo-4,6-dimethylphenylcarbamate (3.35):  To a stirred solution of aniline 3.21 
(1.24 g, 5.00 mmol) in pyridine (10 mL) at 0 °C was added methyl chloroformate (0.709 g, 7.5 
mmol) dropwise via syringe over 5 min.  The solution was warmed to room temperature and 
stirred 9 h.  The mixture was recooled to 0 °C, a second portion of methyl chloroformate (0.709 
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g, 7.5 mmol) was added in the same manner, and the mixture was stirred at room temperature 
overnight (15 h).  A final portion of methyl chloroformate (0.709 g, 7.5 mmol) was again added 
at 0 °C, the mixture was stirred for 2 h at room temperature, and water (50 mL) was slowly 
added.  The mixture was extracted with EtOAc (3 x 50 mL) and the combined organic layers 
were washed sequentially with water, sat. CuSO4 solution, 0.20 M HCl, and brine (50 mL each), 
dried over MgSO4, filtered, and concentrated with rotary evaporation.  Flash chromatography 
(4:1 hexanes:EtOAc) afforded the title compound (1.40 g, 92%) as a white solid, mp 91-92 °C in 
a 2.3:1 ratio of rotamers:  
1
H NMR (300 MHz, CDCl3)  7.54 (s, 1H), 7.03 (s, 1H), 6.14 (br s, 
1H, major), 5.95 (br s, 1H, minor), 3.79 (br s, 3H), 2.30 (s, 3H), 2.28 (s, 3H); 
13
C NMR (75 
MHz, CDCl3)  154.5, 138.6, 137.0, 136.8, 134.1, 131.4, 99.8, 52.5, 20.1, 19.1; FTIR (thin film, 
CHCl3, cm
-1
) 3286 (broad), 2953, 2921, 1710, 1502, 1449, 1349, 1241, 1068, 851, 771; LRMS 
(EI) m/z 305 (M
+
, 28), 178 (100), 163 (62), 118 (27); HRMS (EI) calcd for C10H12INO2 [M]
+
: 
304.9913, found: 304.9904. 
 
NH
I
Cbz
 
Benzyl 2-iodo-4,6-dimethylphenylcarbamate (3.36):  To a stirred solution of aniline 3.21 
(0.988 g, 4.00 mmol) in CH2Cl2 (5.0 mL) at 0 °C was added via syringe an aqueous NaOH 
solution (1.0 M, 5.0 mL) followed by dropwise addition of benzyl chloroformate (0.853 g, 5.00 
mmol), and the mixture was stirred overnight (16 h) at room temperature.  The mixture was then 
extracted with EtOAc (3 x 25 mL), and the combined organic layers were washed with brine (2 x 
25 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Flash 
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chromatography of the crude material (5:1 hexanes:EtOAc) afforded the title compound (1.40 g, 
92%) as a pink solid, mp 102-103 °C, in a 3:1 ratio of rotamers:  
1
H NMR (300 MHz, CDCl3)  
7.54 (s, 1H), 7.50-7.24 (m, 5H), 7.03 (s, 1H), 6.31 (br s, 1H, major), 6.15 (br s, 1H, minor), 5.23 
(s, 2H), 2.29 (br s, 3H), 2.28 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  154.0, 139.0, 137.3, 137.1 
(2C), 136.3, 134.1, 131.8, 128.4 (2C), 128.0 (2C, accidental isochrony, confirmed by DEPT-
135), 99.8, 67.2, 20.3, 19.3; FTIR (thin film, CHCl3, cm
-1
) 3267 (broad), 3032, 2955, 1700, 
1516, 1243, 1061, 847, 746, 699; HRMS (ESI) calcd for C16H16INNaO2 [M + Na]
+
: 404.0124, 
found: 404.0121. 
 
O
O
I
 
Methyl 4-iodocrotonate:  Methyl 4-bromocrotonate (8.06 g, 45.0 mmol) was dissolved in dry 
acetone (100 mL), and NaI (13.5 g, 90.0 mmol) was added to the reaction mixture.  The mixture 
was refluxed for 2 h, cooled to room temperature, and poured into 1 L CH2Cl2.  The resulting 
mixture was washed successively with 10% Na2S2O3 aqueous solution, water, saturated NaHCO3 
solution, and brine (250 mL each), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Flash chromatography of the residue (10:1 pentane:Et2O) gave the title 
compound
274
 (7.43 g, 73%) as a red mobile oil:  
1
H NMR (300 MHz, CDCl3)  7.07 (dt, J = 15.0 
Hz, 8.4 Hz, 1H), 5.95 (d, J = 15.3 Hz, 1H), 5.94 (d, 8.4 Hz, 2H), 3.76 (s, 3H); 
13
C NMR (75 
MHz, CDCl3)  165.7, 143.6, 122.6, 51.6, 0.8; FTIR (neat, cm
-1
) 2950, 1721, 1650, 1322, 1277, 
1206, 1128, 973, 867, 723; LRMS (EI) m/z 226 (M
+
, 20), 195 (28), 127 (57), 99 (100); HRMS 
(EI) calcd for C5H7IO2 [M]
+
: 225.9491, found: 225.9500. 
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Representative procedure for 4-[t-butyloxycarbonyl-(2-iodo-4,6-dimethylphenyl)-amino]-but-
2-enoic acid methyl ester (3.19a): Carbamate 3.28 (0.694 g, 2.00 mmol) was dissolved in DMF 
(6.0 mL) with stirring at 0 °C.  In one portion, Cs2CO3 (1.30 g, 4.00 mmol) was added and the 
mixture was stirred for 10 min.  A solution of methyl 4-iodocrotonate (0.678 g, 3.00 mmol) in 
DMF (3.0 mL) was then added dropwise over 5 min.  The mixture was slowly warmed to room 
temperature and stirred overnight, then poured into water (90 mL) and extracted with Et2O (3 x 
90 mL).  The combined organic layers were washed sequentially with water and brine (2 x 90 
mL each), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Flash 
chromatography of the residue (5:1 hexanes:EtOAc) gave the title compound (0.641 g, 99%) as a 
clear solid, mp 66-68 °C, in a 2.8:1 ratio of rotamers.  The racemate was submitted to preparative 
chiral HPLC separation ((S,S)-Whelk-O1, 99:1 hexanes:i-PrOH), first eluting enantiomer (P)  
[]D
23
 +1, 99/1 er (c 2.4 mg/mL, CHCl3); second eluting enantiomer (M)  []D
23
 –1, 90/10 er (c 
8.0 mg/mL, CHCl3): 
1
H NMR (300 MHz, CDCl3) major rotamer  7.52 (m, 1H), 7.08 (ddd, J = 
15.6 Hz, 7.5 Hz, 6.6 Hz, 1H), 6.98 (m, 1H), 5.83 (dt, J = 15.6 Hz, 1.5 Hz, 1H), 4.47 (ddd, J = 
15.3 Hz, 6.3 Hz, 1.5 Hz, 1H), 3.97 (ddd, J = 15.3 Hz, 7.5 Hz, 1.5 Hz, 1H), 3.72 (s, 3H), 2.27 (s, 
3H), 2.21 (s, 3H), 1.36 (s, 9H), minor rotamer  7.54 (m, 1H), 7.09 (ddd, J = 15.6 Hz, 7.2 Hz, 6.3 
Hz, 1H), 7.00 (m, 1H), 5.86 (dt, J = 15.6 Hz, 1.5 Hz, 1H), 4.40 (ddd, J = 15.9 Hz, 6.3 Hz, 1.5 Hz, 
1H), 3.91 (ddd, J = 15.9 Hz, 7.5 Hz, 1.5 Hz, 1H), 3.75 (s, 3H), 2.25 (s, 3H), 2.23 (s, 3H), 1.54 (s, 
9H), 
13
C NMR (75 MHz, CDCl3) major rotamer  165.9, 153.5, 143.1, 139.8, 138.7, 137.4, 
137.1, 131.3, 122.7, 100.1, 80.0, 51.2, 50.1, 27.9 (3C), 20.1, 19.08, additional peaks from the 
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minor rotamer seen at  166.0, 152.9, 143.5, 140.4, 137.62, 137.59, 131.6, 122.4, 100.3, 80.7, 
51.4, 51.3, 28.1 (3C), 19.14; FTIR (thin film, CHCl3, cm
-1
) 2977, 2927, 1703, 1437, 1389, 1367, 
1316, 1167, 1024, 981, 914, 855, 765, 733; HRMS (ESI) calcd for C18H24NNaIO4 [M + Na]
+
: 
468.0648, found: 468.0685. 
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4-[Allyloxycarbonyl-(2-iodo-4,6-dimethylphenyl)-amino]-but-2-enoic acid methyl ester 
(3.19b):  Carbamate 3.34 (1.01 g, 3.00 mmol) was alkylated in the manner of 3.19a and purified 
with flash chromatography (5:1 hexanes:EtOAc) to give the title compound (1.28 g, 99%) as a 
clear colorless oil, in a 4.0:1 rotamer ratio.  The racemate was submitted to preparative chiral 
HPLC separation (Chiralcel OD, 97:3 hexanes:i-PrOH), first eluting enantiomer (P) []D
23
 –3.4, 
100/0 er (c 13.4 mg/mL, CHCl3); second eluting enantiomer (M) []D
23
 +2.7, 87/13 er (c 26.2 
mg/mL, CHCl3):  
1
H NMR (300 MHz, CDCl3) major rotamer  7.55 (m, 1H), 7.09 (ddd, J = 15.6 
Hz, 7.5 Hz, 6.6 Hz, 1H), 7.01 (m, 1H), 5.87 (dt, J = 15.6 Hz, 1.2 Hz, 1H), 5.83 (ddt, J = 17.1 Hz, 
10.5 Hz, 5.4 Hz, 1H), 5.14 (dq, J = 17.1 Hz, 1.5 Hz, 1H), 5.12 (dq, J = 10.5 Hz, 1.5 Hz, 1H), 
4.58 (dt, J = 5.4 Hz, 1.5 Hz, 1H), 4.52 (ddd, J = 15.3 Hz, 6.3 Hz, 1.2 Hz, 1H), 4.03 (ddd, J = 15.6 
Hz, 7.5 Hz, 1.2 Hz, 1H), 3.73 (s, 3H), 2.28 (s, 3H), 2.22 (s, 3H), minor rotamer  7.55 (m, 1H), 
7.09 (ddd, J = 15.6 Hz, 7.5 Hz, 6.6 Hz, 1H), 7.01 (m, 1H), 5.90-5.83 (m, 1H), 6.01 (ddt, J = 17.1 
Hz, 10.5 Hz, 5.4 Hz, 1H), 5.39 (dq, J = 17.1 Hz, 1.5 Hz, 1H), 5.27 (dq, J = 10.5 Hz, 1.5 Hz, 1H), 
4.75 (ddt, J = 13.5 Hz, 5.7 Hz, 1.5 Hz), 4.69 (ddt, J = 13.5 Hz, 5.7 Hz, 1.5 Hz, 1H), 4.56-4.47 
(m, 1H), 4.05-3.95 (m, 1H), 3.75 (s, 3H), 2.27 (s, 3H), 2.23 (s, 3H); 
13
C NMR (75 MHz, CDCl3) 
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major rotamer  165.8, 154.3, 142.3, 139.3, 139.2, 137.6, 137.2, 132.2, 131.6, 123.2, 117.1, 
100.0, 66.1, 51.2, 50.7, 20.1, 19.1, additional peaks from the minor rotamer seen at  153.6, 
142.6, 139.8, 139.4, 137.7, 132.3, 131.7, 122.9, 117.5, 99.9, 66.2, 51.3,; FTIR (neat, cm
-1
) 2950, 
1716, 1437, 1394, 1308, 1173, 1029, 987, 929, 854, 798, 766; LRMS (EI) m/z 429 (M
+
, 22), 344 
(34), 165 (73), 158 (100), 98 (53); HRMS (EI) calcd for C17H20INO4 [M]
+
: 429.0437, found: 
429.0443. 
 
N
I
Cbz
CO2Me
 
4-[Benzyloxycarbonyl-(2-iodo-4,6-dimethylphenyl)-amino]-but-2-enoic acid methyl ester 
(3.19c):  Carbamate 3.36 (1.14 g, 3.00 mmol) was alkylated in the manner of 3.19a and purified 
with flash chromatography (4:1 hexanes:EtOAc) to give the title compound (1.35 g, 94%) as a 
clear colorless oil in a 3.3:1 rotamer ratio.  The racemate was submitted to preparative chiral 
HPLC separation (Chiralcel OD, 96:4 hexanes:i-PrOH), first eluting enantiomer (P) []D
23
 +8.5, 
99.5/0.5 er (c 8.9 mg/mL, CHCl3); second eluting enantiomer (M) []D
23
 –8.0, 89/11 er (c 28.2 
g/mL, CHCl3):  
1
H NMR (300 MHz, CDCl3) major rotamer  7.55 (m, 1H), 7.45-7.18 (m, 5H), 
7.08 (ddd, J = 15.6 Hz, 7.5 Hz, 6.6 Hz, 1H), 6.99 (m, 1H), 5.87 (dt, J = 15.6 Hz, 1.5 Hz, 1H), 
5.16 (d, J = 12.6 Hz, 1H), 5.10 (d, J = 12.6 Hz, 1H), 4.53 (ddd, J = 15.3 Hz, 6.6 Hz, 1.2 Hz, 1H), 
4.04 (ddd, J = 15.6 Hz, 7.5 Hz, 1.2 Hz, 1H), 3.73 (s, 3H), 2.28 (s, 3H), 2.15 (s, 3H), minor 
rotamer  7.55 (m, 1H), 7.45-7.18 (m, 5H), 7.12-7.00 (m, 1H), 7.02 (m, 1H), 5.82 (dt, J = 15.3 
Hz, 1.5 Hz, 1H), 5.31 (d, J = 12.3 Hz, 1H), 5.22 (d, J = 12.3 Hz, 1H), 4.55-4.45 (m, 1H), 4.04-
3.94 (m, 1H), 3.74 (s, 3H), 2.27 (s, 3H), 2.22 (s, 3H); 
13
C NMR (75 MHz, CDCl3) major rotamer 
  168 
 166.2, 154.9, 142.5, 139.6, 139.5, 137.9, 137.5, 136.3, 131.9, 128.2, 127.8, 127.6, 123.5, 100.3, 
67.5, 51.5, 51.1, 20.4, 19.3, additional peaks from minor rotamer seen at  154.1, 142.9, 140.0, 
139.7, 138.0, 137.8, 136.2, 132.0, 128.4, 128.1, 123.2, 100.1, 67.8, 51.6; FTIR (neat, cm
-1
) 3031, 
2951, 1710, 1437, 1399, 1173, 1127, 1027, 986, 911, 855, 733; LRMS (EI) m/z 479 (M
+
, 17), 
388 (53), 344 (62), 158 (62), 91 (100); HRMS calcd for C21H22INO4 [M]
+
: 479.0594, found: 
479.0589. 
 
N
Br
I
Boc
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4-[t-Butyloxycarbonyl-(4-bromo-2-iodo-6-methylphenyl)-amino]-but-2-enoic acid methyl 
ester (3.19d):  Carbamate 3.29 (0.412 g, 1.00 mmol) was alkylated in the manner of 3.19a and 
purified with flash chromatography (4:1 hexanes:EtOAc) to give the title compound (320. mg, 
63%) as a white solid, mp 45-46 °C, in a 3.1:1 ratio of rotamers. The racemate was submitted to 
preparative chiral HPLC separation ((S,S)-Whelk-O1, 98:2 hexanes:i-PrOH), first eluting 
enantiomer []D
23
 +0.5, 98/2 er (c 6.2 mg/mL, CHCl3); second eluting enantiomer []D
23
 –0.6, 
97/3 (c 30.0 mg/mL, CHCl3):  
1
H NMR (300 MHz, CDCl3) major rotamer  7.84 (d, J = 2.1 Hz, 
1H), 7.35 (d, J = 1.5 Hz, 1H), 7.05 (ddd, J = 15.6 Hz, 7.5 Hz, 6.6 Hz, 1H), 5.84 (dt, J = 15.6 Hz, 
1.5 Hz, 1H), 4.46 (ddd, J = 15.6 Hz, 6.3 Hz, 1.5 Hz, 1H), 3.96 (ddd, J = 15.6 Hz, 7.5 Hz, 1.2 Hz, 
1H), 3.73 (s, 3H), 2.23 (s, 3H), 1.37 (s, 9H), minor rotamer  7.85 (m, 1H), 7.36 (d, J = 2.1 Hz, 
1H), 7.06 (ddd, J = 15.9 Hz, 7.2 Hz, 6.0 Hz, 1H), 5.86 (dt, J = 15.6 Hz, 1.5 Hz, 1H), 4.39 (ddd, J 
= 15.6 Hz, 6.0 Hz, 1.5 Hz, 1H), 3.90 (ddd, J = 15.9 Hz, 7.5 Hz, 1.2 Hz, 1H), 3.76 (s, 3H), 2.25 
(s, 3H), 1.54 (s, 9H); 
13
C NMR (75 MHz, CDCl3) major rotamer  166.15, 153.3, 142.7, 142.1, 
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139.6, 139.3, 133.6, 123.4, 121.5, 101.2, 80.9, 51.6, 50.1, 28.1 (3C), 19.3, additional peaks from 
minor rotamer seen at  166.21, 152.9, 143.1, 142.5, 140.2, 139.5, 133.9, 123.1, 121.9, 101.4, 
81.6, 51.7, 51.4, 28.3 (3C), 19.4; FTIR (thin film, CHCl3, cm
-1
) 2976, 1707, 1435, 1392, 1367, 
1317, 1154, 980, 861, 756; HRMS (ESI) calcd for C17H21
79
BrINNaO4 [M + Na]
+
: 531.9596, 
found: 531.9625. 
 
N
I
Boc
CO2Me
 
4-[t-Butyloxycarbonyl-(2-iodophenyl)-amino]-but-2-enoic acid methyl ester (3.19e):  
Carbamate 3.30 (0.638 g, 2.00 mmol) was alkylated in the manner of 3.19a and purified with 
flash chromatography (3:1 pentane:Et2O) to give the title compound in quantitative yield (843 
mg) as a clear colorless oil containing ~5% of an inseparable impurity.  For further purification, 
400. mg of the oil was purified by preparative HPLC ((S,S)-Whelk O 1, 90:10 hexanes:i-PrOH, 4 
injections) to afford the title compound (0.364 g, 91% overall yield) as a clear colorless oil, with 
a 2.4:1 ratio of rotamers: 
1
H NMR (300 MHz, CDCl3) major rotamer  7.87 (d, J = 7.5 Hz, 1H), 
7.33 (t, J = 7.5 Hz, 1H), 7.15 (d, J = 7.5 Hz, 1H), 7.02 (ddd, J = 15.6 Hz, 6.6 Hz, 5.7 Hz, 1H), 
7.03-6.97 (m, 1H), 5.90 (d, J = 15.6 Hz, 1H), 4.66 (dd, J = 16.5 Hz, 5.4 Hz, 1H), 3.85 (dd, J = 
16.2 Hz, 6.6 Hz, 1H), 3.73 (s, 3H), 1.36 (s, 9H), minor rotamer 7.93-7.85 (br m, 1H), 7.40-7.33 
(br m, 1H), 7.24 (d, J = 7.5 Hz, 1H), 7.02 (ddd, J = 15.6 Hz, 6.6 Hz, 5.7 Hz, 1H), 7.03-6.97 (m, 
1H), 6.00-5.90 (br m, 1H), 4.65-4.53 (br m, 1H), 3.87-3.79 (m, 1H), 3.76 (s, 3H), 1.53 (s, 9H); 
13
C NMR (75 MHz, CDCl3) major rotamer  166.4, 153.7, 143.4, 139.5, 129.7, 129.2, 129.0 (2C, 
accidental isochrony), 122.7, 100.1, 80.8, 51.5, 50.2, 28.1 (3C), peaks from minor rotamer were 
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broadened; FTIR (neat, cm
-1
) 2979, 1705, 1472, 1435, 1386, 1316, 1278, 1166, 1019, 980, 863, 
761; HRMS calcd for C16H20INO4 [M]
+
: 417.0437, found: 417.0445. 
 
N
I
CO2MeO
O
 
4-[Methyloxycarbonyl-(2-iodo-4,6-methylphenyl)-amino]-but-2-enoic acid methyl ester 
(3.19f):  Carbamate 3.35 (0.915 g, 3.00 mmol) was alkylated in the manner of 3.19a and purified 
with flash chromatography (2:1 pentane:Et2O) to give the title compound (0.934 g, 77%) as a 
clear colorless oil in a 5.0:1 ratio of rotamers:  
1
H NMR (300 MHz, CDCl3) major rotamer  7.56 
(m, 1H), 7.09 (ddd, 15.6 Hz, 7.5 Hz, 6.6 Hz, 1H), 7.02 (m, 1H), 5.87 (dt, J = 15.6 Hz, 1.5 Hz, 
1H), 4.49 (ddd, J = 15.6 Hz, 6.6 Hz, 1.5 Hz, 1H), 4.04 (ddd, J = 15.6 Hz, 7.5 Hz, 1.5 Hz, 1H), 
3.73 (s, 3H), 3.68 (s, 3H), 2.28 (s, 3H), 2.21 (s, 3H), minor rotamer  7.56 (m, 1H), 7.08 (ddd, J 
= 15.6 Hz, 7.5 Hz, 6.3 Hz, 1H), 7.02 (m, 1H), 5.85 (dt, J = 15.6 Hz, 1.5 Hz, 1H), 4.51-4.42 (m, 
1H), 4.01-3.93 (m, 1H), 3.84 (s, 3H), 3.75 (s, 3H), 2.27 (s, 3H), 2.22 (s, 3H); 
13
C NMR (75 MHz, 
CDCl3) major rotamer  165.85, 155.2, 142.4, 139.4, 139.3, 137.7, 137.3, 131.7, 123.2, 100.1, 
53.1, 51.3, 50.9, 20.2, 19.1, additional signals from the minor rotamer were seen at  165.91, 
154.4, 142.8, 139.8, 137.8, 137.6, 131.8, 122.8, 100.0, 53.0, 51.4; FTIR (neat, cm
-1
) 2952, 1717, 
1447, 1313, 1193, 1174, 992, 916, 854, 732; LRMS (EI) m/z 403 (M
+
, 46), 276 (100), 216 (32), 
177 (78), 158 (40); HRMS (EI) calcd for C15H18INO4 [M]
+
: 403.0281, found: 403.0299. 
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4-[t-Butyloxycarbonyl-(2-iodo-4-methyl-6-(trimethylsilyl)phenyl)-amino]-but-2-enoic acid 
methyl ester (3.19g):  Carbamate 3.31 (0.203 g, 0.500 mmol) was alkylated in the manner of 
3.19a and purified with flash chromatography (6:1 hexanes:EtOAc) to give the title compound 
(143 mg, 57%) as a white solid, mp 69-71 °C, with a 2.75:1 ratio of rotamers:  
1
H NMR (300 
MHz, CDCl3) major rotamer  7.69 (s, 1H), 7.26 (s, 1H), 7.09 (dt, J = 15.6 Hz, 7.2 Hz, 1H), 5.80 
(d, J = 15.6 Hz, 1H), 4.43 (dd, J = 15.3 Hz, 6.6 Hz, 1H), 4.08 (dd, J = 15.3 Hz, 7.5 Hz, 1H), 3.70 
(s, 3H), 2.30 (s, 3H), 1.39 (s, 9H), 0.28 (s, 9H), minor rotamer  7.69 (s, 1H), 7.26 (s, 1H), 7.19 
(dt, J = 15.6 Hz, 7.2 Hz, 1H), 5.80 (d, J = 15.6 Hz, 1H), 4.31 (dd, J = 15.6 Hz, 6.9 Hz, 1H), 4.15-
4.00 (m, 1H), 3.73 (s, 3H), 2.28 (s, 3H), 1.53 (s, 9H), 0.28 (s, 9H); 
13
C NMR (75 MHz, CDCl3) 
major rotamer  166.1, 154.0, 144.7, 143.2, 141.2, 141.0, 138.2, 136.3, 122.8, 102.1, 80.7, 51.4, 
51.3, 28.2 (3C), 20.4, 0.17 (3C), additional peaks from the minor rotamer seen at  166.2, 153.5, 
145.6, 143.9, 141.6, 141.3, 138.5, 136.5, 122.3, 102.4, 80.9, 52.6, 51.5, 28.3 (3C), –0.0 (3C); 
FTIR (thin film, CHCl3, cm
-1
) 2976, 1727, 1704, 1435, 1366, 1316, 1251, 1165, 895, 839, 757; 
LRMS (EI) m/z 503 (M
+
, 1), 447 (95), 356 (69), 320 (100), 288 (81), 200 (86); HRMS (EI) calcd 
for C20H30INO4Si [M]
+
: 503.0989, found: 503.0977. 
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4-[t-Butyloxycarbonyl-(6-bromo-2-iodo-4-methylphenyl)-amino]-but-2-enoic acid methyl 
ester (3.19h):  Carbamate 3.32 (0.412 g, 1.00 mmol) was alkylated in the manner of 3.19a and 
purified with flash chromatography (4:1 pentane:Et2O) to give the title compound (0.332 g, 65%) 
as a white solid, mp 92-94 °C, with a 3.76:1 ratio of rotamers:  
1
H NMR (300 MHz, CDCl3) 
major rotamer  7.63 (m, 1H), 7.41 (m, 1H), 7.18 (dt, J = 15.6 Hz, 6.9 Hz, 1H), 5.87 (dt, J = 15.6 
Hz, 1.5 Hz, 1H), 4.30 (ddd, J = 15.6 Hz, 6.9 Hz, 1.5 Hz, 1H), 4.23 (m, 1H), 3.72 (s, 3H), 2.30 (s, 
3H), 1.38 (s, 9H), minor rotamer  7.65 (m, 1H), 7.42 (m, 1H), 7.22 (dt, J = 15.6 Hz, 6.6 Hz, 
1H), 5.86 (dt, J = 15.6 Hz, 1.5 Hz, 1H), 4.25-4.19 (m, 1H), 4.15 (ddd, J = 15.9 Hz, 6.9 Hz, 1.5 
Hz, 1H), 3.75 (s, 3H), 2.28 (s, 3H), 1.54 (s, 9H); 
13
C NMR (75 MHz, CDCl3) major rotamer  
166.4, 153.2, 143.5, 140.7, 140.0, 139.3, 134.0, 123.4, 123.1, 101.0, 80.9, 51.5, 50.1, 28.1 (3C), 
20.2, additional signals from the minor rotamer were seen at  166.5, 144.1, 141.1, 139.5, 134.2, 
122.6, 101.2, 81.6, 51.6, 28.4 (3C); FTIR (thin film, CHCl3, cm
-1
) 2976, 1708, 1461, 1435, 1367, 
1315, 1164, 978, 855, 763, 723; HRMS (ESI) calcd for C17H21
79
BrINNaO4 [M + Na]
+
: 531.9596, 
found: 531.9586. 
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4-[t-Butyloxycarbonyl-(4,6-dibromo-2-iodo-6-phenyl)-amino]-but-2-enoic acid methyl ester 
(3.19i):  Carbamate 3.33 (0.715 g, 1.50 mmol) was alkylated in the manner of 3.19a and purified 
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with flash chromatography (6:1 hexanes:EtOAc) to give the title compound (0.742 g, 86%) as a 
white solid, mp 78-79 °C, in a 3.8:1 ratio of rotamers:  
1
H NMR (300 MHz, CDCl3) Major 
rotamer  7.96 (d, J = 2.4 Hz, 1H), 7.76 (d, J = 2.1 Hz, 1H), 7.15 (dt, J = 15.6 Hz, 7.2 Hz, 1H), 
5.85 (dt, J = 15.6 Hz, 1.5 Hz, 1H), 4.29 (ddd, J = 15.6 Hz, 6.9 Hz, 1.5 Hz), 4.22 (ddd, J = 15.6 
Hz, 6.9 Hz, 1.5 Hz), 3.73 (s, 3H), 1.38 (s, 9H), minor rotamer  7.97 (d, J = 2.1 Hz, 1H), 7.77 (d, 
J = 2.1 Hz, 1H), 7.19 (dt, J = 15.9 Hz, 6.9 Hz, 1H), 5.87 (dt, J = 15.6 Hz, 1.5 Hz, 1H), 4.21-4.15 
(m, 2H), 3.76 (s, 3H), 1.54 (s, 9H); 
13
C NMR (75 MHz, CDCl3) major rotamer  165.8, 152.3, 
142.7, 141.9, 140.6, 135.6, 124.1, 123.2, 121.9, 101.8, 81.1, 51.4, 49.6, 27.8 (3C), additional 
peaks from the minor rotamer seen at  165.9, 152.2, 143.2, 142.5, 140.8, 135.8, 124.5, 122.8, 
122.2, 102.0, 81.7, 51.5, 51.1, 28.1 (3C); FTIR (thin film, CHCl3, cm
-1
) 3400 (broad), 2977, 
1714, 1555, 1527, 1443, 1367, 1317, 1163, 978, 860, 814, 759, 718; LRMS (EI) m/z 577 (M
+
 
(
81
Br, 
81
Br), < 1), 521 ((
81
Br, 
81
Br) 44), 290 ((
81
Br, 
81
Br) 19), 99 (39), 91 (71), 57 (100); HRMS 
(EI) calcd for C16H18Br2INO4 [M]
+
: 572.8647, found: 572.8649. 
 
N
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4-[t-Butyloxycarbonyl-(2-iodo-4,6-dimethylphenyl)-amino]-but-2-enoic acid allyl ester 
(3.19j):  To a stirred solution of methyl ester 3.19a (0.891 g, 2.00 mmol) in THF (10 mL) at 0 °C 
was added aqueous NaOH solution (1.0 M, 6.0 mL).  The mixture was warmed to room 
temperature and stirred overnight, volatiles were removed by rotary evaporation, and the mixture 
was acidified to pH 1 at 0 °C with 1 N HCl.  The mixture was extracted with CH2Cl2 (3 x 50 mL) 
and EtOAc (1 x 50 mL), and the combined organic layers were dried over Na2SO4, filtered, and 
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concentrated by rotary evaporation.  This yielded the crude acid 3.37 as a sticky yellow solid in 
quantitative yield (~95% pure by 
1
H NMR), which was used directly in the next step without 
further purification. 
The crude acid 3.37 (0.866 g, ~2.00 mmol) and allyl alcohol (0.139 g, 2.40 mmol) were 
dissolved in CH2Cl2 (10 mL) with stirring.  DCC (0.495 g, 2.40 mmol) was added all at once, 
followed by DMAP (12 mg, 0.1 mmol), and the reaction was stirred for 3 h at room temperature.  
The mixture was filtered through Celite and washed with CH2Cl2 (3 x 20 mL), washed with 
water (1 x 50 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Flash 
chromatography (5:1 hexanes:EtOAc) gave the title compound (0.584 g, 62% over 2 steps) as a 
clear colorless oil in a 3:1 ratio of rotamers:  
1
H NMR (300 MHz, CDCl3) major rotamer  7.52 
(s, 1H), 7.10 (ddd, J = 15.6 Hz, 7.5 Hz, 6.6 Hz, 1H), 6.98 (s, 1H), 6.00-5.83 (m, 1H), 5.86 (dt, J 
= 15.3 Hz, 1.2 Hz), 5.31 (dq, J = 17.1 Hz, 1.5 Hz, 1H), 5.23 (dq, J = 10.5 Hz, 1.5 Hz, 1H), 4.63 
(dt, J = 5.7 Hz, 1.2 Hz, 2H), 4.47 (ddd, J = 15.3 Hz, 6.3 Hz, 1.2 Hz, 1H), 3.99 (ddd, J = 15.6 Hz, 
7.5 Hz, 1.2 Hz, 1H), 2.27 (s, 3H), 2.21 (s, 3H), 1.36 (s, 9H), minor rotamer  7.54 (s, 1H), 7.10 
(ddd, J = 15.6 Hz, 7.5 Hz, 6.6 Hz, 1H), 7.00 (s, 1H), 6.00-5.85 (m, 2H), 5.33 (dq, J = 17.1 Hz, 
1.5 Hz, 1H), 5.28-5.23 (m, 1H), 4.66 (dt, J = 5.4 Hz, 1.2 Hz, 1H), 4.40 (ddd, J = 15.9 Hz, 6.3 Hz, 
1.5 Hz, 1H), 3.92 (ddd, J = 15.7 Hz, 7.2 Hz, 1.2 Hz, 1H), 2.25 (s, 3H), 2.23 (s, 3H), 1.53 (s, 9H); 
13
C NMR (75 MHz, CDCl3) major rotamer  165.4, 153.7, 143.5, 140.0, 138.9, 137.6, 137.3, 
132.1, 131.5, 123.0, 117.8, 100.3, 80.3, 64.8, 50.2, 28.1 (3C), 20.3, 19.2, additional peaks from 
the minor rotamer seen at  153.2, 144.0, 140.5, 139.3, 137.8, 131.8, 122.6, 100.5, 81.0, 64.9, 
51.6, 28.3 (3C), 19.3; FTIR (neat, cm
-1
) 2976, 2927, 1703, 1472, 1367, 1312, 1257, 1166, 1021, 
987, 935, 855, 768; HRMS (ESI) calcd for C20H26INNaO4 [M + Na]
+
: 494.0804, found: 
494.0796. 
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General procedures for the cyclizations of racemic and enantioenriched 3.19a-j to 3.20a-j 
follow.  These procedures describe the experiments outlined in Table 3.2 in Chapter 3.2.2, and 
Table 3.4 in Chapter 3.2.5.  Characterization data for cyclized products 3.20a-j are given below; 
for the associated procedures and yields, refer to these tables in the main text. 
 General procedure (R) for radical mediated cyclizations:  To a non-degassed, stirred 
solution of the appropriate aryl iodide in benzene, open to the atmosphere, was added Bu3SnH 
(0.01 M, 1.5 equiv) at room temperature.  A solution of Et3B in hexane (1.0 M, 1.0 equiv) was 
added via syringe, and the reaction was stirred until completion (< 5 min).  Solvent was removed 
by rotary evaporation, and the crude residue was purified using flash chromatography on 10% 
w/w KF/silica gel
80
 with a hexane/EtOAc solvent system. 
General procedure (R2) for radical cyclizations of Br-containing compounds:  To a 
non-degassed, stirred solution of the appropriate aryl iodide in benzene was added Bu3SnH (0.01 
M, 1.1 equiv) at room temperature.  A solution of Et3B in hexane (1.0 M, 1.0 equiv) was added 
via syringe, and the reaction was completed and purified as described in general procedure R. 
General procedure (A) for lithium-halogen exchange mediated cyclizations:  The 
appropriate aryl iodide was dissolved in a Trapp solvent mixture (4:1:1 THF : Et2O : pentane) 
with stirring to make a ~0.10 M solution.  TMSCl (5.0 equiv) was added via syringe, the mixture 
was stirred for 5 min, and then cooled to –98 °C with a MeOH / liquid nitrogen bath.  A solution 
of BuLi in hexanes (1.29 M, 1.2 equiv) was added dropwise over 10 min, and the reaction was 
stirred until complete (< 10 min).  The reaction was quenched with rapid addition of sat. aqueous 
NH4Cl solution (1 mL), and the mixture was allowed to warm to room temperature and stirred 
for 1 h.  Water (4 mL) was added, and the mixture was extracted with Et2O (3 x 10 mL).  The 
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combined organic layers were washed with brine (1 x 10 mL), dried over MgSO4, filtered, and 
concentrated by rotary evaporation.  The crude residue was purified using flash chromatography 
with the appropriate solvent system. 
General procedure (A2) for lithium-halogen exchange on Br-containing compounds:  
The appropriate aryl iodide was dissolved in toluene with stirring to make a ~0.05 M solution.  
TMSCl (5.0 equiv) was added via syringe, the mixture was stirred for 5 min, and then cooled to 
–91 °C with a heptane / liquid nitrogen bath.  A solution of BuLi in hexanes (1.29 M, 1.2 equiv) 
was added dropwise over 10 min, and the reaction was stirred until complete.  The reaction 
mixture was then quenched, worked up and purified as described in procedure A. 
 
N
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tert-Butyl 3-(2-methoxy-2-oxoethyl)-5,7-dimethylindoline-1-carboxylate (3.20a):  After 
cyclization of 3.19a, flash chromatography (5:1 hexanes:EtOAc) afforded the title compound as 
a clear, colorless oil.  Chiral analysis was performed on the analytical (S,S)-Whelk-O1 column 
(98:2 hexanes:i-PrOH). The atropisomer (P)-(+)-3.19a cyclized to give (S)-(+)-3.20b (first 
eluting enantiomer), [D
23
 +8.2 (c 29.8 mg/mL, CHCl3):  The atropisomer (M)-(–)-3.20a 
cyclized to give (R)-(–)-3.19b (second eluting enantiomer), [D
23
 –9.2 (c 19.5 mg/mL, CHCl3).  
1
H NMR (300 MHz, CDCl3)  6.86 (s, 1H), 6.80 (s, 1H), 4.24 (dd, J = 11.4 Hz, 7.5 Hz, 1H), 3.78 
(dd, J = 11.4 Hz, 5.7 Hz, 1H), 3.74 (s, 3H), 3.56 (m, 1H), 2.71 (dd, J = 16.2 Hz, 5.1 Hz, 1H), 
2.45 (dd, J = 16.2 Hz, 9.3 Hz, 1H), 2.28 (s, 3H), 2.27 (s, 3H), 1.53 (s, 9H); 
13
C NMR (75 MHz, 
CDCl3)  172.2, 153.9, 139.2, 136.4, 134.0, 130.8, 127.8, 121.4, 80.5, 56.8, 51.6, 38.1, 37.9, 28.2 
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(3C), 20.8, 19.6; FTIR (neat, cm
-1
) 2976, 1739, 1708, 1479, 1366, 1246, 1163, 1010, 856, 770, 
733; HRMS (ESI) calcd for C18H25NNaO4 [M + Na]
+
: 342.1681, found: 342.1671. 
 
N
Alloc
CO2Me
 
Allyl 3-(2-methoxy-2-oxoethyl)-5,7-dimethylindoline-1-carboxylate (3.20b):  After 
cyclization of 3.19b, flash chromatography (4:1 hexanes:EtOAc) afforded the title compound as 
a clear, colorless oil.  Chiral analysis was performed on the analytical (S,S)-Whelk-O1 column 
(99:1 hexanes:i-PrOH). The atropisomer (P)-(–)-3.19b cyclized to give (S)-(+)-3.20b (first 
eluting enantiomer), [D
23
 +5.0 (c 9.8 mg/mL, CHCl3):  The atropisomer (M)-(+)-3.19b 
cyclized to give (R)-(–)-3.20b (second eluting enantiomer), [D
23
 –6.4 (c 14.3 mg/mL, CHCl3).  
1
H NMR (300 MHz, CDCl3)  6.87 (s, 1H), 6.82 (s, 1H), 5.99 (ddt, J = 17.1 Hz, 10.5 Hz, 6.0 Hz, 
1H), 5.34 (dq, J = 17.1 Hz, 1.2 Hz, 1H), 5.25 (dd, J = 10.5 Hz, 1.2 Hz, 1H), 4.70 (dd, J = 17.1 
Hz, 1H), 4.68 (dt, J = 6.0 Hz, 1.2 Hz, 1H), 4.35 (dd, J = 11.4 Hz, 7.5 Hz, 1H), 3.83 (dd, J = 11.4 
Hz, 6.0 Hz, 1H), 3.73 (s, 3H), 3.61 (m, 1H), 2.75 (dd, J = 16.2 Hz, 5.1 Hz, 1H), 2.47 (dd, J = 
16.2 Hz, 9.6 Hz, 1H), 2.29 (s, 3H), 2.27 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  172.2, 154.2, 
138.8, 136.3, 134.4, 132.5, 131.1, 127.7, 121.5, 118.0, 66.4, 56.6, 51.7, 38.1, 37.8, 20.8, 19.8; 
FTIR (neat, cm
-1
) 2952, 1715, 1478, 1416, 1382, 1327, 1239, 1169, 1029, 934, 857, 766; HRMS 
(ESI) calcd for C17H21NNaO4 [M + Na]
+
: 326.1368, found: 326.1360. 
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Benzyl 3-(2-methoxy-2-oxoethyl)-5,7-dimethylindoline-1-carboxylate (3.20c): After 
cyclization of 3.19c, flash chromatography (4:1 hexanes:EtOAc) afforded the title compound as 
a clear, colorless oil.  Chiral analysis was performed on the analytical Chiralcel OD column 
(98:2 hexane:i-PrOH). The atropisomer (P)-(+)-3.19c cyclized to give (S)-(+)-3.20c (second 
eluting enantiomer), []D
23
 +9.0 (c 12.3 mg/mL, CHCl3):  The atropisomer (M)-(–)-3.19c 
cyclized to give (R)-(–)-3.20c (first eluting enantiomer), []D
23
 –11 (c 12.4 mg/mL, CHCl3).  
1
H 
NMR (300 MHz, CDCl3)  7.38-7.32 (m, 5H), 6.86 (s, 1H), 6.81 (s, 1H), 5.27 (d, J = 12.3 Hz, 
1H), 5.20 (d, J = 12.3 Hz, 1H), 4.33 (dd, J = 11.4 Hz, 7.8 Hz, 1H), 3.86 (dd, J = 11.4 Hz, 6.0 Hz, 
1H), 3.71 (s, 3H), 3.58 (m, 1H), 2.71 (dd, J = 16.5 Hz, 5.7 Hz, 1H), 2.44 (dd, J = 16.2 Hz, 9.3 
Hz, 1H), 2.28 (s, 3H), 2.24 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  172.1, 154.4, 138.8, 136.3, 
136.2, 134.5, 131.1, 128.4 (2C), 128.1 (2C), 128.1, 127.8, 121.5, 67.5, 56.6, 51.7, 38.1, 37.8, 
20.8, 19.9; FTIR (neat, cm
-1
) 3031, 2952, 1715, 1478, 1390, 1355, 1219, 1169, 1023, 856, 754; 
HRMS (ESI) calcd for C21H23NNaO4 [M + Na]
+
: 376.1525, found: 376.1529. 
 
N
Boc
Br
CO2Me
 
tert-Butyl 3-(2-methoxy-2-oxoethyl)-5-bromo-7-methylindoline-1-carboxylate (3.20d):  After 
cyclization of 3.19d, flash chromatography (5:1 hexanes:EtOAc) afforded the title compound as 
a clear, colorless oil.  Chiral analysis was performed on the analytical (S,S)-Whelk-O1 column 
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(99:1 hexanes:i-PrOH). The atropisomer (+)-3.19d cyclized to give (+)-3.20d (first eluting 
enantiomer), []D
23
 +1.9 (c 5.7 mg/mL, CHCl3).  The atropisomer (–)-3.19d cyclized to give (–)-
3.20d (second eluting enantiomer), []D
23
 –2.2 (c 19.8 mg/mL, CHCl3).  
1
H NMR (300 MHz, 
CDCl3)  7.18 (s, 1H), 7.11 (s, 1H), 4.24 (dd, J = 11.7 Hz, 8.1 Hz, 1H), 3.79 (dd, J = 11.7 Hz, 
5.7 Hz, 1H), 3.74 (s, 3H), 3.59 (m, 1H), 2.69 (dd, J = 16.2 Hz, 5.4 Hz, 1H), 2.46 (dd, J = 16.2 
Hz, 9.0 Hz, 1H), 2.27 (s, 3H), 1.52 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  171.9, 153.6, 141.1, 
138.5, 133.0, 130.3, 124.1, 117.1, 81.2, 56.9, 51.9, 38.0, 37.9, 28.3 (3C), 19.7; FTIR (neat, cm
-1
) 
3011, 2978, 1737, 1707, 1459, 1366, 1238, 1161, 1009, 859, 757; LRMS (EI) m/z 385 (M
+
 
(
81
Br), 4), 285 ((
81
Br) 40), 144 (40), 131 (100); HRMS (EI) calcd for C17H22
79
BrNO4 [M]
+
: 
383.0732, found: 383.0726. 
 
N
Boc
CO2Me
 
rac-tert-Butyl 3-(2-methoxy-2-oxoethyl)-indoline-1-carboxylate (3.20e):  After cyclization of 
rac-3.19e, flash chromatography (4:1 hexanes:EtOAc) afforded the title compound as a clear, 
colorless oil:  
1
H NMR (300 MHz, CDCl3)  7.86 (br, 1H), 7.20 (t, J = 7.8 Hz, 1H), 7.13 (d, J = 
7.5 Hz, 1H), 6.95 (td, J = 7.5 Hz, 1.2 Hz, 1H), 4.21 (dd, J = 11.4 Hz, 9.6 Hz, 1H), 3.83-3.73 (m, 
1H), 3.74 (s, 3H), 3.73- 3.62 (m, 1H), 2.79 (dd, J = 16.5 Hz, 4.8 Hz, 1H), 2.59 (dd, J = 16.5 Hz, 
9.3 Hz, 1H), 1.57 (s, 9H); 
13
C NMR (75 MHz, CDCl3) 172.2, 152.4, 128.2, 123.8, 122.3, 
114.8, 80.8 (br), 53.9, 51.2, 39.9, 35.7, 28.4 (3C), 2 aromatic signals missing, attributed to peak 
broadening from N-CO rotation; FTIR (neat, cm
-1
) 2977, 1738, 1703, 1486, 1393, 1167, 1146, 
1016, 753; HRMS (ESI) calcd for C16H21NNaO4 [M + Na]
+
: 314.1368, found: 314.1368. 
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rac-Methyl 3-(2-methoxy-2-oxoethyl)-5,7-dimethylindoline-1-carboxylate (3.20f):  After 
cyclization of rac-3.19f, flash chromatography (4:1 hexanes:EtOAc) afforded the title compound 
as a clear, colorless oil:  
1
H NMR (300 MHz, CDCl3)  6.88 (s, 1H), 6.81 (s, 1H), 4.33 (dd, J = 
11.4 Hz, 7.8 Hz, 1H), 3.80 (s, 3H), 3.80 (dd, J = 11.4 Hz, 6.3 Hz, 1H), 3.73 (s, 3H), 3.60 (m, 
1H), 2.75 (dd, J = 16.5 Hz, 5.1 Hz, 1H), 2.47 (dd, J = 16.2 Hz, 9.3 Hz, 1H), 2.29 (s, 3H), 2.26 (s, 
3H); 
13
C NMR (75 MHz, CDCl3)  172.0, 154.9, 138.7, 136.1, 134.3, 130.9, 127.6, 121.4, 56.5, 
52.5, 51.6, 37.9, 37.6, 20.7, 19.6; FTIR (neat, cm
-1
) 2954, 1716, 1441, 1367, 1243, 1194, 1169, 
1122, 1055, 857, 767; HRMS (ESI) calcd for C15H19NNaO4 [M + Na]
+
: 300.1212, found: 
300.1208. 
 
N
TMS CO2Me
Boc
 
rac-tert-Butyl 3-(2-methoxy-2-oxoethyl)-5-methyl-7-(trimethylsilyl)indoline-1-carboxylate 
(3.20g):  After cyclization of rac-3.19g, flash chromatography (6:1 hexanes:EtOAc) afforded the 
title compound as a clear, colorless oil:  
1
H NMR (300 MHz, CDCl3)  7.23 (s, 1H), 6.97 (s, 1H), 
4.23 (dd, J = 11.7 Hz, 8.1 Hz, 1H), 3.75 (dd, J = 11.4 Hz, 6.0 Hz, 1H), 3.75 (s, 3H),  2.74 (dd, J 
= 16.2 Hz, 4.8 Hz, 1H), 2.45 (dd, J = 16.2 Hz, 9.9 Hz, 1H), 2.32 (s, 3H), 1.54 (s, 9H), 0.29 (s, 
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9H); 
13
C NMR (75 MHz, CDCl3)  172.5, 154.8, 145.0, 135.3, 134.9, 133.0, 129.6, 124.8, 80.5, 
55.5, 51.7, 38.6, 37.6, 28.4 (3C), 21.0, 0.3 (3C); FTIR (neat, cm
-1
) 2952, 2899, 1740, 1707, 1398, 
1364, 1246, 1164, 1010, 885, 840, 778; HRMS (ESI) calcd for C20H31NNaO4Si [M + Na]
+
: 
400.1920, found: 400.1918. 
 
N
Boc
Br CO2Me
 
rac-tert-Butyl 3-(2-methoxy-2-oxoethyl)-7-bromo-5-methylindoline-1-carboxylate (3.20h):  
After cyclization of rac-3.19h, flash chromatography (4:1 hexanes:EtOAc) afforded the title 
compound as a clear, colorless oil: 
1
H NMR (300 MHz, CDCl3)  7.22 (s, 1H), 6.91 (s, 1H), 4.27 
(dd, J = 11.7 Hz, 7.5 Hz, 1H), 3.81 (dd, J = 11.7 Hz, 5.7 Hz, 1H), 3.74 (s, 3H), 3.62 (m, 1H), 
2.69 (dd, J = 16.5 Hz, 5.7 Hz, 1H), 2.47 (dd, J = 16.2 Hz, 9.0 Hz, 1H), 2.29 (s, 3H), 1.54 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  171.9, 153.5, 140.0, 139.1, 135.9, 132.8, 123.4, 112.6, 81.5, 57.4, 
51.8, 38.6, 38.0, 28.2 (3C), 20.7; FTIR (neat, cm
-1
) 2977, 1703, 1473, 1366, 1249, 1161, 1117, 
1040, 1006, 855, 787, 735; HRMS (ESI) calcd for C17H22
79
BrNNaO4 [M + Na]
+
: 406.0630, 
found: 406.0641. 
 
N
Boc
Br
Br
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rac-tert-Butyl 3-(2-methoxy-2-oxoethyl)-5,7-dibromoindoline-1-carboxylate (3.20i):  After 
cyclization of rac-3.19i, flash chromatography (4:1 hexanes:EtOAc) afforded the title compound 
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as a white solid, mp 101-103 °C:  
1
H NMR (300 MHz, CDCl3)  7.56 (s, 1H), 7.25 (s, 1H), 4.29 
(dd, J = 11.7 Hz, 7.8 Hz, 1H), 3.82 (dd, 11.7 Hz, 6.0 Hz), 3.74 (s, 3H), 3.66 (m, 1H), 2.68 (dd, J 
= 16.5 Hz, 6.0 Hz, 1H), 2.50 (dd, J = 16.5 Hz, 8.4 Hz, 1H), 1.54 (s, 9H); 
13
C NMR (75 MHz, 
CDCl3)  171.5, 152.9, 141.9, 140.8, 134.7, 126.0, 117.3, 113.5, 82.0, 57.3, 51.9, 38.4, 37.7, 28.1 
(3C); FTIR (thin film, CHCl3, cm
-1
) 2979, 1709, 1447, 1368, 1335, 1248, 1160, 858, 759; LRMS 
(EI) m/z 451 (M
+
 (
81
Br, 
81
Br), 7), 351 ((
81
Br, 
81
Br) 65), 290 ((
81
Br, 
81
Br) 34), 210 ((
81
Br) 49), 197 
((
81
Br) 68), 57 (100); HRMS (EI) calcd for C16H19
79
Br2NO4 [M]
+
: 446.9681, found: 446.9670. 
 
N
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O
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rac-tert-Butyl 3-(2-allyloxy-2-oxoethyl)-5,7-dimethylindoline-1-carboxylate (3.20j):  After 
cyclization of rac-3.19j, flash chromatography (4:1 hexanes:EtOAc) afforded the title compound 
as a clear, colorless oil: 
1
H NMR (300 MHz, CDCl3)  6.86 (s, 1H), 6.81 (s, 1H), 5.94 (ddt, J = 
17.1 Hz, 10.5 Hz, 5.7 Hz, 1H), 5.34 (dd, J = 17.1 Hz, 1.2 Hz, 1H), 5.27 (dd, J = 10.5 Hz, 1.2 Hz, 
1H), 4.64 (dt, J = 5.7 Hz, 1.2 Hz, 2H), 4.24 (dd, J = 11.4 Hz, 7.5 Hz, 1H), 3.79 (dd, J = 11.4 Hz, 
6.0 Hz, 1H), 3.57 (m, 1H), 2.73 (dd, J = 16.2 Hz, 5.4 Hz, 1H), 2.47 (dd, J = 16.2 Hz, 9.3 Hz, 
1H), 2.28 (s, 3H), 2.27 (s, 3H), 1.52 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  171.5, 154.0, 139.3, 
136.4, 134.1, 131.9, 130.9, 127.8, 121.5, 118.4, 80.6, 65.3, 56.9, 38.3, 37.9, 28.2 (3C), 20.8, 
19.6; FTIR (neat, cm
-1
) 2976, 2929, 1737, 1709, 1479, 1366, 1245, 1163, 1007, 932, 856, 770; 
HRMS (ESI) calcd for C20H27NNaO4 [M + Na]
+
: 368.1838, found: 368.1837. 
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(S)-2-(1-(Allyloxycarbonyl)-5,7-dimethylindolin-3-yl)acetic acid (3.39):  To a stirred solution 
of enantioenriched ester (+)-3.20b (236 mg, 0.778 mmol, 99/1 er) in THF (5.0 mL) at 0 °C was 
added dropwise an aqueous solution of NaOH (1.0 M, 2.33 mL).  The mixture was allowed to 
warm to room temperature and was stirred overnight.  Organic solvents were removed in vacuo, 
the mixture was cooled to 0 °C with stirring, and acidified to pH 2 with dropwise addition of 1 N 
HCl.  The mixture was extracted with CH2Cl2 (3 x 25 mL), and the combined organic layers 
were dried over Na2SO4, filtered, and concentrated by rotary evaporation to afford the crude title 
compound (201 mg, ~95% pure, ~89% crude yield) as a clear colorless oil.  The acid was not 
purified further and was used directly in the next step.  
1
H NMR (300 MHz, CDCl3)  10.88 (br 
s, 1H), 6.89 (s, 1H), 6.86 (s, 1H), 6.01 (ddt, J = 17.1 Hz, 10.2 Hz, 6.0 Hz, 1H), 5.34 (dd, J = 17.1 
Hz, 1.2 Hz, 1H), 5.27 (dd, J = 10.5 Hz, 0.9 Hz, 1H), 4.72 (dd, J = 5.7 Hz, 0.9 Hz, 2H), 4.39 (dd, 
J = 11.7 Hz, 7.8 Hz, 1H), 3.87 (dd, J = 11.7 Hz, 6.3 Hz, 1H), 3.62 (m, 1H), 2.82 (dd, J = 16.5 
Hz, 4.8 Hz, 1H), 2.53 (dd, J = 16.5 Hz, 9.6 Hz, 1H), 2.31 (s, 3H), 2.29 (s, 3H); 
13
C NMR (75 
MHz, CDCl3)  177.5, 154.4, 138.7, 136.0, 134.6, 132.4, 131.2, 127.8, 121.5, 118.2, 66.6, 56.6, 
38.1, 37.5, 20.9, 19.9. 
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(S)-Allyl 3,5,7-trimethylindoline-1-carboxylate (3.40):  Crude acid 3.39 (~195 mg, ~0.674 
mmol) was dissolved in CH2Cl2 (2.0 mL) at 0 °C, to which oxalyl chloride (171 mg, 1.35 mmol) 
and DMF (1 drop) were added sequentially via syringe.  The reaction mixture was warmed to 
room temperature and stirred for 1 h, after which all volatiles were removed in vacuo. 
The crude acid chloride was redissolved in CH2Cl2 (2.0 mL) at room temperature in a 
round-bottom flask shielded from light with Al foil.  With stirring, 2-mercaptopyridine N-oxide 
sodium salt (111 mg, 0.741 mmol) was added all at once, and the mixture was stirred in the dark 
for 1 h.  Upon completion, solids were removed by rapid filtration into a second Al-foil shielded 
round-bottom flask, and solvent was removed. 
The crude Barton ester was redissolved in benzene (6.75 mL), and to this solution 
Bu3SnH (589 mg, 2.02 mmol) and AIBN (11 mg, 0.067 mmol) were added.  The flask was fitted 
with a condenser, and the reaction vessel was placed into a preheated oil bath and refluxed for 5 
h in the dark.  After cooling to room temperature and removal of solvent by rotary evaporation, 
the crude residue was subjected to flash chromatography on 10% w/w KF/silica gel (8:1 
hexanes:EtOAc) to obtain the title compound (90. mg, 47% from ester (+)-3.19b) as a clear 
colorless oil, []D
23
 +24 (c 8.4 mg/mL, CHCl3):  
1
H NMR (300 MHz, CDCl3)  6.85 (s, 1H), 
6.82 (s, 1H), 5.99 (ddd, J = 16.2 Hz, 10.5 Hz, 5.7 Hz, 1H), 5.37 (d, J = 17.4 Hz, 1H), 5.27 (d, 
10.2 Hz, 1H), 4.68 (d, J = 5.7 Hz, 2H), 4.33 (dd, J = 11.1 Hz, 7.8 Hz, 1H), 3.57 (dd, J = 11.1 Hz, 
7.8 Hz, 1H), 3.30 (m, 1H), 2.30 (s, 3H), 2.27 (s, 3H), 1.26 (d, J = 6.6 Hz, 3H); 
13
C NMR (75 
MHz, CDCl3)  154.4, 139.5, 138.7, 134.4, 132.7, 130.4, 127.5, 121.2, 118.0, 66.4, 58.6, 36.1, 
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20.9, 19.9, 18.1; FTIR (neat, cm
-1
) 2960, 2925, 2876, 1715, 1477, 1414, 1382, 1326, 1214, 1128, 
1031, 995, 931, 854, 764; LRMS (EI) m/z 245 (M
+
, 51), 188 (76), 161 (93), 144 (100), 130 (83), 
91 (67); HRMS (EI) calcd for C15H19NO2 [M]
+
: 245.1416, found: 245.1407. 
 
HN
 
(S)-3,5,7-Trimethylindoline (3.41):  To a stirred solution of 3.40 (57 mg, 0.232 mmol) in 
MeOH (2.5 mL) was added Pd(PPh3)4 (27 mg, 0.0232 mmol) in one portion, and the mixture was 
stirred at room temperature for 5 min.  Solid NaBH4 (18 mg, 0.464 mmol) was added in one 
portion, the reaction was stirred for 5 min, cooled to 0 °C, quenched with 2 mL saturated 
aqueous NH4Cl, and warmed to room temperature.  Another 5 mL water was added, and the 
mixture was extracted with CH2Cl2 (3 x 10 mL), the combined organic layers were washed with 
brine (2 x 10 mL), dried over MgSO4, filtered, and concentrated using rotary evaporation.  Flash 
chromatography (4:1 hexanes:EtOAc) yielded the title compound
105
 (30 mg, 80%) as a bright 
yellow oil, []D
23
 +34 (c 4.3 mg/mL, CHCl3):  
1
H NMR (300 MHz, CDCl3)  6.80 (s, 1H), 6.72 
(s, 1H), 3.72 (t, J = 8.7 Hz, 1H), 3.37 (m, 1H), 3.11 (t, J = 8.7 Hz, 1H), 2.27 (s, 3H), 2.13 (s, 3H), 
1.32 (d, J = 6.9 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  147.3, 134.1, 128.8, 128.4, 121.5, 119.0, 
55.6, 37.0, 20.8, 18.7, 16.6; FTIR (neat, cm
-1
) 3366 (broad), 2959, 2922, 2860, 1485, 1266, 1225, 
1140, 1012, 855, 751; LRMS (EI) m/z 161 (M
+
, 56), 146 (100), 69 (77), 57 (95); HRMS (EI) 
calcd for C11H15N [M]
+
: 161.1204, found: 161.1211. 
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(S)-Phenyl(3,5,7-trimethylindolin-1-yl)methanone (3.42):  To a stirred solution of indoline 
3.41 (14 mg, 0.0868 mmol), pyridine (14 mg, 0.174 mmol) and DMAP (1 mg) in CH2Cl2 (2 mL) 
at 0 °C was added benzoyl chloride (18 mg, 0.130 mmol) via syringe.  The mixture was warmed 
to room temperature and stirred for 15 min.  Upon completion, the reaction mixture was 
quenched with sat. aq. NH4Cl (5 mL), extracted with CH2Cl2 (3 x 5 mL), and the combined 
organic layers were washed with brine (2 x 5 mL), dried over MgSO4, filtered, and concentrated 
in vacuo.  Flash chromatography of the crude residue (3:1 hexanes:EtOAc) afforded the title 
compound (14 mg, 61%) as a white solid.  Chiral analysis was performed on the analytical (S,S)-
Whelk-O1 column (85:15 hexanes:iPrOH) to give (S)-3.42 (first eluting enantiomer), [D
23
 +3.0 
(c 6.0 mg/mL, CHCl3).  The HPLC analysis was performed against an enantioenriched authentic 
sample previously made by Dr. Andre Lapierre.
105
  The compound’s optical rotation matched 
that previously reported ([D
23
 +3.0, (c 6.2 mg/mL, CHCl3)), as did the spectral data:  
1
H NMR 
(300 MHz, CDCl3)  7.79-7.70 (m, 2H), 7.55-7.40 (m, 3H), 6.90 (s, 1H), 6.87 (s, 1H), 4.21 (dd, J 
= 10.5 Hz, 7.8 Hz, 1H), 3.64 (dd, J = 10.5 Hz, 8.1 Hz, 1H), 3.33 (sextet, J = 6.9 Hz, 1H), 2.33 (s, 
3H), 2.19 (s, 3H), 1.24 (d, J = 6.9 Hz, 3H). 
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(S)-Methyl 2-(5,7-dimethylindolin-3-yl)acetate (3.43):  This compound was prepared by the 
three procedures shown below.  Analysis was performed on the analytical (S,S)-Whelk O1 
column, eluting with 90:10 hexane:i-PrOH.  In each case, the major enantiomer (+)-3.43 was the 
first eluting enantiomer, [D
23
 +23 (c 6.0 mg/mL, CHCl3).  
1
H NMR (300 MHz, CDCl3)  6.78 
(s, 1H), 6.74 (s, 1H), 3.81 (t, J = 8.7 Hz, 1H), 3.73 (s, 3H), 3.71 (m, 1H), 3.47 (br s, 1H), 3.27 
(dd, J = 8.7 Hz, 6.3 Hz, 1H), 2.78 (dd, J = 15.9 Hz, 5.1 Hz, 1H), 2.57 (dd, J = 15.9 Hz, 9.0 Hz, 
1H), 2.25 (s, 1H), 2.12 (s, 1H); 
13
C NMR (75 MHz, CDCl3)  172.8, 147.2, 130.8, 129.4, 128.2, 
121.2, 119.1, 53.4, 51.5, 38.74, 38.66, 20.6, 16.6; FTIR (neat, cm
-1
) 3371, 3002, 2950, 2859, 
1734, 1486, 1437, 1326, 1227, 1165, 1011, 856, 755; LRMS (EI) m/z 219 (M
+
, 32), 158 (25), 
146 (100), 131 (25), 130 (17); HRMS (EI) calcd for C13H17NO2 [M]
+
: 219.1259, found: 
219.1259. 
Procedure 1:  N-Boc (S)-(+)-3.20a (0.029 g, 0.091 mmol, 86/14 er) was dissolved in 
CH2Cl2 (0.90 mL) at room temperature with stirring.  Trifluoroacetic acid (0.10 mL) was added 
dropwise via syringe, and the reaction mixture was stirred at room temperature for 7 h.  The 
mixture was concentrated by rotary evaporation, and to the crude residue was sequentially added 
water (1 mL) and NaHCO3 (4 mL).  The mixture was extracted with EtOAc (3 x 5 mL), and the 
combined organic layers were washed with brine (2 x 5 mL), dried over MgSO4, filtered, and 
concentrated by rotary evaporation.  The residue consisted of indoline (S)-(+)-3.43 (0.015 g, 
75%) as a yellow oil, determined to be pure by 
1
H NMR. 
Procedure 2:  N-Cbz (S)-(+)-3.20c (0.012 g, 0.034 mmol, 91/9 er) was dissolved in 
EtOH (1.5 mL) at room temperature with stirring.  Solid 10% w/w Pd/C (2.0 mg, 0.0019 mmol) 
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was added, and the mixture was placed under a H2 atmosphere.  After stirring for 6 h, the 
mixture was filtered through a pad of Celite, rinsing the pad with EtOH, and the filtrate was 
concentrated in vacuo.  Short column chromatography (2:1 hexanes:EtOAc) furnished (S)-(+)-
3.43 (0.006 g, 80%) as a yellow oil. 
Procedure 3:  N-Alloc (S)-(+)-3.20b (0.010 g, 0.033 mmol, 98/2 er) was dissolved in 
MeOH (1.0 mL) with stirring at 0 °C.  Solid Pd(PPh3)4 (0.003 g, 0.0026 mmol) was added all at 
once, followed by solid NaBH4 (0.005 g, 0.132 mmol).  The mixture was stirred for 10 min, and 
saturated aqueous NH4Cl solution (1 mL) was added, followed by water (4 mL).  The mixture 
was extracted with CH2Cl2 (3 x 5 mL), and the combined organic layers were washed with brine 
(3 x 5 mL), dried over MgSO4, filtered, and concentrated in vacuo.  The mostly pure crude (~9 
mg) indoline (S)-(+)-3.43 was directly analyzed by chiral HPLC without further purification.  
The same conditions, when applied to (R)-(–)-3.20b on a 0.500 mmol scale, produced (R)-(–)-
3.43 in 94% yield after purification by column chromatography. 
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6.4 COMPOUND DATA FOR CHAPTER 4 
Experimental procedures and spectroscopic data have been previously reported in the literature 
for compounds 4.54,
48
 4.55,
93,105
 and trans-4-chlorocyclohex-2-enyl acetate.
212
  These 
procedures were followed, and the products’ physical properties and spectroscopic data were 
consistent with those previously reported.  The preparation of 3.21 is described in Chapter 6.3. 
 
General procedure for radical reactions:  To a stirred PhH solution of the appropriate 
substrate (1.0 equiv) at room temperature, open to the atmosphere, was added Bu3SnH (1.5 
equiv) all at once.  The initial hydride concentration [Bu3SnH]i is detailed for each individual 
reaction.  A 1.0 M hexanes solution of Et3B (1.0 equiv) was added all at once, and the reaction 
was stirred until the starting material was completely consumed (usually < 5 min).  The reaction 
mixture was concentrated by rotary evaporation, and the crude residue was directly 
chromatographed on 10% w/w KF/silica gel,
80
 using the appropriate eluent. 
 
HN
I
 
rac-N-(Cyclohex-2-enyl)-2-iodoaniline (4.12):  A stirred mixture of 2-iodoaniline (5.26 g, 24.0 
mmol) and K2CO3 (8.30 g, 60.0 mmol) in MeCN (25 mL) was cooled to 0 °C.  By syringe, 3-
bromocyclohex-1-ene (3.22 g, 20.0 mmol) was added dropwise over 10 min, and the mixture 
was allowed to warm to room temperature and stir for 12 h.  The reaction mixture was filtered 
through a Celite pad, rinsing with a small amount of MeCN, and the filtrate was concentrated by 
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rotary evaporation.  Column chromatography (20:1 hexanes:EtOAc) afforded the title compound 
(5.21 g, 87%) as a yellow oil: 
1
H NMR (300 MHz, CDCl3)  7.67 (dd, J = 7.8 Hz, 1.5 Hz, 1H), 
7.20 (m with clear d, J = 1.5 Hz, 1H), 6.63 (dd, J = 8.1 Hz, 1.2 Hz, 1H), 6.43 (ddd, J = 7.8 Hz, 
7.2 Hz, 1.5 Hz, 1H), 5.91 (dtd, J = 9.9 Hz, 3.6 Hz, 1.8 Hz, 1H), 5.77 (ddt, J = 9.9 Hz, 3.0 Hz, 2.1 
Hz, 1H), 4.17 (br d, 1H), 4.04 (br m, 1H), 2.20-1.98 (m, 2H), 1.98-1.83 (m, 1H), 1.83-1.59 (m, 
3H); 
13
C NMR (75 MHz, CDCl3)  146.2, 139.1, 130.6, 129.2, 127.7, 118.3, 111.0, 85.8, 48.1, 
28.5, 25.0, 19.4; FTIR (neat, cm
-1
) 3390, 3021, 2934, 2859, 1587, 1500, 1450, 1313, 1279, 1170, 
1088, 1004, 741; LRMS (EI) m/z 299 (M
+
, 83), 271 (37), 219 (100), 172 (38), 144 (35), 81 (82); 
HRMS (EI) calcd for C12H14IN: 299.0171, found: 299.0167. 
 
N
O H
N
O H
II
 
rac-N-(Cyclohex-2-enyl)-N-(2-iodophenyl)acetamide (4.13):  To a stirred solution of 4.12 
(1.50 g, 5.00 mmol) in acetone (5 mL) was added solid K2CO3 (2.76 g, 20.0 mmol) all at once, 
and the mixture was cooled to 0 °C.  To this mixture, acetyl chloride (1.18 g, 15.0 mmol) was 
added dropwise via syringe, and the mixture was warmed to room temperature and stirred for 24 
h.  The mixture was recooled to 0 °C, and saturated aqueous NaHCO3 solution (50 mL) was 
added.  This mixture was extracted with EtOAc (3 x 50 mL), and the combined organic layers 
were washed with brine (3 x 50 mL), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Exhaustive gradient column chromatography (2 columns, hexanes to 2:1 
hexanes:EtOAc) provided acylated products enriched in one atropisomer.  The first eluting 
compound was collected as a mixture of 95:5 anti:syn atropisomers (0.992 g, 58%) as a white 
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solid:  
1
H NMR (300 MHz, CDCl3)  7.96 (dd, J = 8.1 Hz, 1.5 Hz, 1H), 7.39 (td, J = 7.5 Hz, 1.5 
Hz, 1H), 7.23 (dd, J = 7.8 Hz, 1.8 Hz, 1H), 7.07 (td, J = 7.8 Hz, 1.5 Hz, 1H), 5.83 (dq, J = 10.2 
Hz, 2.1 Hz, 1H), 5.77 (m, 1H), 5.32 (m, 1H), 2.10-1.98 (m, 1H), 1.93-1.80 (m, 1H), 1.82 (s, 3H), 
1.63-1.53 (m, 2H), 1.22-1.08 (m, 1H); 
13
C NMR (75 MHz, CDCl3)  169.3, 142.4, 139.5, 129.5, 
129.3, 129.1, 128.9, 128.8, 103.1, 52.6, 25.3, 23.8, 23.2, 20.8; FTIR (thin film, CHCl3, cm
-1
) 
3022, 2933, 2864, 1660, 1468, 1432, 1378, 1308, 1081, 1019, 753.  The second eluting 
compound was collected as a mixture of 18:82 anti:syn atropisomers (0.370 g, 22%) as a white 
solid:  
1
H NMR (300 MHz, CDCl3)  7.95 (dd, J = 7.8 Hz, 1.5 Hz, 1H), 7.40 (td, J = 7.5 Hz, 1.5 
Hz, 1H), 7.26 (dd, J = 7.8 Hz, 1.5 Hz, 1H), 7.07 (td, J = 7.8 Hz, 1.5 Hz, 1H), 5.68-5.57 (m, 2H), 
5.23-5.14 (m, 1H), 2.30-2.18 (m, 1H), 1.97-1.87 (m, 2H), 1.80 (s, 3H), 1.78-1.65 (m, 2H); 
13
C 
NMR (75 MHz, CDCl3)  169.9, 143.6, 139.9, 130.3 (2C, accidental isochrony), 129.5, 129.2, 
126.6, 103.9, 53.4, 28.4, 24.5, 23.7, 20.9; FTIR (thin film, CHCl3, cm
-1
) 3029, 2931, 2862, 1661, 
1468, 1377, 1308, 1082, 1019, 752, 724; HRMS (ESI) calcd for C14H16INNaO [M + Na]
+
: 
364.0174, found: 364.0152. 
 
HN
I
 
rac-N-(Cyclohex-2-enyl)-2-iodo-4,6-dimethylaniline (4.14):  To a stirred mixture of 3.21 (4.94 
g, 20.0 mmol) and K2CO3 (8.30 g, 60.0 mmol) in MeCN (20 mL) was added 3-bromocyclohex-
1-ene (3.22 g, 20.0 mmol) dropwise via syringe over 10 min, and the mixture was stirred for 18 
h.  The reaction mixture was filtered through a Celite pad, rinsing with MeCN (3 x 20 mL), and 
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the filtrate was concentrated by rotary evaporation.  Column chromatography (40:1 
pentane:Et2O) afforded the title compound (4.02 g, 61%) as a yellow oil: 
1
H NMR (300 MHz, 
CDCl3)  7.46 (s, 1H), 6.92 (s, 1H), 5.85-5.78 (m, 1H), 5.76 (m with clear d, J = 11.7 Hz, 1H), 
3.76 (br m, 1H), 3.39 (br s, 1H), 2.31 (s, 3H), 2.22 (s, 3H), 2.17-1.92 (m, 2H), 1.91-1.75 (m, 2H), 
1.66-1.51 (m, 2H); 
13
C NMR (75 MHz, CDCl3)  144.6, 137.2, 132.8, 132.5, 130.2, 129.7, 
129.1, 95.7, 52.9, 30.0, 25.1, 20.3, 19.87, 19.85; FTIR (neat, cm
-1
) 3332, 3020, 2925, 2857, 
1473, 1441, 1273, 1234, 1126, 1074, 984, 852, 777, 723; LRMS (EI) m/z 327 (M
+
, 43), 247 
(100), 200 (33), 120 (29), 81 (75); HRMS (EI) calcd for C14H18IN: 327.0484, found: 327.0484. 
 
N
O H
I
N
O H
I
 
rac-N-(Cyclohex-2-enyl)-N-(2-iodo-4,6-dimethylphenyl)acetamide (4.15):  To a stirred 
mixture of 4.14 (1.64 g, 5.00 mmol) and K2CO3 (2.76 g, 20.0 mmol) in acetone (10 mL) at 0 °C 
was added acetyl chloride (1.18 g, 15.0 mmol) dropwise via syringe.  The mixture was warmed 
to room temperature and stirred for 5 days, recooled to 0 °C, and saturated aqueous NaHCO3 
solution (50 mL) was added.  The mixture was extracted with EtOAc (3 x 50 mL), and the 
combined organic layers were washed with brine (3 x 50 mL), dried over MgSO4, filtered, and 
concentrated by rotary evaporation.  Exhaustive gradient column chromatography (2 columns, 
hexanes to 3:1 hexanes:EtOAc) afforded the acylated compound as two separate atropisomers.  
The first eluting compound consisted of anti-4.15 (0.830 g, 45%) as a white solid, mp 66-68 °C:  
1
H NMR (300 MHz, CDCl3)  7.58 (s, 1H), 7.06 (s, 1H), 6.02 (dt, J = 10.2 Hz, 1.8 Hz, 1H), 5.70 
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(m with clear d, 10.2 Hz, 1H), 4.91 (m, 1H), 2.30 (s, 3H), 2.27 (s, 3H), 1.99-1.79 (m, 2H), 1.75 
(s, 3H), 1.71-1.52 (m, 2H), 1.02 (qd, J = 11.7 Hz, 3.9 Hz, 1H); 
13
C NMR (75 MHz, CDCl3)  
169.9, 139.6, 139.4, 138.1, 137.4, 131.5, 129.8, 127.1, 103.7, 53.3, 26.1, 24.3, 23.1, 21.2, 20.3, 
20.0; FTIR (thin film, CHCl3, cm
-1
) 3002, 2929, 2863, 1659, 1468, 1375, 1324, 1304, 1270, 
1240, 1070, 1036, 855, 754; LRMS (EI) m/z 369 (M
+
, 100), 289 (81), 247 (48), 232 (41), 200 
(56), 162 (48), 81 (71); HRMS (EI) calcd for C16H20INO: 369.0590, found: 369.0585.  The 
second eluting compound consisted of syn-4.15 (0.737 g, 40%) as an off-white solid, mp 82-83 
°C:  
1
H NMR (300 MHz, CDCl3)  7.60 (s, 1H), 7.06 (s, 1H), 5.78 (dt, J = 10.2 Hz, 1.8 Hz, 1H), 
5.65 (m with clear d, J = 10.5 Hz, 1H), 4.78 (m, 1H), 2.30 (s, 3H), 2.26 (s, 3H), 2.17-2.05 (m, 
1H), 2.03-1.93 (m, 2H), 1.79-1.60 (m, 2H), 1.75 (s, 3H), 1.55-1.43 (m with clear d, J = 3.3 Hz, 
1H); 
13
C NMR (75 MHz, CDCl3)  170.2, 140.3, 139.3, 137.8, 137.7, 131.7, 128.2, 128.0, 103.4, 
54.6, 27.2, 24.3, 23.3, 21.3, 20.0, 19.9; FTIR (thin film, CHCl3, cm
-1
) 2929, 1662, 1466, 1373, 
1331, 1303, 1135, 855, 789, 755; LRMS (EI) m/z 369 (M
+
, 100), 289 (98), 247 (91), 200 (67), 
162 (55), 81 (68); HRMS (EI) calcd for C16H20INO: 369.0590, found: 369.0572. 
 
N
O
 
rac-N-(Cyclohex-2-enyl)-N-(2,4-dimethylphenyl)acetamide (4.17):  Iodide anti-4.15 (0.111 g, 
0.30 mmol) was reacted according to the general radical procedure, with [Bu3SnH]i = 0.10 M.  
Column chromatography (2:1 hexanes:EtOAc) provided the title compound (0.052 g, 71%) as a 
white solid, mp 95-97 °C, in a 3:2 ratio of atropisomers:  
1
H NMR (300 MHz, CDCl3)  7.09 (m, 
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1H, both), 7.00 (m with clear d, J = 8.1 Hz, 1H, both), 6.95 (d, J = 8.1 Hz, 1H, minor), 6.94 (d, J 
= 7.8 Hz, 1H, major), 5.79 (dq, J = 10.2 Hz, 1.8 Hz, 1H, major), 5.77-5.70 (m, 1H, major), 5.64 
(dq, J = 10.2 Hz, 2.7 Hz, 1H, minor), 5.51 (d of pentets, J = 10.5 Hz, 1.8 Hz, 1H, minor), 5.40-
5.29 (m, 1H, major), 5.25-5.15 (m, 1H, minor), 2.34 (s, 3H, both), 2.23 (s, 3H, minor), 2.21 (s, 
3H, major), 2.10-2.00 (m, 1H, minor), 1.95-1.76 (m, 3H, both), 1.74 (s, 3H, major), 1.72 (s, 3H, 
minor), 1.65-1.47 (m, 2H, both), 1.27-1.12 (m, 1H, major); 
13
C NMR (75 MHz, CDCl3) all 
signals, both atropisomers  170.7, 170.6, 137.9, 137.8, 137.1, 136.5, 136.4, 131.8, 131.7, 
129.59, 129.55, 129.45, 129.4, 129.1, 127.5, 127.4, 127.3, 52.9, 52.7, 28.2, 25.8, 24.5, 24.2, 22.9, 
22.8, 21.3, 21.2, 20.9, 18.4, 18.0; FTIR (thin film, CHCl3, cm
-1
) 3024, 2935, 2864, 1657, 1503, 
1380, 1309, 1053, 754; LRMS (EI) m/z 243 (M
+
, 44), 200 (20), 163 (37), 121 (100), 81 (30), 79 
(39), 77 (41); HRMS (EI) calcd for C16H21NO: 243.1623, found: 243.1620.  
 
N
O
H
H
 
rac-1-(cis-6,8-dimethyl-2,3,4,4a-tetrahydro-1H-carbazol-9(9aH)-yl)ethanone (4.18):  Iodide 
syn-4.15 (0.111 g, 0.30 mmol) was reacted according to the general radical procedure, with 
[Bu3SnH]i = 0.10 M.  Gradient column chromatography (hexanes to 3:2 hexanes:EtOAc) gave 
4.17 (3 mg, 4%) as a first eluting minor byproduct.  The second eluting compound consisted of 
the title compound (0.066 g, 92%) as a white solid, mp 90-91°C:  
1
H NMR (300 MHz, CDCl3)  
6.86 (s, 1H), 6.81 (s, 1H), 4.31 (br s, 1H), 3.51 (br m, 1H), 2.32 (s, 3H), 2.26 (s, 3H), 2.23 (s, 
3H), 1.95 (m, 1H), 1.85-1.70 (m with clear dd, J = 5.7 Hz, 3.9 Hz, 1H), 1.60-1.47 (m, 2H), 1.30-
1.00 (m, 4H); 
13
C NMR (75 MHz, CDCl3)  167.3 (br), 138.7, 136.6 (br), 134.7, 129.9, 129.2 
  195 
(br), 120.5, 63.6, 41.0, 27.6, 24.5, 23.0 (br), 22.9, 21.0, 20.5, 20.1; FTIR (thin film, CHCl3, cm
-1
) 
2928, 2858, 1664, 1473, 1412, 1388, 1275, 853, 757; LRMS (EI) m/z 243 (M
+
, 57), 201 (60), 
158 (100); HRMS (EI) calcd for C16H21NO [M]
+
: 243.1623, found: 243.1628. 
 
N
O
 
rac-N-Cyclohexyl-N-(2,4-dimethylphenyl)acetamide (4.19):  A mixture of 4.17 (0.061 g, 
0.250 mmol) and 10% Pd on C (0.027 g, 0.025 mmol) in EtOAc (4 mL) was stirred under a H2 
atmosphere (1 atm) at room temperature for 3 days.  The mixture was filtered a Celite pad, which 
was washed with a few mL of EtOAc.  The filtrate was concentrated by rotary evaporation.  
Column chromatography (3:2 hexanes:EtOAc) furnished the title compound (0.061 g, 100%) as 
a white solid, mp 69-70 °C:  
1
H NMR (300 MHz, CDCl3)  7.10 (s, 1H), 7.02 (d, J = 7.8 Hz, 
1H), 6.93 (d, J = 7.8 Hz, 1H), 4.52 (tt, J = 12.0 Hz, 3.6 Hz, 1H), 2.35 (s, 3H), 2.20 (s, 3H), 2.02 
(m with clear d, J = 11.7 Hz, 1H), 1.70-1.53 (m, 3H), 1.69 (s, 3H), 1.63-1.52 (m, 1H), 1.45-1.20 
(m, 3H), 0.95 (qt, J = 12.9 Hz, 3.6 Hz, 1H), 0.90 (qd, J = 12.6 Hz, 4.5 Hz, 1H); 
13
C NMR (75 
MHz, CDCl3)  170.3, 137.9, 136.6, 136.5, 131.9, 129.7, 127.3, 55.3, 32.0, 30.1, 25.7 (2C, 
accidental isochrony), 25.4, 23.0, 20.9, 18.2; FTIR (thin film, CHCl3, cm
-1
) 2931, 2855, 1655, 
1503, 1387, 1315, 1262, 1227, 1075; LRMS (EI) m/z 245 (M
+
, 10), 202 (17), 163 (100), 160 
(45), 132 (28), 121 (63), 83 (25), 77 (20); HRMS (EI) calcd for C16H23NO: 245.1780, found: 
245.1769. 
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Iodide anti-4.13 (0.171 g, 0.50 mmol) was reacted according to the general radical procedure, 
with [Bu3SnH]i = 0.83 M.  Column chromatography (3:2 hexanes:EtOAc) gave the first eluting 
product, rac-N-(cyclohex-2-enyl)-N-phenylacetamide (4.24), as an orange oil (0.011 g, 10%):  
1
H NMR (300 MHz, CDCl3)  7.44-7.32 (m, 3H), 7.17-7.08 (m, 2H), 5.73 (ddt, J = 10.2 Hz, 4.2 
Hz, 2.4 Hz, 1H), 5.62 (J = 10.2 Hz, 1H), 5.45 (m, 1H), 1.95-1.80 (m, 3H), 1.76 (s, 3H), 1.66-1.54 
(m, 2H), 1.42-1.30 (m, 1H); 
13
C NMR (75 MHz, CDCl3)  170.4, 140.1, 130.1, 129.9 (2C), 
129.1 (2C), 128.6, 128.0, 51.4, 27.6, 24.3, 23.4, 21.2; FTIR (neat, cm
-1
) 3027, 2935, 2864, 1656, 
1594, 1494, 1385, 1314, 747; LRMS (EI) m/z 215 (M
+
, 56), 172 (26), 81 (49), 77 (100); HRMS 
(EI) calcd for C14H17NO: 215.1310, found: 215.1319.  The second eluting compound consisted 
of rac-1-(cis-2,3,4,4a-tetrahydro-1H-carbazol-9(9aH)-yl)ethanone (4.23) as a white solid 
(0.082 g, 76%), mp 96-97 °C (lit. 98 °C).
275
  The compound exists in a 3:1 amide rotamer ratio:  
1
H NMR (300 MHz, CDCl3)  8.13 (br d, J = 7.5 Hz, 1H, major), 7.26-7.13 (m, 2H, both), 7.20-
7.13 (m, 1H, minor), 7.08 (td, J = 7.5 Hz, 0.9 Hz, both), 4.79 (br s, 1H, minor), 4.25 (br q, J = 
5.7 Hz, major), 3.53 (m, 1H, major), 3.41 (br s, 1H, minor), 2.37 (s, 3H, minor), 2.30 (s, 3H, 
major), 2.35-2.25 (m, 1H, both), 2.05-1.92 (br m, 1H, both), 1.90-1.75 (m, 1H, both), 1.70-1.50 
(br m, 2H, both), 1.35-1.00 (m, 3H, both); 
13
C NMR (75 MHz, CDCl3) major rotamer  167.8, 
142.1, 133.8, 127.3, 123.8, 122.3, 118.1, 61.8, 40.0, 28.0, 24.0, 23.2, 22.6, 20.7, additional peaks 
from the minor rotamer were seen at  127.0, 123.6, 60.9, 39.0, 26.7; FTIR (thin film, CHCl3, 
cm
-1
) 2930, 2858, 1657, 1477, 1460, 1401, 1358, 1276, 1128, 759; LRMS (EI) m/z 215 (M
+
, 36), 
173 (31), 130 (100), 117 (23); HRMS (EI) calcd for C14H17NO: 215.1310, found: 215.1311. 
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rac-(E)-N-(Cyclohex-2-enyl)-N-(2-iodophenyl)but-2-enamide (4.32):  To a stirred mixture of 
4.13 (1.20 g, 4.00 mmol) and K2CO3 (2.21 g, 16.0 mmol) in acetone (4 mL) at 0 °C was added 
trans-crotonyl chloride (1.25 g, 12.0 mmol) dropwise via syringe over 10 min.  The mixture was 
warmed to room temperature and stirred for 20 h, recooled to 0 °C, and saturated aqueous 
NaHCO3 solution (20 mL) was added.  The mixture was extracted with EtOAc (3 x 40 mL), and 
the combined organic layers were washed with brine (3 x 40 mL), dried over MgSO4, filtered, 
and concentrated by rotary evaporation.  Column chromatography (4:1 hexanes:EtOAc) 
furnished unreacted starting material (0.475 g, 40%), and the title compound (0.717 g, 49%) as a 
white solid, mp 106-108 °C.  The compound was isolated as an inseparable 2:1 anti:syn mixture 
of atropisomers.  
1
H NMR (300 MHz, CDCl3)  7.96 (dd, J = 8.1 Hz, 1.2 Hz, 1H, major), 7.94 
(dd, J = 7.8 Hz, 1.2 Hz, 1H, minor), 7.40 (td, J = 7.8 Hz, 1.5 Hz, 1H, minor), 7.39 (td, J = 7.5 
Hz, 1.5 Hz, 1H, major), 7.24 (dt, J = 7.5 Hz, 1.2 Hz, 1H, both), 7.08 (dt, J = 7.5 Hz, 1.5 Hz, 1H, 
both), 6.98 (dq, J = 15.0 Hz, 6.9 Hz, 1H, major), 6.97 (dq, J = 15.0 Hz, 6.9 Hz, 1H, minor), 5.88-
5.76 (m, 2H, major), 5.65 (dq, J = 10.2 Hz, 2.4 Hz, 1H, minor), 5.59 (m with clear d, J = 10.8 
Hz, 1H, minor), 5.44 (dq, J = 15.0 Hz, 1.8 Hz, 1H, major), 5.42 (dq, J = 15.0 Hz, 1.8 Hz, 1H, 
minor), 5.37-5.28 (m, 1H, major), 5.27-5.17 (m, 1H, minor), 2.33-2.23 (m, 1H, minor), 2.08-1.98 
(m, 1H, major), 1.98-1.80 (m, 2H, both), 1.78-1.55 (m, 2H both and 1H minor), 1.72 (dq, J = 6.9 
Hz, 1.5 Hz, 3H, both), 1.31-1.15 (m, 1H, major); 
13
C NMR (75 MHz, CDCl3) all signals, both 
atropisomers  165.12, 165.06, 142.6, 142.0, 141.4, 141.2, 139.7, 139.6, 130.5, 130.2, 130.0, 
129.35, 129.30, 129.28, 129.2, 128.9, 126.6, 123.1, 123.0, 104.2, 103.6, 53.5, 53.2, 28.3, 25.6, 
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24.3, 24.1, 21.1, 20.9, 17.7; FTIR (thin film, CHCl3, cm
-1
) 3023, 2934, 2863, 1665, 1627, 1466, 
1443, 1374, 1350, 1294, 1239, 1065, 1019, 963, 927, 738; HRMS (EI) calcd for C16H18INO: 
367.0433, found: 367.0429. 
 
N
O H
I
N
O H
I
 
rac-(E)-N-(Cyclohex-2-enyl)-N-(2-iodo-4,6-dimethylphenyl)but-2-enamide (4.33):  To a 
stirred mixture of 4.15 (0.327 g, 1.00 mmol) and K2CO3 (0.553 g, 4.00 mmol) in acetone (1 mL) 
at 0 °C was added trans-crotonyl chloride (0.314 g, 3.00 mmol) dropwise via syringe.  The 
reaction mixture was allowed to warm to room temperature, and stirring was continued for 1 h.  
The mixture was recooled to 0 °C, and saturated aqueous NaHCO3 solution (5 mL) was added.  
The mixture was extracted with EtOAc (3 x 10 mL), and the combined organic layers were 
washed with brine (3 x 10 mL), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Gradient column chromatography (hexanes to 5:1 hexanes:EtOAc) provided the 
acylated product as two separable atropisomers.  The first eluting compound consisted of anti-
4.33 (0.152 g, 38%) as a white solid, mp 90-91 °C:  
1
H NMR (300 MHz, CDCl3)  7.58 (s, 1H), 
7.05 (s, 1H), 6.97 (dq, J = 15.0 Hz, 6.9 Hz, 1H), 6.04 (dt, J = 10.2 Hz, 1.8 Hz, 1H), 5.70 (dq, J = 
10.2 Hz, 2.4 Hz, 1H), 5.41 (dq, J = 15.0 Hz, 1.8 Hz, 1H), 4.89 (m, 1H), 2.32 (s, 3H), 2.24 (s, 
3H), 1.95 (m, 2H), 1.84 (m, 1H), 1.71 (dd, J = 6.9 Hz, 1.8 Hz, 3H), 1.74-1.50 (m, 2H), 1.16 (qd, 
J = 11.4 Hz, 3.6 Hz, 1H); 
13
C NMR (75 MHz, CDCl3)  166.0, 141.6, 139.8, 139.5, 139.2, 137.9, 
131.7, 130.3, 127.4, 123.1, 104.4, 54.4, 26.7, 24.8, 21.8, 20.7, 20.4, 18.0; FTIR (thin film, 
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CHCl3, cm
-1
) 2931, 1666, 1630, 1445, 1358, 1235, 963, 926, 855, 753; LRMS (EI) m/z 395 (M
+
, 
100), 315 (20), 247 (28), 200 (28), 188 (50), 158 (24), 121 (30), 104 (36); HRMS (EI) calcd for 
C18H22INO: 395.0746, found: 395.0733.  The second eluting compound consisted of syn-4.33 
(0.114 g, 29%) as a white solid, mp 128 °C:  
1
H NMR (300 MHz, CDCl3)  7.60 (s, 1H), 7.05 (s, 
1H), 6.96 (dq, J = 15.0 Hz, 6.9 Hz, 1H), 5.80 (d, J = 10.2 Hz, 1H), 5.65 (dq, J = 10.2 Hz, 3.0 Hz, 
1H), 5.42 (dq, J = 15.0 Hz, 1.8 Hz, 1H), 4.75 (m, 1H), 2.31 (s, 3H), 2.22 (s, 3H), 2.11 (m, 1H), 
2.05-1.90 (m, 2H), 1.80-1.73 (m, 1H), 1.71 (dd, J = 6.9 Hz, 1.8 Hz, 3H), 1.68-1.56 (m, 2H); 
13
C 
NMR (75 MHz, CDCl3)  166.2, 141.4, 140.1, 139.7, 138.7, 138.1, 131.9, 128.9, 128.2, 123.3, 
104.0, 55.6, 27.6, 24.7, 21.9, 20.42, 20.35, 18.0; FTIR (thin film, CHCl3, cm
-1
) 2932, 2862, 
1667, 1630, 1444, 1355, 1293, 1235, 963, 855, 754; LRMS (EI) m/z 395 (M
+
, 100), 315 (17), 
247 (19), 200 (25), 188 (37), 158 (23); HRMS (EI) calcd for C18H22INO: 395.0746, found: 
395.0742. 
 
N
O
H
H
 
rac-(E)-1-(cis-6,8-Dimethyl-2,3,4,4a-tetrahydro-1H-carbazol-9(9aH)-yl)but-2-en-1-one 
(4.33):   Iodide syn-4.33 (0.099 g, 0.25 mmol) was reacted according to the general radical 
procedure, with [Bu3SnH]i = 0.01 M.  Column chromatography (3:1 hexanes:EtOAc) provided 
the title compound (0.054 g, 81%) as a white solid, mp 117-119 °C:  
1
H NMR (300 MHz, 
CDCl3)  7.02 (dq, J = 15.0 Hz, 6.9 Hz, 1H), 6.86 (s, 1H), 6.82 (s, 1H), 6.16 (br d, J = 14.4 Hz, 
1H), 4.49 (br s, 1H), 3.49 (t, J = 6.0 Hz, 1H), 2.33 (s, 3H), 2.31-2.22 (m, 1H), 2.20 (s, 3H), 2.05-
1.95 (m, 1H), 1.93 (dd, J = 6.9 Hz, 1.2 Hz, 3H), 1.77 (tdd, J = 14.1 Hz, 5.7 Hz, 4.5 Hz, 1H), 
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1.65-1.45 (m, 2H), 1.23 (t, J = 9.3 Hz, 2H), 1.14 (m with clear q, J = 12.6 Hz, 1H); 
13
C NMR (75 
MHz, CDCl3)  164.3, 141.5, 138.7, 137.2 (br), 134.8, 130.0, 128.9 (br), 124.3, 120.7, 63.5, 
41.2, 27.9, 24.6, 23.0, 21.1, 20.6, 20.0, 18.0; FTIR (thin film, CHCl3, cm
-1
) 2928, 2857, 1667, 
1630, 1472, 1446, 1413, 1378, 1237, 966, 854, 754; LRMS (EI) m/z 269 (M
+
, 38), 201 (63), 158 
(57), 69 (100); HRMS (EI) calcd for C18H23NO: 269.1780, found: 269.1776. 
 
N
H
H
O
N
O H
 
Iodide 4.32 (0.184 g, 0.50 mmol, 2:1 anti:syn) was reacted according to the general radical 
procedure, with [Bu3SnH]i = 0.01 M.  Column chromatography (3:1 hexanes:EtOAc) gave two 
products.  The first eluting product, rac-1-(Cyclohex-2-enyl)-3-ethylindolin-2-one (4.35), was 
isolated as a yellow oil in a 5:1 dr:  
1
H NMR (300 MHz, CDCl3)  7.24 (d, J = 7.2 Hz, 1H, both), 
7.20 (d, J = 7.8 Hz, 1H, minor), 7.18 (d, J = 7.8 Hz, 1H, major), 7.08 (d, J = 7.8 Hz, 1H, major), 
7.60 (d, J = 8.1 Hz, 1H, minor), 7.02 (t, J = 7.5 Hz, 1H, both), 6.05-5.95 (m, 1H, both), 5.63 (m 
with clear d, J = 9.9 Hz, 1H, major), 5.57 (m with clear d, J = 10.2 Hz, 1H, minor), 5.25-5.13 (m, 
1H, both), 3.43 (t, J = 5.4 Hz, 1H, both), 2.23-2.13 (m, 2H, both), 2.10-2.00 (m, 2H, both), 2.00-
1.70 (m, 4H, both), 0.88 (t, J = 7.5 Hz, 3H, minor), 0.84 (t, J = 7.5 Hz, 3H, major); 
13
C NMR (75 
MHz, CDCl3) Major diastereomer  177.6, 143.0, 130.9, 129.2, 127.6, 127.3, 123.7, 121.7, 
110.7, 48.2, 46.2, 25.8, 24.5, 23.8, 21.7, 9.6; additional non-overlapping signals for the minor 
diastereomer were also seen at  177.5, 143.0, 129.2, 127.8, 123.8, 48.1, 46.3, 25.7, 23.9, 9.8; 
FTIR (neat, cm
-1
) 3029, 2935, 2874, 1695, 1609, 1484, 1357, 1196, 1059, 1025, 750; LRMS (EI) 
m/z 241 (M
+
, 76), 162 (87), 161 (100), 133 (61), 81 (41); HRMS (EI) calcd for C16H19NO: 
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241.1467, found: 241.1466.  The second eluting product, rac-(E)-1-(cis-2,3,4,4a-tetrahydro-
1H-carbazol-9(9aH)-yl)but-2-en-1-one (4.36), was isolated as a white solid, mp 95-97 °C, in a 
2:1 amide rotamer ratio:  
1
H NMR (300 MHz, CDCl3)  8.20 (br s, 1H, major), 7.45-7.30 (br s, 
1H, minor), 7.25-7.15 (m with clear d, J = 7.5 Hz, 2H, both), 7.15-7.03 (m, 2H, both), 6.34 (br d, 
J = 14.4 Hz, 1H, both), 4.46 (br s, 1H, both), 3.51 (br t, J = 6.6 Hz, 1H, both), 2.35 (m with clear 
d, J = 14.7 Hz, 1H, both), 2.10-1.95 (m, 1H, both), 1.96 (dd, J = 6.9 Hz, 1.5 Hz, 3H, both), 1.95-
1.72 (m, 2H, both), 1.66-1.54 (m, 2H, both), 1.30-1.18 (m, 2H, both); 
13
C NMR (75 MHz, 
CDCl3)  163.8, 142.4, 142.2 (br), 127.3, 123.8, 123.5, 123.3 (br), 122.5, 118.3 (br), 60.9 (br), 
39.9, 28.5 (br), 24.0, 22.6, 20.8, 18.2; FTIR (thin film, CHCl3, cm
-1
) 2931, 2858, 1663, 1624, 
1475, 1460, 1402, 1273, 1242, 962, 756; LRMS (EI) m/z 241 (M
+
, 45), 173 (51), 130 (55), 86 
(65), 84 (100), 69 (43); HRMS (EI) calcd for C16H19NO: 241.1467, found: 241.1465. 
 
N
O H
CO2t -Bu
 
rac-syn-(E)-t-Butyl 3-(2-(N-(cyclohex-2-enyl)acetamido)-3,5-dimethylphenyl)acrylate (4.43):  
To a solid mixture of Pd2(dba)3•CHCl3 (0.041 g, 0.040 mmol) and P(t-Bu)3•HBF4 (0.046 g, 
0.160 mmol) was added degassed DMF (2.0 mL) via syringe.  The mixture was stirred for 10 
min, at which point syn-4.15 (0.148 g, 0.40 mmol) was added as a solid all at once, followed by 
t-butyl acrylate (0.205 g, 1.60 mmol) via syringe.  Finally, Et3N (0.061 mg, 0.600 mmol) was 
added via syringe, and the mixture was stirred at room temperature for 24 h.  The mixture was 
quenched with brine (5 mL) and extracted with Et2O (3 x 10 mL).  The combined organic layers 
were dried over MgSO4, filtered, and concentrated by rotary evaporation.  Column 
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chromatography (2:1 hexanes:EtOAc) furnished the title compound (0.102 g, 69%) as a clear 
colorless oil:  
1
H NMR (300 MHz, CDCl3)  7.70 (d, J = 15.9 Hz, 1H), 7.33 (s, 1H), 7.13 (s, 1H), 
6.26 (d, J = 15.9 Hz, 1H), 5.97 (m with clear d, J = 9.9 Hz, 1H), 5.73 (dq, J = 9.6 Hz, 2.4 Hz, 
1H), 4.91 (m, 1H), 2.36 (s, 3H), 2.21 (s, 3H), 1.95-1.85 (m, 2H), 1.75-1.40 (m, 3H), 1.68 (s, 3H), 
1.53 (s, 9H), 1.27-1.12 (m, 1H); 
13
C NMR (75 MHz, CDCl3)  170.7, 165.6, 139.9, 138.1, 137.4, 
137.2, 134.2, 133.4, 128.8, 128.6, 125.2, 122.4, 80.5, 54.4, 28.1 (3C), 26.3, 24.6, 23.2, 21.4, 
21.0, 18.5; FTIR (neat, cm
-1
) 2976, 2932, 1708, 1656, 1472, 1370, 1328, 1303, 1256, 1154, 983, 
919, 855, 731; LRMS (EI) m/z 369 (M
+
, 11), 312 (25), 270 (100), 252 (25), 174 (43), 158 (30), 
121 (25), 81 (58); HRMS (EI) calcd for C23H31NO3: 369.2304, found: 369.2289. 
 
N
O H
t-BuO2C
 
rac-anti-(E)-t-Butyl-3-(2-(N-(cyclohex-2-enyl)acetamido)-3,5-dimethylphenyl)acrylate 
(4.44):  To a solid mixture of Pd2(dba)3•CHCl3 (0.026 g, 0.025 mmol) and P(t-Bu)3•HBF4 (0.029 
g, 0.10 mmol) was added degassed DMF (1.5 mL) via syringe.  The mixture was stirred for 10 
min, at which point syn-4.15 (0.092 g, 0.25 mmol) was added as a solid all at once, followed by 
t-butyl acrylate (0.128 g, 1.00 mmol) via syringe.  Finally, Et3N (0.038 mg, 0.375 mmol) was 
added via syringe, and the mixture was stirred at room temperature for 20 h.  The mixture was 
quenched with saturated aqueous LiCl (5 mL) and extracted with Et2O (3 x 10 mL).  The 
combined organic layers were dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Gradient column chromatography (hexanes to 3:2 hexanes:EtOAc) gave the title 
compound (0.029 g, 31%), the first eluting product, as a light yellow oil:  
1
H NMR (300 MHz, 
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CDCl3)  7.60 (d, J = 15.9 Hz, 1H), 7.34 (s, 1H), 7.12 (s, 1H), 6.32 (d, J = 15.9 Hz, 1H), 5.81 
(dt, J = 10.2 Hz, 1.2 Hz, 1H), 5.68 (dq, J = 10.2 Hz, 2.7 Hz, 1H), 4.93 (m, 1H), 2.35 (s, 3H), 2.22 
(s, 3H), 1.95-1.78 (m, 3H), 1.75-1.55 (m, 2H), 1.67 (s, 3H), 1.53 (s, 9H), 1.38-1.22 (m, 1H); 
13
C 
NMR (75 MHz, CDCl3)  170.7, 165.7, 139.3, 138.1, 137.9, 137.4, 134.0, 133.5, 128.8, 128.7, 
125.5, 122.5, 80.7, 54.6, 28.2 (3C), 27.1, 24.6, 23.2, 21.6, 21.0, 19.2; FTIR (neat, cm
-1
) 2977, 
2933, 1709, 1657, 1370, 1329, 1291, 1258, 1154, 984, 855, 754; LRMS (EI) m/z 369 (M
+
, 50), 
312 (78), 270 (98), 268 (78), 252 (73), 191 (63), 190 (73), 174 (90), 156 (56), 146 (70), 81 (88), 
57 (100); HRMS (EI) calcd for C23H31NO3: 369.2304, found: 369.2295.  The second eluting 
product consisted of a mixture of 4.42a/4.42b (0.41 mg, 68%) in a 25:75 ratio.  Spectral data for 
this product is listed later in the chapter. 
 
N
O
I
 
rac-3-(2-Iodophenyl)-2-oxa-3-azabicyclo[2.2.2]oct-5-ene (4.48):  In a round bottom flask fitted 
with an addition funnel, 2-iodoaniline (5.48 g, 25.0 mmol) was dissolved in CH2Cl2 (125 mL) at 
0 °C with stirring.  To this, a solution of 77% w/w m-CPBA (9.06 g, 52.5 mmol) in CH2Cl2 (250 
mL) was added dropwise over 1 h at 0 °C.  Immediately after addition was complete, the mixture 
was successively washed with saturated aqueous NaHCO3 solution (3 x 400 mL) and brine (400 
mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  The crude nitroso 
compound was immediately used in the next reaction without further purification. 
The crude nitroso compound was dissolved in PhMe (50 mL) at 0 °C with stirring.  To 
this mixture was added 1,3-cyclohexadiene (3.01 g, 37.5 mmol) dropwise via syringe over 10 
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min.  The mixture was stirred for 30 min at 0 °C, at which point the entire reaction mixture was 
loaded directly onto a short silica gel column.  Column chromatography (9:1 pentane:Et2O) 
afforded the title compound as a red oil (4.60 g, ~59%) of approximate 80-90% purity by 
1
H 
NMR.  This compound was characterized solely by 
1
H NMR, and the entirety of the product was 
taken forward to the next step:  
1
H NMR (300 MHz, CDCl3)  7.74 (dd, J = 7.8 Hz, 1.5 Hz, 1H), 
7.21 (ddd, J = 8.1 Hz, 7.2 Hz, 1.5 Hz, 1H), 7.07 (dd, J = 8.1 Hz, 1.5 Hz, 1H), 6.82-6.73 (m, 2H), 
6.05 (ddd, J = 8.1 Hz, 6.0 Hz, 1.5 Hz, 1H), 4.77 (ddt, J = 5.4 Hz, 3.9 Hz, 1.5 Hz, 1H), 4.48 (m, 
1H), 2.44 (ddt, J = 12.6 Hz, 9.6 Hz, 3.3 Hz, 1H), 2.29 (ddt, J = 12.6 Hz, 9.0 Hz, 3.3 Hz, 1H), 
1.56 (tt, J = 12.0 Hz, 3.0 Hz, 1H), 1.40 (tdd, J = 12.0 Hz, 3.0 Hz, 1.5 Hz, 1H). 
 
OH
HN
I
 
rac-cis-4-(2-Iodophenylamino)cyclohex-2-enol (4.49):  In a round bottom flask fitted with a 
reflux condenser, crude 4.48 (4.60 g, ~14.7 mmol) was dissolved in 9:1 MeCN:H2O (150 mL) 
with stirring at room temperature.  Solid Mo(CO)6 (3.88 g, 14.7 mmol) was added all at once, 
followed by addition of solid NaBH4 (0.613 g, 16.2 mmol) in one portion, and the mixture was 
refluxed for 4 h.  At this time, a second equivalent portion of NaBH4 (0.613 g, 16.2 mmol) was 
added, and the mixture was refluxed another 4 h.  A final portion of NaBH4 (0.613 g, 16.2 mmol) 
was added, and the stirred mixture was refluxed for 12 h.  The mixture was cooled to room 
temperature, filtered through a Celite pad followed by a small rinse of the pad with MeCN, and 
the filtrate was concentrated by rotary evaporation.  The crude residue was mixed with 2:1 
hexanes:EtOAc, and the soluble material was subjected to column chromatography (2:1 
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hexanes:EtOAc) to furnish the title compound (3.13 g, 40% over 3 steps from 2-iodoaniline) as a 
red oil:  
1
H NMR (300 MHz, CDCl3)  7.68 (dd, J = 7.8 Hz, 1.5 Hz, 1H), 7.21 (ddd, J = 8.1 Hz, 
7.2 Hz, 1.5 Hz, 1H), 6.62 (dd, J = 8.4 Hz, 1.2 Hz, 1H), 6.46 (ddd, J = 7.8 Hz, 7.2 Hz, 1.5 Hz, 
1H); 
13
C NMR (75 MHz, CDCl3)  146.1, 139.4, 132.9, 130.6, 129.5, 118.8, 111.1, 86.0, 65.3, 
48.2, 28.9, 24.8; FTIR (neat, cm
-1
) 3386 (broad), 3062, 3024, 2941, 2862, 1586, 1499, 1450, 
1313, 1130, 1052, 1004, 947, 739; LRMS (EI) m/z 315 (M
+
, 100), 287 (52), 271 (46), 219 (100), 
144 (41), 130 (79), 117 (32), 91 (65), 77 (67); HRMS (EI) calcd for C12H14INO: 315.0120, 
found: 315.0118. 
 
N
O
I
 
rac-3-(2-Iodo-4,6-dimethylphenyl)-2-oxa-3-azabicyclo[2.2.2]oct-5-ene (4.50):  In a round 
bottom flask fitted with an addition funnel, 3.21 (7.41 g, 30.0 mmol) was dissolved in CH2Cl2 
(125 mL) at 0 °C with stirring.  To this, a solution of 77% w/w m-CPBA (10.87 g, 63.0 mmol) in 
CH2Cl2 (250 mL) was added dropwise over 1 h at 0 °C.  Immediately after addition was 
complete, the mixture was successively washed with saturated aqueous NaHCO3 solution (3 x 
400 mL) and brine (400 mL), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  The crude nitroso compound was immediately used in the next reaction without 
further purification. 
The crude nitroso compound was dissolved in PhMe (25 mL) at 0 °C with stirring.  To 
this mixture was added 1,3-cyclohexadiene (3.61 g, 45.0 mmol) dropwise via syringe over 10 
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min.  The mixture was stirred for 3 h at 0 °C, at which point the entire reaction mixture was 
loaded directly onto a short silica gel column.  Column chromatography (19:1 pentane:Et2O) 
afforded the title compound as a red oil (8.31 g, ~81%) of approximate 90% purity by 
1
H NMR.  
This compound was characterized solely by 
1
H NMR, and the entirety of the product was taken 
forward to the next step:  
1
H NMR (300 MHz, CDCl3)  7.51 (s, 1H), 6.78 (s, 1H), 6.70 (ddd, J = 
8.1 Hz, 5.7 Hz, 1.5 Hz, 1H), 6.58 (ddd, J = 8.1 Hz, 6.3 Hz, 1.5 Hz, 1H), 4.75 (td, J = 3.6 Hz, 1.8 
Hz, 1H), 4.25 (m, 1H), 2.59 (td, J = 9.3 Hz, 3.3 Hz, 1H), 2.40 (s, 3H), 2.38-2.28 (m, 1H), 2.18 (s, 
3H), 1.49-1.34 (m, 2H). 
 
OH
HN
I
 
rac-cis-4-(2-Iodo-4,6-dimethylphenylamino)cyclohex-2-enol (4.51):  To a stirred mixture of 
NaI (7.49 g, 50.0 mmol) in MeCN (500 mL) at room temperature was added trimethylsilyl 
chloride (5.43 g, 50.0 mmol) via syringe.  The mixture was stirred at room temperature for 1 h, 
and then cooled to 0 °C.  Crude 4.50 (8.31 g, ~24.4 mmol) in MeCN (50 mL) was added to the 
stirred mixture dropwise via syringe over 10 min, followed by addition of water (0.225 g, 12.5 
mmol) via syringe all at once.  The mixture was stirred at 0 °C for 4 h, at which time water (250 
mL) and brine (250 mL) were added, and the mixture was extracted with EtOAc (3 x 500 mL).  
The combined organic layers were washed successively with saturated aqueous NaHCO3 
solution (3 x 500 mL), 10% w/w aqueous Na2S2O3 solution (2 x 500 mL), and brine (2 x 500 
mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Column 
chromatography (2:1 hexanes:EtOAc) furnished the title compound (4.03 g, 39% over 3 steps 
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from 3.21) as a viscous red oil:  
1
H NMR (300 MHz, CDCl3)  7.46 (s, 1H), 6.93 (s, 1H), 5.92 
(dd, J = 10.2 Hz, 1.8 Hz, 1H), 5.86 (dd, J = 10.2 Hz, 2.1 Hz, 1H), 4.20 (br m, 1H), 3.68 (br m, 
1H), 3.41 (br s, 1H), 2.31 (s, 3H), 2.22 (s, 3H), 1.90-1.71 (m, 4H); 
13
C NMR (75 MHz, CDCl3)  
144.3, 137.3, 133.3, 132.7, 132.6, 131.1, 130.4, 95.9, 64.9, 53.0, 29.4, 25.7, 19.9, 19.8; FTIR 
(neat, cm
-1
) 3335 (broad), 3022, 2938, 2857, 1473, 1440, 1271, 1233, 1064, 989, 851, 727; 
LRMS (EI) m/z 343 (M
+
, 77), 315 (16), 299 (22), 247 (100), 216 (17), 172 (16), 158 (30), 120 
(37); HRMS (EI) calcd for C14H18INO: 343.0433, found: 343.0444. 
 
OAc
N
I
O
 
rac-cis-4-(N-(2-Iodophenyl)acetamido)cyclohex-2-enyl acetate (4.52):  A stirred mixture of 
4.49 (2.21 g, 7.00 mmol) and K2CO3 (14.5 g, 105 mmol) in acetone (20 mL) was cooled to 0 °C.  
Acetyl chloride (4.12 g, 52.5 mmol) was added dropwise via syringe over 5 min, and the mixture 
was warmed to room temperature and stirred for 60 h.  The mixture was recooled to 0 °C, water 
(50 mL) was added, and the mixture was extracted with EtOAc (3 x 50 mL).  The combined 
organic layers were washed with brine (3 x 50 mL), dried over MgSO4, filtered, and concentrated 
by rotary evaporation.  Column chromatography (1:1 hexanes:EtOAc) furnished the title 
compound (2.11 g, 75%) as a yellow viscous oil in a 3:2 anti:syn atropisomer ratio:  
1
H NMR 
(300 MHz, CDCl3)  7.98 (dd, J = 7.8 Hz, 1.2 Hz, 1H, major), 7.97 (dd, J = 8.1 Hz, 1.2 Hz, 1H, 
minor), 7.43 (dt, J = 7.8 Hz, 1.5 Hz, 1H, minor), 7.42 (dt, J = 7.5 Hz, 1.8 Hz, 1H, major), 7.30-
7.25 (m with clear d, J = 1.5 Hz, minor), 7.21 (dd, J = 7.8 Hz, 1.5 Hz, 1H, major), 7.11 (td, J = 
7.8 Hz, 1.5 Hz, minor), 7.10 (td, J = 7.8 Hz, 1.5 Hz, 1H, major), 6.12 (m with clear d, J = 9.9 Hz, 
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1H, major), 5.94 (m with clear d, J = 10.8 Hz, 1H, minor), 5.90 (dddd, J = 10.2 Hz, 4.5 Hz, 2.4 
Hz, 1.2 Hz, 1H, major), 5.70 (dq, J = 10.5 Hz, 2.4 Hz, 1H, minor), 5.23-5.05 (m, 2H, both), 2.18-
2.09 (m, 1H, major), 1.99 (s, 3H, minor), 1.92 (s, 3H, major), 1.91-1.86 (m, 1H both and 1H 
minor), 1.84 (s, 3H, major), 1.81 (s, 3H, minor), 1.80-1.68 (m, 1H both and 1H minor), 1.40 (qd, 
J = 11.7 Hz, 3.9 Hz, 1H, major); 
13
C NMR (75 MHz, CDCl3) All signals, both atropisomers  
170.27, 170.26, 170.2, 170.0, 143.3, 142.8, 140.2, 140.1, 135.2, 132.8, 130.3, 130.0, 129.83, 
129.75, 129.4, 129.3, 127.2, 126.6, 103.7, 103.2, 65.6, 65.2, 53.2, 53.0, 26.9, 26.7, 23.8, 23.5, 
21.1, 21.0, 20.8; FTIR (neat, cm
-1
) 3056, 2950, 2872, 1729, 1661, 1468, 1433, 1373, 1305, 1242, 
1078, 1017, 968, 899, 760, 726; HRMS (ESI) calcd for C16H18INNaO3 [M + Na]
+
: 422.0229, 
found: 422.0246. 
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rac-cis-4-(N-(2-Iodo-4,6-dimethylphenyl)acetamido)cyclohex-2-enyl acetate (4.53):  To a 
stirred mixture of 4.50 (2.06 g, 6.00 mmol) and K2CO3 (12.44 g, 90.0 mmol) in acetone (40 mL) 
at 0 °C was added acetyl chloride (3.53 g, 45.0 mmol) dropwise via syringe.  The mixture was 
stirred at 0 °C for 2 h, warmed to room temperature, and stirred an additional 16 h.  The mixture 
was then recooled to 0 °C, and saturated aqueous NaHCO3 solution (50 mL) was added.  The 
mixture was extracted with EtOAc (3 x 50 mL), and the combined organic layers were washed 
with brine (50 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  
Exhaustive gradient column chromatography (2 columns, hexanes to 2:1 hexanes:EtOAc) 
provided the acylated compound as two separable atropisomers.  The first eluting compound 
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consisted of anti-4.53 (0.812 g, 32%) as a cream-colored solid, mp 120-121 °C: 
1
H NMR (300 
MHz, CDCl3)  7.60 (s, 1H), 7.09 (s, 1H), 6.37 (d, J = 10.2 Hz, 1H), 5.79 (ddd, J = 10.2 Hz, 4.2 
Hz, 1.8 Hz, 1H), 5.13 (q, J = 3.3 Hz, 1H), 4.86-4.75 (m, 1H), 2.32 (s, 3H), 2.27 (s, 3H), 1.99 (s, 
3H), 1.86-1.79 (m, 2H), 1.77 (s, 3H), 1.72-1.62 (m, 1H), 1.34-1.19 (m, 1H); 
13
C NMR (75 MHz, 
CDCl3)  170.11, 169.8, 139.8, 139.3, 138.2, 137.6, 135.8, 131.7, 124.1, 103.6, 65.1, 53.1, 26.9, 
23.1, 21.2, 20.8, 20.3, 20.1; FTIR (thin film, CHCl3, cm
-1
) 3007, 2955, 2871, 1731, 1660, 1468, 
1373, 1243, 1073, 1013, 960, 901, 754; HRMS (ESI) calcd for C18H22INNaO3 [M + Na]
+
: 
450.0542, found: 450.0555.  The second eluting compound consisted of syn-4.53 (0.670 g, 26%) 
as a cream-colored solid, mp 87-88 °C:  
1
H NMR (300 MHz, CDCl3)  7.62 (s, 1H), 7.08 (s, 1H), 
6.11 (d, J = 10.2 Hz, 1H), 5.76-5.70 (m, 1H), 5.12 (m, 1H), 4.73-4.63 (m, 1H), 2.31 (s, 3H), 2.27 
(s, 3H), 2.02 (s, 3H), 2.00-1.79 (m, 3H), 1.76 (s, 3H), 1.75-1.65 (m, 1H); 
13
C NMR (75 MHz, 
CDCl3)  170.3, 169.9, 139.8, 139.7, 137.8, 137.7, 134.3, 131.8, 124.6, 103.3, 65.0, 54.1, 26.9, 
23.1, 22.2, 20.8, 20.0, 19.8; FTIR (thin film, CHCl3, cm
-1
) 2954, 1730, 1661, 1468, 1373, 1243, 
1043, 1012, 966, 899, 754; LRMS (EI) m/z 427 (M
+
, 7), 368 (78), 367(77), 325 (100), 272 (35), 
198 (48), 158 (32), 79 (65); HRMS (EI) calcd for C18H22INO3: 427.0644, found: 427.0643. 
 
N
I
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rac-trans-4-(N-(2-Iodophenyl)acetamido)cyclohex-2-enyl acetate (4.56):  In a round bottom 
flask fitted with a reflux condenser, solid 60% w/w NaH/mineral oil (0.336 g, 8.40 mmol) was 
slurried in DMF (3 mL) at 0 °C with stirring.  A solution of 4.54
48
 (1.83 g, 7.0 mmol) in DMF 
(10 mL) was added to this slurry dropwise via syringe over 10 min.  The resulting mixture was 
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warmed to room temperature, stirred for 30 min, and recooled to 0 °C.  A solution of trans-4-
chlorocyclohex-2-enyl acetate
212
 (1.83 g, 10.5 mmol) in DMF (2 mL) was added dropwise via 
syringe over 5 min, and the stirred mixture was then heated at 80 °C for 40 h.  The mixture was 
cooled to room temperature, and saturated aqueous NH4Cl solution (150 mL) was added.  The 
mixture was extracted with Et2O (3 x 150 mL), and the combined organic layers were washed 
successively with water (3 x 150 mL) and brine (3 x 150 mL), dried over MgSO4, filtered, and 
concentrated by rotary evaporation.  Column chromatography (1:1 hexanes:EtOAc) furnished the 
title compound (2.21 g, 79%) as a yellow oil, in a 3:2 anti:syn ratio of atropisomers:  
1
H NMR 
(300 MHz, CDCl3)  7.97 (dd, J = 8.1 Hz, 1.5 Hz, 1H, major), 7.96 (dd, J = 8.1 Hz, 1.2 Hz, 1H, 
minor), 7.45-7.37 (m, 1H, both), 7.21 (dd, J = 7.8 Hz, 1.5 Hz, 1H, minor), 7.17 (dd, J = 7.8 Hz, 
1.5 Hz, major), 7.09 (td, J = 7.8 Hz, 1.5 Hz, 1H, both), 5.97 (dq, J = 10.5 Hz, 1.5 Hz, 1H, major), 
5.82 (dq, J = 10.5 Hz, 1.5 Hz, 1H, minor), 5.74 (dq, J = 10.2 Hz, 1.8 Hz, 1H, major), 5.54 (dq, J 
= 10.5 Hz, 1.5 Hz, 1H, minor), 5.41-5.31 (m, 1H, major), 5.31-5.18 (m, 2H, minor), 5.18-5.09 
(m, 1H, major), 2.45-2.33 (m, 1H, minor), 2.23-2.10 (m, 1H, both), 2.04 (s, 3H, both), 2.03-1.93 
(m, 1H, major), 1.83 (s, 3H, major), 1.80 (s, 3H, minor), 1.78-1.56 (m, 1H both and 1H minor), 
1.30 (ddd, J = 13.2 Hz, 10.5 Hz, 2.7 Hz, 1H, major); 
13
C NMR (75 MHz, CDCl3) all signals, 
both atropisomers  170.6, 170.2, 170.1, 143.2, 142.6, 140.3, 140.2, 132.8, 130.6, 130.2, 130.0, 
129.9, 129.82, 129.78, 129.53, 129.47, 103.7, 103.3, 68.9, 53.3, 52.9, 27.7, 27.0, 24.3, 23.6, 
21.1; FTIR (neat, cm
-1
) 3037, 2937, 2870, 1732, 1659, 1468, 1373, 1306, 1235, 1084, 1029, 901, 
759; HRMS (ESI) calcd for C16H18INNaO3 [M + Na]
+
: 422.0229, found: 422.0238. 
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rac-trans-4-(N-(2-Iodo-4,6-dimethylphenyl)acetamido)cyclohex-2-enyl acetate (4.57):  Solid 
60% w/w NaH (0.173 g, 7.20 mmol) was slurried in DMF (3 mL) at 0 °C with stirring.  A 
solution of 4.55
93,105
 (1.74 g, 6.00 mmol) in DMF (10 mL) was added dropwise via syringe over 
10 min, and the mixture was warmed to room temperature and stirred for 1 h.  The mixture was 
then recooled to 0 °C, and a solution of trans-4-chlorocyclohex-2-enyl acetate
212
 (1.57 g) in 
DMF (2 mL) was added via syringe over 5 min.  The mixture was then stirred at 75 °C for 15 h, 
cooled to 0 °C, and water (150 mL) was added.  The mixture was extracted with Et2O (3 x 150 
mL), and the combined organic layers were washed with water (3 x 150 mL) and brine (1 x 150 
mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Exhaustive column 
chromatography (2 columns, 1:1 hexanes:EtOAc) provided the pure atropisomers.  The first 
eluting compound, anti-4.57 (0.440 g, 17%) was isolated as a white solid, mp 124-126 °C:  
1
H 
NMR (300 MHz, CDCl3)  7.58 (s, 1H), 7.07 (s, 1H), 6.22 (dq, J = 10.2 Hz, 1.8 Hz, 1H), 5.64 
(dq, J = 10.5 Hz, 1.8 Hz, 1H), 5.23 (m, 1H), 4.94 (m, 1H), 2.31 (s, 3H), 2.24 (s, 3H), 2.11-2.01 
(m, 1H), 2.05 (s, 3H), 2.01-1.89 (m, 1H), 1.76 (s, 3H), 1.63 (m with clear d, J = 2.4 Hz, 1H), 
1.19 (m with clear d, J = 2.4 Hz, 1H); 
13
C NMR (75 MHz, CDCl3)  170.81, 170.75, 140.3, 
139.7, 138.5, 138.2, 133.9, 132.1, 127.5, 103.9, 69.6, 53.6, 28.2, 25.5, 23.5, 21.3, 20.7, 20.4; 
FTIR (thin film, CHCl3, cm
-1
) 2953, 2871, 1730, 1659, 1467, 1372, 1238, 1031, 905, 733; 
HRMS (ESI) calcd for C18H22INNaO3 [M + Na]
+
: 450.0542, found: 450.0551.  The second 
eluting compound, syn-4.57 (0.281 g, 11%), was isolated as a white solid, mp 139-141 °C: 
1
H 
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NMR (300 MHz, CDCl3)  7.60 (s, 1H), 7.06 (s, 1H), 5.97 (dq, J = 10.5 Hz, 2.1 Hz, 1H), 5.56 
(dq, J = 10.2 Hz, 1.5 Hz, 1H), 5.37-5.27 (m, 1H), 4.87-4.76 (m, 1H), 2.29 (s, 3H), 2.24 (s, 3H), 
2.22-2.05 (m, 2H), 2.03 (s, 3H), 1.74 (s, 3H), 1.66-1.58 (m with clear d, J = 2.4 Hz, 1H); 
13
C 
NMR (75 MHz, CDCl3)  170.9, 170.7, 140.2, 140.1, 138.4, 138.1, 132.4, 132.2, 128.0, 103.6, 
69.6, 54.6, 28.2, 26.5, 23.5, 21.2, 20.4, 20.3; FTIR (thin film, CHCl3, cm
-1
) 2935, 2870, 1731, 
1662, 1466, 1372, 1303, 1239, 1030, 904, 732; HRMS (ESI) calcd for C18H22INNaO3 [M + Na]
+
: 
450.0542, found: 450.0527.  The third eluting compound, starting material 4.55, was also 
recovered (0.723 g, 42%). 
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rac-(3R,4aR,9aR)-9-Acetyl-2,3,4,4a,9,9a-hexahydro-1H-carbazol-3-yl acetate (4.58):  Iodide 
4.56 (0.160 g, 0.40 mmol, 2:1 anti:syn) was reacted according to the general radical procedure, 
with [Bu3SnH]i = 0.01 M.  Column chromatography (1:2 hexanes:EtOAc) provided the title 
compound (0.097 g, 89%) as a white solid, mp 146 °C, in a 2:1 rotamer ratio: 
1
H NMR (300 
MHz, CDCl3)  8.11 (br d, J = 5.7 Hz, 1H, major), 7.31-7.25 (m, 1H, both), 7.22 (d, J = 7.8 Hz, 
1H, both), 7.10 (t, J = 7.5 Hz, 1H, both), 4.77 (br m, 1H, minor), 4.70 (br m, 1H, both), 4.27 (br 
m, 1H, major), 3.72 (br m, 1H, major), 3.61 (br m, 1H, minor), 2.70-2.52 (m, 1H, both), 2.39 (br 
s, 3H, minor), 2.31 (br s, 3H, major), 2.07 (s, 3H, both), 1.94 (dq, J = 13.5 Hz, 6.3 Hz, 1H, both), 
1.90 (dq, J = 13.5 Hz, 6.3 Hz, 1H, both), 1.60-1.32 (m, 3H, both); 
13
C NMR (75 MHz, CDCl3)  
170.2, 167.6, 141.3, 132.4, 127.6, 124.1, 122.4, 118.0, 68.9, 60.3, 40.2, 29.2, 27.9, 26.1, 23.1, 
21.1; additional signals from the minor amide rotamer were seen at 140.5, 135.1, 123.6, 115.4, 
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59.3, 39.0, 24.8, 23.8; FTIR (thin film, CHCl3, cm
-1
) 3009, 2945, 2866, 1731, 1658, 1599, 1478, 
1402, 1246, 1038, 964, 930, 755; HRMS (ESI) calcd for C16H19NNaO3 [M + Na]
+
: 296.1263, 
found: 296.1252. 
 
N
O
H
H
OAc
 
rac-(3R,4aR,9aS)-9-Acetyl-2,3,4,4a,9,9a-hexahydro-1H-carbazol-3-yl acetate (4.59):  Iodide 
4.52 (0.16 g, 0.40 mmol, 3:2 anti:syn) was reacted according to the general radical procedure, 
with [Bu3SnH]i = 0.01 M.  Column chromatography (100% EtOAc) provided the title compound 
(0.101 g, 92%) as a white solid, mp 127-128 °C, in a 2:1 rotamer ratio: 
1
H NMR (300 MHz, 
CDCl3)  8.14 (br s, 1H, major), 7.45-7.20 (br s, 1H, minor), 7.21 (t, J = 7.5 Hz, 1H, both), 7.13 
(d, J = 7.2 Hz, 1H, both), 7.05 (t, J = 7.5 Hz, 1H, both), 5.03 (m, 1H, both), 4.78 (br s, 1H, 
minor), 3.57 (br s, 1H, major), 3.68 (m with clear d, J = 15.3 Hz, 1H, both), 2.34 (br s, 3H, both), 
2.04 (ddd, J = 15.3 Hz, 6.9 Hz, 3.3 Hz, 1H, both), 1.95-1.78 (m, 2H, both), 1.76 (s, 3H, both), 
1.75-1.57 (m, 2H, both); 
13
C NMR (75 MHz, CDCl3)  170.5, 167.6, 140.9 (br), 134.5 (br), 
127.1, 123.4, 122.6 (br), 117.8 (br), 67.3, 60.4 (br), 37.5 (br), 27.0, 26.3, 23.2 (br), 21.9 (br), 
21.0; FTIR (thin film, CHCl3, cm
-1
) 2947, 2862, 1732, 1656, 1479, 1403, 1238, 1023, 994, 755; 
HRMS (ESI) calcd for C16H20NO3 [M + H]
+
: 274.1443, found: 274.1451. 
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rac-(3R,4aR,9aR)-9-Acetyl-6,8-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazol-3-yl acetate 
(4.60):  Iodide syn-4.57 (0.107 g, 0.250 mmol) was reacted according to the general radical 
procedure, with [Bu3SnH]i = 0.01 M.  Column chromatography (3:1 hexanes:EtOAc) provided 
the title compound (0.058 g, 77%) as a white solid, mp 134-136 °C:  
1
H NMR (300 MHz, 
CDCl3)  6.89 (s, 1H), 6.87 (s, 1H), 4.56 (tt, J = 11.4 Hz, 3.6 Hz, 1H), 4.37 (br s, 1H), 3.69 (br 
m, 1H), 2.56 (m with clear d, J = 14.1 Hz, 1H), 2.32 (s, 3H), 2.24 (br s, 3H), 2.21 (s, 3H), 2.10-
2.00 (m, 1H), 2.05 (s, 3H), 1.88 (dd, J = 11.7 Hz, 6.0 Hz, 1H), 1.83 (dd, J = 11.7 Hz, 6.3 Hz, 
1H), 1.53-1.23 (m, 2H); 
13
C NMR (75 MHz, CDCl3)  170.4, 167.7 (br), 138.1, 135.6 (br), 
135.3, 130.5, 129.3 (br), 120.7, 69.0, 62.3, 41.5, 29.9, 28.4, 25.9, 23.0, 21.3, 21.0, 20.0; FTIR 
(thin film, CHCl3, cm
-1
) 2944, 2865, 1732, 1665, 1412, 1379, 1244, 1038, 754; LRMS (EI) m/z 
301 (M
+
, 36), 259 (29), 256 (15), 199 (15), 158 (40), 81 (100); HRMS (ESI) calcd for 
C18H23NNaO3 [M + Na]
+
: 324.1576, found: 324.1575. 
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rac-(3S,4aR,9aR)-9-Acetyl-6,8-dimethyl-2,3,4,4a,9,9a-hexahydro-1H-carbazol-3-yl acetate 
(4.61):  Iodide syn-4.53 (0.085 g, 0.200 mmol) was reacted according to the general radical 
procedure, with [Bu3SnH]i = 0.01 M.  Column chromatography (3:1 hexanes:EtOAc) provided 
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the title compound (0.043 g, 71%) as a white solid, mp 121-122 °C:  
1
H NMR (300 MHz, 
CDCl3)  6.84 (s, 1H), 6.73 (s, 1H), 4.96 (pentet, J = 3.0 Hz, 1H), 4.48 (br s, 1H), 3.56 (t, J = 6.6 
Hz, 1H), 2.92 (m with clear d, J = 15.6 Hz, 1H), 2.29 (s, 3H), 2.25 (s, 3H), 2.24 (s, 3H), 1.97 
(ddd, J = 15.6 Hz, 6.9 Hz, 3.3 Hz, 1H), 1.87-1.75 (m, 2H), 1.71 (s, 3H), 1.65-1.55 (m , 2H); 
13
C 
NMR (75 MHz, CDCl3)  170.5, 167.9 (br), 137.8, 137.5 (br), 134.3, 129.8, 128.7 (br), 120.8, 
67.4, 62.4, 38.7, 27.2, 26.6, 22.9, 21.5, 20.9 (2C, accidental isochrony), 20.1; FTIR (thin film, 
CHCl3, cm
-1
) 2945, 2862, 1732, 1663, 1413, 1378, 1257, 1234, 1023, 904, 855, 755; LRMS (EI) 
m/z 301 (M
+
, 79), 259 (57), 145 (25), 140 (23), 93 (23), 86 (62), 84 (100); HRMS (EI) calcd for 
C18H23NO3 [M]
+
: 301.1678, found: 301.1682. 
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rac-trans-4-(N-(2,4-Dimethylphenyl)acetamido)cyclohex-2-enyl acetate (4.62):  Iodide anti-
4.57 (0.100 g, 0.234 mmol) was reacted according to the general radical procedure, with 
[Bu3SnH]i = 0.21 M.  Column chromatography (2:1 hexanes:EtOAc) provided the title 
compound (0.068 g, 96%) as a yellow oil in a 2:1 ratio of atropisomers:  
1
H NMR (300 MHz, 
CDCl3)  7.10 (m, 1H, both), 7.05-6.96 (m, 1H, both), 6.91 (d, J = 9.0 Hz, 1H, minor), 6.88 (d, J 
= 8.1 Hz, 1H, major), 5.92 (dq, J = 10.2 Hz, 1.5 Hz, 1H, major), 5.75-5.66 (m with clear d, 10.2 
Hz, 1H, both), 5.56 (dq, J = 10.5 Hz, 1.5 Hz, 1H, minor), 5.32-5.24 (m, 1H, minor), 5.24-5.08 
(m, 1H, both), 2.34 (s, 3H, both), 2.22 (s, 3H, minor), 2.20 (s, 3H, major), 2.03 (s, 3H, both), 
2.01-1.84 (m, 1H both and 1H minor), 1.75 (s, 3H, major), 1.73 (s, 3H, minor), 1.70-1.55 (m, 
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2H, both), 1.41-1.25 (m, 1H, major); 
13
C NMR (75 MHz, CDCl3) all signals, both atropisomers  
170.9, 170.8, 170.6, 138.4, 138.3, 136.5, 136.4, 136.3, 136.0, 132.9, 132.0, 131.9, 131.3, 129.5, 
129.24, 129.19, 129.1, 127.7, 127.6, 69.1, 69.0, 52.7, 52.2, 27.80, 27.78, 26.6, 24.2, 22.8, 22.7, 
21.2, 20.9, 18.4, 18.0; FTIR (neat, cm
-1
) 2946, 2871, 1732, 1656, 1502, 1375, 1309, 1239, 1030; 
HRMS (ESI) calcd for C18H23NNaO3 [M + Na]
+
: 324.1576, found: 324.1549. 
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rac-cis-4-(N-(2,4-Dimethylphenyl)acetamido)cyclohex-2-enyl acetate (4.63):  Iodide anti-4.53 
(0.107 g, 0.250 mmol) was reacted according to the general radical procedure, with [Bu3SnH]i = 
0.21 M.  Column chromatography (1:1 hexanes:EtOAc) provided the title compound (0.072 g, 
96%) as a yellow oil in a 2:1 ratio of atropisomers:  
1
H NMR (300 MHz, CDCl3)  7.13 (m, 1H, 
both), 7.05-6.99 (m, 1H, both), 6.96 (d, J = 8.1 Hz, 1H, minor), 6.92 (d, J = 7.8 Hz, 1H, 
major),6.08 (d, J = 9.9 Hz, 1H, major), 5.90-5.83 (m, 1H, major), 6.85 (d, J = 10.2 Hz, 1H, 
minor), 5.71 (dq, J = 10.2 Hz, 2.7 Hz, 1H, minor), 5.25-5.15 (m, 1H, minor), 5.15-5.05 (m, 1H, 
major), 2.35 (s, 3H, both), 2.24 (s, 3H, minor), 2.23 (s, 3H, major), 1.98 (s, 3H, minor), 1.92 (s, 
3H, major), 1.90-1.60 (m, 3H from both, 1H from minor), 1.76 (s, 3H, major), 1.74 (s, 3H, 
minor), 1.53-1.38 (m, 1H, minor); 
13
C NMR (75 MHz, CDCl3) All signals, both atropisomers  
170.9, 170.8, 170.4, 138.3, 138.1, 136.8, 136.4, 136.30, 136.26, 135.5, 133.8, 131.94, 131.88, 
129.5, 129.1, 127.6, 127.5, 126.5, 126.3, 65.6, 65.3, 52.9, 52.6, 26.9, 23.4, 22.8, 22.7, 21.2, 21.1, 
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20.9, 18.4, 18.0; FTIR (neat, cm
-1
) 2950, 1731, 1657, 1502, 1376, 1310, 1242, 1046, 1014, 967, 
898, 769, 733; HRMS (ESI) calcd for C18H23NNaO3 [M + Na]
+
: 324.1576, found: 324.1596. 
 
N
O
H
H
 
rac-1-(cis-1H-Carbazol-9(2H,4aH,9aH)-yl)ethanone (4.64):  In a sealable pressure tube were 
placed a stir bar, 4.56 (0.200 g, 0.500 mmol, 3:2 anti:syn), Pd2(dba)3•CHCl3 (0.026 g, 0.025 
mmol), and P(o-tol)3 (0.040 g, 0.132 mmol).  A degassed 10:1 MeCN:H2O solvent mixture (6 
mL) was added, followed by Me2NBu (0.121 g, 1.20 mmol).  The tube was sealed, heated at 80 
°C for 6 h, and recooled to room temperature.  Saturated aqueous NH4Cl (10 mL) was added, and 
the mixture was extracted with EtOAc (3 x 10 mL).  The combined organic layers were washed 
with brine (1 x 10 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  
Column chromatography (2 columns, 1:3 pentane:Et2O) provided the title compound (0.061 g, 
47%) as a yellow oil in a 3:1 ratio of amide rotamers: 
1
H NMR (300 MHz, CDCl3)  8.14 (br d, J 
= 7.5 Hz, 1H, major), 7.19 (t, J = 7.5 Hz, 2H, both), 7.17 (br m, minor), 7.05 (t, J = 7.5 Hz, 1H, 
both), 6.17-6.02 (br m, 1H, both), 6.00-5.90 (m, 1H, both), 4.88 (br s, 1H, minor), 4.39 (m, 1H, 
major), 3.94 (br s, 1H, major), 3.80 (br s, 1H, minor), 2.41 (s, 3H, minor), 2.31 (s, 3H, major), 
2.21-1.91 (m, 3H, both), 1.63-1.45 (m, 1H, major), 1.38-1.20 (br m, 1H, minor); 
13
C NMR (75 
MHz, CDCl3)  167.9, 140.7, 128.1, 127.4, 123.9 (2C, accidental isochrony), 123.2, 118.1, 60.4, 
40.6, 25.0, 23.2, 22.8, peaks from the minor rotamer were also seen at 129.0, 124.5, 115.3, 59.6, 
39.2, 24.2; FTIR (neat, cm
-1
) 3031, 2935, 2841, 1650, 1480, 1403, 1319, 1080, 1015, 912, 730; 
  218 
LRMS (EI) m/z 213 (M
+
, 60), 171 (72), 170 (55), 156 (52), 143 (42), 130 (100), 77 (30); HRMS 
(EI) calcd for C14H15NO [M]
+
: 213.1154, found: 213.1153. 
 
N
O
H
H
 
rac-1-(cis-6,8-Dimethyl-1H-carbazol-9(2H,4aH,9aH)-yl)ethanone (4.42a):  In a sealable 
pressure tube were placed a stir bar, anti-4.53 (0.107 g, 0.250 mmol), Pd2(dba)3•CHCl3 (0.013 g, 
0.0125 mmol), and P(o-tol)3 (0.017 g, 0.055 mmol).  A degassed 10:1 MeCN:H2O solvent 
mixture (2.5 mL) was added, followed by Me2NBu (0.051 g, 0.500 mmol).  The tube was sealed, 
heated at 80 °C for 4 h, and recooled to room temperature.  Saturated aqueous NH4Cl (5 mL) was 
added, and the mixture was extracted with EtOAc (3 x 5 mL).  The combined organic layers 
were dried over MgSO4, filtered, and concentrated by rotary evaporation.  Gradient column 
chromatography (7:1 pentane:Et2O to 1:2 pentane:Et2O) provided the title compound (0.044 g, 
73%) as a white solid, mp 136-137 °C:  
1
H NMR (300 MHz, CDCl3)  6.85 (s, 1H), 6.82 (s, 1H), 
6.06 (m with clear d, J = 9.9 Hz, 1H), 5.94-5.85 (m, 1H), 4.50 (br s, 1H), 3.90 (br s, 1H), 2.30 (s, 
3H), 2.27 (s, 3H), 2.23 (s, 3H), 2.17-2.04 (m, 2H), 2.03-1.90 (m, 1H), 1.58-1.38 (br m, 1H); 
13
C 
NMR (75 MHz, CDCl3)  168.2 (br), 138.1, 137.5 (br), 137.3, 135.0, 130.2, 128.1, 124.5, 121.5, 
61.9, 41.2, 24.5, 23.0, 22.9, 20.9, 20.3; FTIR (thin film, CHCl3, cm
-1
) 3025, 2924, 2840, 1666, 
1412, 1385, 1350, 853, 783; LRMS (EI) m/z 241 (M
+
, 100), 199 (98), 184 (50), 158 (52); HRMS 
(EI) calcd for C16H19NO [M]
+
: 241.1467, found: 241.1461. 
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N
O
H
H
 
rac-1-((4aR,9aR)-6,8-dimethyl-4,4a-dihydro-1H-carbazol-9(9aH)-yl)ethanone (4.42b):  This 
compound was never isolated as a pure isomer, but co-eluted with 4.42a in several reactions:  
1
H 
NMR (300 MHz, CDCl3)  6.86 (s, 1H), 6.79 (s, 1H), 5.76 (dq, J = 10.2 Hz, 3.0 Hz, 1H), 5.72-
5.57 (m, 1H), 4.44 (br s, 1H), 3.66 (br t, J = 6.6 Hz, 1H), 2.73-2.58 (m, 1H), 2.58-2.48 (m, 1H), 
2.43 (dt, J = 16.8 Hz, 6.3 Hz, 1H), 2.31 (s, 3H), 2.27 (s, 3H), 2.24 (s, 3H), 1.95-1.85 (m, 1H). 
 
N
O
OAc
H
H
 
rac-cis-9-Acetyl-2,4a,9,9a-tetrahydro-1H-carbazol-3-yl acetate (4.65):  In a sealable pressure 
tube were placed a stir bar, 4.52 (0.240 g, 0.250 mmol, 3:2 anti:syn), Pd2(dba)3•CHCl3 (0.031 g, 
0.030 mmol), and P(o-tol)3 (0.033 g, 0.110 mmol).  A degassed 10:1 MeCN:H2O solvent mixture 
(5 mL) was added, followed by Me2NBu (0.101 g, 1.00 mmol).  The tube was sealed, heated at 
80 °C for 3 h, and recooled to room temperature.  Saturated aqueous NH4Cl (5 mL) was added, 
and the mixture was extracted with EtOAc (3 x 10 mL).  The combined organic layers were 
washed with brine (1 x 10 mL), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Gradient column chromatography (hexanes to 2:3 hexanes:EtOAc) provided the 
title compound (0.111 g, 82%) as a white solid, mp 132-133 °C, in a 2:1 amide rotamer ratio:  
1
H 
NMR (300 MHz, CDCl3)  8.14 (br d, J = 6.9 Hz, 1H, major), 7.22 (t, J = 7.5 Hz, 1H, both), 
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7.18 (br m, 1H, minor), 7.18-7.11 (m, 1H, both), 7.07 (td, J = 7.5 Hz, 1.2 Hz, 1H, both), 5.82 (br 
s, 1H, both), 4.89 (m, 1H, minor), 4.42 (m, 1H, major), 4.13 (br m, 1H, major), 4.00 (br m, 1H, 
minor), 2.60-2.237 (m, 1H both and 1H minor), 2.33 (br s, 3H, both), 2.16 (s, 3H, both), 2.12-
1.98 (m, 2H, both), 1.87-1.67 (br m, 1H, minor); 
13
C NMR (75 MHz, CDCl3) major rotamer  
169.0, 168.1, 149.2, 140.4, 133.1, 127.7, 124.2, 123.3, 118.1, 115.5, 110.6, 59.5, 40.0, 25.4, 25.1, 
23.0, 20.9, additional signals from the minor rotamer also seen at  168.6, 131.0, 124.7, 58.8, 
24.1, 20.5; FTIR (thin film, CHCl3, cm
-1
) 3011, 2847, 1752, 1656, 1479, 1401, 1369, 1275, 
1208, 1132, 1014, 915, 755; HRMS (ESI) calcd for C16H18NO3 [M + Na]
+
: 272.1287, found: 
272.1311. 
 
N
O
OAc
H
H
 
rac-cis-9-Acetyl-6,8-dimethyl-2,4a,9,9a-tetrahydro-1H-carbazol-3-yl acetate (4.66):  In a 
sealable pressure tube were placed a stir bar, syn-4.57 (0.092 g, 0.250 mmol), Pd2(dba)3•CHCl3 
(0.013 g, 0.0125 mmol), and P(o-tol)3 (0.017 g, 0.055 mmol).  A degassed 10:1 MeCN:H2O 
solvent mixture (2.5 mL) was added, followed by Me2NBu (0.063 g, 0.625 mmol).  The tube was 
sealed, heated at 80 °C for 1 h, and recooled to room temperature.  Saturated aqueous NH4Cl (5 
mL) was added, and the mixture was extracted with EtOAc (3 x 5 mL).  The combined organic 
layers were washed with brine (1 x 10 mL), dried over MgSO4, filtered, and concentrated by 
rotary evaporation.  Column chromatography (1:1 hexanes:EtOAc) provided an inseparable 
mixture (63 mg total) of the title compound (0.054 g, 0.182 mmol, 73%) and tri(o-
tolyl)phosphine oxide
276
 (0.009 g, 0.027 mmol):  
1
H NMR (300 MHz, CDCl3)  6.86 (s, 1H), 
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6.79 (s, 1H), 5.76 (dd, J = 4.8 Hz, 2.4 Hz, 1H), 4.53 (br s, 1H), 4.06 (br m, 1H), 2.58-2.43 (m, 
1H), 2.28 (s, 3H), 2.26 (s, 3H), 2.22 (s, 3H), 2.14 (s, 3H), 2.08-1.95 (m, 2H), 1.70 (dq, J = 12.6 
Hz, 4.5 Hz, 1H); HRMS (EI) calcd for C18H21NNaO3 [M + Na]
+
: 322.1419, found: 322.1440. 
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6.5 COMPOUND DATA FOR CHAPTER 5 
Experimental procedures and spectroscopic data have been previously reported in the literature 
for compound 5.21.
234
  These procedures were followed, and the product’s physical properties 
and spectroscopic data were consistent with those previously reported.  The preparations of 3.21, 
3.23, and 3.27 are described in Chapter 6.3. 
 
NH
I
 
2-Iodo-N-4,6-trimethylaniline (5.19):  LDA was made by dissolving N,N-diisopropylamine 
(2.43 g, 24.0 mmol) in THF (10 mL) at −78 °C with stirring, and adding a hexanes solution of 
BuLi (15.7 mL, 22.0 mmol) dropwise.  The reaction mixture was stirred at this temperature for 
40 min, warmed to 0 °C and stirred for 10 min.  The resulting solution of LDA was then added 
dropwise over 10 min to a stirred solution of o-iodoaniline 3.21 (4.94 g, 20.0 mmol) in THF (150 
mL) at −78 °C, and the mixture was stirred for an additional 20 min.  Methyl iodide (2.98 g, 21.0 
mmol) was added dropwise via syringe, the reaction mixture was warmed to room temperature, 
and stirred for 1 h.  The mixture was quenched with saturated aqueous NH4Cl solution (200 mL) 
and diluted with Et2O (250 mL).  The organic layer was separated and washed with saturated 
aqueous NH4Cl (3 x 250 mL) and brine (250 mL) solutions, dried over MgSO4, filtered, and 
concentrated by rotary evaporation.  Flash chromatography (25:1 pentane:Et2O) afforded the title 
compound (4.40 g, 84%) as a red-brown, acrid-smelling liquid:  
1
H NMR (300 MHz, CDCl3)  
7.44 (s, 1H), 6.93 (s, 1H), 3.31 (br s, 1H), 2.73 (s, 3H), 2.35 (s, 3H), 2.22 (s, 3H); 
13
C NMR (75 
MHz, CDCl3)  146.8, 136.8, 133.6, 132.5, 130.8, 95.3, 35.3, 19.9, 19.5; FTIR (neat, cm
-1
) 3348, 
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2949, 2917, 2860, 1481, 1411, 1277, 1108, 1028, 852, 790, 726; LRMS (EI) m/z 261 (M
+
, 75), 
246 (32), 134 (29), 118 (27), 105 (45), 91 (100), 78 (87), 76 (99); HRMS (EI) calcd for C9H12IN: 
261.0015, found: 261.0019. 
 
NH
I
PMB
 
2-Iodo-N-(4-methoxybenzyl)-4,6-dimethylaniline (5.20):  To a stirred solution of 3.21 (6.18 g, 
25.0 mmol) and p-anisaldehyde (3.57 g, 26.3 mmol) in EtOAc (75 mL) was added trifluoroacetic 
acid (5.70 g, 50.0 mmol).  The mixture was stirred at room temperature for 30 min, and solid 
NaBH(OAc)3 (9.54 g, 45.0 mmol) was added portionwise over 5 min.  The reaction mixture was 
stirred for 3 h, cooled to 0 °C, and quenched with 10% w/w aqueous NaOH solution (very slowly 
at first, until gas production stopped) until two distinct layers formed.  The organic layer was 
separated and washed with brine (2 x 100 mL), dried over MgSO4, filtered, and concentrated by 
rotary evaporation.  Column chromatography (10:1 hexanes:EtOAc) afforded the title compound 
(7.59 g, 83%) as an off-white solid, mp 69-70 °C:  
1
H NMR (300 MHz, CDCl3)  7.47 (s, 1H), 
7.36 (d, J = 8.7 Hz, 2H), 6.95 (s, 1H), 6.90 (d, J = 8.7 Hz, 2H), 4.02 (s, 2H), 3.83 (s, 3H), 3.44 
(br s, 1H), 2.37 (s, 3H), 2.23 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  158.7, 145.2, 137.0, 133.9, 
132.3, 131.6, 131.3, 129.3 (2C), 113.7 (2C), 96.2, 55.0, 52.1, 19.9, 19.4; FTIR (thin film, CHCl3, 
cm
-1
) 3326, 2928, 2832, 1509, 1471, 1462, 1275, 1179, 1055, 1029, 831, 820, 738; LRMS (EI) 
m/z 368 (26), 367 (M
+
, 82), 238 (37), 122 (65), 121 (100), 91 (32), 77 (40); HRMS (EI) calcd for 
C16H18INO: 367.0433, found: 367.0430. 
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MeO I
PMB
 
2-Iodo-6-methoxy-N-(4-methoxybenzyl)aniline (5.22):  To a stirred solution of N-Boc aniline 
5.21
234
 (4.36 g, 12.5 mmol) in CH2Cl2 (60 mL) at 0 °C was added trifluoroacetic acid (14.25 g, 
125 mmol) in one portion via syringe.  The reaction mixture was warmed to room temperature 
and stirred for 1.5 h, at which time p-anisaldehyde (1.79 g, 13.1 mmol) was added in one portion 
via syringe.  The reaction was stirred for 10 min, and solid NaBH(OAc)3 (7.95 g, 37.5 mmol) 
was added portionwise over 10 min.  The mixture was stirred for 1 h, cooled to 0 °C, and 
quenched (very slowly at first, until gas production stopped) with 10% w/w aqueous NaOH 
solution (50 mL).  The organic layer was separated and washed with brine (50 mL), dried over 
MgSO4, filtered, and concentrated by rotary evaporation.  Column chromatography (6:1 
pentane:Et2O) afforded the title compound (3.36 g, 76%) as a yellow oil:  
1
H NMR (300 MHz, 
CDCl3)  7.35 (dd, J = 8.1 Hz, 1.2 Hz, 1H), 7.30 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 
6.81 (dd, J = 8.1 Hz, 1.2 Hz, 1H), 6.64 (t, J = 8.1 Hz, 1H), 4.32 (s, 2H), 4.02 (br s, 1H), 3.82 (s, 
3H), 3.81 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  158.6, 151.2, 139.0, 132.1, 131.2 (2C), 129.3, 
123.1, 113.6 (2C), 111.4, 92.3, 55.7, 55.1, 51.4; FTIR (neat, cm
-1
) 3347, 2934, 2833, 1611, 1582, 
1512, 1463, 1247, 1175, 1031, 830, 760, 726; LRMS (EI) m/z 369 (M
+
, 25), 240 (5), 121 (100), 
91 (6), 77 (7); HRMS (EI) calcd for C15H16INO2: 369.0226, found: 369.0227. 
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Ts
 
N-(2-Iodo-4,6-dimethylphenyl)-4-methylbenzenesulfonamide (5.23):  To a stirred solution of 
3.21 (2.47 g, 10.0 mmol) in pyridine (10 mL) was added p-toluenesulfonyl chloride (2.29 g, 12.0 
mmol) all at once.  The reaction mixture was stirred at room temperature for 5 h, at which point 
saturated aqueous NH4Cl solution (40 mL) was added to quench the reaction.  The mixture was 
extracted with CH2Cl2 (4 x 40 mL), and the combined organic layers were washed with 1 N HCl 
(3 x 40 mL) and brine (3 x 40 mL), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Column chromatography (4:1 hexanes:EtOAc) afforded the title compound (3.63 g, 
90%) as a white solid, mp 157-158 °C:  
1
H NMR (300 MHz, CDCl3)  7.56 (d, J = 8.1 Hz, 2H), 
7.39 (s, 1H), 7.25 (d, J = 8.1 Hz, 2H), 7.07 (s, 1H), 6.04 (s, 1H), 2.49 (s, 3H), 2.44 (s, 3H), 2.26 
(s, 3H); 
13
C NMR (75 MHz, CDCl3)  143.9, 139.4, 139.2, 137.5, 137.2, 133.2, 132.7, 129.5 
(2C), 127.9 (2C), 100.2, 21.6, 20.7, 20.3; FTIR (thin film, CHCl3, cm
-1
) 3270 (broad), 2922, 
1598, 1465, 1387, 1330, 1162, 1091, 891, 813, 756, 709; HRMS (ESI) calcd for C15H16INNaO2S 
[M + Na]
+
: 423.9844, found: 423.9849. 
 
TMS I
NH
PMB
 
2-Iodo-N-(4-methoxybenzyl)-4-methyl-6-(trimethylsilyl)aniline (5.24):  To a stirred solution 
of 3.27 (5.26 g, 17.2 mmol) in THF (85 mL) at −78 °C was added a hexanes solution of 
LiHMDS (19.0 mL, 19.0 mmol) dropwise via syringe.  The reaction mixture was warmed to 
  226 
room temperature, stirred for 30 min, and recooled to −78 °C.  A solution of 4-methoxybenzyl 
bromide (4.16 g, 20.7 mmol) in THF (15 mL) was added to the reaction mixture dropwise via 
syringe, the mixture was warmed to room temperature and stirred for 3 h.  Saturated aqueous 
NH4Cl solution (100 mL) was added, and the mixture was extracted with Et2O (3 x 100 mL).  
The combined organic layers were washed with brine (100 mL), dried over MgSO4, filtered, and 
concentrated by rotary evaporation.  Column chromatography (98:2 pentane:Et2O) furnished the 
title compound (5.94 g, 81%) as an orange oil:  
1
H NMR (300 MHz, CDCl3)  7.71 (dd, J = 1.8 
Hz, 0.6 Hz, 1H), 7.44 (d, J = 8.7 Hz, 2H), 7.24 (d, J = 1.5 Hz, 1H), 6.92 (d, J = 8.7 Hz, 2H), 4.05 
(d, J = 6.9 Hz, 2 H), 3.84 (s, 3H), 3.26 (br t, J = 6.9 Hz, 1H), 2.29 (s, 3H), 0.34 (s, 9H); 
13
C NMR 
(75 MHz, CDCl3)  158.8, 151.7, 141.3, 136.6, 136.2, 134.9, 131.6, 129.1 (2C), 113.8 (2C), 
98.9, 55.2, 54.6, 20.2, 0.4 (3C); FTIR (neat, cm
-1
) 3297, 2952, 2899, 2833, 1611, 1584, 1513, 
1426, 1301, 1247, 1173, 1074, 1037, 905, 839, 766; HRMS (ESI) calcd for C18H25INOSi [M + 
H]
+
: 426.0750, found: 426.0788. 
 
NH
Br I
PMB
 
2-Bromo-6-iodo-N-(4-methoxybenzyl)-4-methylaniline (5.25):  A solution of 3.23 (3.12 g, 
10.0 mmol), p-anisaldehyde (1.36 g, 10.0 mmol), and trifluoroacetic acid (.228 g, 2.00 mmol) in 
toluene (10 mL) was stirred in a round-bottom flask fitted with a Dean-Stark trap and a reflux 
condenser.  The reaction mixture was refluxed for 12 h with azeotropic removal of water, cooled 
to room temperature, and solvent was removed by rotary evaporation.  The crude residue was 
redissolved in EtOAc (30 mL) with stirring, trifluoroacetic acid (2.28 g, 20.0 mmol) was added, 
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and the mixture was stirred for 30 min.  Solid NaBH(OAc)3 (4.24 g, 20.0 mmol) was added 
portionwise over 5 min, and the reaction mixture was stirred for 2 h at room temperature.  The 
mixture was cooled to 0 °C, and quenched with 10% w/w aqueous NaOH solution (very slowly 
at first, until gas production stopped) until two distinct layers formed.  The organic layer was 
separated and washed with brine (2 x 20 mL), dried over MgSO4, filtered, and concentrated by 
rotary evaporation.  Column chromatography (20:1 pentane:Et2O) afforded the title compound 
(3.12 g, 72%) as a pink solid, mp 41-42 °C:  
1
H NMR (300 MHz, CDCl3)  7.59 (s, 1H), 7.39 (d, 
J = 8.7 Hz, 2H), 7.37 (s, 1H), 6.89 (d, J = 8.7 Hz, 2H), 4.22 (s, 2H, 3.82 (s, 3H), 2.25 (s, 3H); 
13
C 
NMR (75 MHz, CDCl3)  158.9, 144.5, 139.5, 135.6, 134.1, 131.3, 129.6 (2C), 117.0, 113.8 
(2C), 94.6, 55.2, 52.1, 19.7; FTIR (thin film, CHCl3, cm
-1
) 3332, 2993, 2958, 2927, 2831, 1610, 
1584, 1510, 1455, 1244, 1173, 1034, 852, 826, 745, 714; LRMS (EI) m/z 433 (M
+
 (
81
Br), 7), 431 
(M
+
 (
79
Br), 7), 313 (5), 311 (5), 121 (100); HRMS (EI) calcd for C15H15
79
BrINO: 430.9382, 
found: 430.9379. 
 
NH
Ot-Bu
O
 
(E)-tert-Butyl 3-(3,5-dimethyl-2-(methylamino)phenyl)acrylate (5.26a):  In a round-bottom 
flask fitted with a reflux condenser were combined 5.19 (1.31 g, 5.00 mmol), K2CO3 (1.04 g, 
7.50 mmol), tert-butyl acrylate (0.961 g, 7.50 mmol), and 10% Pd/C (0.186 g, 0.175 mmol) in 
DMF (10 mL).  The stirred mixture was heated at 140 °C for 2 h, cooled to room temperature, 
and filtered through a pad of Celite, followed by rinsing the pad with Et2O (100 mL).  The 
combined filtrates were washed with water (3 x 100 mL) and brine (100 mL), dried over MgSO4, 
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filtered, and concentrated by rotary evaporation.  Column chromatography (5:1 hexanes:EtOAc) 
afforded the title compound (1.20 g, 92%) as a bright yellow solid, mp 76 °C:  
1
H NMR (300 
MHz, CDCl3)  7.91 (d, J = 15.9 Hz, 1H), 7.17 (s, 1H), 6.98 (s, 1H), 6.29 (d, J = 15.9 Hz, 1H), 
3.17 (br s, 1H), 2.81 (3H, s), 2.26 (s, 3H), 2.25 (s, 3H), 1.55 (s, 9H); 
13
C NMR (75 MHz, CDCl3) 
 166.6, 146.2, 141.3, 132.9, 130.7, 129.1, 126.4, 126.0, 119.4, 79.9, 37.3, 28.1 (3C), 20.4, 17.6; 
FTIR (thin film, CHCl3, cm
-1
) 3390, 2976, 2931, 1705, 1628, 1480, 1367, 1332, 1278, 1151, 984, 
757, 714; LRMS (EI) m/z 262 (M+H
+
, 1), 206 (65), 188 (100), 173 (66), 160 (96), 145 (41); 
HRMS (EI) calcd for C16H24NO2 [M + H]
+
: 262.1807, found: 262.1794. 
 
NH
PMB
Ot-Bu
O
 
(E)-tert-Butyl 3-(2-(4-methoxybenzylamino)-3,5-dimethylphenyl)acrylate (5.26b):  In a 
round-bottom flask fitted with a reflux condenser were combined 5.20 (3.67 g, 10.0 mmol), 
K2CO3 (2.07 g, 15.0 mmol), tert-butyl acrylate (1.92 g, 15.0 mmol), and 10% Pd/C (0.372 g, 
0.350 mmol) in DMF (20 mL).  The stirred mixture was heated at 130 °C for 4 h, cooled to room 
temperature, diluted with Et2O (200 mL), and filtered through a pad of Celite, followed by 
rinsing the pad with Et2O (50 mL).  The filtrate was washed with water (3 x 200 mL) and brine 
(200 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Column 
chromatography (10:1 hexanes:EtOAc) gave the title compound (3.02 g, 82%) as a bright 
yellow-green solid, mp 68-70 °C:  
1
H NMR (300 MHz, CDCl3)  8.00 (d, J = 15.9 Hz, 1H), 7.25 
(d, J = 9.3 Hz, 2H), 7.21 (s, 1H), 6.97 (s, 1H), 6.86 (d, J = 8.7 Hz, 2H), 6.31 (d, J = 15.9 Hz, 1H), 
4.04 (s, 2H), 3.81 (s, 2H), 3.27 (br s, 1H), 2.28 (s, 3H), 2.14 (s, 3H), 1.54 (s, 9H); 
13
C NMR (75 
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MHz, CDCl3)  166.6, 158.8, 144.4, 141.3, 133.0, 132.2, 131.4, 129.8 (2C), 129.2, 127.2, 126.1, 
119.8, 113.8 (2C), 80.0, 55.2, 54.7, 28.2 (3C), 20.6, 17.8; FTIR (thin film, CHCl3, cm
-1
) 3368, 
2975, 2933, 2835, 1703, 1628, 1611, 1512, 1476, 1278, 1248, 1153, 1036, 983, 854, 823, 757; 
LRMS (EI) m/z 367 (M
+
, 14), 310 (6), 256 (9), 146 (11), 121 (100), 69 (55); HRMS (EI) calcd 
for C23H29NO3: 367.2147, found: 367.2144. 
 
NH
MeO
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(E)-tert-Butyl 3-(3-methoxy-2-(4-methoxybenzylamino)phenyl)acrylate (5.26c):  In a round-
bottom flask fitted with a reflux condenser were combined 5.22 (3.32 g, 9.00 mmol), K2CO3 
(1.87 g, 13.5 mmol), tert-butyl acrylate (1.73 g, 13.5 mmol), and 10% Pd/C (0.335 g, 0.315 
mmol) in DMF (18 mL).  The stirred mixture was heated at 130 °C for 4 h, cooled to room 
temperature, and filtered through a pad of Celite, followed by rinsing the pad with Et2O (180 
mL).  Water (180 mL) was added to the filtrate, the organic layer was removed, and the aqueous 
layer was extracted with Et2O (3 x 180 mL).  The combined organic layers were washed with 
water (3 x 180 mL) and brine (180 mL), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Column chromatography (3:1 hexanes:EtOAc) afforded the title compound (2.83 g, 
85%) as a bright yellow-green solid, mp 67-68 °C:  
1
H NMR (300 MHz, CDCl3)  8.00 (d, J = 
15.9 Hz, 1H), 7.27 (d, J = 9.0 Hz, 2H), 7.09 (dd, J = 7.8 Hz, 1.2 Hz, 1H), 6.88 (t, J = 8.1 Hz, 
1H), 6.86 (d, J = 8.7 Hz, 2H), 6.81 (dd, J = 7.8 Hz, 1.2 Hz, 1H), 6.30 (d, J = 15.9 Hz, 1H), 4.29 
(br s, 1H), 4.16 (s, 2H), 3.81 (s, 3H), 3.79 (s, 3H), 1.53 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  
166.3, 158.6, 150.9, 141.0, 138.5, 132.1, 128.9 (2C), 125.9, 120.8, 119.8, 119.5, 113.6 (2C), 
111.0, 79.9, 55.6, 54.9, 54.2, 28.0 (3C); FTIR (thin film, CHCl3, cm
-1
) 3359, 2976, 2935, 2835, 
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1701, 1628, 1581, 1513, 1456, 1243, 1147, 1078, 1036, 983, 852, 824, 759; HRMS (ESI) calcd 
for C22H27NNaO4 [M + Na]
+
: 392.1838, found: 392.1832. 
 
NH
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Ot -Bu
O
 
(E)-tert-Butyl 3-(3,5-dimethyl-2-(4-methylphenylsulfonamido)phenyl)acrylate (5.26d):  In a 
round-bottom flask fitted with a reflux condenser were combined 5.23 (2.01 g, 5.00 mmol), 
K2CO3 (1.04 g, 7.50 mmol), tert-butyl acrylate (0.961 g, 7.50 mmol), and 10% Pd/C (0.186 g, 
0.175 mmol) in DMF (10 mL).  The stirred mixture was heated at 140 °C for 1 h, cooled to room 
temperature and filtered through a pad of Celite, followed by rinsing the pad with Et2O (100 
mL).  Water (100 mL) was added to the filtrate, the organic layer was removed, and the aqueous 
layer was extracted with Et2O (3 x 100 mL).  The combined organic layers were washed with 
water (3 x 100 mL) and brine (100 mL), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Column chromatography (3:1 hexanes:EtOAc) afforded the title compound (1.80 g, 
90%) as a white solid, mp 150-152 °C:  
1
H NMR (300 MHz, CDCl3)  7.52 (d, J = 8.1 Hz, 2H), 
7.39 (d, J = 15.9 Hz, 2H), 7.18 (s, 1H), 7.17 (d, J = 7.8 Hz, 2H), 7.09 (s, 1H), 6.49 (s, 1H), 5.99 
(d, J = 15.9 Hz, 2H), 2.38 (s, 3H), 2.31 (s, 3H), 2.28 (s, 3H), 1.49 (s, 9H); 
13
C NMR (75 MHz, 
CDCl3)  165.8, 143.5, 139.3, 139.0, 137.9, 136.3, 133.9, 133.6, 130.5, 129.6 (2C), 127.5 (2C), 
125.2, 120.5, 80.3, 28.1 (3C), 21.6, 21.0, 18.8; FTIR (thin film, CHCl3, cm
-1
) 3256 (broad), 
2978, 2928, 1691, 1633, 1331, 1258, 1160, 1092, 982, 899, 855, 814, 756; HRMS (ESI) calcd 
for C22H27NNaO4S [M + Na]
+
: 424.1559, found: 424.1542. 
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(E)-tert-Butyl-3-(2-(4-methoxybenzylamino)-5-methyl-3-(trimethylsilyl)phenyl)acrylate 
(5.26e):  In a round-bottom flask fitted with a reflux condenser were combined 5.24 (3.40 g, 8.00 
mmol), K2CO3 (1.54 g, 12.0 mmol), tert-butyl acrylate (1.54 g, 12.0 mmol), and 10% Pd/C 
(0.298 g, 0.280 mmol) in DMF (16 mL).  The stirred mixture was heated at 130 °C for 8 h, 
cooled to room temperature and filtered through a pad of Celite, followed by rinsing the pad with 
Et2O (160 mL).  Water (160 mL) was added to the filtrate, the organic layer was removed, and 
the aqueous layer was extracted with Et2O (3 x 160 mL).  The combined organic layers were 
washed with water (3 x 160 mL) and brine (160 mL), dried over MgSO4, filtered, and 
concentrated by rotary evaporation.  Column chromatography (10:1 pentane:Et2O) afforded the 
title compound (2.62 g, 77%) as a bright yellow-green oil:  
1
H NMR (300 MHz, CDCl3)  8.06 
(d, J = 16.2 Hz, 1H), 7.38 (d, J = 8.7 Hz, 2H), 7.37 (s, 1H), 7.21 (d, J = 1.5 Hz, 1H), 6.31 (d, J = 
16.2 Hz, 1H), 4.02 (br d, J = 5.1 Hz, 2H), 3.83 (s, 3H), 3.37 (br m, 1H), 2.32 (s, 3H), 1.53 (s, 
9H), 0.30 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  166.5, 158.9, 151.1, 141.8, 137.5, 131.8, 131.6, 
131.4, 129.9, 129.4 (2C), 127.5, 119.8, 113.9 (2C), 80.0, 56.0, 55.2, 28.2 (3C), 20.7, 0.2 (3C); 
FTIR (neat, cm
-1
) 3391, 2955, 2836, 1705, 1629, 1514, 1455, 1320, 1250, 1152, 1037, 910, 883, 
837, 734; LRMS (EI) m/z 425 (M
+
, 15), 369 (12), 309 (8), 216 (8), 121 (100); HRMS (EI) calcd 
for C25H35NO3Si: 425.2386, found: 425.2389. 
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(E)-tert-Butyl 3-(3-bromo-2-(4-methoxybenzylamino)-5-methylphenyl)acrylate (5.26f):  To a 
stirred solution of o-iodoaniline 5.25 (1.73 g, 4.00 mmol) in DMF (20. mL) were added Bu4NBr 
(1.29 g, 4.00 mmol), KOAc (1.18 g, 12.0 mmol), Pd(OAc)2 (0.180 g, 0.80 mmol), and crushed 
activated 4Å molecular sieves (~2 g).  Finally, tert-butyl acrylate (2.56 g, 20.0 mmol) was added, 
and the reaction mixture was stirred at room temperature for 2 days.  The mixture was vacuum 
filtered through a Celite pad, and the pad was rinsed with Et2O (200 mL).  The filtrate was 
washed with saturated aqueous NaHCO3 solution (200 mL), water (3 x 200 mL), and brine (200 
mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Gradient column 
chromatography (hexanes to 10:1 hexanes:EtOAc) furnished the title compound (1.40 g, 81%) as 
a bright yellow oil:  
1
H NMR (300 MHz, CDCl3)  7.97 (d, J = 15.9 Hz, 1H), 7.34 (d, J = 1.5 Hz, 
1H), 7.29 (d, J = 8.4 Hz, 2H), 7.25 (s, 1H), 6.87 (d, J = 8.7 Hz, 2H), 6.31 (d, J = 15.9 Hz, 1H), 
4.07 (d, J = 6.6 Hz, 2H), 3.97 (br t, J = 6.6 Hz, 1H), 3.82 (s, 3H), 2.28 (s, 3H), 1.54 (s, 9H); 
13
C 
NMR (75 MHz, CDCl3)  166.1, 158.9, 143.5, 140.9, 134.0, 132.7, 131.5, 129.4 (2C), 128.4, 
128.0, 120.8, 118.1, 113.8 (2C), 80.4, 55.2, 54.6, 28.2 (3C), 20.3; FTIR (neat, cm
-1
) 3344, 2975, 
2932, 2835, 1705, 1631, 1611, 1513, 1460, 1321, 1249, 1150, 1036, 980, 854, 828, 736; HRMS 
(ESI) calcd for C22H26
79
BrNNaO3 [M + Na]
+
: 454.0994, found: 454.0996. 
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(E)-2-(4-Bromostyryl)-N-(4-methoxybenzyl)-4,6-dimethylaniline (5.26g):  In a round-bottom 
flask fitted with a reflux condenser were combined 5.20 (1.84 g, 5.00 mmol), K2CO3 (1.04 g, 
7.50 mmol), 4-bromostyrene (1.37 g, 7.50 mmol), and 10% Pd/C (0.186 g, 0.175 mmol) in DMF 
(10 mL).  The stirred mixture was heated at 130 °C for 2 h, cooled to room temperature and 
filtered through a pad of Celite, followed by rinsing the pad with Et2O (100 mL).  Water (100 
mL) was added to the filtrate, the organic layer was removed, and the aqueous layer was 
extracted with Et2O (3 x 100 mL).  The combined organic layers were washed with water (3 x 
100 mL) and brine (100 mL), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Gradient column chromatography (hexanes to 6:1 hexanes:EtOAc) gave the title 
compound (0.602 g, 29%) as a bright yellow solid, mp 63-65 °C:  
1
H NMR (300 MHz, CDCl3)  
7.48 (d, J = 8.4 Hz, 2H), 7.47 (d, J = 15.9 Hz, 1H), 7.35 (d, J = 8.7 Hz, 2H), 7.29 (s, 1H), 7.26 
(d, J = 8.7 Hz, 2H), 6.95 (d, J = 16.2 Hz, 1H), 6.95 (s, 1H), 6.89 (d, J = 8.4 Hz, 2H), 4.13 (s, 2H), 
3.82 (s, 3H), 2.35 (s, 3H), 2.21 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  158.8, 143.2, 136.9, 131.6 
(2C), 131.5, 131.1, 129.9, 129.7, 129.0 (2C), 127.8 (2C), 127.3, 127.2, 125.3, 120.8, 113.9 (2C), 
55.2, 54.1, 20.8, 17.9; FTIR (thin film, CHCl3, cm
-1
) 3363, 3001, 2912, 2834, 1610, 1511, 1487, 
1246, 1175, 1072, 1035, 1007, 977, 908, 811, 732; HRMS (ESI) calcd for C24H25NO
79
Br [M + 
H]
+
: 422.1120, found: 422.1133. 
 
  234 
NH
PMB
CN
 
(E)-3-(2-(4-Methoxybenzylamino)-3,5-dimethylphenyl)acrylonitrile (5.26h):  To a stirred 
solution of 5.20 (1.84 g, 5.00 mmol) in DMF (25 mL) were added Bu4NBr (1.61 g, 5.00 mmol), 
KOAc (1.47 g, 15.0 mmol), Pd(OAc)2 (0.112 g, 0.50 mmol), and crushed activated 4Å molecular 
sieves (~2.5 g).  Finally, acrylonitrile (1.33 g, 25.0 mmol) was added, and the reaction mixture 
was heated at 80 °C for 8 h.  The mixture was cooled to room temperature, diluted with Et2O 
(250 mL), and filtered through Celite, rinsing with Et2O (25 mL).  The filtrate was washed with 
saturated aqueous NaHCO3 solution (250 mL), water (3 x 250 mL), and brine (250 mL), dried 
over MgSO4, filtered, and concentrated by rotary evaporation.  Column chromatography (4:1 
hexanes:EtOAc) afforded the title compound (0.660 g, 45%) as a bright yellow-green oil, 
containing ~5% of an inseparable impurity by 
1
H NMR:  
1
H NMR (300 MHz, CDCl3)  7.78 (d, 
J = 16.8 Hz, 1H), 7.17 (d, J = 8.7 Hz, 2H), 7.10 (s, 1H), 7.02 (s, 1H), 6.87 (d, J = 8.7 Hz, 2H), 
5.86 (d, J = 16.8 Hz, 1H), 4.01 (br s, 2H), 3.82 (s, 3H), 3.27 (br s, 1H), 2.29 (s, 3H), 2.09 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  159.1, 148.8, 144.5, 134.1, 131.9, 131.8, 130.4, 129.1 (2C), 126.4, 
125.6, 119.0, 114.1 (2C), 95.1, 55.3, 55.2, 20.6, 17.7; FTIR (neat, cm
-1
) 3362, 3011, 2933, 2836, 
2214, 1610, 1512, 1475, 1248, 1175, 1033, 982, 822, 755; HRMS (ESI) calcd for C19H21N2O [M 
+ H]
+
: 293.1654, found: 293.1678. 
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N-(4-Methoxybenzyl)-2,4-dimethyl-6-(2-methylprop-1-enyl)aniline (5.26i):  To a stirred 
solution of 2-methyl-1-propenylmagnesium bromide (7.17 g, 45.0 mmol) in THF (90. mL) at 
room temperature was added ZnCl2 (6.13 g, 45.0 mmol) dropwise via syringe over 15 min.  The 
mixture was stirred for 2 h, solid Pd(dppf)Cl2•CH2Cl2 (0.184 g, 0.225 mmol) was added all at 
once, and the mixture was stirred an additional 5 min.  5.20 (1.65 g, 4.50 mmol) in THF (20 mL) 
was added dropwise via syringe, the reaction mixture was stirred for 2.5 h at rt, cooled to 0 °C, 
and saturated aqueous NH4Cl solution (200 mL) was added to quench the reaction.  The mixture 
was extracted with Et2O (3 x 200 mL), and the combined organic layers were washed with brine 
(200 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Column 
chromatography (10:1 hexanes:EtOAc) afforded the title compound (1.30 g, 98%) as a light 
yellow oil:  
1
H NMR (300 MHz, CDCl3)  7.24 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 
6.85 (s, 1H), 6.79 (s, 1H), 6.15 (s, 1H), 4.03 (s, 2H), 3.81 (s, 3H), 3.33 (br s, 1H), 2.26 (s, 3H), 
2.25 (s, 3H), 1.88 (d, J = 1.5 Hz, 3H), 1.73 (d, J = 1.2 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  
158.5, 142.8, 135.3, 132.7, 130.3, 129.9, 129.8, 128.9 (2C), 128.7, 128.5, 122.9, 113.5 (2C), 
54.8, 52.2, 25.8, 20.5, 19.2, 18.2; FTIR (neat, cm
-1
) 3369, 2911, 1611, 1512, 1475, 1247, 1174, 
1036, 861, 823, 737; LRMS (EI) m/z 295 (M
+
, 10), 252 (9), 174 (37), 121 (100); HRMS (EI) 
calcd for C20H25NO: 295.1936, found: 295.1925. 
 
General acylation procedure (compounds 5.27a-i):  To a stirred solution of 5.26a-i (1.0 
equiv.) in CH2Cl2 (10 mL/mmol = X mL) at 0 °C was added Et3N (2.0 equiv.) all at once, 
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followed by chloroacetyl chloride (1.5 equiv.) dropwise via syringe.  The mixture was stirred at 0 
°C until completion, at which point saturated aqueous NH4Cl solution (X mL) was added.  The 
mixture was extracted with CH2Cl2 (3 x X mL), and the combined organic layers were washed 
with brine (X mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  The 
crude residue was subjected to column chromatography, using the appropriate eluent, to furnish 
the desired -Cl amide 5.27a-i. 
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rac-(E)-tert-Butyl 3-(2-(2-chloro-N-methylacetamido)-3,5-dimethylphenyl)acrylate (5.27a):  
Aniline 5.26a (1.05 g, 4.00 mmol) was reacted according to the general procedure, and the 
reaction was complete after 2 h.  After workup, column chromatography (2:1 hexanes:EtOAc) 
provided the title compound (1.21 g, 90%) as a white solid, mp 87 °C, as a mixture of amide 
rotamers in a 19:1 ratio:  
1
H NMR (300 MHz, CDCl3) Major rotamer  7.48 (d, J = 15.9 Hz, 1H), 
7.35 (s, 1H), 7.16 (s, 1H), 6.36 (d, J = 15.9 Hz, 1H), 3.69 (d, J = 13.5 Hz, 1H), 3.64 (d, J = 13.5 
Hz, 1H), 3.21 (s, 3H), 2.36 (s, 3H), 2.22 (s, 3H), 1.52 (s, 9H); minor rotamer  7.52 (d, J = 15.9 
Hz, 1H), 7.35 (s, 1H), 7.12 (s, 1H), 6.35 (d, J = 15.9 Hz, 1H), 4.31 (d, J = 12.0 Hz, 1H), 4.23 (d, 
J = 12.0 Hz, 1H), 3.34 (s, 3H), 2.33 (s, 3H), 2.19 (s, 3H), 1.52 (s, 9H); 
13
C NMR (75 MHz, 
CDCl3)  166.2, 165.2, 138.9, 137.22, 137.17, 136.0, 133.8, 132.3, 125.8, 123.4, 80.6, 41.3, 36.0, 
27.9 (3C), 20.8, 17.2; FTIR (thin film, CHCl3, cm
-1
) 2978, 2931, 1712, 1475, 1368, 1330, 1256, 
1154, 1110, 983, 855, 755; HRMS (ESI) calcd for C18H24ClNNaO3 [M + Na]
+
: 360.1342, found: 
360.1325. 
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rac-(E)-tert-Butyl-3-(2-(2-chloro-N-(4-methoxybenzyl)acetamido)-3,5-dimethylphenyl) 
acrylate (5.27b):  Aniline 5.26b (1.84 g, 7.00 mmol) was reacted according to the general 
procedure, and the reaction was complete after 3 h.  After workup, column chromatography (3:1 
hexanes:EtOAc) provided the title compound (3.01 g, 97%) as a yellow oil:  
1
H NMR (300 MHz, 
CDCl3)  7.12 (d, J = 15.9 Hz, 2H), 7.09 (s, 1H), 7.07 (d, J = 8.4 Hz, 2H), 6.73 (d, J = 8.7 Hz, 
2H), 6.14 (d, J = 15.9 Hz, 2H), 4.87 (d, J = 13.8 Hz, 1H), 4.58 (d, J = 13.5 Hz, 1H), 3.76 (s, 3H), 
3.69 (d, J = 13.8 Hz, 1H), 3.64 (d, J = 13.8 Hz, 1H), 2.35 (s, 3H), 1.93 (s, 3H), 1.49 (s, 9 H); 
13
C 
NMR (75 MHz, CDCl3)  165.6, 164.7, 159.0, 138.6, 137.4, 136.3, 135.1, 133.6, 132.8, 131.1 
(2C), 127.1, 125.4, 122.2, 113.3 (2C), 80.0, 54.6, 52.0, 41.6, 27.6 (3C), 20.7, 17.2; FTIR (neat, 
cm
-1
) 2977, 2933, 2837, 1708, 1667, 1513, 1469, 1327, 1248, 1152, 1035, 984, 851, 792, 733; 
HRMS (ESI) calcd for C25H30ClNNaO4 [M + Na]
+
: 466.1761, found: 466.1730. 
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rac-(E)-t-Butyl 3-(2-(2-chloro-N-(4-methoxybenzyl)acetamido)-3-methoxyphenyl) acrylate 
(5.27c):  Aniline 5.26c (1.35 g, 3.65 mmol) was reacted according to the general procedure, and 
the reaction was complete after 1 h.  After workup, column chromatography (2:1 
hexanes:EtOAc) provided the title compound (1.39 g, 85%) as a yellow oil:  
1
H NMR (300 MHz, 
CDCl3)  7.33 (t, J = 8.1 Hz, 1H), 7.24 (d, J = 16.8 Hz, 1H), 7.18 (d, J = 7.8 Hz, 1H), 7.01 (d, J 
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= 8.4 Hz, 2H), 6.91 (d, J = 8.4 Hz, 1H), 6.69 (d, J = 8.4 Hz, 2H), 6.18 (d, J = 15.9 Hz, 1H), 4.85 
(d, J = 13.8 Hz, 1H), 4.63 (d, J = 13.8 Hz, 1H), 3.76 (d, J = 15.3 Hz, 1H), 3.74 (s, 3H), 3.71 (d, J 
= 14.7 Hz, 1H), 3.64 (s, 3H), 1.50 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  166.7, 165.1, 159.0, 
155.5, 137.3, 134.6, 131.2 (2C), 129.9, 127.8, 127.6, 123.3, 118.8, 113.3 (2C), 112.7, 80.7, 55.7, 
55.0, 51.8, 42.5, 27.8 (3C); FTIR (neat, cm
-1
) 2977, 2937, 2838, 2249, 1708, 1674, 1578, 1513, 
1476, 1392, 1249, 1153, 1070, 1035, 984, 913, 849, 790, 733; HRMS (ESI) calcd for 
C24H28ClNNaO5 [M + Na]
+
: 468.1554, found: 468.1530. 
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rac-(E)-tert-Butyl 3-(2-(2-chloro-N-tosylacetamido)-3,5-dimethylphenyl)acrylate (5.27d):  
Aniline 5.26d (1.20 g, 3.00 mmol) was reacted according to the general procedure, and the 
reaction was complete after 1 h.  After workup, column chromatography (4:1 hexanes:EtOAc) 
provided the title compound (1.27 g, 89%) as a white solid, mp 170 °C (decomp.):  
1
H NMR 
(300 MHz, CDCl3)  8.02 (d, J = 8.4 Hz, 2H), 7.43 (s, 1H), 7.34 (d, J = 8.4 Hz, 2H), 7.27 (d, J = 
15.9 Hz, 1H), 7.24 (s, 1H), 6.38 (d, J = 15.9 Hz, 1H), 3.66 (s, 2H), 2.46 (s, 3H), 2.404 (s, 3H), 
2.396 (s, 3H), 1.47 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  165.0, 164.7, 145.5, 140.8, 139.4, 
137.2, 134.3, 134.1 (2C, accidental isochrony), 130.6, 130.2 (2C), 129.3 (2C), 125.9, 123.9, 80.6, 
43.2, 27.8 (3C), 21.6, 21.1, 18.7; FTIR (thin film, CHCl3, cm
-1
) 2979, 1709, 1367, 1307, 1264, 
1170, 1085, 983, 886, 814, 757; HRMS (ESI) calcd for C24H28ClNNaO5S: [M + Na]
+
: 500.1274, 
found: 500.1273. 
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rac-(E)-t-Butyl 3-(2-(2-chloro-N-(4-methoxybenzyl)acetamido)-5-methyl-3-(trimethylsilyl) 
phenyl)acrylate (5.27e):  Aniline 5.26e was reacted according to the general procedure, and the 
reaction was complete after 7 h.  After workup, column chromatography (5:1 hexanes:EtOAc) 
provided the title compound (2.50 g, 99%) as a white solid, mp 69-71 °C: 
1
H NMR (300 MHz, 
CDCl3)  7.47 (d, J = 1.8 Hz, 1H), 7.34 (s, 1H), 7.03 (d, J = 8.4 Hz, 2H), 6.71 (d, J = 8.4 Hz, 
2H), 6.68 (d, J = 15.9 Hz, 1H), 5.92 (d, J = 15.9 Hz, 1H), 5.76 (d, J = 13.5 Hz, 1H), 3.76 (d, J = 
11.7 Hz, 3.74 (s, 3H), 3.73 (d, J = 14.1 Hz, 1H), 3.67 (d, J = 13.8 Hz, 1H), 2.39 (s, 3H), 1.44 (s, 
9H), 0.35 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  165.1, 164.5, 159.1, 140.8, 139.3, 139.2, 138.1, 
137.5, 133.6, 131.3 (2C), 128.5, 126.7, 121.9, 113.5 (2C), 79.9, 54.7, 54.1, 42.2, 27.7 (3C), 20.9, 
0.1 (t, JSi-C = 26.3 Hz, 3C); FTIR (thin film, CHCl3, cm
-1
) 2977, 1707, 1670, 1512, 1437, 1320, 
1252, 1155, 982, 874, 839, 757; HRMS (ESI) calcd for C27H36ClNNaO4Si [M + Na]
+
: 524.2000, 
found: 524.1974. 
 
N
Br
PMB
Ot-Bu
O
O
Cl
 
rac-(E)-tert-Butyl 3-(3-bromo-2-(2-chloro-N-(4-methoxybenzyl)acetamido)-5-methylphenyl) 
acrylate (5.27f):  Aniline 5.26f (2.34 g, 5.50 mmol) was reacted according to the general 
procedure, and the reaction was complete after 2 h.  After workup, column chromatography (3:1 
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hexanes:EtOAc) provided the title compound (2.51 g, 90%) as a white solid, mp 117 °C:  
1
H 
NMR (300 MHz, CDCl3)  7.53 (d, J = 1.2 Hz, 1H), 7.31 (d, J = 1.2 Hz, 1H), 7.03 (d, J = 8.7 
Hz, 2H), 6.97 (d, J = 15.9 Hz, 1H), 6.71 (d, J = 8.7 Hz, 2H), 6.01 (d, J = 15.9 Hz, 1H), 5.38 (d, J 
= 13.8 Hz, 1H), 4.21 (d, J = 14.1 Hz, 1H), 3.78 (d, J = 13.8 Hz, 1H), 3.75 (s, 3H), 3.66 (d, J = 
14.1 Hz, 1H), 2.38 (s, 3H), 1.48 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  165.6, 164.5, 159.3, 
140.8, 136.9, 135.9, 135.4, 134.9, 131.5 (2C), 127.0, 126.7, 124.6, 123.3, 113.6 (2C), 80.6, 54.9, 
51.9, 42.3, 27.9 (3C), 20.8; FTIR (thin film, CHCl3, cm
-1
) 3007, 2978, 2934, 1709, 1513, 1459, 
1323, 1249, 1152, 1036, 983, 851, 826, 756; HRMS (ESI) calcd for C24H27
79
BrClNNaO4 [M + 
Na]
+
: 530.0710, found: 530.0761. 
 
N
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O
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rac-(E)-N-(2-(4-Bromostyryl)-4,6-dimethylphenyl)-2-chloro-N-(4-methoxybenzyl)acetamide 
(5.27g):  Aniline 5.26g (0.472 g, 1.12 mmol) was reacted according to the general procedure, 
and the reaction was complete after 2 h.  After workup, column chromatography (4:1 
hexanes:EtOAc) provided the title compound (0.498 g, 89%) as a yellow solid, mp 130-131 °C:  
1
H NMR (300 MHz, CDCl3)  7.38 (d, J = 8.4 Hz, 2H), 7.33 (s, 1H), 7.20 (d, J = 8.7 Hz, 2H), 
7.06 (s, 1H), 6.99 (d, J = 8.4 Hz, 2H), 6.81 (d, J = 16.2 Hz, 1H), 6.71 (d, J = 8.7 Hz, 2H), 6.41 
(d, J = 16.2 Hz, 2H), 5.24 (d, J = 13.5 Hz, 1H), 4.24 (d, J = 13.5 Hz, 1H), 3.68 (s, 2H), 3.65 (s, 
3H), 2.38 (s, 3H), 2.08 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  166.5, 159.3, 138.8,136.1, 135.6, 
135.4, 134.9, 132.0, 131.54 (2C), 131.50 (2C), 129.8, 128.2, 128.1 (2C), 124.5, 124.1, 121.7, 
113.7 (2C), 55.0, 52.6, 42.3, 21.2, 17.8; FTIR (thin film, CHCl3, cm
-1
) 3001, 2932, 2835, 1667, 
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1512, 1488, 1394, 1325, 1303, 1247, 1176, 1035, 1008, 965, 910, 849, 810, 732; HRMS (ESI) 
calcd for C26H25
79
BrClNNaO2 [M + Na]
+
: 520.0655, found: 520.0690. 
 
N
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rac-(E)-2-Chloro-N-(2-(2-cyanovinyl)-4,6-dimethylphenyl)-N-(4-methoxybenzyl)acetamide 
(5.27h):  Aniline 5.26h (0.731 g, 2.50 mmol) was reacted according to the general procedure, 
and the reaction was complete after 5 h.  After workup, column chromatography (2:1 
hexanes:EtOAc) provided the title compound (0.687 g, 74%) as a white solid, mp 159-160 °C:  
1
H NMR (300 MHz, CDCl3)  7.22 (s, 1H), 7.16 (s, 1H), 7.06 (d, J = 8.4 Hz, 2H), 6.80 (d, J = 
8.7 Hz, 2H), 6.70 (d, J = 16.5 Hz, 1H), 5.56 (d, J = 16.8 Hz, 1H), 5.31 (d, J = 13.5 Hz, 1H), 4.13 
(d, J = 13.5 Hz, 1H), 3.83 (s, 3H), 3.64 (d, J = 13.2 Hz, 1H), 3.59 (d, J = 13.5 Hz, 1H), 2.37 (s, 
3H), 2.10 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  166.0, 159.7, 144.8, 139.4, 136.9, 135.2, 135.1, 
132.2, 131.4 (2C), 127.0, 124.6, 117.4, 114.0 (2C), 97.8, 55.2, 52.2, 41.6, 21.0, 17.6; FTIR (thin 
film, CHCl3, cm
-1
) 3012, 2936, 2837, 2218, 1669, 1612, 1513, 1467, 1392, 1249, 1176, 1111, 
1033, 966, 849, 761; LRMS (EI) m/z 368 (M
+
, 8), 304 (12), 291 (15), 183 (10), 169 (15), 155 
(18), 121 (100), 91 (37), 84 (50); HRMS (EI) calcd for C21H21ClN2O2: 368.1292, found: 
368.1295. 
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rac-2-Chloro-N-(2,4-dimethyl-6-(2-methylprop-1-enyl)phenyl)-N-(4-methoxybenzyl) 
acetamide (5.27i):  Aniline 5.26i (0.886 g, 3.00 mmol) was reacted according to the general 
procedure, and the reaction was complete after 90 min.  After workup, column chromatography 
(4:1 hexanes:EtOAc) provided the title compound (1.09 g, 98%) as a yellow oil:  
1
H NMR (300 
MHz, CDCl3)  7.13 (d, J = 8.4 Hz, 2H), 6.90 (s, 2H), 6.75 (d, J = 8.4 Hz, 2H), 5.60 (s, 1H), 4.74 
(d, J = 13.8 Hz, 1H), 4.62 (d, J = 13.8 Hz, 1H), 3.78 (s, 3H), 3.67 (d, 2H), 2.32 (s, 3H), 1.84 (s, 
3H), 1.72 (s, 6H); 
13
C NMR (75 MHz, CDCl3)  166.1, 158.9, 137.7, 137.4, 136.5, 135.5, 134.7, 
131.1 (2C), 130.1, 129.5, 128.4, 121.2, 113.3 (2C), 54.9, 51.7, 41.9, 26.2, 20.8, 19.0, 17.4; FTIR 
(neat, cm
-1
) 2933, 2836, 1667, 1512, 1441, 1247, 1176, 1110, 1035, 915, 849, 822, 791, 733; 
HRMS (ESI) calcd for C22H26ClNNaO2 [M + Na]
+
: 394.1550, found: 394.1529. 
 
General procedure for Finkelstein reactions (Compounds 5.17a-i):  To a solution of -Cl 
amide 5.27a-i (1.0 equiv.) in acetone (10 mL/mmol = X mL) was added NaI (10.0 equiv.) all at 
once, and the reaction mixture was stirred at room temperature overnight (16-20 h).  The mixture 
was diluted with Et2O (10X mL) and washed with 10% aqueous Na2S2O3 (3 x X mL), dried over 
MgSO4, filtered, and concentrated by rotary evaporation.  The crude residue was subjected to 
column chromatography, using the appropriate eluent, to furnish the desired product. 
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(E)-t-Butyl 3-(2-(2-iodo-N-methylacetamido)-3,5-dimethylphenyl)acrylate (5.17a): Chloride 
rac-5.27a (1.01 g, 3.00 mmol) was reacted according to the general procedure.  Column 
chromatography (2:1 hexanes:EtOAc) furnished rac-5.17a (1.20 g, 93%) as a yellow oil in a 
14:1 ratio of amide rotamers.  The racemate was submitted to preparative chiral HPLC 
separation ((S,S)-Whelk-O1, 80:20 hexanes:i-PrOH), first eluting enantiomer []D
23 –153, 85/15 
er (c 6.7 mg/mL, CHCl3), second eluting enantiomer []D
23
 +131, 98.5/1.5 er (c 4.7 mg/mL, 
CHCl3):  
1
H NMR (300 MHz, CDCl3) major rotamer  7.55 (d, J = 15.9 Hz, 1H), 7.36 (s, 1H), 
7.15 (s, 1H), 6.35 (d, J = 15.9 Hz, 1H), 3.48 (d, J = 10.2 Hz, 1H), 3.44 (d, J = 10.2 Hz, 1H), 3.17 
(s, 3H), 2.36 (s, 3H), 2.26 (s, 3H), 1.52 (s, 9H); minor rotamer  7.55 (d, J = 15.9 Hz, 1H), 7.31 
(s, 1H), 7.09 (s, 1H), 6.34 (d, J = 15.9 Hz, 1H), 3.96 (d, J = 9.6 Hz, 1H), 3.88 (d, J = 9.6 Hz, 1H), 
3.28 (s, 3H), 2.32 (s, 3H), 2.26 (s, 3H), 1.52 (s, 9H); 
13
C NMR (75 MHz, CDCl3) major rotamer 
only  167.7, 165.1, 138.6, 137.6, 135.6, 133.7, 131.9, 125.7, 123.1, 80.3, 36.2, 27.9, 27.9 (3C), 
20.8, 17.5, −3.7; FTIR (neat, cm-1) 2977, 2930, 2246, 1708, 1662, 1474, 1427, 1367, 1329, 1300, 
1253, 1153, 1096, 983, 916, 855, 732; HRMS (ESI) calcd for C18H24INNaO3 [M + Na]
+
: 
452.0699, found: 452.0661. 
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(E)-tert-Butyl 3-(2-(2-iodo-N-(4-methoxybenzyl)acetamido)-3,5-dimethylphenyl)acrylate  
(5.17b):  Chloride rac-5.27b (2.00 g, 4.50 mmol) was reacted according to the general 
procedure.  Column chromatography (2:1 hexanes:EtOAc) furnished rac-5.17b (2.22 g, 92%) as 
a yellow oil.  The racemate was submitted to preparative chiral HPLC separation ((S,S)-Whelk-
O1, 70:30 hexanes:iPrOH), first eluting enantiomer []D
23 –16, 100/0 er (c 16.7 mg/mL, CHCl3), 
second eluting enantiomer []D
23
 +15, 100/0 er (c 9.5 mg/mL, CHCl3):  
1
H NMR (300 MHz, 
CDCl3)  7.27 (s, 1H), 7.19 (d, J = 15.9 Hz, 1H), 7.10 (s, 1H), 7.05 (d, J = 8.7 Hz, 2H), 6.72 (d, J 
= 8.7 Hz, 2H), 6.13 (d, J = 15.9 Hz, 1H), 3.76 (s, 3H), 3.47 (s, 2H), 2.35 (s, 3H), 1.98 (s, 3H), 
1.49 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  167.5, 165.2, 159.2, 138.6, 138.3, 136.5, 136.4, 
133.8, 132.9, 131.4 (2C), 127.5, 125.7, 122.4, 113.6 (2C), 80.4, 55.0, 52.4, 28.0 (3C), 21.0, 18.0, 
−2.5; FTIR (thin film, CHCl3, cm
-1
) 2977, 2933, 2836, 1707, 1655, 1512, 1469, 1368, 1326, 
1303, 1249, 1158, 1036, 984, 912, 852, 732; HRMS (ESI) calcd for C25H30INNaO4 [M + Na]
+
: 
558.1117, found: 558.1071. 
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(E)-t-Butyl 3-(2-(2-Iodo-N-(4-methoxybenzyl)acetamido)-3-methoxyphenyl)acrylate (5.17c):  
Chloride rac-5.27c (0.981 g, 2.20 mmol) was reacted according to the general procedure.  
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Column chromatography (2:1 hexanes:EtOAc) furnished rac-5.17c (1.16 g, 98%) as a yellow oil.  
The racemate was submitted to preparative chiral HPLC separation (Chiralcel OD, 90:10 
hexanes:i-PrOH), first eluting enantiomer []D
23 –27, 99/1 er (c 9.5 mg/mL, CHCl3), second 
eluting enantiomer []D
23
 +28, 99/1 er (c 13.6 mg/mL, CHCl3):  
1
H NMR (300 MHz, CDCl3)  
7.32 (t, J = 7.8 Hz, 1H), 7.30 (d, J = 16.2 Hz, 1H), 7.18 (d, J = 7.8 Hz, 1H), 7.00 (d, J = 8.7 Hz, 
2H), 6.90 (d, J = 8.1 Hz, 1H), 6.69 (d, J = 8.7 Hz, 2H), 6.16 (d, J = 16.2 Hz, 1H), 4.87 (d, J = 
13.8 Hz, 1H), 4.56 (d, J = 13.8 Hz, 1H), 3.74 (s, 3H), 3.67 (s, 3H), 3.50 (s, 2H), 1.50 (s, 9H); 
13
C 
NMR (75 MHz, CDCl3)  168.0, 165.0, 158.8, 155.2, 137.6, 134.1, 131.0 (2C), 129.6, 128.5, 
127.7, 122.7, 118.5, 113.1 (2C), 112.7, 80.3, 55.5, 54.9, 51.6, 27.9, –2.1; FTIR (neat, cm-1) 2976, 
2935, 2837, 1708, 1659, 1577, 1513, 1368, 1248, 1153, 1070, 1035, 983, 849, 913, 849, 800, 
732; HRMS (ESI) calcd for C24H28INNaO5 [M + Na]
+
: 560.0910, found: 560.0901. 
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(E)-tert-Butyl 3-(2-(2-iodo-N-tosylacetamido)-3,5-dimethylphenyl)acrylate (5.17d):  Chloride 
rac-5.27d (0.717 g, 1.50 mmol) was reacted according to the general procedure.  Column 
chromatography (2:1 hexanes:EtOAc) furnished rac-5.17d (0.662 g, 78%) as a white solid, mp 
205 °C (decomp.):  
1
H NMR (300 MHz, CDCl3)  8.00 (d, J = 8.1 Hz, 2H), 7.43 (s, 1H), 7.33 (d, 
J = 8.4 Hz, 2H), 7.33 (d, J = 15.6 Hz, 1H), 7.25 (s, 1H), 6.37 (d, J = 15.9 Hz, 1H), 3.48 (s, 2H), 
2.46 (2 overlapping s, 2 x 3H), 2.41 (s, 3H), 1.47 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  166.7, 
165.0, 145.5, 140.6, 139.6, 137.9, 134.5, 134.3, 134.1, 132.0, 130.4 (2C), 129.4 (2C), 125.9, 
123.7, 80.6, 28.0 (3C), 21.8, 21.2, 19.3, −2.2; FTIR (thin film, CHCl3, cm
-1
) 2978, 1705, 1365, 
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1275, 1171, 1083, 982, 885, 815, 758; HRMS (ESI) calcd for C24H28INNaO5S [M + Na]
+
: 
592.0631, found: 592.0616. 
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(E)-t-Butyl 3-(2-(2-iodo-N-(4-methoxybenzyl)acetamido)-5-methyl-3-(trimethylsilyl)phenyl) 
acrylate (5.17e):  In a round bottom flask equipped with a reflux condenser, chloride rac-5.27e 
(1.51 g, 3.00 mmol) was mixed with NaI (4.50 g, 30.0 mmol) in acetone (30 mL).  The stirred 
mixture was refluxed for 40 h until complete conversion had been achieved (monitored using 
GC).  The mixture was cooled to room temperature, and was worked up according to the general 
procedure.  Column chromatography (5:1 hexanes:EtOAc) furnished rac-5.17e (2.88 g, 96%) as 
a glassy yellow solid, mp 51-53 °C.  The racemate was submitted to preparative chiral HPLC 
separation ((S,S)-Whelk-O1, 70:30 hexanes:i-PrOH), first eluting enantiomer []D
23
 +86, 100/0 
er (c 8.8 mg/mL, CHCl3), second eluting enantiomer []D
23
 –87, 100/0 er (c 12.2 mg/mL, CHCl3-
):  
1
H NMR (300 MHz, CDCl3)  7.47 (d, J = 1.8 Hz, 1H), 7.35 (d, J = 1.8 Hz, 1H), 7.02 (d, J = 
8.7 Hz, 2H), 6.78 (d, J = 15.9 Hz, 1H), 6.70 (d, J = 8.7 Hz, 2H), 5.92 (d, J = 15.9 Hz, 1H), 5.70 
(d, J = 13.5 Hz, 1H), 3.77 (d, J = 13.5 Hz, 1H), 3.74 (s, 3H), 3.55 (d, J = 11.1 Hz, 1H), 3.51 (d, J 
= 11.4 Hz, 1H), 2.39 (s, 3H), 1.45 (s, 9H), 0.36 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  165.5, 
164.3, 158.9, 141.7, 138.9, 137.8, 137.6, 133.2, 131.1 (2C), 128.2, 126.5, 121.3, 113.3 (2C), 
79.5, 54.5, 54.2, 27.6 (3C), 20.8, 0.18 (3C), −0.6; FTIR (thin film, CHCl3, cm
-1
) 2976, 2836, 
1706, 1659, 1512, 1437, 1367, 1320, 1250, 1161, 1109, 1036, 1007, 983, 874, 838, 757; HRMS 
(ESI) calcd for C27H36INNaO4Si [M + Na]
+
: 616.1356, found: 616.1395. 
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(E)-t-Butyl 3-(3-bromo-2-(2-iodo-N-(4-methoxybenzyl)acetamido)-5-methylphenyl) acrylate 
(5.17f):  Chloride rac-5.27f (2.20 g, 4.32 mmol) was reacted according to the general procedure.  
Column chromatography (3:1 hexanes:EtOAc) furnished rac-5.17f (2.35 g, 91%) as a sticky 
yellow semi-solid.  The racemate was submitted to preparative chiral HPLC separation ((S,S)-
Whelk-O1, 70:30 hexanes:i-PrOH), first eluting enantiomer []D
23
 +21, 99/1 er (c 14.4 mg/mL, 
CHCl3), second eluting enantiomer []D
23
 –19, 100/0 er (c 10.9 mg/mL, CHCl3):  
1
H NMR (300 
MHz, CDCl3)  7.50 (d, J = 1.2 Hz, 1H), 7.33 (s, 1H), 7.11 (d, J = 15.9 Hz, 1H), 7.02 (d, J = 8.7 
Hz, 2H), 6.70 (d, J = 8.7 Hz, 2H), 6.01 (d, J = 15.9 Hz, 1H), 5.27 (d, J = 14.1 Hz, 1H), 4.26 (d, J 
= 13.8 Hz, 1H), 3.74 (s, 3H), 3.58 (d, J = 10.8 Hz, 1H), 3.44 (d, J = 10.5 Hz, 1H), 2.38 (s, 3H), 
1.48 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  166.9, 164.3, 159.0, 140.4, 137.3, 135.8, 135.3, 
135.2, 131.2 (2C), 126.8, 126.6, 124.3, 122.7, 113.4 (2C), 80.2, 54.7, 51.8, 27.7 (3C), 20.7, −2.5; 
FTIR (thin film, CHCl3, cm
-1
) 2977, 2932, 2836, 1708, 1665, 1513, 1459, 1368, 1321, 1248, 
1154, 1035, 982, 851, 822, 756; HRMS (ESI) calcd for C24H27
79
BrINNaO4 [M + Na]
+
: 622.0066, 
found: 622.0031. 
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(E)-N-(2-(4-Bromostyryl)-4,6-dimethylphenyl)-2-iodo-N-(4-methoxybenzyl)acetamide 
(5.17g):  Chloride rac-5.27g (0.399 g, 0.800 mmol) was reacted according to the general 
procedure.  Column chromatography (4:1 hexanes:EtOAc) furnished rac-5.17g (0.408 g, 86%) 
as a yellow-orange solid, mp 97-98 °C:  
1
H NMR (300 MHz, CDCl3)  7.39 (d, J = 8.4 Hz, 2H), 
7.34 (s, 1H), 7.17 (d, J = 8.7 Hz, 2H), 7.05 (s, 1H), 7.04 (d, J = 8.4 Hz, 2H), 6.80 (d, J = 16.2 Hz, 
1H), 6.70 (d, J = 8.4 Hz, 2H), 6.51 (d, J = 16.2 Hz, 1H), 5.14 (d, J = 13.5 Hz, 1H), 4.28 (d, J = 
13.5 Hz, 1H), 3.64 (s, 3H), 3.50 (d, J = 10.2 Hz, 1H), 3.46 (d, J = 10.2 Hz, 1H), 2.38 (s, 3H), 
2.10 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  168.1, 159.2, 138.6, 136.0, 135.9, 135.7, 135.0, 
132.0, 131.5 (4C = two overlapping 2C), 129.4, 128.2, 128.1 (2C), 124.7, 124.5, 121.6, 113.7 
(2C), 55.0, 52.6, 21.2, 18.1, −2.1; FTIR (thin film, CHCl3, cm
-1
) 3002, 2933, 2835, 1651, 1512, 
1487, 1386, 1322, 1302, 1249, 1176, 1107, 1073, 1035, 1008, 909, 849, 810, 732; HRMS (ESI) 
calcd for C26H25
79
BrINNaO2 [M + Na]
+
: 612.0011, found: 612.0002. 
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(E)-N-(2-(2-cyanovinyl)-4,6-dimethylphenyl)-2-iodo-N-(4-methoxybenzyl)acetamide 
(5.17h):  To a solution of chloride rac-5.27h (0.619 g, 1.60 mmol) in acetone (65 mL) was added 
NaI (2.40 g, 16.0 mmol) all at once and the reaction mixture was stirred at room temperature 
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overnight.  After 16 h, 10% aqueous Na2S2O3 (65 mL) was added and the mixture was extracted 
with EtOAc (3 x 160 mL).  The combined organic layers were dried over MgSO4, filtered, and 
concentrated by rotary evaporation.  Column chromatography (2:1 hexanes:EtOAc) furnished 
rac-5.17h (0.633 g, 86%) as a white solid, mp 144-145 °C.  The racemate was submitted to 
preparative chiral HPLC separation ((S,S)-Whelk-O1, 80:20 hexanes:EtOAc), first eluting 
enantiomer []D
23
 –0.4, 99/1 er (c 11.2 mg/mL, CHCl3), second eluting enantiomer []D
23
 +0.5, 
99.5/0.5 er (c 43.9 mg/mL, CHCl3):  
1
H NMR (300 MHz, CDCl3)  7.27 (s, 1H), 7.21 (s, 1H), 
7.04 (d, J = 8.7 Hz, 2H), 6.81 (d, J = 16.8 Hz, 1H), 6.80 (d, J = 7.8 Hz, 2H), 5.56 (d, J = 16.5 Hz, 
1H), 5.22 (d, J = 13.5 Hz, 1H), 4.16 (d, J = 13.8 Hz, 1H), 3.82 (s, 3H), 3.44 (d, J = 10.2 Hz, 1H), 
3.39 (d, J = 10.2 Hz, 1H), 2.37 (s, 3H), 2.11 (s, 3H); 
13
C NMR (75 MHz, CDCl3)  167.5, 159.6, 
145.3, 139.1, 136.7, 136.1, 135.2, 131.8, 131.3 (2C), 127.1, 124.6, 117.5, 113.9 (2C), 97.4, 55.2, 
52.2, 21.0, 17.9, −3.2; FTIR (thin film, CHCl3, cm
-1
) 3004, 2934, 2217, 1655, 1512, 1385, 1304, 
1250, 1176, 1107, 1033, 1007, 965, 849, 822, 755; HRMS (ESI) calcd for C21H21IN2NaO2 [M + 
Na]
+
: 483.0545, found: 483.0533. 
 
N
PMB
O
I
 
N-(2,4-Dimethyl-6-(2-methylprop-1-enyl)phenyl)-2-iodo-N-(4-methoxybenzyl)acetamide 
(5.17i):  Chloride rac-5.27i (0.744 g, 2.00 mmol) was reacted according to the general 
procedure.  Column chromatography (4:1 hexanes:EtOAc) furnished rac-5.17i (0.816 g, 88%) as 
a white solid, mp 73-74 °C.  The racemate was submitted to preparative chiral HPLC separation 
((S,S)-Whelk-O1, 80:20 hexanes:i-PrOH), first eluting enantiomer []D
23–4.4, 99/1 er (c 2.8 
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mg/mL, CHCl3), second eluting enantiomer []D
23
 +4.2, 100/0 er (c 5.2 mg/mL, CHCl3):  
1
H 
NMR (300 MHz, CDCl3)  7.11 (d, J = 8.7 Hz, 2H), 6.90 (br s, 2H), 6.74 (d, J = 8.7 Hz, 2H), 
5.69 (s, 1H), 4.70 (d, J = 13.5 Hz, 1H), 4.61 (d, J = 13.8 Hz, 1H), 3.77 (s, 3H), 3.47 (s, 2H), 2.32 
(s, 3H), 1.89 (s, 3H), 1.72 (s, 6H); 
13
C NMR (75 MHz, CDCl3)  167.5, 158.9, 137.4, 137.2, 
136.3, 135.8, 135.3, 131.1 (2C), 130.1, 129.4, 128.4, 121.6, 113.3 (2C), 54.9, 51.7, 26.3, 20.9, 
19.1, 17.8, −1.6; FTIR (thin film, CHCl3, cm
-1
) 2931, 2857, 2835, 1655, 1612, 1512, 1440, 1385, 
1303, 1247, 1176, 1107, 1035, 849, 835, 822, 756; HRMS (ESI) calcd for C22H26INNaO2 [M + 
Na]
+
: 486.0906, found: 486.0867. 
 
MeO
N
PMB
Ot-Bu
O
O
Br
 
(E)-t-Butyl 3-(2-(2-bromo-N-(4-methoxybenzyl)propanamido)-3-methoxyphenyl) acrylate 
(5.34a and 5.34b):  To a stirred solution of 5.26c (1.11 g, 3.00 mmol) and Et3N (0.455 g, 4.50 
mmol) in THF (6.0 mL) at 0 °C was added 2-bromopropionyl bromide (0.971 g, 4.50 mmol) 
dropwise via syringe.  The mixture was stirred at 0 °C for 30 min, and saturated aqueous NH4Cl 
(15 mL) was added.  The mixture was extracted with Et2O (3 x 30 mL), and the combined 
organic layers were washed with brine (30 mL), dried over MgSO4, filtered, and concentrated by 
rotary evaporation.  Column chromatography (3:1 hexanes:EtOAc) provided two diastereomers.  
The first eluting diastereomer, rac-5.34a, was isolated (0.497 g, 33%) as a clear, pale yellow oil.  
This racemate was submitted to preparative chiral HPLC separation ((S,S)-Whelk-O1, 75:25 
hexanes:i-PrOH), first eluting enantiomer []D
23
 +47, 98/2 er (c 13.4 mg/mL, CHCl3), second 
eluting enantiomer []D
23
 –48, 99/1 er (c 15.1 mg/mL, CHCl3): 
1
H NMR (300 MHz, CDCl3)  
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7.34 (t, J = 8.1 Hz, 1H), 7.12 (d, J = 7.8 Hz, 1H), 7.03 (d, J = 8.7 Hz, 2H), 7.00 (d, J = 8.7 Hz, 
2H), 6.90 (d, J = 15.9 Hz, 1H), 6.69 (d, J = 8.7 Hz, 1H), 5.43 (d, J = 15.9 Hz, 1H), 4.15 (d, J = 
13.8 Hz, 1H), 4.01 (q, J = 6.6 Hz, 1H), 3.84 (s, 3H), 3.73 (s, 3H), 1.69 (d, J = 6.6 Hz, 3H), 1.46 
(s, 9H); 
13
C NMR (75 MHz, CDCl3)  169.7, 165.0, 159.1, 155.7, 137.3, 134.7, 131.3 (2C), 
129.7, 128.0, 127.9, 123.2, 118.0, 113.5 (2C), 113.1, 80.5, 55.7, 55.0, 51.3, 39.1, 28.0 (3C), 22.1; 
FTIR (neat, cm
-1
) 2975, 2936, 2838, 2249, 1708, 1666, 1612, 1578, 1513, 1477, 1394, 1272, 
1248, 1175, 1154, 1072, 1036, 984, 912, 849, 800, 733; HRMS (ESI) calcd for C25H30BrNNaO5 
[M + Na]
+
: 526.1205, found: 526.1214.  The second eluting diastereomer, rac-5.34b, was 
isolated (0.983 g, 65%) as a clear, colorless oil.  This racemate was submitted to preparative 
chiral HPLC separation ((S,S)-Whelk-O1, 70:30 hexanes:i-PrOH), first eluting enantiomer []D
23
 
+66, 100/0 er (c 9.9 mg/mL, CHCl3), second eluting enantiomer []D
23
 –67, 100/0 er (c 6.3 
mg/mL, CHCl3):  
1
H NMR (300 MHz, CDCl3)  7.55 (d, J = 15.9 Hz, 1H), 7.31 (t, J = 8.1 Hz, 
1H), 7.23 (d, J = 8.1 Hz, 1H), 6.98 (d, J = 8.7 Hz, 2H), 6.85 (d, J = 7.8 Hz, 1H), 6.68 (d, J = 8.4 
Hz, 2H), 6.20 (d, J = 15.9 Hz, 1H), 4.82 (d, J = 13.8 Hz, 1H), 4.56 (d, J = 13.8 Hz, 1H), 4.11 (q, 
J = 6.6 Hz, 1H), 3.74 (s, 3H), 3.53 (s, 3H), 1.74 (d, J = 6.6 Hz, 3H), 1.51 (s, 9H); 
13
C NMR (75 
MHz, CDCl3)  170.8, 165.2, 158.9, 155.3, 138.2, 134.4, 131.0 (2C), 129.5, 128.3, 127.9, 122.6, 
119.0, 113.1 (2C), 112.3, 80.3, 55.5, 54.9, 51.7, 39.6, 27.9 (3C), 21.7; FTIR (neat, cm
-1
) 2976, 
2934, 2839, 1708, 1670, 1577, 1513, 1475, 1394, 1368, 1271, 1248, 1152, 1068, 984, 849, 801, 
732; HRMS (ESI) calcd for C25H30BrNNaO5 [M + Na]
+
: 526.1205, found: 526.1206. 
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HO
O
Br  
rac-2-Bromopent-4-enoic acid (5.39):  To a stirred solution of NaBr (6.47 g, 62.9 mmol) in 
aqueous HBr (0.75 M, 60 mL) at −15 °C was added, in one portion, NaNO2 (1.52 g, 22.1 mmol).  
After stirring at this temperature for 15 min, (±)-2-amino-4-pentenoic acid (1.96 g, 17.0 mmol) 
was added in one portion.  The reaction mixture was stirred at −15 °C for 1 h, 0 °C for 1 h, and at 
room temperature for 2 h, and was then extracted with EtOAc (3 x 125 mL).  The combined 
organic layers were dried over MgSO4, filtered, and concentrated by rotary evaporation.  Column 
chromatography (50:50:1 hexanes:EtOAc:AcOH) provided the title compound (1.75 g, 58%) as 
a mobile red liquid:  
1
H NMR (300 MHz, CDCl3)  5.79 (ddt, J = 16.8 Hz, 10.2 Hz, 6.9 Hz, 1H), 
5.23 (d, J = 16.5 Hz, 1H), 5.22 (d, J = 10.5 Hz, 1H), 4.28 (t, J = 7.2 Hz, 1H), 2.89 (dt, J = 14.4 
Hz, 7.2 Hz, 1H), 2.76 (dd, J = 14.4 Hz, 7.2 Hz, 1H); 
13
C NMR (75 MHz, CDCl3)  175.3, 132.5, 
119.5, 43.7, 38.6; FTIR (neat, cm
-1
) 3083, 3000 (broad), 1720, 1430, 1253, 1201, 1171, 993, 
927; HRMS (EI) calcd for C5H7
79
BrO2 [M]
+
: 177.9629, found: 177.9626. 
 
N
PMB
CO2t-Bu
O
Br
MeO
 
(E)-t-Butyl 3-(2-(2-bromo-N-(4-methoxybenzyl)pent-4-enamido)-3-methoxyphenyl) acrylate 
(5.40a and 5.40b):  To a stirred solution of rac-5.39 (0.896 g, 5.00 mmol) in CH2Cl2 (20 mL) at 
0 °C was added oxalyl chloride (0.635 g, 5.00 mmol) via syringe, followed by catalytic DMF (~1 
drop).  The mixture was warmed to room temperature and stirred for 2 h.  This mixture 
containing the crude acid chloride was transferred dropwise over 10 min via syringe to a stirred 
  253 
solution of 5.26c (0.739 g, 2.00 mmol) in CH2Cl2 at 0 °C.  After 10 min of stirring, Et3N (0.202 
g, 2.00 mmol) was added to this mixture via syringe, and the mixture was stirred at room 
temperature for 1 h.  Saturated aqueous NH4Cl (35 mL) was added, and the mixture was 
extracted with CH2Cl2 (3 x 35 mL).  The combined organic layers were washed with brine (35 
mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Column 
chromatography (4:1 hexanes:EtOAc) provided two diastereomers.  The first eluting 
diastereomer, rac-5.40a, was isolated (0.370 g, 35%) as a clear, colorless oil:  
1
H NMR (300 
MHz, CDCl3)  7.34 (t, J = 8.1 Hz, 1H), 7.12 (d, J = 7.2 Hz, 1H), 7.03 (d, J = 8.4 Hz, 2H), 6.98 
(d, J = 8.1 Hz, 1H), 6.95 (d, J = 15.9 Hz, 1H), 6.70 (d, J = 8.4 Hz, 2H), 6.06 (d, J = 15.9 Hz, 1H), 
5.60 (ddt, J = 14.1 Hz, 9.9 Hz, 7.2 Hz, 1H), 5.40 (d, J = 13.8 Hz, 1H), 5.10-5.01 (m, 2H), 4.20 
(d, J = 14.1 Hz, 1H), 3.83 (s, 3H), 3.79 (t, J = 7.2 Hz, 1H), 3.73 (s, 3H), 2.86 (dt, 14.1 Hz, 7.2 
Hz, 1H), 2.62 (dt, J = 14.1 Hz, 7.2 Hz, 1H), 1.47 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  168.7, 
164.9, 159.0, 155.7, 137.7, 134.6, 133.6, 131.1 (2C), 129.7, 127.9, 127.8, 123.0, 118.8, 117.9, 
113.4 (2C), 113.0, 80.3, 55.6, 54.9, 51.3, 43.1, 39.7, 27.9 (3C); FTIR (neat, cm
-1
) 2977, 2936, 
2837, 1708, 1666, 1612, 1578, 1513, 1476, 1439, 1393, 1271, 1248, 1152, 1071, 1035, 983, 929, 
849, 798; HRMS (ESI) calcd for C27H32
79
BrNNaO5 [M + Na]
+
: 552.1362, found: 552.1337.  The 
second eluting diastereomer, rac-5.40b, was isolated (0.413 g, 39%) as a clear, colorless oil.  The 
racemate was submitted to preparative chiral HPLC separation ((S,S)-Whelk-O1, 80:20 
hexanes:i-PrOH), first eluting enantiomer []D
23
 +84, 100/0 er (c 3.4 mg/mL, CHCl3), second 
eluting enantiomer []D
23
 –83, 100/0 er (c 4.1 mg/mL, CHCl3):  
1
H NMR (300 MHz, CDCl3)  
7.53 (d, J = 15.9 Hz, 1H), 7.31 (t, J = 8.1 Hz, 1H), 7.22 (d, J = 7.8 Hz, 1H), 6.99 (d, J = 8.7 Hz, 
2H), 6.84 (d, J = 8.1 Hz, 1H), 6.68 (d, J = 8.7 Hz, 2H), 6.18 (d, J = 16.2 Hz, 1H), 5.67 (dddd, J = 
16.8 Hz, 10.2 Hz, 7.5 Hz, 6.6 Hz, 1H), 5.06 (d, J = 17.1 Hz, 1H), 5.05 (d, J = 9.9 Hz, 1H), 4.77 
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(d, J = 13.8 Hz, 1H), 4.64 (d, J = 13.8 Hz, 1H), 3.89 (t, J = 7.2 Hz, 1H), 3.74 (s, 3H), 3.54 (s, 
3H), 2.89 (dt, J = 14.4 Hz, 6.9 Hz, 1H), 2.68 (dt, J = 14.4 Hz, 7.5 Hz, 1H), 1.50 (s, 9H); 
13
C 
NMR (75 MHz, CDCl3)  169.7, 165.2, 158.9, 155.1, 138.3, 134.5, 134.1, 131.1 (2C), 129.6, 
128.1, 127.9, 122.5, 118.8, 117.7, 113.1 (2C), 112.1, 80.3, 55.2, 54.9, 51.7, 43.6, 39.4, 28.0 (3C); 
FTIR (neat, cm
-1
) 2977, 2934, 2837, 1707, 1670, 1577, 1513, 1475, 1438, 1394, 1270, 1247, 
1152, 1070, 1035, 984, 921, 848, 800, 732; HRMS (ESI) calcd for C27H32
79
BrNNaO5 [M + Na]
+
: 
552.1362, found: 552.1349. 
 
N
PMB
Ot-Bu
O
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(E)-tert-Butyl 3-(2-(N-(4-methoxybenzyl)acetamido)-3,5-dimethylphenyl)acrylate (5.28b):  
To a stirred solution of 5.26b (0.147 g, 0.400 mmol) and Et3N (0.080 g, 0.800 mmol) in CH2Cl2 
(4.0 mL) at 0 °C was added acetyl chloride (0.047 g, 0.600 mmol) dropwise via syringe.  The 
mixture was stirred at this temperature for 15 min, and saturated aqueous NH4Cl solution (5 mL) 
was added.  The mixture was extracted with CH2Cl2 (3 x 5 mL), and the combined organic layers 
were washed with brine (10 mL), dried over MgSO4, filtered, and concentrated by rotary 
evaporation.  Column chromatography (2:1 hexanes:EtOAc) provided the title compound (0.150 
g, 92%) as a clear, colorless oil: 
1
H NMR (300 MHz, CDCl3)  7.26 (s, 1H), 7.17 (d, J = 15.9 
Hz, 1H), 7.07 (s, 1H), 7.05 (d, J = 8.7 Hz, 1H), 7.72 (d, J = 8.4 Hz, 1H), 6.13 (d, J = 15.9 Hz, 
1H), 4.83 (d, J = 13.8 Hz, 1H), 4.55 (d, J = 13.5 Hz, 1H), 3.76 (s, 3H), 2.34 (s, 3H), 1.91 (s, 3H), 
1.72 (s, 3H), 1.50 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  170.3, 165.4, 159.0, 138.4, 138.0, 
137.5, 136.6, 133.6, 133.0, 131.3 (2C), 128.4, 125.5, 122.0, 113.5 (2C), 80.3, 55.0, 51.2, 28.0 
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(3C), 22.0, 21.0, 17.5; FTIR (neat, cm
-1
) 2977, 2931, 2836, 1708, 1659, 1612, 1512, 1471, 1391, 
1326, 1247, 1151, 1035, 984, 851, 731; HRMS (ESI) calcd for C25H31NNaO4 [M + Na]
+
: 
432.2151, found: 432.2149. 
 
N
Ts
Ot -Bu
O
O
 
rac-(E)-tert-Butyl 3-(3,5-dimethyl-2-(N-tosylacetamido)phenyl)acrylate (5.28d):  To a stirred 
solution of 5.26d (0.402 g, 1.00 mmol) and Et3N (0.202 g, 2.00 mmol) in CH2Cl2 (5.0 mL) at 0 
°C was added AcCl (0.118 g, 1.50 mmol) dropwise via syringe.  The reaction mixture was stirred 
at this temperature for 30 min, and saturated aqueous NH4Cl solution (10 mL) was added.  The 
mixture was extracted with CH2Cl2 (3 x 10 mL), and the combined organic layers were washed 
with brine (10 mL), dried over MgSO4, filtered, and concentrated by rotary evaporation.  Column 
chromatography (3:1 hexanes:EtOAc) furnished the title compound (0.400 g, 90%) as a flaky 
white solid, mp 144-145 °C:  
1
H NMR (300 MHz, CDCl3)  7.99 (d, J = 8.4 Hz, 2H), 7.41 (s, 
1H), 7.32 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 16.2 Hz, 1H), 7.23 (s, 1H), 6.37 (d, J = 15.6 Hz, 1H), 
2.45 (s, 3H), 2.40 (s, 3H), 2.39 (s, 3H), 1.78 (s, 3H), 1.47 (9H); 
13
C NMR (75 MHz, CDCl3)  
169.5, 164.8, 144.8, 139.8, 139.1, 137.8, 135.0, 133.7 (2C, accidental isochrony), 132.6, 129.9 
(2C), 129.0 (2C), 125.5, 123.1, 80.2, 27.7 (3C), 23.9, 21.4, 20.9, 18.6; FTIR (thin film, CHCl3, 
cm
-1
) 2978, 2929, 1709, 1635, 1366, 1332, 1258, 1169, 1086, 1011, 983, 881, 853, 814, 756; 
HRMS (ESI) calcd for C24H29NNaO5S [M + Na]
+
: 466.1664, found: 466.1634. 
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(P)-(E)-3-(3-Bromo-2-(2-iodo-N-(4-methoxybenzyl)acetamido)-5-methylphenyl)acrylic acid 
(5.31):  To a stirred solution of (+)-5.17f (0.284 g, 0.473 mmol, 99/1 er) in CH2Cl2 (2.0 mL) at 
room temperature was added trifluoroacetic acid (2.0 mL) via syringe all at once.  The reaction 
mixture was stirred for 1 h, at which point solvent was removed by rotary evaporation.  The 
crude residue was directly subjected to column chromatography (40:60:1 hexanes:EtOAc:AcOH) 
to furnish the title compound (0.183 g, 71%) as a pale yellow solid, mp 109-110 °C, []D
23
 +21, 
99/1 er (c 14.9 mg/mL, CHCl3):  
1
H NMR (300 MHz, CDCl3)  7.59 (s, 1H), 7.36 (s, 1H), 7.26 
(d, J = 15.9 Hz, 1H), 7.04 (d, J = 8.4 Hz, 2H), 6.72 (d, J = 8.4 Hz, 2H), 6.07 (d, J = 15.9 Hz, 1H), 
5.38 (d, J = 14.1 Hz, 1H), 4.21 (d, J = 14.1 Hz, 1H), 3.75 (s, 3H), 3.60 (d, J = 10.5 Hz, 1H), 3.43 
(d, J = 10.8 Hz, 1H), 2.41 (s, 3H);  
13
C NMR (75 MHz, CDCl3)  170.6, 167.7, 159.4, 140.8 (2C, 
accidental isochrony), 136.1, 136.0, 135.0, 131.5 (2C), 127.2, 126.8, 124.7, 120.1, 113.8 (2C), 
55.1, 52.1, 20.9, −2.6; FTIR (thin film, CHCl3, cm
-1
) 2999 (broad), 2836, 1693, 1662, 1512, 
1461, 1383, 1320, 1283, 1250, 1176, 1106, 1034, 982, 910, 851, 822, 732; HRMS (ESI) calcd 
for C20H19
79
BrINNaO4 [M + Na]
+
: 565.9440, found: 565.9465. 
 
General procedure for radical cyclizations (Compounds 5.18a-c,e,f,i, 5.35, 5.41):  Bu3SnH 
(0.122 g, 0.42 mmol) and Et3B (0.35 mL of a 1.0 M hexane solution, 0.35 mmol) were dissolved 
in degassed benzene (20 mL).  This solution was added via syringe pump over a period of 2 h to 
a stirred solution of  the appropriate -halo amide (0.35 mmol) in benzene (35 mL).  Upon 
completion of the reaction, solvent was removed by rotary evaporation, and the crude residue 
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was directly subjected to flash chromatography on 10% w/w KF/silica gel
80
 using the appropriate 
eluent. 
 
N
Ot-Bu
O
O
 
t-Butyl 2-(1,6,8-trimethyl-2-oxo-1,2,3,4-tetrahydroquinolin-4-yl)acetate (5.18a):  According 
to the general procedure, 5.18a was prepared from the reaction of 5.17a and chromatographed 
eluting with 3:1 hexanes:EtOAc.  Chiral analysis was performed on the analytical (S,S)-Whelk-
O1 column (75:25 hexanes:i-PrOH).  rac-5.17a yielded rac-5.18a as a clear, colorless oil (0.088 
g, 83%).  The atropisomer (–)-5.17a yielded (+)-5.18a as a clear, colorless oil (0.086 g, 81%), 
[D
23
 +6.3 (c 9.6 mg/mL, CHCl3), 84/16 er, first eluting enantiomer.  The atropisomer (+)-5.17a 
yielded (–)-5.18a as a clear, colorless oil (0.084 g, 79%), [D
23
 –6.0 (c 8.5 mg/mL, CHCl3), 91/9 
er, second eluting enantiomer:  
1
H NMR (300 MHz, CDCl3)  6.90 (s, 1H), 6.88 (s, 1H), 3.34 (s, 
3H), 3.29 (tt, J = 7.5 Hz, 4.8 Hz, 1H), 2.67 (dd, J = 15.3 Hz, 4.8 Hz, 1H), 2.54 (dd, J = 15.3 Hz, 
4.5 Hz, 1H), 2.44 (dd, J = 15.3 Hz, 7.5 Hz, 1H), 2.38 (dd, J = 15.6 Hz, 7.2 Hz, 1H), 2.33 (s, 3H), 
2.27 (s, 3H), 1.45 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  171.8, 170.7, 138.3, 133.6, 132.3, 
131.8, 127.6, 125.3, 80.9, 38.9, 37.8, 35.7, 33.4, 28.0 (3C), 20.6, 20.4; FTIR (neat, cm
-1
) 2976. 
2929, 1728, 1674, 1482, 1426, 1366, 1309, 1256, 1148, 1082, 1039, 961, 859, 844, 733; HRMS 
(ESI) calcd for C18H25NNaO3 [M + Na]
+
: 326.1732, found: 326.1756. 
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t-Butyl 2-(1-(4-methoxybenzyl)-6,8-dimethyl-2-oxo-1,2,3,4-tetrahydroquinolin-4-yl) acetate 
(5.18b):  According to the general procedure, 5.18b was prepared from the reaction of 5.17b and 
chromatographed eluting with 3:1 hexanes:EtOAc.  Chiral analysis was performed on the 
analytical (S,S)-Whelk-O1 column (80:20 hexanes:i-PrOH).  rac-5.17b yielded rac-5.18b as a 
clear, pale yellow oil (0.126 g, 88%).  The atropisomer (+)-5.17b yielded (+)-5.18b as a clear, 
pale yellow oil (0.122 g, 85%), [D
23
 +64 (c 9.5 mg/mL, CHCl3), 96/4 er, first eluting 
enantiomer.  The atropisomer (–)-5.17b yielded (–)-5.18b as a clear, pale yellow oil (0.126 g, 
87%), [D
23
 –64 (c 16.7 mg/mL, CHCl3), 95/5 er, second eluting enantiomer:  
1
H NMR (300 
MHz, CDCl3)  7.07 (d, J = 8.4 Hz, 2H), 6.90 (s, 1H), 6.82 (s, 1H), 6.75 (d, J = 8.7 Hz, 2H), 5.15 
(d, J = 14.7 Hz, 1H), 4.87 (d, J = 14.7 Hz, 1H), 3.75 (s, 3H), 3.17 (tt, J = 7.5 Hz, 5.1 Hz, 1H), 
2.63 (dd, J = 15.0 Hz, 5.1 Hz, 1H), 2.46 (dd, J = 15.0 Hz, 5.1 Hz, 1H), 2.34 (s, 3H), 2.26 (s, 3H), 
2.08 (dd, J = 15.6 Hz, 7.8 Hz, 1H), 2.01 (dd, J = 15.6 Hz, 7.5 Hz, 1H), 1.41 (s, 9H); 
13
C NMR 
(75 MHz, CDCl3)  172.1, 170.8, 158.6, 137.1, 133.7, 133.5, 131.8, 129.5, 129.4 (2C), 127.9, 
125.5, 113.5 (2C), 80.5, 55.0, 48.6, 38.2, 33.5, 27.9 (3C), 21.0, 20.5, missing peak due to 
accidental isochrony; FTIR (neat, cm
-1
) 2976, 2932, 2836, 1727, 1674, 1611, 1513, 1479, 1368, 
1248, 1147, 1035, 911, 845, 733; HRMS (ESI) calcd for C25H31NNaO4 [M + Na]
+
: 432.2151, 
found: 432.2142. 
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tert-Butyl 2-(8-methoxy-1-(4-methoxybenzyl)-2-oxo-1,2,3,4-tetrahydroquinolin-4-yl)acetate 
(5.18c):  According to the general procedure, 5.18c was prepared from the reaction of 5.17c and 
chromatographed eluting with 2:1 hexanes:EtOAc.  Chiral analysis was performed on the 
analytical (S,S)-Whelk-O1 column (50:50 hexanes:i-PrOH).  rac-5.17c yielded rac-5.18c as a 
clear, colorless oil (0.140 g, 97%).  The atropisomer (–)-5.17c yielded (+)-5.18c as a clear, 
colorless oil (0.138 g, 96%), [D
23
 +86 (c 4.1 mg/mL, CHCl3), 93/7 er, first eluting enantiomer.  
The atropisomer (+)-5.17c yielded (–)-5.18c as a clear, colorless oil (0.136 g, 94%), [D
23
 –87 
(c 7.3 mg/mL, CHCl3), 93/7 er, second eluting enantiomer:  
1
H NMR (300 MHz, CDCl3)  7.11 
(d, J = 8.7 Hz, 2H), 7.01 (t, J = 7.8 Hz, 1H), 6.81 (d, J = 8.4 Hz, 1H), 6.79 (d, J = 7.8 Hz, 1H), 
6.74 (d, J = 8.7 Hz, 2H), 5.38 (d, J = 14.4 Hz, 1H), 5.22 (d, J = 14.7 Hz, 1H), 3.81 (s, 3H), 3.74 
(s, 3H), 3.27 (m, 1H), 2.70 (dd, J = 15.0 Hz, 5.1 Hz, 1H), 2.54 (dd, J = 15.0 Hz, 4.8 Hz, 1H), 
2.22 (dd, J = 15.9 Hz, 7.8 Hz, 1H), 2.17 (dd, J = 16.2 Hz, 7.8 Hz, 1H), 1.40 (s, 9H); 
13
C NMR 
(75 MHz, CDCl3)  170.8, 170.7, 158.4, 149.9, 133.9, 130.4, 129.3 (2C), 128.1, 124.7, 119.6, 
113.3 (2C), 111.5, 80.7, 55.5, 55.0, 46.7, 38.2, 37.7, 33.4, 28.0 (3C); FTIR (neat, cm
-1
) 2976, 
2936, 2837, 2248, 1727, 1674, 1612, 1589, 1513, 1484, 1462, 1368, 1248, 1148, 1102, 1033, 
912, 845, 784, 733; HRMS (ESI) calcd for C24H29NNaO5 [M + Na]
+
: 434.1943, found: 
434.1945. 
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tert-Butyl 2-(1-(4-methoxybenzyl)-6-methyl-2-oxo-8-(trimethylsilyl)-1,2,3,4-tetrahydroquin-
olin-4-yl) acetate (5.18e):  According to the general procedure, 5.18e was prepared from the 
reaction of 5.17e and chromatographed eluting with 3:1 hexanes:EtOAc.  Chiral analysis was 
performed on the analytical (S,S)-Whelk-O1 column (80:20 hexanes:i-PrOH).  rac-5.17e yielded 
rac-5.18e as a clear, colorless oil (0.152 g, 93%).  The atropisomer (+)-5.17e yielded (+)-5.18e 
as a clear, colorless oil (0.155 g, 95%), [D
23
 +122 (c 4.8 mg/mL, CHCl3), 95/5 er, first eluting 
enantiomer.  The atropisomer (–)-5.17e yielded (–)-5.18e as a clear, colorless oil (0.152 g, 93%), 
[D
23
 –120 (c 15.2 mg/mL, CHCl3), 94/6 er, second eluting enantiomer:  
1
H NMR (300 MHz, 
CDCl3)  7.29 (d, J = 1.8 Hz, 1H), 7.02 (d, J = 8.7 Hz, 2H), 6.97 (d, J = 1.8 Hz, 1H), 6.71 (d, J = 
8.7 Hz, 2H), 5.34 (d, J = 13.5 Hz, 1H), 4.69 (d, J = 13.5 Hz, 1H), 3.73 (s, 3H), 3.08 (m, 1H), 
2.59 (dd, J = 15.0 Hz, 5.1 Hz, 1H), 2.41 (dd, J = 15.0 Hz, 4.2 Hz, 1H), 2.31 (s, 3H), 1.73 (m, 
2H), 0.41 (s, 9H); 
13
C NMR (75 MHz, CDCl3)  171.0, 170.9, 158.9, 143.5, 136.0, 133.1, 132.6, 
130.3, 130.2 (2C), 129.1, 129.0, 113.5 (2C), 80.3, 55.0, 51.7, 37.9, 37.8, 33.4, 27.9 (3C), 20.7, 
0.6 (3C); FTIR (thin film, CHCl3, cm
-1
) 2975, 2836, 1727, 1675, 1611, 1513, 1452, 1368, 1249, 
1151, 1112, 1037, 922, 864, 838, 757; HRMS (ESI) calcd for C27H37NNaO4Si [M + Na]
+
: 
490.2390, found: 490.2409. 
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tert-Butyl 2-(8-bromo-1-(4-methoxybenzyl)-6-methyl-2-oxo-1,2,3,4-tetrahydroquinolin-4-yl) 
acetate (5.18f):  According to the general procedure, 5.18f was prepared from the reaction of 
5.17f and chromatographed eluting with 3:1 hexanes:EtOAc.  Chiral analysis was performed on 
the analytical (S,S)-Whelk-O1 column (70:30 hexanes:i-PrOH).  rac-5.17f yielded rac-5.18f as a 
clear, colorless oil (0.102 g, 61%).  The atropisomer (+)-5.17f yielded (+)-5.18f as a white solid 
(0.104 g, 63%), [D
23
 +100 (c 7.0 mg/mL, CHCl3), 95/5 er, first eluting enantiomer.  The 
atropisomer (–)-5.17f yielded (–)-5.18f as a clear, colorless oil (0.109 g, 66%), [D
23
 –100 (c 
10.3 mg/mL, CHCl3), 96/4 er, second eluting enantiomer:  
1
H NMR (300 MHz, CDCl3)  7.34 
(s, 1H), 7.11 (d, J = 8.7 Hz, 2H), 6.93 (s, 1H), 6.74 (d, J = 8.4 Hz, 2H), 5.42 (d, J = 14.7 Hz, 1H), 
5.34 (d, J = 15.3 Hz, 1H), 3.74 (s, 3H), 3.15 (m, 1H), 2.62 (dd, J = 15.0 Hz, 4.8 Hz, 1H), 2.47 
(dd, J = 15.0 Hz, 5.1 Hz, 1H), 2.27 (s, 3H), 1.97 (d, J = 7.5 Hz, 2H), 1.39 (s, 9H); 
13
C NMR (75 
MHz, CDCl3)  171.5, 170.5, 158.8, 136.3, 135.5, 133.9, 130.2 (2C), 129.3, 127.3, 113.5, 113.4 
(2C), 80.7, 55.0, 47.5, 38.0, 37.7, 33.6, 27.9 (3C), 20.3, missing peak due to accidental 
isochrony; FTIR (neat, cm
-1
) 2977, 2932, 2836, 1725, 1685, 1611, 1513, 1467, 1366, 1302, 1248, 
1153, 1035, 917, 827, 761, 734; HRMS (ESI) calcd for C24H28
79
BrNNaO4 [M + Na]
+
: 496.1099, 
found: 496.1104. 
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2-(1-(4-Methoxybenzyl)-6,8-dimethyl-2-oxo-1,2,3,4-tetrahydroquinolin-4-yl)acetonitrile 
(5.18h):  To a stirred solution of 5.17h (0.161 g, 0.35 mmol) in non-degassed benzene (84 mL) 
were added sequentially Bu3SnH (0.122 g, 0.42 mmol) and Et3B in hexane (0.35 mL of a 1.0 M 
solution, 0.35 mmol).  The reaction was stirred for 5 min, and solvent was removed by rotary 
evaporation.  The crude residue was directly chromatographed on 10% w/w KF/silica gel, eluting 
with 3:2 hexanes:EtOAc.  The fractions containing the desired product were collected and 
concentrated, and a second flash column (silica gel only) was performed, eluting with 3:2 
hexanes:EtOAc to remove residual impurities.  The products were ~95% pure by 
1
H NMR, 
containing trace unidentifiable impurities.  Chiral analysis was performed on the analytical (S,S)-
Whelk-O1 column (80:20 hexanes:EtOAc).  rac-5.17h yielded rac-5.18h as a white solid (0.082 
g, 70%), mp 101-102 °C.  The atropisomer (–)-5.17h yielded (+)-5.18h as a white solid (0.080 g, 
68%), [D
23
 +99 (c 19.8 mg/mL, CHCl3), 96/4 er, first eluting enantiomer.  The atropisomer (+)-
5.17h yielded (–)-5.18h as a white solid (0.083 g, 71%), [D
23
 –97 (c 4.5 mg/mL, CHCl3), 93/7 
er, second eluting enantiomer:  
1
H NMR (300 MHz, CDCl3)  7.03 (s, 1H), 6.87 (s, 1H), 7.02 (d, 
J = 8.4 Hz, 2H), 6.76 (d, J = 8.7 Hz, 2H), 5.25 (d, J = 14.4 Hz, 1H), 4.73 (d, J = 14.4 Hz, 1H), 
3.75 (s, 3H), 2.97 (m, 1H), 2.71 (dd, J = 15.3 Hz, 4.8 Hz, 1H), 2.50 (dd, J = 15.3 Hz, 4.2 Hz, 
1H), 2.41 (s, 3H), 2.33 (s, 3H), 2.03 (dd, J = 16.8 Hz, 6.6 Hz, 1H), 1.75 (dd, J = 16.8 Hz, 9.0 Hz, 
1H); 
13
C NMR (75 MHz, CDCl3)  170.7, 159.0, 136.8, 134.5, 132.8, 130.7, 129.8 (2C), 129.1, 
128.5, 125.9, 117.5, 113.7 (2C), 55.1, 48.6, 37.7, 34.0, 20.8, 20.6, 20.3; FTIR (thin film, CHCl3, 
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cm
-1
) 3012, 2959, 2837, 1673, 1513, 1479, 1376, 1249, 1176, 1033, 859, 757; HRMS (ESI) calcd 
for C21H22N2NaO2 [M + Na]
+
: 357.1579, found: 357.1612. 
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4-Isopropyl-1-(4-methoxybenzyl)-6,8-dimethyl-3,4-dihydroquinolin-2(1H)-one (5.18i): 
According to the general procedure, 5.18i was prepared from the reaction of 5.17i and 
chromatographed eluting with 3:1 pentane:Et2O.  Chiral analysis was performed on the analytical 
(S,S)-Whelk-O1 column (80:20 hexanes:i-PrOH).  rac-5.17i yielded rac-5.18i as a clear, 
colorless oil (0.060 g, 51%).  The atropisomer (–)-5.17i yielded (–)-5.18i as a clear, colorless oil 
(0.065 g, 55%), [D
23
 –44 (c 6.3 mg/mL, CHCl3), 80/20 er, second eluting enantiomer.  The 
atropisomer (+)-5.17i yielded (+)-5.18i as a clear, colorless oil (0.067 g, 57%), [D
23
 +44 (c 8.6 
mg/mL, CHCl3), 80/20 er, first eluting enantiomer:  
1
H NMR (300 MHz, CDCl3)  7.04 (d, J = 
8.7 Hz, 2H), 6.90 (s, 1H), 6.73 (d, J = 8.7 Hz, 2H), 6.71 (s, 1H), 5.22 (d, J = 14.7 Hz, 1H), 4.74 
(d, J = 14.7 Hz, 1H), 3.75 (s, 3H), 2.65 (dd, J = 15.0 Hz, 3.6 Hz, 1H), 2.54 (dd, J = 14.7 Hz, 4.8 
Hz, 1H), 2.33 (s, 3H), 2.28 (s, 3H), 2.19 (dt, J = 9.3 Hz, 4.2 Hz, 1H), 1.06 (d of septets, J = 9.3 
Hz, 6.6 Hz, 2.7 Hz, 1H), 0.84 (d, J = 6.6 Hz, 3H), 0.66 (d, J = 6.6 Hz, 3H); 
13
C NMR (75 MHz, 
CDCl3)  172.9, 158.6, 137.3, 134.8, 133.2, 131.3, 129.7, 129.5 (2C), 128.1, 127.3, 113.3 (2C), 
55.2, 48.6, 44.8, 36.3, 28.2, 21.5, 21.1, 20.6, 19.8; FTIR (neat, cm
-1
) 2957, 2868, 2835, 1673, 
1611, 1513, 1477, 1365, 1295, 1247, 1177, 1162, 1112, 1035, 860, 812; HRMS (ESI) calcd for 
C22H27NNaO2 [M + Na]
+
: 360.1939, found: 360.1911. 
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trans-tert-Butyl 2-(8-methoxy-1-(4-methoxybenzyl)-3-methyl-2-oxo-1,2,3,4-tetrahydroquin-
olin-4-yl)acetate (5.35):  According to the general procedure, 5.35 was prepared from the 
reaction of 5.34b and chromatographed eluting with 2:1 hexanes:EtOAc.  Chiral analysis was 
performed on the analytical (S,S)-Whelk-O1 column (70:30 hexanes:i-PrOH).  rac-5.34b yielded 
rac-5.35 as a clear, colorless oil (0.145 g, 97%).  The atropisomer (+)-5.34b yielded (–)-5.35 as a 
clear, colorless oil (0.146 g, 98%), [D
23
 –109 (c 13.2 mg/mL, CHCl3), 99/1 er, second eluting 
enantiomer.  The atropisomer (–)-5.34b yielded (+)-5.35 as a clear, colorless oil (0.145 g, 97%), 
[D
23
 +111 (c 20.4 mg/mL, CHCl3), 99.5/0.5 er, first eluting enantiomer:  
1
H NMR (300 MHz, 
CDCl3)  7.12 (d, J = 8.7 Hz, 2H), 7.01 (t, J = 8.4 Hz, 1H), 6.82 (d, J = 8.4 Hz, 1H), 6.80 (d, J = 
8.1 Hz, 1H), 6.75 (d, J = 8.7 Hz, 2H), 5.41 (d, J = 14.4 Hz, 1H), 5.17 (d, J = 14.7 Hz, 1H), 3.79 
(s, 3H), 3.74 (s, 3H), 2.97 (m with clear d, J = 2.7 Hz, 1H), 2.68 (qd, J = 7.2 Hz, 2.7 Hz, 1H), 
2.21 (dd, J = 15.6 Hz, 6.9 Hz, 1H), 2.10 (dd, J = 15.6 Hz, 8.1 Hz, 1H), 1.38 (s, 9H), 1.05 (d, J = 
7.5 Hz, 3H); 
13
C NMR (75 MHz, CDCl3)  173.6, 170.7, 158.3, 149.5, 131.2, 130.6, 129.2 (2C), 
127.1, 124.7, 121.5, 113.2 (2C), 111.7, 80.5, 55.4, 54.9, 46.7, 41.8, 40.4, 39.0, 27.9 (3C), 14.9; 
FTIR (thin film, CHCl3, cm
-1
) 2974, 2934, 2837, 1727, 1669, 1612, 1590, 1512, 1483, 1461, 
1365, 1248, 1175, 1150, 1107, 1085, 1036, 976, 935, 846, 790, 740; HRMS (ESI) calcd for 
C25H31NNaO5 [M + Na]
+
: 448.2100, found: 448.2128. 
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(±)-(1S,2S,3aR,9bS)-t-Butyl 6-methoxy-5-(4-methoxybenzyl)-2-methyl-4-oxo-2,3,3a,4,5,9b-
hexahydro-1H-cyclopenta[c]quinoline-1-carboxylate (5.41):  According to the general 
procedure, 5.41 was prepared from the reaction of 5.40 (0.143 g, 0.270 mmol) and 
chromatographed eluting with 3:1 hexanes:EtOAc on 10% w/w KF/silica.  A second flash 
column was run with 3:2 pentane:Et2O on silica only to remove residual impurities.  Chiral 
analysis was performed on the analytical (S,S)-Whelk-O1 column (60:40 hexanes:i-PrOH).  The 
atropisomer (+)-5.40 yielded (–)-5.41 as a clear, colorless oil (0.062 g, 51%, ~95% 
diastereomeric purity), [D
23
 –113 (c 12.3 mg/mL, CHCl3), 99/1 er, first eluting enantiomer.  
The atropisomer (–)-5.40 yielded (+)-5.41 as a clear, colorless solid, (0.060 g, 49%, ~95% 
diastereomeric purity), [D
23
 +110 (c 10.4 mg/mL, CHCl3), 98/2 er, second eluting enantiomer:  
1
H NMR (75 MHz, CDCl3)  7.07 (d, J = 8.7 Hz, 2H), 7.00 (t, J = 7.5 Hz, 1H), 6.76 (d, J = 7.8 
Hz, 1H), 6.73 (d, J = 8.7 Hz, 2H), 6.53 (d, J = 7.5 Hz,1H), 5.51 (d, J = 15.0 Hz, 1H), 5.01 (d, J = 
15.0 Hz, 1H), 3.77 (s, 3H), 3.73 (s, 3H), 3.30 (dd, J = 14.1 Hz, 10.8 Hz, 1H), 2.89 (t, J = 10.8 
Hz, 1H), 2.69 (d of sextets, J = 10.5 Hz, 7.2 Hz, 1H), 2.40 (ddd, J = 14.4 Hz, 11.1 Hz, 7.2 Hz, 
1H), 2.30 (dt, J = 12.6 Hz, 7.2 Hz, 1H), 1.68 (m, 1H), 1.51 (s, 9H), 1.10 (d, J = 7.2 Hz, 3H); 
13
C 
NMR (75 MHz, CDCl3)  173.3, 172.4, 158.2, 149.9, 135.3, 130.9, 129.1, 128.4 (2C), 125.0, 
116.2, 113.4 (2C), 111.1, 80.9, 55.4, 55.0, 50.7, 46.9, 46.8, 44.2, 35.1, 33.7, 28.1 (3C), 18.2; 
FTIR (thin film, CHCl3, cm
-1
) 2971, 2837, 1724, 1678, 1513, 1459, 1368, 1280, 1247, 1148, 
1067, 1036, 800, 763; HRMS (ESI) calcd for C27H33NNaO5 [M + Na]
+
: 474.2256, found: 
474.2293. 
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6.6 N-ARYL BOND ROTATION STUDIES 
Racemization of 3.19a-c, 5.17a,c,f, 5.27c: The appropriate compound, enantiomerically 
enriched in the second eluting enantiomer, was dissolved in a 9:1 hexanes:i-PrOH solvent 
mixture to make a ~2 mg/mL solution in a sealable tube.  The tube was sealed and placed in a 
pre-heated oil bath with an electronic temperature controller.  At various time intervals, the 
sealed tube was removed briefly (1-2 minutes) from the bath, opened, and a 10 L aliquot was 
removed via syringe and injected onto the appropriate analytical HPLC column to measure the 
enantiomeric ratio.  The decrease in enantiomeric excess (y-axis) was plotted against time (x-
axis), and the barrier to rotation was calculated from the plot.
141
  In the y-axis term of the plot, 
“F” denotes the fraction of the first eluting enantiomer, and “S” denotes the fraction of the 
second eluting enantiomer.  A conversion factor of 1 cal = 4.184 J was used in all calculations.
60
  
The half-life for racemization at ambient temperature is determined by first calculating the rate 
of racemization (krac) from the barrier to rotation at 25 °C, assuming that G
‡
rot is mostly 
constant over a large temperature range. 







 

RT
G
B
rotrac
rot
e
h
Tk
kk
‡
2
2   
rack
t
2ln
2/1   
A sample full data treatment is shown for 3.19a. 
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Table 6.1  Thermal Racemization of 3.19a 
time 
(min) 
% ee 
NO
O
CO2Me
I
NO
O
CO2Me
I115 °C
 
0 100.0 
30 97.0 
80 93.0 
143 86.9 
258 79.3 
370 75.2 
439 70.1 
500 67.7 
569 66.2 
   
 
Equation for racemization:  ctkctk
aSaF
aSaF
rotrac 







2
]19.3/[]19.3[1
]19.3/[]19.3[1
ln  
Corresponding plot:    







]19.3][19.3[1
]19.3/[]19.3[1
ln
aSaF
aSaF
 vs. time, where slope = 2krot 
16
15
1016.6
2
10533.9
2




 s
sslope
krot  
molkcalmolkJ
Tk
hk
RTG
B
rot
rot /2.32/6.134ln
‡ 





  
t1/2 for racemization at 25 °C = 690 years 
 
y = 1.232x + 0.017
R² = 0.989
0
0.1
0.2
0.3
0.4
0.5
0 0.1 0.2 0.3 0.4
ln
((
1
+
F/
S)
/(
1
-F
/S
))
Time (106 s)
Barrier to Rotation, 3.19a
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Table 6.2  Thermal Racemization of 3.19b 
time 
(min) 
% ee 
NO
O
CO2Me
I
NO
O
CO2Me
I115 °C
 
0 66.6 
20 64.7 
93 62.6 
171 59.3 
254 56.4 
388 53.6 
519 49.3 
596 46.4 
   
 
krot = 4.77 x 10
-6
 s
-1
 
G
‡
rot = 32.4 kcal/mol 
t1/2 at 25 °C = 960 years 
  
y = 0.953x + 0.416
R² = 0.993
0
0.2
0.4
0.6
0.8
1
0 0.1 0.2 0.3 0.4
ln
((
1
+
F/
S)
/(
1
-F
/S
))
Time (106 s)
Barrier to Rotation, 3.19b
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Table 6.3  Thermal Racemization of 3.19c 
time 
(min) 
% ee 
NO
O
CO2Me
I
NO
O
CO2Me
I114 °C
 
0 78.5 
37 75.0 
78 73.6 
114 71.0 
185 67.1 
263 63.7 
352 61.1 
554 49.4 
1252 31.2 
 
 
 
krot = 6.12 x 10
-6
 s
-1
 
G
‡
rot = 32.1 kcal/mol  
t1/2 at 25 °C = 601 years 
  
y = 1.224x + 0.256
R² = 0.995
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 0.2 0.4 0.6 0.8
ln
((
1
+
F/
S)
/(
1
-F
/S
))
Time (106 s)
Barrier to Rotation, 3.19c
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Table 6.4  Thermal Racemization of 5.17b 
time 
(min) 
% ee 
N
140 °C
N
O
I
CO2t-Bu
PMB
t-BuO2C
PMB I
O
 
0 99.7 
39 95.6 
90 93.4 
190 89.5 
276 81.8 
367 80.3 
481 72.5 
575 66.4 
670 62.1 
 
 
krot = 5.74 x 10
-6
 s
-1
 
G
‡
rot = 34.3 kcal/mol  
t1/2 at 25 °C = 27,500 years 
  
y = 1.147x + 0.000
R² = 0.988
0
0.1
0.2
0.3
0.4
0.5
0.6
0 0.1 0.2 0.3 0.4 0.5
ln
((
1
+
F/
S)
/(
1
-F
/S
))
Time (106 s)
Barrier to Rotation, 5.17b
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Table 6.5  Thermal Racemization of 5.17c 
time 
(min) 
% ee 
MeO
N
OMe
55 °C
N
O
I
CO2t-Bu
PMB
t-BuO2C
PMB I
O
 
0 96.2 
22 91.3 
57 82.9 
125 69.1 
201 56.2 
284 46.1 
378 35.8 
489 27.7 
 
 
 
krot = 2.14 x 10
-5
 s
-1
 
G
‡
rot = 26.3 kcal/mol  
t1/2 at 25 °C = 12 days 
  
y = 4.278x + 0.044
R² = 0.999
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 0.1 0.2 0.3 0.4
ln
((
1
+
F/
S)
/(
1
-F
/S
))
Time (106 s)
Barrier to Rotation, 5.17c
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Table 6.6  Thermal Racemization of 5.17f 
time 
(min) 
% ee 
Br
N
Br143 °C
N
O
I
CO2t-Bu
PMB
t-BuO2C
PMB I
O
 
0 99.5 
23 95.3 
63 91.9 
133 86.3 
200 76.2 
274 71.1 
348 66.7 
397 60.7 
469 57.4 
 
 
 
krot = 9.85 x 10
-6
 s
-1
 
G
‡
rot = 34.2 kcal/mol  
t1/2 at 25 °C = 19,900 years 
  
y = 1.969x + 0.011
R² = 0.994
0
0.1
0.2
0.3
0.4
0.5
0.6
0 0.05 0.1 0.15 0.2 0.25 0.3
ln
((
1
+
F/
S)
/(
1
-F
/S
))
Time (106 s)
Barrier to Rotation, 5.17f
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Table 6.7  Thermal Racemization of 5.27c 
time 
(min) 
% ee 
MeO
N
OMe
52 °C
N
O
Cl
CO2t-Bu
PMB
t-BuO2C
PMB Cl
O
 
0 94.1 
9 91.1 
29 77.1 
49 65.9 
86 47.9 
122 35.1 
172 23.5 
232 14.4 
 
 
 
 
 
 
krot = 6.85 x 10
-5
 s
-1
 
G
‡
rot = 25.3 kcal/mol  
t1/2 at 25 °C = 2.2 days 
  
y = 13.70x + 0.031
R² = 0.999
0
0.5
1
1.5
2
2.5
0 0.05 0.1 0.15
ln
((
1
+
F/
S)
/(
1
-F
/S
))
Time (106 s)
Barrier to Rotation, 5.27c
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Thermal equilibration of 4.13, 4.15: The appropriate compound, enriched in the syn 
diastereomer, was dissolved in a 9:1 hexanes:EtOAc solvent mixture to make a ~2 mg/mL 
solution in a sealable tube.  The tube was sealed and placed in a pre-heated oil bath with an 
electronic temperature controller.  At various time intervals, the sealed tube was removed briefly 
(1-2 minutes) from the bath, opened, and a 10 L aliquot was removed via syringe and injected 
onto an analytical Waters NovaPak silica HPLC column to measure the dr.  The sample was 
heated until equilibrium was reached, and the solution was concentrated and analyzed by 
1
H 
NMR to ensure that the final ratio as determined by HPLC analysis was accurate.  The first-order 
conversion of the syn isomer to the anti isomer, approaching equilibrium, was plotted against 
time.
60
  In the resulting plot, the slope is equal to k1, the conversion rate of syn to anti.  The 
reverse rate k-1 was calculated from the equilibrium value (k-1 = k1 / K).  Finally, the barrier to 
rotation for each process was determined from the experimentally determined rate and the Eyring 
equation.  A conversion factor of 1 cal = 4.184 J was used in all calculations.
60
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Table 6.8  Thermal Equilibration of 4.13 
time 
(min) 
% 
anti 
%   
syn 
k1
k-1
N
O H
I
N
O H
I
36 oC
K = 1.84  
0 28.3 71.7 
13 38.7 61.3 
23 45.7 54.3 
32 50.3 49.7 
43 54.0 46.0 
52 56.7 43.3 
61 58.7 41.3 
73 60.5 39.5 
88 62.2 37.8  
112 63.6 36.4  
149 64.4 35.6  
186 64.7 35.3  
247 64.9 35.1  
312 64.8 35.2  
 
 
k1 = 5.16 x 10
-4
 s
-1
 
k-1 = 2.80 x 10
-4
 s
-1
 
G
‡
rot (syn to anti) = 22.8 kcal/mol 
G
‡
rot (syn to anti) = 23.1 kcal/mol 
  
y = 5.16E-04x + 5.00E-01
R² = 1.00E+00
0
1
2
3
4
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6
7
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ln
([
an
ti
] e
q
/(
[a
n
ti
] e
q
-[
an
ti
] t
)
Time (s)
Equilibration of 4.13
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Table 6.9  Thermal Equilibration of 4.15 
time 
(min) 
% 
anti 
%   
syn 
k1
k-1
N
O H
I
N
O H
I
153 oC
K = 2.08  
0 4.3 95.7 
95 5.0 95.0 
245 5.8 94.2 
645 12.7 87.3 
1430 22.2 77.8 
1728 23.7 76.3 
2054 26.0 74.0 
2847 30.5 69.5 
3485 35.6 64.4  
4345 40.2 59.8  
4939 42.5 57.5  
5807 45.7 54.3  
21699 67.4 32.6  
30340 67.6 32.4  
 
 
k1 = 3.10 x 10
-6
 s
-1
 
k-1 = 1.49 x 10
-6
 s
-1
 
G
‡
rot (syn to anti) = 36.0 kcal/mol 
G
‡
rot (syn to anti) = 36.6 kcal/mol 
y = 3.10E-06x + 8.30E-02
R² = 9.95E-01
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 100000 200000 300000 400000
ln
([
an
ti
] e
q
/(
[a
n
ti
] e
q
-[
an
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] t
)
Time (s)
Equilibration of 4.15
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6.7 N-VINYL BOND ROTATION STUDIES 
For each compound 1.15a,c and 1.29-1.32, a sample of the -haloenamide was dissolved 
in the appropriate solvent (CDCl3 or toluene-d8) with a small amount of tetramethylsilane, and 
the solution was placed in a standard 5 mm NMR sample tube.  The samples were loaded into 
the NMR spectrometer and the probe was heated or cooled, allowing ~10 min equilibration time 
at each temperature before the spectrum was collected.  The spectra for 1.29-1.32 were collected 
by Dr. Damodaran Krishnan Achary.  Fourier transforms were performed using NUTS data 
processing software (www.acornnmr.com).
62
  For each compound, the benzylic signals were 
used for line-shape analysis.  For these signals, all compounds analyzed showed geminally 
coupled doublets at lower temperatures, coalescing to a singlet as temperature was increased.  
The only exception to this was 1.32, which decoalesced to two quartets in a 2:1 ratio upon 
cooling. 
At all temperatures, the standard peak width was determined by measuring the peak 
width at half-height of the tetramethylsilane internal standard.  For at least two low-temperature 
spectra in the decoalesced temperature region, the A and B of the benzylic signals in Hz were 
also measured.  By plotting the log  (y-axis) vs. 1/T (x-axis) at these temperatures, the  for 
the spectra at higher temperatures could be calculated. 
Line-shape analysis of each spectrum was accomplished with WINDNMR-Pro 
software.
55
  At each temperature, the appropriate line width and  were entered, and line-shape 
analysis was performed by changing the k variable until the best fit was achieved.  Simulation 
near the coalescence temperature was typically not performed, due to low accuracy (signals had 
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typically disappearing into the baseline).  An Eyring plot was then derived from the data by 
plotting 1/T on the x-axis vs. ln (k/T) on the y-axis, according to the equation:  

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From the Eyring plot, the thermodynamic parameters for the rotation were calculated 
using the following equations: 
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A conversion factor of 1 cal = 4.184 J was used in all calculations.60  The calculated 
thermodynamic values for all compounds analyzed are listed in Table 1.3, Chapter 1.2.1.
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Table 6.10  Rotational Data for 1.15a in CDCl3 
temp. 
(K) 
k 
(s
-1
) 
calc. a-b 
(Hz) 
actual a-b 
(Hz) 
O
N Ph
Cl
O
N Ph
Cl
 
216 21.5 263.0 263.0 
220 30.1 259.5 259.5 
227 52.2 253.8 253.8 
232 82.2 250.0 250.0 
238 159 245.8 245.8 
244 242 241.8 241.8 
249 386 238.7 238.7 
257 673 234.0 234.0 
263 1.06 x 10
3 
230.8 230.8 
270 1.51 x 10
3 
227.2 227.2 
 
 
Figure 6.1  Eyring Plot for 1.15a 
  
y = -4497.x + 18.44
R² = 0.997
-3
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ln
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(k
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s·
K
)]
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Table 6.11  Rotational Data for 1.15c in CDCl3 
temp. 
(K) 
k 
(s
-1
) 
calc. a-b 
(Hz) 
actual a-b 
(Hz) 
O
N Ph
I
O
N Ph
I
 
215 20.5 246.5 246.5 
220 32.2 242.6 242.6 
228 68.2 236.8 236.8 
234 131 232.9 232.9 
237 166 231.0 231.0 
240 211 229.2 229.2 
249 418 224.0 224.0 
252 508 222.4 222.4 
254 632 221.4 221.4 
258 826 219.3 219.3 
265 1.35 x 10
3 
216.0 216.0 
275 2.92 x 10
3 
211.6 211.6 
297 1.14 x 10
4 
203.2 203.2 
 
 
Figure 6.2  Eyring Plot for 1.15c 
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Table 6.12  Rotational Data for 1.29a in Toluene-d8 
temp. 
(K) 
k 
(s
-1
) 
calc. a-b 
(Hz) 
actual a-b 
(Hz) 
O
N Ph
Br
O
N Ph
Br
 
186 57.7 546.3 546.5 
191 102 533.3 533.5 
202 303 507.9 507.9 
222 2.40 x 10
3 
470.6 470.6 
233 6.90 x 10
3
 453.8 453.8 
245 1.42 x 10
4
 437.7 437.7 
256 2.90 x 10
4
 424.8 424.8 
266 5.75 x 10
4
 414.3 414.3 
279 1.05 x 10
5 
402.0 402.0 
290 1.97 x 10
5 
392.8 392.8 
 
 
 
Figure 6.3  Eyring Plot for 1.29a 
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Table 6.13  Rotational Data for 1.29b in Toluene-d8 
temp. 
(K) 
k 
(s
-1
) 
calc. a-b 
(Hz) 
actual a-b 
(Hz) 
O
N Ph
Br
O
N Ph
Br
 
233 5.4 431.8 432.8 
245 15.0 409.7 411.1 
256 31.9 392.1 391.8 
266 80.0 378.0 366.9 
279 207 361.9 346.7 
311 2.43 x 10
3
 330.0 331.2 
327 5.99 x 10
3 
317.3 318.2 
339 1.67 x 10
4 
308.9 308.2 
 
 
Figure 6.4  Eyring Plot for 1.29b 
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Table 6.14  Rotational Data for 1.29c in Toluene-d8 
temp. 
(K) 
k 
(s
-1
) 
calc. a-b 
(Hz) 
actual a-b 
(Hz) 
O
N Ph
Br
O
N Ph
Br
 
250 16.7 548.5 549.2 
261 40.5 522.8 522.3 
271 91.5 489.3 491.6 
281 172 460.1 459.6 
292 374 432.1 412.6 
311 1.62 x 10
3 
391.8 392.4 
321 3.12 x 10
3 
373.8 374.4 
331 5.76 x 10
3 
357.7 356.4 
341 1.19 x 10
4 
343.1 344.4 
350 2.11 x 10
4 
331.2 331.6 
 
 
Figure 6.5  Eyring Plot for 1.29c 
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Table 6.15  Rotational Data for 1.29d in Toluene-d8 
temp. 
(K) 
k 
(s
-1
) 
calc. a-b 
(Hz) 
actual a-b 
(Hz) 
O
N Ph
Br
O
N Ph
Br
 
230 11.0 506.6 508.5 
240 22.5 483.5 484.1 
250 60.0 463.2 461.6 
261 161 443.6 440.6 
271 365 427.7 426.1 
292 1.73 x 10
3 
399.5 399.6 
301 3.43 x 10
3 
389.1 388.6 
311 7.33 x 10
3 
378.6 379.6 
321 1.41 x 10
4 
369.0 369.6 
331 2.63 x 10
4 
360.1 359.9 
341 4.62 x 10
4 
352.0 350.9 
 
 
Figure 6.6  Eyring Plot for 1.29d 
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Table 6.16  Rotational Data for 1.29e in Toluene-d8 
temp. 
(K) 
k 
(s
-1
) 
calc. a-b 
(Hz) 
actual a-b 
(Hz) 
O
N Ph
Br
O
N Ph
Br
 
230 15.1 603.9 604.8 
240 35.4 584.2 583.8 
250 101 566.7 565.9 
261 280 549.4 549.9 
292 2.80 x 10
3 
510.0 510.0 
301 5.17 x 10
3 
500.5 500.0 
311 1.06 x 10
4 
490.8 490.0 
321 2.36 x 10
4 
481.9 481.7 
331 3.94 x 10
4 
473.6 473.4 
341 7.01 x 10
4 
466.0 467.1 
 
 
Figure 6.7  Eyring Plot for 1.29e 
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Table 6.17  Rotational Data for 1.30 in Toluene-d8 
temp. 
(K) 
k 
(s
-1
) 
calc. a-b 
(Hz) 
actual a-b 
(Hz) 
O
N Ph
Br
O
N Ph
Br
 
220 8.0 110.9 111.2 
230 17.8 105.8 105.8 
240 42.8 101.3 101.4 
250 106 97.4 97.4 
271 432 90.4 90.4 
281 836 87.6 87.6 
292 1.80 x 10
3 
84.9 84.9 
301 3.03 x 10
3 
82.8 82.7 
311 5.58 x 10
3 
80.7 80.6 
 
 
Figure 6.8  Eyring Plot for 1.30 
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Table 6.18  Rotational Data for 1.31 in Toluene-d8 
temp. 
(K) 
k 
(s
-1
) 
calc. a-b 
(Hz) 
actual a-b 
(Hz) 
O
N Ph
Br
O
N Ph
Br
 
341 6.0 600.5 599.3 
349 8.9 592.4 587.0 
359 14.6 582.9 576.6 
369 23.6 574.1 564.7 
379 38.9 565.9 553.5 
 
 
Figure 6.9  Eyring Plot for 1.31 
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Table 6.19  Rotational Data for 1.32 in Toluene-d8 
temp. 
(K) 
k1 + k-1 
(s
-1
) 
calc. a-b 
(Hz) 
actual a-b 
(Hz) 
O
N Ph
Br
O
N Ph
Br
k1
k-1
** Note: actual configuration of major
diastereomer is unknown.  
271 67.0 182.9 180.7 
281 136 175.5 175.5 
292 316 168.1 168.3 
301 656 162.7 162.7 
311 1.39 x 10
3 
157.3 157.1 
321 2.66 x 10
3
 152.3 152.4 
331 4.88 x 10
3 
147.9 148.0 
341 1.02 x 10
4 
143.7 143.7 
350 1.70 x 10
4 
140.3 140.2 
 
Upon cooling, two diastereomers were seen in a 2:1 ratio. 
Therefore, k1 = (1/3)(k1 + k-1), and k-1 = (2/3)(k1 + k-1) for each temperature. 
 
Figure 6.10  Eyring Plot for 1.32 
 
 
 
y = -6416.x + 21.04
R² = 0.998
y = -6416.x + 21.73
R² = 0.998
-3
-2
-1
0
1
2
3
4
0.0025 0.0027 0.0029 0.0031 0.0033 0.0035 0.0037 0.0039
ln
 [
(k
/T
)(
s·
K
)]
1/T (K-1)
  289 
APPENDIX A 
X-RAY CRYSTALLOGRAPHY DATA 
 
The corresponding CIF file for 1.15a is shown below, between the lines of “+” symbols. 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
data_dguth1 
 
_audit_creation_method           SHELXL-97 
_chemical_name_systematic        ? 
_chemical_name_common            ? 
_chemical_melting_point          ? 
_chemical_formula_moiety         'C15 H18 Cl N O' 
_chemical_formula_sum            'C15 H18 Cl N O' 
_chemical_formula_weight         263.75 
 
loop_ 
_atom_type_symbol 
_atom_type_description 
_atom_type_scat_dispersion_real 
  290 
_atom_type_scat_dispersion_imag 
_atom_type_scat_source 
C C 0.0033 0.0016 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4' 
H H 0.0000 0.0000 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4' 
N N 0.0061 0.0033 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4' 
O O 0.0106 0.0060 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4' 
Cl Cl 0.1484 0.1585 'International Tables Vol C Tables 4.2.6.8 and 
6.1.1.4' 
 
_symmetry_cell_setting           monoclinic 
_symmetry_space_group_name_H-M   'P 21' 
_symmetry_int_tables_number      4 
 
loop_ 
_symmetry_equiv_pos_as_xyz 
'x, y, z' 
'-x, y+1/2, -z' 
 
_cell_length_a                   8.852(5) 
_cell_length_b                   9.106(5) 
_cell_length_c                   9.389(5) 
_cell_angle_alpha                90.00 
_cell_angle_beta                 113.263(9) 
_cell_angle_gamma                90.00 
_cell_volume                     695.2(6) 
_cell_formula_units_Z            2 
_cell_measurement_temperature    295(2) 
_cell_measurement_reflns_used    999 
_cell_measurement_theta_min      5 
_cell_measurement_theta_max      25 
 
_exptl_crystal_description       plate 
_exptl_crystal_colour            colorless 
_exptl_crystal_size_max          0.49 
_exptl_crystal_size_mid          0.33 
_exptl_crystal_size_min          0.06 
_exptl_crystal_density_meas      ? 
_exptl_crystal_density_diffrn    1.260 
_exptl_crystal_density_method    'not measured' 
_exptl_crystal_F_000             280 
_exptl_absorpt_coefficient_mu    0.263 
_exptl_absorpt_correction_type   multi-scan 
_exptl_absorpt_correction_T_min  0.8820 
_exptl_absorpt_correction_T_max  0.9844 
_exptl_absorpt_process_details   'Bruker Sadabs' 
 
_exptl_special_details            
;  
 ?  
; 
 
_diffrn_ambient_temperature      295(2) 
_diffrn_radiation_probe          x-ray 
_diffrn_radiation_type           MoK\a 
  291 
_diffrn_radiation_wavelength     0.71073 
_diffrn_source                   'fine-focus sealed tube' 
_diffrn_source_type              'Bruker AXS Smart Apex CDD' 
_diffrn_radiation_monochromator  graphite 
_diffrn_measurement_device_type  'CCD area detector' 
_diffrn_measurement_method       'phi and omega scans' 
_diffrn_detector_area_resol_mean ? 
_diffrn_standards_number         ? 
_diffrn_standards_interval_count ? 
_diffrn_standards_interval_time  ? 
_diffrn_standards_decay_%        ? 
_diffrn_reflns_number            6450 
_diffrn_reflns_av_R_equivalents  0.0354 
_diffrn_reflns_av_sigmaI/netI    0.0511 
_diffrn_reflns_limit_h_min       -11 
_diffrn_reflns_limit_h_max       11 
_diffrn_reflns_limit_k_min       -11 
_diffrn_reflns_limit_k_max       11 
_diffrn_reflns_limit_l_min       -12 
_diffrn_reflns_limit_l_max       12 
_diffrn_reflns_theta_min         2.50 
_diffrn_reflns_theta_max         27.50 
_reflns_number_total             3132 
_reflns_number_gt                2471 
_reflns_threshold_expression     >2sigma(I) 
 
_computing_data_collection       'Bruker SMART' 
_computing_cell_refinement       'Bruker SMART' 
_computing_data_reduction        'Bruker SAINT' 
_computing_structure_solution    'SHELXS-97 (Sheldrick, 1990)' 
_computing_structure_refinement  'SHELXL-97 (Sheldrick, 1997)' 
_computing_molecular_graphics    'Bruker SHELXTL' 
_computing_publication_material  'Bruker SHELXTL' 
 
_refine_special_details           
;  
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and  
 goodness of fit S are based on F^2^, conventional R-factors R are based  
 on F, with F set to zero for negative F^2^. The threshold expression of  
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and 
is  
 not relevant to the choice of reflections for refinement.  R-factors 
based  
 on F^2^ are statistically about twice as large as those based on F, and 
R-  
 factors based on ALL data will be even larger.  
; 
 
_refine_ls_structure_factor_coef Fsqd 
_refine_ls_matrix_type           full 
_refine_ls_weighting_scheme      calc 
_refine_ls_weighting_details      
'calc w=1/[\s^2^(Fo^2^)+(0.0820P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3' 
_atom_sites_solution_primary     direct 
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_atom_sites_solution_secondary   difmap 
_atom_sites_solution_hydrogens   geom 
_refine_ls_hydrogen_treatment    constr 
_refine_ls_extinction_method     none 
_refine_ls_extinction_coef       ? 
_refine_ls_abs_structure_details  
'Flack H D (1983), Acta Cryst. A39, 876-881, 1434 Friedel pairs' 
_refine_ls_abs_structure_Flack   0.03(8) 
_refine_ls_number_reflns         3132 
_refine_ls_number_parameters     164 
_refine_ls_number_restraints     1 
_refine_ls_R_factor_all          0.0643 
_refine_ls_R_factor_gt           0.0511 
_refine_ls_wR_factor_ref         0.1386 
_refine_ls_wR_factor_gt          0.1313 
_refine_ls_goodness_of_fit_ref   0.999 
_refine_ls_restrained_S_all      0.999 
_refine_ls_shift/su_max          0.000 
_refine_ls_shift/su_mean         0.000 
 
loop_ 
_atom_site_label 
_atom_site_type_symbol 
_atom_site_fract_x 
_atom_site_fract_y 
_atom_site_fract_z 
_atom_site_U_iso_or_equiv 
_atom_site_adp_type 
_atom_site_occupancy 
_atom_site_symmetry_multiplicity 
_atom_site_calc_flag 
_atom_site_refinement_flags 
_atom_site_disorder_assembly 
_atom_site_disorder_group 
Cl Cl 0.75491(10) 0.74726(7) 0.65329(10) 0.0778(3) Uani 1 1 d . . . 
O O 0.7614(3) 0.5602(2) 0.4044(2) 0.0684(5) Uani 1 1 d . . . 
N N 0.8214(2) 0.3496(2) 0.5397(2) 0.0480(5) Uani 1 1 d . . . 
C1 C 0.9909(3) 0.2263(4) 0.7891(3) 0.0644(7) Uani 1 1 d . . . 
H1A H 1.0366 0.3139 0.8497 0.077 Uiso 1 1 calc R . . 
H1B H 1.0634 0.1971 0.7391 0.077 Uiso 1 1 calc R . . 
C2 C 0.9846(4) 0.1050(5) 0.8962(4) 0.0914(11) Uani 1 1 d . . . 
H2A H 0.9779 0.0109 0.8456 0.110 Uiso 1 1 calc R . . 
H2B H 1.0849 0.1062 0.9895 0.110 Uiso 1 1 calc R . . 
C3 C 0.8403(5) 0.1223(5) 0.9390(5) 0.0948(12) Uani 1 1 d . . . 
H3A H 0.8407 0.0434 1.0085 0.114 Uiso 1 1 calc R . . 
H3B H 0.8503 0.2143 0.9940 0.114 Uiso 1 1 calc R . . 
C4 C 0.6824(4) 0.1206(3) 0.8024(4) 0.0703(8) Uani 1 1 d . . . 
H4A H 0.5964 0.1574 0.8324 0.084 Uiso 1 1 calc R . . 
H4B H 0.6552 0.0200 0.7677 0.084 Uiso 1 1 calc R . . 
C5 C 0.6860(3) 0.2105(3) 0.6714(3) 0.0519(6) Uani 1 1 d . . . 
H5A H 0.5872 0.2319 0.5892 0.062 Uiso 1 1 calc R . . 
C6 C 0.8245(3) 0.2614(3) 0.6674(2) 0.0449(5) Uani 1 1 d . . . 
C7 C 0.8700(3) 0.2771(3) 0.4252(3) 0.0530(6) Uani 1 1 d . . . 
H7A H 0.9690 0.2203 0.4788 0.064 Uiso 1 1 calc R . . 
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H7B H 0.8952 0.3512 0.3637 0.064 Uiso 1 1 calc R . . 
C8 C 0.7385(3) 0.1774(3) 0.3192(3) 0.0480(6) Uani 1 1 d . . . 
C9 C 0.7523(4) 0.0264(3) 0.3392(4) 0.0639(7) Uani 1 1 d . . . 
H9A H 0.8443 -0.0127 0.4184 0.077 Uiso 1 1 calc R . . 
C10 C 0.6327(5) -0.0662(4) 0.2440(5) 0.0772(9) Uani 1 1 d . . . 
H10A H 0.6430 -0.1672 0.2599 0.093 Uiso 1 1 calc R . . 
C11 C 0.4994(5) -0.0100(4) 0.1265(4) 0.0772(10) Uani 1 1 d . . . 
H11A H 0.4201 -0.0728 0.0598 0.093 Uiso 1 1 calc R . . 
C12 C 0.4807(4) 0.1416(4) 0.1054(4) 0.0738(8) Uani 1 1 d . . . 
H12A H 0.3879 0.1803 0.0269 0.089 Uiso 1 1 calc R . . 
C13 C 0.6011(3) 0.2329(3) 0.2021(3) 0.0591(6) Uani 1 1 d . . . 
H13A H 0.5894 0.3340 0.1880 0.071 Uiso 1 1 calc R . . 
C14 C 0.7709(3) 0.4906(2) 0.5168(3) 0.0487(5) Uani 1 1 d . . . 
C15 C 0.7258(4) 0.5560(3) 0.6432(3) 0.0638(7) Uani 1 1 d . . . 
H15A H 0.7934 0.5122 0.7421 0.077 Uiso 1 1 calc R . . 
H15B H 0.6117 0.5341 0.6220 0.077 Uiso 1 1 calc R . . 
 
loop_ 
_atom_site_aniso_label 
_atom_site_aniso_U_11 
_atom_site_aniso_U_22 
_atom_site_aniso_U_33 
_atom_site_aniso_U_23 
_atom_site_aniso_U_13 
_atom_site_aniso_U_12 
Cl 0.0953(5) 0.0447(3) 0.1103(6) -0.0148(4) 0.0586(5) -0.0098(3) 
O 0.0942(15) 0.0537(11) 0.0656(11) 0.0091(9) 0.0404(10) 0.0001(10) 
N 0.0520(10) 0.0454(11) 0.0513(11) -0.0008(8) 0.0256(9) -0.0006(8) 
C1 0.0541(14) 0.0692(19) 0.0618(15) 0.0029(14) 0.0142(11) -0.0066(13) 
C2 0.077(2) 0.101(3) 0.087(2) 0.032(2) 0.0236(18) 0.017(2) 
C3 0.103(3) 0.108(3) 0.083(2) 0.046(2) 0.046(2) 0.024(2) 
C4 0.0782(18) 0.0528(16) 0.099(2) 0.0161(16) 0.0553(18) 0.0041(14) 
C5 0.0522(13) 0.0442(13) 0.0603(14) -0.0031(11) 0.0233(11) 0.0011(10) 
C6 0.0511(12) 0.0384(11) 0.0467(11) -0.0037(10) 0.0210(9) -0.0003(10) 
C7 0.0560(14) 0.0527(15) 0.0597(14) -0.0058(12) 0.0328(12) -0.0015(11) 
C8 0.0609(15) 0.0447(13) 0.0517(13) -0.0006(10) 0.0363(12) 0.0032(10) 
C9 0.0672(18) 0.0524(16) 0.0782(18) 0.0048(13) 0.0353(15) 0.0143(12) 
C10 0.087(2) 0.0494(15) 0.111(3) -0.0177(17) 0.057(2) -0.0073(15) 
C11 0.082(2) 0.083(2) 0.080(2) -0.0334(18) 0.0467(18) -0.0331(18) 
C12 0.0663(17) 0.098(3) 0.0549(15) 0.0028(16) 0.0221(13) -0.0038(17) 
C13 0.0726(16) 0.0557(16) 0.0516(13) 0.0073(13) 0.0273(12) 0.0047(14) 
C14 0.0512(14) 0.0424(12) 0.0523(13) -0.0024(11) 0.0202(11) -0.0066(10) 
C15 0.0881(19) 0.0401(13) 0.0739(17) -0.0010(13) 0.0436(16) -0.0005(13) 
 
_geom_special_details             
;  
 All esds (except the esd in the dihedral angle between two l.s. planes)  
 are estimated using the full covariance matrix.  The cell esds are taken  
 into account individually in the estimation of esds in distances, angles  
 and torsion angles; correlations between esds in cell parameters are only  
 used when they are defined by crystal symmetry.  An approximate 
(isotropic)  
 treatment of cell esds is used for estimating esds involving l.s. planes.  
; 
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loop_ 
_geom_bond_atom_site_label_1 
_geom_bond_atom_site_label_2 
_geom_bond_distance 
_geom_bond_site_symmetry_2 
_geom_bond_publ_flag 
Cl C15 1.757(3) . ? 
O C14 1.206(3) . ? 
N C14 1.348(3) . ? 
N C6 1.434(3) . ? 
N C7 1.463(3) . ? 
C1 C6 1.499(4) . ? 
C1 C2 1.510(5) . ? 
C1 H1A 0.9700 . ? 
C1 H1B 0.9700 . ? 
C2 C3 1.491(5) . ? 
C2 H2A 0.9700 . ? 
C2 H2B 0.9700 . ? 
C3 C4 1.478(6) . ? 
C3 H3A 0.9700 . ? 
C3 H3B 0.9700 . ? 
C4 C5 1.488(4) . ? 
C4 H4A 0.9700 . ? 
C4 H4B 0.9700 . ? 
C5 C6 1.325(3) . ? 
C5 H5A 0.9300 . ? 
C7 C8 1.501(4) . ? 
C7 H7A 0.9700 . ? 
C7 H7B 0.9700 . ? 
C8 C13 1.374(4) . ? 
C8 C9 1.386(4) . ? 
C9 C10 1.373(5) . ? 
C9 H9A 0.9300 . ? 
C10 C11 1.358(5) . ? 
C10 H10A 0.9300 . ? 
C11 C12 1.395(5) . ? 
C11 H11A 0.9300 . ? 
C12 C13 1.373(4) . ? 
C12 H12A 0.9300 . ? 
C13 H13A 0.9300 . ? 
C14 C15 1.515(4) . ? 
C15 H15A 0.9700 . ? 
C15 H15B 0.9700 . ? 
 
loop_ 
_geom_angle_atom_site_label_1 
_geom_angle_atom_site_label_2 
_geom_angle_atom_site_label_3 
_geom_angle 
_geom_angle_site_symmetry_1 
_geom_angle_site_symmetry_3 
_geom_angle_publ_flag 
C14 N C6 124.18(19) . . ? 
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C14 N C7 119.2(2) . . ? 
C6 N C7 116.6(2) . . ? 
C6 C1 C2 112.3(2) . . ? 
C6 C1 H1A 109.1 . . ? 
C2 C1 H1A 109.1 . . ? 
C6 C1 H1B 109.1 . . ? 
C2 C1 H1B 109.1 . . ? 
H1A C1 H1B 107.9 . . ? 
C3 C2 C1 111.3(3) . . ? 
C3 C2 H2A 109.4 . . ? 
C1 C2 H2A 109.4 . . ? 
C3 C2 H2B 109.4 . . ? 
C1 C2 H2B 109.4 . . ? 
H2A C2 H2B 108.0 . . ? 
C4 C3 C2 112.5(3) . . ? 
C4 C3 H3A 109.1 . . ? 
C2 C3 H3A 109.1 . . ? 
C4 C3 H3B 109.1 . . ? 
C2 C3 H3B 109.1 . . ? 
H3A C3 H3B 107.8 . . ? 
C3 C4 C5 112.9(3) . . ? 
C3 C4 H4A 109.0 . . ? 
C5 C4 H4A 109.0 . . ? 
C3 C4 H4B 109.0 . . ? 
C5 C4 H4B 109.0 . . ? 
H4A C4 H4B 107.8 . . ? 
C6 C5 C4 122.5(3) . . ? 
C6 C5 H5A 118.7 . . ? 
C4 C5 H5A 118.7 . . ? 
C5 C6 N 120.5(2) . . ? 
C5 C6 C1 123.1(2) . . ? 
N C6 C1 116.4(2) . . ? 
N C7 C8 112.57(18) . . ? 
N C7 H7A 109.1 . . ? 
C8 C7 H7A 109.1 . . ? 
N C7 H7B 109.1 . . ? 
C8 C7 H7B 109.1 . . ? 
H7A C7 H7B 107.8 . . ? 
C13 C8 C9 118.4(3) . . ? 
C13 C8 C7 121.2(2) . . ? 
C9 C8 C7 120.4(3) . . ? 
C10 C9 C8 121.1(3) . . ? 
C10 C9 H9A 119.4 . . ? 
C8 C9 H9A 119.4 . . ? 
C11 C10 C9 119.8(3) . . ? 
C11 C10 H10A 120.1 . . ? 
C9 C10 H10A 120.1 . . ? 
C10 C11 C12 120.3(3) . . ? 
C10 C11 H11A 119.8 . . ? 
C12 C11 H11A 119.8 . . ? 
C13 C12 C11 119.2(3) . . ? 
C13 C12 H12A 120.4 . . ? 
C11 C12 H12A 120.4 . . ? 
C8 C13 C12 121.1(3) . . ? 
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C8 C13 H13A 119.4 . . ? 
C12 C13 H13A 119.4 . . ? 
O C14 N 123.0(2) . . ? 
O C14 C15 122.0(2) . . ? 
N C14 C15 115.0(2) . . ? 
C14 C15 Cl 110.72(18) . . ? 
C14 C15 H15A 109.5 . . ? 
Cl C15 H15A 109.5 . . ? 
C14 C15 H15B 109.5 . . ? 
Cl C15 H15B 109.5 . . ? 
H15A C15 H15B 108.1 . . ? 
 
_diffrn_measured_fraction_theta_max 0.985 
_diffrn_reflns_theta_full        27.50 
_diffrn_measured_fraction_theta_full 0.985 
_refine_diff_density_max         0.331 
_refine_diff_density_min         -0.193 
_refine_diff_density_rms         0.044 
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
 
The corresponding CIF file for anti-4.15 is shown below, between the lines of “+” symbols. 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
data_dg1009s  
   
_audit_creation_method            SHELXL-97  
_chemical_name_systematic  
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;  
 ?  
;  
_chemical_name_common             ?  
_chemical_melting_point           ?  
_chemical_formula_moiety          ?  
_chemical_formula_sum  
 'C16 H20 I N O'  
_chemical_formula_weight          369.23  
   
loop_  
 _atom_type_symbol  
 _atom_type_description  
 _atom_type_scat_dispersion_real  
 _atom_type_scat_dispersion_imag  
 _atom_type_scat_source  
 'C'  'C'   0.0033   0.0016  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'H'  'H'   0.0000   0.0000  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'N'  'N'   0.0061   0.0033  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'O'  'O'   0.0106   0.0060  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'I'  'I'  -0.4742   1.8119  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
   
_symmetry_cell_setting            Triclinic  
_symmetry_space_group_name_H-M    P-1  
   
loop_  
 _symmetry_equiv_pos_as_xyz  
 'x, y, z'  
 '-x, -y, -z'  
   
_cell_length_a                    9.0294(5)  
_cell_length_b                    9.6581(5)  
_cell_length_c                    19.4301(10)  
_cell_angle_alpha                 79.2830(10)  
_cell_angle_beta                  79.3550(10)  
_cell_angle_gamma                 79.7700(10)  
_cell_volume                      1618.13(15)  
_cell_formula_units_Z             4  
_cell_measurement_temperature     203(2)  
_cell_measurement_reflns_used     5413  
_cell_measurement_theta_min       2.16  
_cell_measurement_theta_max       32.33  
   
_exptl_crystal_description        ?  
_exptl_crystal_colour             ?  
_exptl_crystal_size_max           0.26  
_exptl_crystal_size_mid           0.21  
_exptl_crystal_size_min           0.13  
_exptl_crystal_density_meas       0  
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_exptl_crystal_density_diffrn     1.516  
_exptl_crystal_density_method     'not measured'  
_exptl_crystal_F_000              736  
_exptl_absorpt_coefficient_mu     1.972  
_exptl_absorpt_correction_type    none  
_exptl_absorpt_correction_T_min   0.6281  
_exptl_absorpt_correction_T_max   0.7836  
_exptl_absorpt_process_details    ?  
   
_exptl_special_details  
;  
 ?  
;  
   
_diffrn_ambient_temperature       203(2)  
_diffrn_radiation_wavelength      0.71073  
_diffrn_radiation_type            MoK\a  
_diffrn_radiation_source          'fine-focus sealed tube'  
_diffrn_radiation_monochromator   graphite  
_diffrn_measurement_device_type   'CCD area detector'  
_diffrn_measurement_method        'phi and omega scans'  
_diffrn_detector_area_resol_mean  ?  
_diffrn_standards_number          ?  
_diffrn_standards_interval_count  ?  
_diffrn_standards_interval_time   ?  
_diffrn_standards_decay_%         ?  
_diffrn_reflns_number             15820  
_diffrn_reflns_av_R_equivalents   0.0195  
_diffrn_reflns_av_sigmaI/netI     0.0291  
_diffrn_reflns_limit_h_min        -11  
_diffrn_reflns_limit_h_max        11  
_diffrn_reflns_limit_k_min        -12  
_diffrn_reflns_limit_k_max        12  
_diffrn_reflns_limit_l_min        -25  
_diffrn_reflns_limit_l_max        25  
_diffrn_reflns_theta_min          2.16  
_diffrn_reflns_theta_max          27.50  
_reflns_number_total              7401  
_reflns_number_gt                 5740  
_reflns_threshold_expression      >2sigma(I)  
   
_computing_data_collection        'Bruker SMART'  
_computing_cell_refinement        'Bruker SMART'  
_computing_data_reduction         'Bruker SAINT'  
_computing_structure_solution     'SHELXS-97 (Sheldrick, 1990)'  
_computing_structure_refinement   'SHELXL-97 (Sheldrick, 1997)'  
_computing_molecular_graphics     'Bruker SHELXTL'  
_computing_publication_material   'Bruker SHELXTL'  
   
_refine_special_details  
;  
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and  
 goodness of fit S are based on F^2^, conventional R-factors R are based  
 on F, with F set to zero for negative F^2^. The threshold expression of  
  299 
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and 
is  
 not relevant to the choice of reflections for refinement.  R-factors 
based  
 on F^2^ are statistically about twice as large as those based on F, and 
R-  
 factors based on ALL data will be even larger.  
;  
   
_refine_ls_structure_factor_coef  Fsqd  
_refine_ls_matrix_type            full  
_refine_ls_weighting_scheme       calc  
_refine_ls_weighting_details  
 'calc w=1/[\s^2^(Fo^2^)+(0.0780P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3'  
_atom_sites_solution_primary      direct  
_atom_sites_solution_secondary    difmap  
_atom_sites_solution_hydrogens    geom  
_refine_ls_hydrogen_treatment     mixed  
_refine_ls_extinction_method      none  
_refine_ls_extinction_coef        ?  
_refine_ls_number_reflns          7401  
_refine_ls_number_parameters      343  
_refine_ls_number_restraints      0  
_refine_ls_R_factor_all           0.0627  
_refine_ls_R_factor_gt            0.0490  
_refine_ls_wR_factor_ref          0.1482  
_refine_ls_wR_factor_gt           0.1410  
_refine_ls_goodness_of_fit_ref    1.184  
_refine_ls_restrained_S_all       1.184  
_refine_ls_shift/su_max           0.001  
_refine_ls_shift/su_mean          0.000  
   
loop_  
 _atom_site_label  
 _atom_site_type_symbol  
 _atom_site_fract_x  
 _atom_site_fract_y  
 _atom_site_fract_z  
 _atom_site_U_iso_or_equiv  
 _atom_site_adp_type  
 _atom_site_occupancy  
 _atom_site_symmetry_multiplicity  
 _atom_site_calc_flag  
 _atom_site_refinement_flags  
 _atom_site_disorder_assembly  
 _atom_site_disorder_group  
I1 I 0.49755(3) 0.95261(3) 0.131604(19) 0.06503(13) Uani 1 1 d . . .  
N1 N 0.2237(4) 0.8249(3) 0.08862(17) 0.0442(7) Uani 1 1 d . . .  
C1 C 0.2910(5) 0.9000(4) 0.1920(2) 0.0505(10) Uani 1 1 d . . .  
O1 O 0.2479(4) 0.9101(3) -0.02927(17) 0.0645(8) Uani 1 1 d . . .  
I2 I 0.59107(4) -0.00035(3) 0.382897(17) 0.06506(13) Uani 1 1 d . . .  
N2 N 0.4249(4) 0.3198(4) 0.40633(16) 0.0473(8) Uani 1 1 d . . .  
C2 C 0.1861(4) 0.8503(4) 0.1602(2) 0.0453(9) Uani 1 1 d . . .  
O2 O 0.3729(4) 0.2951(4) 0.52553(16) 0.0740(10) Uani 1 1 d . . .  
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C3 C 0.0471(4) 0.8257(4) 0.2000(2) 0.0498(9) Uani 1 1 d . . .  
C4 C 0.0174(5) 0.8438(5) 0.2703(2) 0.0596(11) Uani 1 1 d . . .  
H4A H -0.0771 0.8261 0.2972 0.071 Uiso 1 1 calc R . .  
C5 C 0.1225(6) 0.8871(5) 0.3026(3) 0.0645(12) Uani 1 1 d . . .  
C6 C 0.2579(5) 0.9181(5) 0.2619(3) 0.0603(11) Uani 1 1 d . . .  
H6A H 0.3285 0.9520 0.2821 0.072 Uiso 1 1 calc R . .  
C7 C 0.3017(4) 0.6813(4) 0.0725(2) 0.0456(9) Uani 1 1 d . . .  
H7A H 0.3926 0.6967 0.0364 0.055 Uiso 1 1 calc R . .  
C8 C 0.2010(5) 0.6114(5) 0.0406(2) 0.0521(10) Uani 1 1 d . . .  
H8A H 0.1329 0.6696 0.0122 0.063 Uiso 1 1 calc R . .  
C9 C 0.2034(5) 0.4727(5) 0.0503(3) 0.0590(11) Uani 1 1 d . . .  
H9A H 0.1372 0.4365 0.0284 0.071 Uiso 1 1 calc R . .  
C10 C 0.3066(6) 0.3694(5) 0.0946(3) 0.0658(12) Uani 1 1 d . . .  
H10A H 0.2457 0.3272 0.1380 0.079 Uiso 1 1 calc R . .  
H10B H 0.3573 0.2923 0.0682 0.079 Uiso 1 1 calc R . .  
C11 C 0.4246(6) 0.4400(5) 0.1139(3) 0.0648(12) Uani 1 1 d . . .  
H11A H 0.5057 0.4531 0.0731 0.078 Uiso 1 1 calc R . .  
H11B H 0.4701 0.3782 0.1529 0.078 Uiso 1 1 calc R . .  
C12 C 0.3564(5) 0.5854(4) 0.1363(2) 0.0550(10) Uani 1 1 d . . .  
H12A H 0.2712 0.5748 0.1753 0.066 Uiso 1 1 calc R . .  
H12B H 0.4337 0.6260 0.1523 0.066 Uiso 1 1 calc R . .  
C13 C 0.2072(5) 0.9316(4) 0.0316(3) 0.0536(10) Uani 1 1 d . . .  
C14 C 0.1313(6) 1.0770(5) 0.0490(3) 0.0737(14) Uani 1 1 d . . .  
H14A H 0.1250 1.1440 0.0054 0.111 Uiso 1 1 calc R . .  
H14B H 0.1909 1.1099 0.0778 0.111 Uiso 1 1 calc R . .  
H14C H 0.0296 1.0700 0.0750 0.111 Uiso 1 1 calc R . .  
C15 C -0.0720(5) 0.7786(6) 0.1682(3) 0.0676(13) Uani 1 1 d . . .  
H15A H -0.0345 0.7716 0.1187 0.101 Uiso 1 1 calc R . .  
H15B H -0.1643 0.8475 0.1719 0.101 Uiso 1 1 calc R . .  
H15C H -0.0941 0.6862 0.1936 0.101 Uiso 1 1 calc R . .  
C17 C 0.0905(8) 0.9005(7) 0.3813(3) 0.0940(19) Uani 1 1 d . . .  
H17A H 0.1764 0.9323 0.3941 0.141 Uiso 1 1 calc R . .  
H17B H 0.0751 0.8085 0.4094 0.141 Uiso 1 1 calc R . .  
H17C H -0.0004 0.9691 0.3905 0.141 Uiso 1 1 calc R . .  
C18 C 0.6153(5) 0.1998(5) 0.3213(2) 0.0517(10) Uani 1 1 d . . .  
C19 C 0.5357(4) 0.3236(4) 0.34344(19) 0.0458(9) Uani 1 1 d . . .  
C20 C 0.5639(5) 0.4556(5) 0.3033(2) 0.0506(9) Uani 1 1 d . . .  
C21 C 0.6696(5) 0.4553(5) 0.2416(2) 0.0598(11) Uani 1 1 d . . .  
H21A H 0.6894 0.5430 0.2142 0.072 Uiso 1 1 calc R . .  
C22 C 0.7466(5) 0.3317(6) 0.2190(2) 0.0646(12) Uani 1 1 d . . .  
C23 C 0.7207(5) 0.2047(5) 0.2591(2) 0.0601(11) Uani 1 1 d . . .  
H23A H 0.7743 0.1195 0.2448 0.072 Uiso 1 1 calc R . .  
C24 C 0.2611(5) 0.3116(5) 0.4029(2) 0.0565(10) Uani 1 1 d . . .  
H24A H 0.2311 0.2291 0.4380 0.068 Uiso 1 1 calc R . .  
C25 C 0.1575(6) 0.4417(6) 0.4231(3) 0.0669(12) Uani 1 1 d . . .  
H25A H 0.1774 0.4816 0.4604 0.080 Uiso 1 1 calc R . .  
C26 C 0.0406(6) 0.5032(6) 0.3917(3) 0.0787(15) Uani 1 1 d . . .  
H26A H -0.0179 0.5856 0.4071 0.094 Uiso 1 1 calc R . .  
C27 C -0.0040(7) 0.4482(7) 0.3327(3) 0.0849(16) Uani 1 1 d . . .  
H27A H -0.1148 0.4509 0.3407 0.102 Uiso 1 1 calc R . .  
H27B H 0.0239 0.5103 0.2879 0.102 Uiso 1 1 calc R . .  
C28 C 0.0713(7) 0.3003(7) 0.3273(3) 0.0856(17) Uani 1 1 d . . .  
H28A H 0.0582 0.2753 0.2824 0.103 Uiso 1 1 calc R . .  
H28B H 0.0237 0.2343 0.3662 0.103 Uiso 1 1 calc R . .  
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C29 C 0.2413(6) 0.2861(6) 0.3309(3) 0.0695(13) Uani 1 1 d . . .  
H29A H 0.2918 0.1905 0.3231 0.083 Uiso 1 1 calc R . .  
H29B H 0.2882 0.3557 0.2937 0.083 Uiso 1 1 calc R . .  
C30 C 0.4657(6) 0.3075(5) 0.4722(2) 0.0559(10) Uani 1 1 d . . .  
C31 C 0.6300(6) 0.3130(6) 0.4740(3) 0.0724(14) Uani 1 1 d . . .  
H31A H 0.6455 0.3038 0.5228 0.109 Uiso 1 1 calc R . .  
H31B H 0.6570 0.4032 0.4480 0.109 Uiso 1 1 calc R . .  
H31C H 0.6936 0.2355 0.4524 0.109 Uiso 1 1 calc R . .  
C32 C 0.5031(8) 0.6039(5) 0.3257(2) 0.093(2) Uani 1 1 d . . .  
H32A H 0.5385 0.6775 0.2882 0.139 Uiso 1 1 calc R . .  
H32B H 0.5403 0.6090 0.3688 0.139 Uiso 1 1 calc R . .  
H32C H 0.3926 0.6177 0.3342 0.139 Uiso 1 1 calc R . .  
C33 C 0.8587(7) 0.3350(8) 0.1495(3) 0.096(2) Uani 1 1 d . . .  
H33A H 0.9033 0.2384 0.1429 0.145 Uiso 1 1 calc R . .  
H33B H 0.9387 0.3888 0.1512 0.145 Uiso 1 1 calc R . .  
H33C H 0.8052 0.3799 0.1103 0.145 Uiso 1 1 calc R . .  
   
loop_  
 _atom_site_aniso_label  
 _atom_site_aniso_U_11  
 _atom_site_aniso_U_22  
 _atom_site_aniso_U_33  
 _atom_site_aniso_U_23  
 _atom_site_aniso_U_13  
 _atom_site_aniso_U_12  
I1 0.04592(18) 0.0609(2) 0.0939(3) -0.01275(16) -0.02136(15) -0.01130(13)  
N1 0.0427(17) 0.0396(16) 0.0523(19) -0.0072(14) -0.0150(14) -0.0040(13)  
C1 0.044(2) 0.043(2) 0.067(3) -0.0152(19) -0.0163(19) -0.0005(16)  
O1 0.072(2) 0.069(2) 0.054(2) 0.0052(15) -0.0150(16) -0.0230(16)  
I2 0.0679(2) 0.0574(2) 0.0637(2) -0.00712(14) -0.00463(15) -0.00129(15)  
N2 0.0428(18) 0.062(2) 0.0365(17) -0.0104(15) -0.0044(13) -0.0057(15)  
C2 0.044(2) 0.041(2) 0.052(2) -0.0082(16) -0.0145(17) 0.0014(15)  
O2 0.084(2) 0.092(2) 0.0349(17) -0.0033(15) -0.0019(16) 0.0025(19)  
C3 0.040(2) 0.050(2) 0.059(3) -0.0112(18) -0.0124(18) 0.0022(16)  
C4 0.058(3) 0.054(2) 0.062(3) -0.015(2) -0.006(2) 0.004(2)  
C5 0.072(3) 0.055(3) 0.067(3) -0.024(2) -0.020(2) 0.013(2)  
C6 0.059(3) 0.055(3) 0.075(3) -0.025(2) -0.026(2) 0.000(2)  
C7 0.0380(19) 0.046(2) 0.051(2) -0.0081(17) -0.0058(16) -0.0015(15)  
C8 0.052(2) 0.059(3) 0.048(2) -0.0086(18) -0.0146(18) -0.0067(19)  
C9 0.055(3) 0.056(3) 0.073(3) -0.023(2) -0.014(2) -0.009(2)  
C10 0.068(3) 0.048(2) 0.086(4) -0.019(2) -0.018(3) -0.007(2)  
C11 0.064(3) 0.051(3) 0.082(3) -0.017(2) -0.025(2) 0.006(2)  
C12 0.055(2) 0.053(2) 0.060(3) -0.017(2) -0.022(2) 0.0048(19)  
C13 0.045(2) 0.050(2) 0.071(3) -0.002(2) -0.021(2) -0.0136(17)  
C14 0.080(4) 0.050(3) 0.097(4) -0.001(2) -0.046(3) -0.003(2)  
C15 0.048(3) 0.089(4) 0.072(3) -0.015(3) -0.011(2) -0.025(2)  
C17 0.114(5) 0.100(5) 0.069(4) -0.031(3) -0.015(3) 0.000(4)  
C18 0.054(2) 0.059(3) 0.042(2) -0.0081(18) -0.0120(18) -0.0034(19)  
C19 0.044(2) 0.061(2) 0.0344(19) -0.0093(17) -0.0085(15) -0.0070(17)  
C20 0.053(2) 0.061(2) 0.044(2) -0.0058(18) -0.0148(18) -0.0177(19)  
C21 0.057(3) 0.075(3) 0.051(3) -0.002(2) -0.012(2) -0.025(2)  
C22 0.048(2) 0.100(4) 0.046(2) -0.011(2) -0.0033(19) -0.016(2)  
C23 0.051(2) 0.076(3) 0.053(3) -0.022(2) -0.005(2) 0.002(2)  
C24 0.045(2) 0.073(3) 0.051(2) -0.007(2) -0.0066(18) -0.012(2)  
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C25 0.055(3) 0.080(3) 0.063(3) -0.018(2) 0.002(2) -0.008(2)  
C26 0.055(3) 0.083(4) 0.089(4) -0.003(3) -0.010(3) 0.003(3)  
C27 0.060(3) 0.097(4) 0.088(4) 0.004(3) -0.014(3) -0.003(3)  
C28 0.068(4) 0.113(5) 0.086(4) -0.018(3) -0.027(3) -0.024(3)  
C29 0.057(3) 0.086(4) 0.075(3) -0.035(3) -0.013(2) -0.008(2)  
C30 0.070(3) 0.057(2) 0.038(2) -0.0047(18) -0.016(2) 0.001(2)  
C31 0.071(3) 0.099(4) 0.052(3) -0.014(3) -0.027(2) -0.005(3)  
C32 0.161(6) 0.048(3) 0.035(2) -0.0027(19) 0.009(3) 0.046(3)  
C33 0.079(4) 0.133(6) 0.067(4) -0.009(3) 0.019(3) -0.024(4)  
   
_geom_special_details  
;  
 All esds (except the esd in the dihedral angle between two l.s. planes)  
 are estimated using the full covariance matrix.  The cell esds are taken  
 into account individually in the estimation of esds in distances, angles  
 and torsion angles; correlations between esds in cell parameters are only  
 used when they are defined by crystal symmetry.  An approximate 
(isotropic)  
 treatment of cell esds is used for estimating esds involving l.s. planes.  
;  
   
loop_  
 _geom_bond_atom_site_label_1  
 _geom_bond_atom_site_label_2  
 _geom_bond_distance  
 _geom_bond_site_symmetry_2  
 _geom_bond_publ_flag  
I1 C1 2.102(4) . ?  
N1 C13 1.376(5) . ?  
N1 C2 1.426(5) . ?  
N1 C7 1.500(5) . ?  
C1 C6 1.373(6) . ?  
C1 C2 1.412(5) . ?  
O1 C13 1.217(5) . ?  
I2 C18 2.101(4) . ?  
N2 C30 1.375(5) . ?  
N2 C19 1.428(5) . ?  
N2 C24 1.509(5) . ?  
C2 C3 1.382(6) . ?  
O2 C30 1.208(5) . ?  
C3 C4 1.380(6) . ?  
C3 C15 1.506(6) . ?  
C4 C5 1.390(7) . ?  
C4 H4A 0.9400 . ?  
C5 C6 1.377(7) . ?  
C5 C17 1.528(7) . ?  
C6 H6A 0.9400 . ?  
C7 C8 1.499(6) . ?  
C7 C12 1.509(5) . ?  
C7 H7A 0.9900 . ?  
C8 C9 1.314(6) . ?  
C8 H8A 0.9400 . ?  
C9 C10 1.501(7) . ?  
C9 H9A 0.9400 . ?  
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C10 C11 1.497(7) . ?  
C10 H10A 0.9800 . ?  
C10 H10B 0.9800 . ?  
C11 C12 1.537(6) . ?  
C11 H11A 0.9800 . ?  
C11 H11B 0.9800 . ?  
C12 H12A 0.9800 . ?  
C12 H12B 0.9800 . ?  
C13 C14 1.518(7) . ?  
C14 H14A 0.9700 . ?  
C14 H14B 0.9700 . ?  
C14 H14C 0.9700 . ?  
C15 H15A 0.9700 . ?  
C15 H15B 0.9700 . ?  
C15 H15C 0.9700 . ?  
C17 H17A 0.9700 . ?  
C17 H17B 0.9700 . ?  
C17 H17C 0.9700 . ?  
C18 C19 1.380(6) . ?  
C18 C23 1.391(6) . ?  
C19 C20 1.404(6) . ?  
C20 C21 1.388(6) . ?  
C20 C32 1.551(6) . ?  
C21 C22 1.374(7) . ?  
C21 H21A 0.9400 . ?  
C22 C23 1.359(7) . ?  
C22 C33 1.530(7) . ?  
C23 H23A 0.9400 . ?  
C24 C25 1.496(7) . ?  
C24 C29 1.511(6) . ?  
C24 H24A 0.9900 . ?  
C25 C26 1.311(7) . ?  
C25 H25A 0.9400 . ?  
C26 C27 1.494(8) . ?  
C26 H26A 0.9400 . ?  
C27 C28 1.483(9) . ?  
C27 H27A 0.9800 . ?  
C27 H27B 0.9800 . ?  
C28 C29 1.530(7) . ?  
C28 H28A 0.9800 . ?  
C28 H28B 0.9800 . ?  
C29 H29A 0.9800 . ?  
C29 H29B 0.9800 . ?  
C30 C31 1.501(7) . ?  
C31 H31A 0.9700 . ?  
C31 H31B 0.9700 . ?  
C31 H31C 0.9700 . ?  
C32 H32A 0.9700 . ?  
C32 H32B 0.9700 . ?  
C32 H32C 0.9700 . ?  
C33 H33A 0.9700 . ?  
C33 H33B 0.9700 . ?  
C33 H33C 0.9700 . ?  
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loop_  
 _geom_angle_atom_site_label_1  
 _geom_angle_atom_site_label_2  
 _geom_angle_atom_site_label_3  
 _geom_angle  
 _geom_angle_site_symmetry_1  
 _geom_angle_site_symmetry_3  
 _geom_angle_publ_flag  
C13 N1 C2 122.6(3) . . ?  
C13 N1 C7 116.8(3) . . ?  
C2 N1 C7 120.1(3) . . ?  
C6 C1 C2 120.6(4) . . ?  
C6 C1 I1 119.2(3) . . ?  
C2 C1 I1 120.2(3) . . ?  
C30 N2 C19 121.6(4) . . ?  
C30 N2 C24 117.8(3) . . ?  
C19 N2 C24 120.2(3) . . ?  
C3 C2 C1 118.8(4) . . ?  
C3 C2 N1 120.7(3) . . ?  
C1 C2 N1 120.6(4) . . ?  
C4 C3 C2 119.3(4) . . ?  
C4 C3 C15 119.4(4) . . ?  
C2 C3 C15 121.3(4) . . ?  
C3 C4 C5 122.2(5) . . ?  
C3 C4 H4A 118.9 . . ?  
C5 C4 H4A 118.9 . . ?  
C6 C5 C4 118.3(4) . . ?  
C6 C5 C17 120.3(5) . . ?  
C4 C5 C17 121.5(5) . . ?  
C5 C6 C1 120.8(4) . . ?  
C5 C6 H6A 119.6 . . ?  
C1 C6 H6A 119.6 . . ?  
C8 C7 N1 110.9(3) . . ?  
C8 C7 C12 111.2(3) . . ?  
N1 C7 C12 112.7(3) . . ?  
C8 C7 H7A 107.3 . . ?  
N1 C7 H7A 107.3 . . ?  
C12 C7 H7A 107.3 . . ?  
C9 C8 C7 123.1(4) . . ?  
C9 C8 H8A 118.4 . . ?  
C7 C8 H8A 118.4 . . ?  
C8 C9 C10 123.2(4) . . ?  
C8 C9 H9A 118.4 . . ?  
C10 C9 H9A 118.4 . . ?  
C11 C10 C9 111.8(4) . . ?  
C11 C10 H10A 109.3 . . ?  
C9 C10 H10A 109.3 . . ?  
C11 C10 H10B 109.3 . . ?  
C9 C10 H10B 109.3 . . ?  
H10A C10 H10B 107.9 . . ?  
C10 C11 C12 111.7(4) . . ?  
C10 C11 H11A 109.3 . . ?  
C12 C11 H11A 109.3 . . ?  
C10 C11 H11B 109.3 . . ?  
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C12 C11 H11B 109.3 . . ?  
H11A C11 H11B 107.9 . . ?  
C7 C12 C11 107.4(4) . . ?  
C7 C12 H12A 110.2 . . ?  
C11 C12 H12A 110.2 . . ?  
C7 C12 H12B 110.2 . . ?  
C11 C12 H12B 110.2 . . ?  
H12A C12 H12B 108.5 . . ?  
O1 C13 N1 122.0(4) . . ?  
O1 C13 C14 121.9(4) . . ?  
N1 C13 C14 116.1(4) . . ?  
C13 C14 H14A 109.5 . . ?  
C13 C14 H14B 109.5 . . ?  
H14A C14 H14B 109.5 . . ?  
C13 C14 H14C 109.5 . . ?  
H14A C14 H14C 109.5 . . ?  
H14B C14 H14C 109.5 . . ?  
C3 C15 H15A 109.5 . . ?  
C3 C15 H15B 109.5 . . ?  
H15A C15 H15B 109.5 . . ?  
C3 C15 H15C 109.5 . . ?  
H15A C15 H15C 109.5 . . ?  
H15B C15 H15C 109.5 . . ?  
C5 C17 H17A 109.5 . . ?  
C5 C17 H17B 109.5 . . ?  
H17A C17 H17B 109.5 . . ?  
C5 C17 H17C 109.5 . . ?  
H17A C17 H17C 109.5 . . ?  
H17B C17 H17C 109.5 . . ?  
C19 C18 C23 120.7(4) . . ?  
C19 C18 I2 121.2(3) . . ?  
C23 C18 I2 117.9(3) . . ?  
C18 C19 C20 119.3(4) . . ?  
C18 C19 N2 121.2(4) . . ?  
C20 C19 N2 119.4(4) . . ?  
C21 C20 C19 117.9(4) . . ?  
C21 C20 C32 115.6(4) . . ?  
C19 C20 C32 126.1(4) . . ?  
C22 C21 C20 122.5(4) . . ?  
C22 C21 H21A 118.7 . . ?  
C20 C21 H21A 118.7 . . ?  
C23 C22 C21 119.0(4) . . ?  
C23 C22 C33 119.8(5) . . ?  
C21 C22 C33 121.2(5) . . ?  
C22 C23 C18 120.5(4) . . ?  
C22 C23 H23A 119.8 . . ?  
C18 C23 H23A 119.8 . . ?  
C25 C24 N2 111.4(4) . . ?  
C25 C24 C29 110.9(4) . . ?  
N2 C24 C29 112.0(3) . . ?  
C25 C24 H24A 107.5 . . ?  
N2 C24 H24A 107.5 . . ?  
C29 C24 H24A 107.5 . . ?  
C26 C25 C24 123.8(5) . . ?  
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C26 C25 H25A 118.1 . . ?  
C24 C25 H25A 118.1 . . ?  
C25 C26 C27 123.0(5) . . ?  
C25 C26 H26A 118.5 . . ?  
C27 C26 H26A 118.5 . . ?  
C28 C27 C26 111.8(5) . . ?  
C28 C27 H27A 109.3 . . ?  
C26 C27 H27A 109.3 . . ?  
C28 C27 H27B 109.3 . . ?  
C26 C27 H27B 109.3 . . ?  
H27A C27 H27B 107.9 . . ?  
C27 C28 C29 110.4(5) . . ?  
C27 C28 H28A 109.6 . . ?  
C29 C28 H28A 109.6 . . ?  
C27 C28 H28B 109.6 . . ?  
C29 C28 H28B 109.6 . . ?  
H28A C28 H28B 108.1 . . ?  
C24 C29 C28 109.4(4) . . ?  
C24 C29 H29A 109.8 . . ?  
C28 C29 H29A 109.8 . . ?  
C24 C29 H29B 109.8 . . ?  
C28 C29 H29B 109.8 . . ?  
H29A C29 H29B 108.2 . . ?  
O2 C30 N2 121.3(4) . . ?  
O2 C30 C31 122.1(4) . . ?  
N2 C30 C31 116.6(4) . . ?  
C30 C31 H31A 109.5 . . ?  
C30 C31 H31B 109.5 . . ?  
H31A C31 H31B 109.5 . . ?  
C30 C31 H31C 109.5 . . ?  
H31A C31 H31C 109.5 . . ?  
H31B C31 H31C 109.5 . . ?  
C20 C32 H32A 109.5 . . ?  
C20 C32 H32B 109.5 . . ?  
H32A C32 H32B 109.5 . . ?  
C20 C32 H32C 109.5 . . ?  
H32A C32 H32C 109.5 . . ?  
H32B C32 H32C 109.5 . . ?  
C22 C33 H33A 109.5 . . ?  
C22 C33 H33B 109.5 . . ?  
H33A C33 H33B 109.5 . . ?  
C22 C33 H33C 109.5 . . ?  
H33A C33 H33C 109.5 . . ?  
H33B C33 H33C 109.5 . . ?  
   
_diffrn_measured_fraction_theta_max    0.994  
_diffrn_reflns_theta_full              27.50  
_diffrn_measured_fraction_theta_full   0.994  
_refine_diff_density_max    1.559  
_refine_diff_density_min   -0.605  
_refine_diff_density_rms    0.107  
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
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The corresponding CIF file for syn-4.15 is shown below, between the lines of “+” symbols. 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
data_dg1012s  
   
_audit_creation_method            SHELXL-97  
_chemical_name_systematic  
;  
 ?  
;  
_chemical_name_common             ?  
_chemical_melting_point           ?  
_chemical_formula_moiety          ?  
_chemical_formula_sum  
 'C16 H20 I N O'  
_chemical_formula_weight          369.23  
   
loop_  
 _atom_type_symbol  
 _atom_type_description  
 _atom_type_scat_dispersion_real  
 _atom_type_scat_dispersion_imag  
 _atom_type_scat_source  
 'C'  'C'   0.0033   0.0016  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'H'  'H'   0.0000   0.0000  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'N'  'N'   0.0061   0.0033  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
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 'O'  'O'   0.0106   0.0060  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'I'  'I'  -0.4742   1.8119  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
   
_symmetry_cell_setting            Triclinic  
_symmetry_space_group_name_H-M    P-1  
   
loop_  
 _symmetry_equiv_pos_as_xyz  
 'x, y, z'  
 '-x, -y, -z'  
   
_cell_length_a                    9.3192(3)  
_cell_length_b                    9.4812(3)  
_cell_length_c                    19.0469(7)  
_cell_angle_alpha                 98.0530(10)  
_cell_angle_beta                  96.6240(10)  
_cell_angle_gamma                 101.0690(10)  
_cell_volume                      1617.72(9)  
_cell_formula_units_Z             4  
_cell_measurement_temperature     295(2)  
_cell_measurement_reflns_used     7246  
_cell_measurement_theta_min       2.18  
_cell_measurement_theta_max       27.28  
   
_exptl_crystal_description        ?  
_exptl_crystal_colour             ?  
_exptl_crystal_size_max           0.29  
_exptl_crystal_size_mid           0.25  
_exptl_crystal_size_min           0.24  
_exptl_crystal_density_meas       0  
_exptl_crystal_density_diffrn     1.516  
_exptl_crystal_density_method     'not measured'  
_exptl_crystal_F_000              736  
_exptl_absorpt_coefficient_mu     1.973  
_exptl_absorpt_correction_type    none  
_exptl_absorpt_correction_T_min   0.5985  
_exptl_absorpt_correction_T_max   0.6489  
_exptl_absorpt_process_details    ?  
   
_exptl_special_details  
;  
 ?  
;  
   
_diffrn_ambient_temperature       295(2)  
_diffrn_radiation_wavelength      0.71073  
_diffrn_radiation_type            MoK\a  
_diffrn_radiation_source          'fine-focus sealed tube'  
_diffrn_radiation_monochromator   graphite  
_diffrn_measurement_device_type   'CCD area detector'  
_diffrn_measurement_method        'phi and omega scans'  
_diffrn_detector_area_resol_mean  ?  
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_diffrn_standards_number          ?  
_diffrn_standards_interval_count  ?  
_diffrn_standards_interval_time   ?  
_diffrn_standards_decay_%         ?  
_diffrn_reflns_number             21333  
_diffrn_reflns_av_R_equivalents   0.0144  
_diffrn_reflns_av_sigmaI/netI     0.0217  
_diffrn_reflns_limit_h_min        -14  
_diffrn_reflns_limit_h_max        14  
_diffrn_reflns_limit_k_min        -13  
_diffrn_reflns_limit_k_max        14  
_diffrn_reflns_limit_l_min        -28  
_diffrn_reflns_limit_l_max        28  
_diffrn_reflns_theta_min          2.18  
_diffrn_reflns_theta_max          32.61  
_reflns_number_total              11088  
_reflns_number_gt                 8383  
_reflns_threshold_expression      >2sigma(I)  
   
_computing_data_collection        'Bruker SMART'  
_computing_cell_refinement        'Bruker SMART'  
_computing_data_reduction         'Bruker SAINT'  
_computing_structure_solution     'SHELXS-97 (Sheldrick, 1990)'  
_computing_structure_refinement   'SHELXL-97 (Sheldrick, 1997)'  
_computing_molecular_graphics     'Bruker SHELXTL'  
_computing_publication_material   'Bruker SHELXTL'  
   
_refine_special_details  
;  
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and  
 goodness of fit S are based on F^2^, conventional R-factors R are based  
 on F, with F set to zero for negative F^2^. The threshold expression of  
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and 
is  
 not relevant to the choice of reflections for refinement.  R-factors 
based  
 on F^2^ are statistically about twice as large as those based on F, and 
R-  
 factors based on ALL data will be even larger.  
;  
   
_refine_ls_structure_factor_coef  Fsqd  
_refine_ls_matrix_type            full  
_refine_ls_weighting_scheme       calc  
_refine_ls_weighting_details  
 'calc w=1/[\s^2^(Fo^2^)+(0.0780P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3'  
_atom_sites_solution_primary      direct  
_atom_sites_solution_secondary    difmap  
_atom_sites_solution_hydrogens    geom  
_refine_ls_hydrogen_treatment     mixed  
_refine_ls_extinction_method      none  
_refine_ls_extinction_coef        ?  
_refine_ls_number_reflns          11088  
_refine_ls_number_parameters      343  
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_refine_ls_number_restraints      0  
_refine_ls_R_factor_all           0.0536  
_refine_ls_R_factor_gt            0.0390  
_refine_ls_wR_factor_ref          0.1298  
_refine_ls_wR_factor_gt           0.1177  
_refine_ls_goodness_of_fit_ref    1.039  
_refine_ls_restrained_S_all       1.039  
_refine_ls_shift/su_max           0.001  
_refine_ls_shift/su_mean          0.000  
   
loop_  
 _atom_site_label  
 _atom_site_type_symbol  
 _atom_site_fract_x  
 _atom_site_fract_y  
 _atom_site_fract_z  
 _atom_site_U_iso_or_equiv  
 _atom_site_adp_type  
 _atom_site_occupancy  
 _atom_site_symmetry_multiplicity  
 _atom_site_calc_flag  
 _atom_site_refinement_flags  
 _atom_site_disorder_assembly  
 _atom_site_disorder_group  
I1 I 0.082354(19) 0.53458(2) 0.136297(10) 0.05819(7) Uani 1 1 d . . .  
N1 N -0.2580(2) 0.5478(2) 0.08324(10) 0.0419(4) Uani 1 1 d . . .  
O1 O -0.2990(2) 0.5602(2) -0.03504(10) 0.0574(4) Uani 1 1 d . . .  
C1 C -0.0706(3) 0.6223(3) 0.19130(13) 0.0466(5) Uani 1 1 d . . .  
I2 I 0.40251(2) -0.091842(19) 0.382080(10) 0.06055(7) Uani 1 1 d . . .  
C2 C -0.2107(2) 0.6212(2) 0.15520(12) 0.0415(4) Uani 1 1 d . . .  
N2 N 0.5514(2) 0.2559(2) 0.40194(10) 0.0432(4) Uani 1 1 d . . .  
O2 O 0.6019(3) 0.3210(2) 0.52205(10) 0.0656(5) Uani 1 1 d . . .  
C3 C -0.3061(3) 0.6932(3) 0.19152(15) 0.0497(5) Uani 1 1 d . . .  
C4 C -0.2588(3) 0.7592(3) 0.26230(16) 0.0606(7) Uani 1 1 d . . .  
H4A H -0.3216 0.8074 0.2863 0.073 Uiso 1 1 calc R . .  
C5 C -0.1238(3) 0.7566(3) 0.29841(15) 0.0605(7) Uani 1 1 d . . .  
C6 C -0.0280(3) 0.6887(3) 0.26180(15) 0.0567(6) Uani 1 1 d . . .  
H6A H 0.0653 0.6882 0.2850 0.068 Uiso 1 1 calc R . .  
C7 C -0.3425(3) 0.3932(2) 0.06832(13) 0.0452(5) Uani 1 1 d . . .  
H7A H -0.4355 0.3899 0.0377 0.054 Uiso 1 1 calc R . .  
C8 C -0.2594(3) 0.2939(3) 0.02792(15) 0.0567(6) Uani 1 1 d . . .  
H8A H -0.2012 0.3310 -0.0045 0.068 Uiso 1 1 calc R . .  
C9 C -0.2657(4) 0.1582(3) 0.03654(18) 0.0670(8) Uani 1 1 d . . .  
H9A H -0.2123 0.1043 0.0091 0.080 Uiso 1 1 calc R . .  
C10 C -0.3517(4) 0.0841(3) 0.08696(19) 0.0655(8) Uani 1 1 d . . .  
H10A H -0.2843 0.0680 0.1263 0.079 Uiso 1 1 calc R . .  
H10B H -0.4083 -0.0101 0.0623 0.079 Uiso 1 1 calc R . .  
C11 C -0.4564(4) 0.1751(3) 0.1164(2) 0.0670(8) Uani 1 1 d . . .  
H11A H -0.5424 0.1642 0.0806 0.080 Uiso 1 1 calc R . .  
H11B H -0.4897 0.1398 0.1584 0.080 Uiso 1 1 calc R . .  
C12 C -0.3814(4) 0.3354(3) 0.13642(17) 0.0604(7) Uani 1 1 d . . .  
H12A H -0.2924 0.3469 0.1704 0.072 Uiso 1 1 calc R . .  
H12B H -0.4471 0.3899 0.1586 0.072 Uiso 1 1 calc R . .  
C13 C -0.2441(3) 0.6190(3) 0.02624(14) 0.0454(5) Uani 1 1 d . . .  
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C14 C -0.1566(4) 0.7733(3) 0.04084(17) 0.0650(7) Uani 1 1 d . . .  
H14A H -0.1557 0.8115 -0.0032 0.097 Uiso 1 1 calc R . .  
H14B H -0.0571 0.7753 0.0614 0.097 Uiso 1 1 calc R . .  
H14C H -0.2012 0.8318 0.0737 0.097 Uiso 1 1 calc R . .  
C15 C -0.4604(3) 0.7025(3) 0.15444(16) 0.0539(6) Uani 1 1 d . . .  
H15A H -0.5086 0.7554 0.1879 0.081 Uiso 1 1 calc R . .  
H15B H -0.5191 0.6060 0.1383 0.081 Uiso 1 1 calc R . .  
H15C H -0.4490 0.7520 0.1141 0.081 Uiso 1 1 calc R . .  
C16 C -0.0768(5) 0.8298(5) 0.37642(18) 0.0935(13) Uani 1 1 d . . .  
H16A H -0.1556 0.8708 0.3933 0.140 Uiso 1 1 calc R . .  
H16B H 0.0095 0.9058 0.3800 0.140 Uiso 1 1 calc R . .  
H16C H -0.0548 0.7589 0.4051 0.140 Uiso 1 1 calc R . .  
C17 C 0.3690(3) 0.0661(3) 0.31857(13) 0.0481(5) Uani 1 1 d . . .  
C18 C 0.4425(3) 0.2118(2) 0.33867(12) 0.0414(4) Uani 1 1 d . . .  
C19 C 0.4064(3) 0.3143(3) 0.29812(13) 0.0458(5) Uani 1 1 d . . .  
C20 C 0.3005(3) 0.2682(3) 0.23734(14) 0.0529(6) Uani 1 1 d . . .  
H20A H 0.2769 0.3370 0.2101 0.063 Uiso 1 1 calc R . .  
C21 C 0.2293(3) 0.1248(4) 0.21590(14) 0.0578(6) Uani 1 1 d . . .  
C22 C 0.2632(3) 0.0229(3) 0.25719(15) 0.0587(7) Uani 1 1 d . . .  
H22A H 0.2154 -0.0744 0.2440 0.070 Uiso 1 1 calc R . .  
C23 C 0.7090(3) 0.2502(3) 0.39875(15) 0.0535(6) Uani 1 1 d . . .  
H23A H 0.7408 0.2020 0.4383 0.064 Uiso 1 1 calc R . .  
C24 C 0.8095(4) 0.3981(4) 0.4097(3) 0.0833(11) Uani 1 1 d . . .  
H24A H 0.8076 0.4498 0.4572 0.100 Uiso 1 1 calc R . .  
H24B H 0.7749 0.4539 0.3748 0.100 Uiso 1 1 calc R . .  
C25 C 0.9651(4) 0.3842(6) 0.4018(3) 0.1050(16) Uani 1 1 d . . .  
H25A H 1.0289 0.4805 0.4119 0.126 Uiso 1 1 calc R . .  
H25B H 0.9988 0.3282 0.4369 0.126 Uiso 1 1 calc R . .  
C27 C 0.8521(4) 0.1901(5) 0.3022(2) 0.0868(12) Uani 1 1 d . . .  
H27A H 0.8589 0.1278 0.2610 0.104 Uiso 1 1 calc R . .  
C28 C 0.7306(4) 0.1609(4) 0.33100(18) 0.0667(8) Uani 1 1 d . . .  
H28A H 0.6558 0.0824 0.3086 0.080 Uiso 1 1 calc R . .  
C29 C 0.5106(3) 0.2901(3) 0.46752(13) 0.0491(5) Uani 1 1 d . . .  
C30 C 0.3511(4) 0.2902(4) 0.47089(17) 0.0661(8) Uani 1 1 d . . .  
H30A H 0.3372 0.3151 0.5199 0.099 Uiso 1 1 calc R . .  
H30B H 0.2924 0.1952 0.4511 0.099 Uiso 1 1 calc R . .  
H30C H 0.3213 0.3605 0.4438 0.099 Uiso 1 1 calc R . .  
C31 C 0.4732(4) 0.4763(3) 0.31916(17) 0.0662(8) Uani 1 1 d . . .  
H31A H 0.5445 0.4923 0.3617 0.099 Uiso 1 1 calc R . .  
H31B H 0.3966 0.5281 0.3282 0.099 Uiso 1 1 calc R . .  
H31C H 0.5210 0.5107 0.2809 0.099 Uiso 1 1 calc R . .  
C32 C 0.1149(5) 0.0765(5) 0.15004(19) 0.0911(13) Uani 1 1 d . . .  
H32A H 0.1044 0.1590 0.1274 0.137 Uiso 1 1 calc R . .  
H32B H 0.0219 0.0343 0.1634 0.137 Uiso 1 1 calc R . .  
H32C H 0.1454 0.0053 0.1173 0.137 Uiso 1 1 calc R . .  
C26 C 0.9787(5) 0.3127(6) 0.3294(3) 0.0985(14) Uani 1 1 d . . .  
H26A H 0.9830 0.3832 0.2969 0.118 Uiso 1 1 calc R . .  
H26B H 1.0698 0.2771 0.3312 0.118 Uiso 1 1 calc R . .  
   
loop_  
 _atom_site_aniso_label  
 _atom_site_aniso_U_11  
 _atom_site_aniso_U_22  
 _atom_site_aniso_U_33  
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 _atom_site_aniso_U_23  
 _atom_site_aniso_U_13  
 _atom_site_aniso_U_12  
I1 0.04572(10) 0.07246(13) 0.06288(12) 0.01521(9) 0.01161(8) 0.02336(9)  
N1 0.0418(9) 0.0354(8) 0.0477(10) 0.0035(7) 0.0074(8) 0.0085(7)  
O1 0.0566(11) 0.0664(12) 0.0504(10) 0.0098(8) 0.0041(8) 0.0183(9)  
C1 0.0450(12) 0.0466(12) 0.0494(12) 0.0105(10) 0.0127(10) 0.0072(9)  
I2 0.07096(13) 0.04767(11) 0.06312(12) 0.01719(8) 0.00559(9) 0.00955(8)  
C2 0.0412(11) 0.0377(10) 0.0447(11) 0.0039(8) 0.0086(9) 0.0071(8)  
N2 0.0446(10) 0.0460(10) 0.0388(9) 0.0052(7) 0.0053(7) 0.0109(8)  
O2 0.0822(15) 0.0719(13) 0.0397(9) 0.0062(8) 0.0029(9) 0.0146(11)  
C3 0.0470(12) 0.0398(11) 0.0605(14) -0.0006(10) 0.0152(11) 0.0068(9)  
C4 0.0629(17) 0.0477(13) 0.0667(17) -0.0070(12) 0.0238(14) 0.0041(12)  
C5 0.0633(17) 0.0574(15) 0.0509(14) -0.0028(12) 0.0136(12) -0.0059(13)  
C6 0.0531(15) 0.0593(15) 0.0508(14) 0.0084(11) 0.0045(11) -0.0026(12)  
C7 0.0427(11) 0.0399(11) 0.0514(12) 0.0013(9) 0.0105(9) 0.0071(9)  
C8 0.0644(16) 0.0485(13) 0.0584(15) -0.0007(11) 0.0251(13) 0.0125(12)  
C9 0.079(2) 0.0462(14) 0.080(2) 0.0005(13) 0.0325(16) 0.0183(13)  
C10 0.076(2) 0.0428(13) 0.080(2) 0.0092(13) 0.0220(16) 0.0119(13)  
C11 0.0723(19) 0.0436(13) 0.084(2) 0.0065(13) 0.0299(16) 0.0005(13)  
C12 0.0749(19) 0.0420(12) 0.0664(17) 0.0029(11) 0.0351(15) 0.0072(12)  
C13 0.0424(11) 0.0449(11) 0.0526(13) 0.0097(10) 0.0105(9) 0.0153(9)  
C14 0.080(2) 0.0484(14) 0.0692(18) 0.0203(13) 0.0144(15) 0.0098(13)  
C15 0.0440(12) 0.0479(13) 0.0674(16) -0.0008(11) 0.0117(11) 0.0089(10)  
C16 0.108(3) 0.103(3) 0.0533(18) -0.0136(18) 0.0140(18) -0.001(2)  
C17 0.0511(13) 0.0447(12) 0.0477(12) 0.0097(10) 0.0068(10) 0.0068(10)  
C18 0.0434(11) 0.0427(11) 0.0384(10) 0.0053(8) 0.0079(8) 0.0096(9)  
C19 0.0498(12) 0.0468(12) 0.0433(11) 0.0078(9) 0.0102(9) 0.0141(10)  
C20 0.0538(14) 0.0631(16) 0.0474(13) 0.0167(11) 0.0077(10) 0.0205(12)  
C21 0.0516(14) 0.0739(18) 0.0445(13) 0.0086(12) 0.0010(10) 0.0094(13)  
C22 0.0553(15) 0.0566(15) 0.0559(15) 0.0060(12) 0.0028(12) -0.0025(12)  
C23 0.0457(13) 0.0643(16) 0.0505(13) 0.0052(11) 0.0040(10) 0.0163(11)  
C24 0.0532(17) 0.076(2) 0.110(3) -0.012(2) 0.0173(18) 0.0030(16)  
C25 0.055(2) 0.131(4) 0.115(4) -0.009(3) 0.017(2) 0.003(2)  
C27 0.073(2) 0.114(3) 0.074(2) -0.005(2) 0.0250(18) 0.028(2)  
C28 0.0567(16) 0.074(2) 0.0669(18) -0.0054(15) 0.0116(13) 0.0188(15)  
C29 0.0626(15) 0.0451(12) 0.0413(11) 0.0084(9) 0.0127(10) 0.0118(11)  
C30 0.0663(18) 0.081(2) 0.0565(16) 0.0072(14) 0.0243(14) 0.0241(16)  
C31 0.088(2) 0.0445(13) 0.0618(17) 0.0148(12) -0.0052(15) 0.0082(14)  
C32 0.083(2) 0.114(3) 0.0596(19) 0.0132(19) -0.0214(17) 0.000(2)  
C26 0.066(2) 0.131(4) 0.102(3) 0.017(3) 0.030(2) 0.019(2)  
   
_geom_special_details  
;  
 All esds (except the esd in the dihedral angle between two l.s. planes)  
 are estimated using the full covariance matrix.  The cell esds are taken  
 into account individually in the estimation of esds in distances, angles  
 and torsion angles; correlations between esds in cell parameters are only  
 used when they are defined by crystal symmetry.  An approximate 
(isotropic)  
 treatment of cell esds is used for estimating esds involving l.s. planes.  
;  
   
loop_  
  313 
 _geom_bond_atom_site_label_1  
 _geom_bond_atom_site_label_2  
 _geom_bond_distance  
 _geom_bond_site_symmetry_2  
 _geom_bond_publ_flag  
I1 C1 2.092(2) . ?  
N1 C13 1.362(3) . ?  
N1 C2 1.426(3) . ?  
N1 C7 1.496(3) . ?  
O1 C13 1.227(3) . ?  
C1 C6 1.379(4) . ?  
C1 C2 1.401(3) . ?  
I2 C17 2.098(2) . ?  
C2 C3 1.406(3) . ?  
N2 C29 1.362(3) . ?  
N2 C18 1.439(3) . ?  
N2 C23 1.488(3) . ?  
O2 C29 1.226(3) . ?  
C3 C4 1.387(4) . ?  
C3 C15 1.551(4) . ?  
C4 C5 1.369(4) . ?  
C4 H4A 0.9300 . ?  
C5 C6 1.391(4) . ?  
C5 C16 1.525(4) . ?  
C6 H6A 0.9300 . ?  
C7 C8 1.514(3) . ?  
C7 C12 1.531(4) . ?  
C7 H7A 0.9800 . ?  
C8 C9 1.312(4) . ?  
C8 H8A 0.9300 . ?  
C9 C10 1.486(5) . ?  
C9 H9A 0.9300 . ?  
C10 C11 1.524(5) . ?  
C10 H10A 0.9700 . ?  
C10 H10B 0.9700 . ?  
C11 C12 1.521(4) . ?  
C11 H11A 0.9700 . ?  
C11 H11B 0.9700 . ?  
C12 H12A 0.9700 . ?  
C12 H12B 0.9700 . ?  
C13 C14 1.503(4) . ?  
C14 H14A 0.9600 . ?  
C14 H14B 0.9600 . ?  
C14 H14C 0.9600 . ?  
C15 H15A 0.9600 . ?  
C15 H15B 0.9600 . ?  
C15 H15C 0.9600 . ?  
C16 H16A 0.9600 . ?  
C16 H16B 0.9600 . ?  
C16 H16C 0.9600 . ?  
C17 C22 1.397(4) . ?  
C17 C18 1.398(3) . ?  
C18 C19 1.389(3) . ?  
C19 C20 1.391(4) . ?  
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C19 C31 1.520(4) . ?  
C20 C21 1.375(4) . ?  
C20 H20A 0.9300 . ?  
C21 C22 1.387(4) . ?  
C21 C32 1.504(4) . ?  
C22 H22A 0.9300 . ?  
C23 C28 1.497(4) . ?  
C23 C24 1.502(5) . ?  
C23 H23A 0.9800 . ?  
C24 C25 1.504(5) . ?  
C24 H24A 0.9700 . ?  
C24 H24B 0.9700 . ?  
C25 C26 1.480(6) . ?  
C25 H25A 0.9700 . ?  
C25 H25B 0.9700 . ?  
C27 C28 1.313(5) . ?  
C27 C26 1.475(6) . ?  
C27 H27A 0.9300 . ?  
C28 H28A 0.9300 . ?  
C29 C30 1.495(4) . ?  
C30 H30A 0.9600 . ?  
C30 H30B 0.9600 . ?  
C30 H30C 0.9600 . ?  
C31 H31A 0.9600 . ?  
C31 H31B 0.9600 . ?  
C31 H31C 0.9600 . ?  
C32 H32A 0.9600 . ?  
C32 H32B 0.9600 . ?  
C32 H32C 0.9600 . ?  
C26 H26A 0.9700 . ?  
C26 H26B 0.9700 . ?  
   
loop_  
 _geom_angle_atom_site_label_1  
 _geom_angle_atom_site_label_2  
 _geom_angle_atom_site_label_3  
 _geom_angle  
 _geom_angle_site_symmetry_1  
 _geom_angle_site_symmetry_3  
 _geom_angle_publ_flag  
C13 N1 C2 121.8(2) . . ?  
C13 N1 C7 117.33(19) . . ?  
C2 N1 C7 120.41(19) . . ?  
C6 C1 C2 120.9(2) . . ?  
C6 C1 I1 119.0(2) . . ?  
C2 C1 I1 119.98(17) . . ?  
C1 C2 C3 118.8(2) . . ?  
C1 C2 N1 121.3(2) . . ?  
C3 C2 N1 119.9(2) . . ?  
C29 N2 C18 120.7(2) . . ?  
C29 N2 C23 118.0(2) . . ?  
C18 N2 C23 121.00(19) . . ?  
C4 C3 C2 118.5(2) . . ?  
C4 C3 C15 119.5(2) . . ?  
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C2 C3 C15 122.0(2) . . ?  
C5 C4 C3 122.9(3) . . ?  
C5 C4 H4A 118.6 . . ?  
C3 C4 H4A 118.6 . . ?  
C4 C5 C6 118.5(3) . . ?  
C4 C5 C16 121.1(3) . . ?  
C6 C5 C16 120.4(3) . . ?  
C1 C6 C5 120.3(3) . . ?  
C1 C6 H6A 119.8 . . ?  
C5 C6 H6A 119.8 . . ?  
N1 C7 C8 111.3(2) . . ?  
N1 C7 C12 112.74(19) . . ?  
C8 C7 C12 109.8(2) . . ?  
N1 C7 H7A 107.6 . . ?  
C8 C7 H7A 107.6 . . ?  
C12 C7 H7A 107.6 . . ?  
C9 C8 C7 123.1(3) . . ?  
C9 C8 H8A 118.5 . . ?  
C7 C8 H8A 118.5 . . ?  
C8 C9 C10 124.8(3) . . ?  
C8 C9 H9A 117.6 . . ?  
C10 C9 H9A 117.6 . . ?  
C9 C10 C11 111.1(3) . . ?  
C9 C10 H10A 109.4 . . ?  
C11 C10 H10A 109.4 . . ?  
C9 C10 H10B 109.4 . . ?  
C11 C10 H10B 109.4 . . ?  
H10A C10 H10B 108.0 . . ?  
C12 C11 C10 111.4(3) . . ?  
C12 C11 H11A 109.3 . . ?  
C10 C11 H11A 109.3 . . ?  
C12 C11 H11B 109.3 . . ?  
C10 C11 H11B 109.3 . . ?  
H11A C11 H11B 108.0 . . ?  
C11 C12 C7 108.7(2) . . ?  
C11 C12 H12A 109.9 . . ?  
C7 C12 H12A 109.9 . . ?  
C11 C12 H12B 109.9 . . ?  
C7 C12 H12B 109.9 . . ?  
H12A C12 H12B 108.3 . . ?  
O1 C13 N1 121.9(2) . . ?  
O1 C13 C14 120.6(2) . . ?  
N1 C13 C14 117.5(2) . . ?  
C13 C14 H14A 109.5 . . ?  
C13 C14 H14B 109.5 . . ?  
H14A C14 H14B 109.5 . . ?  
C13 C14 H14C 109.5 . . ?  
H14A C14 H14C 109.5 . . ?  
H14B C14 H14C 109.5 . . ?  
C3 C15 H15A 109.5 . . ?  
C3 C15 H15B 109.5 . . ?  
H15A C15 H15B 109.5 . . ?  
C3 C15 H15C 109.5 . . ?  
H15A C15 H15C 109.5 . . ?  
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H15B C15 H15C 109.5 . . ?  
C5 C16 H16A 109.5 . . ?  
C5 C16 H16B 109.5 . . ?  
H16A C16 H16B 109.5 . . ?  
C5 C16 H16C 109.5 . . ?  
H16A C16 H16C 109.5 . . ?  
H16B C16 H16C 109.5 . . ?  
C22 C17 C18 120.4(2) . . ?  
C22 C17 I2 117.76(19) . . ?  
C18 C17 I2 121.70(18) . . ?  
C19 C18 C17 119.3(2) . . ?  
C19 C18 N2 120.4(2) . . ?  
C17 C18 N2 120.3(2) . . ?  
C18 C19 C20 119.0(2) . . ?  
C18 C19 C31 122.6(2) . . ?  
C20 C19 C31 118.4(2) . . ?  
C21 C20 C19 122.5(2) . . ?  
C21 C20 H20A 118.8 . . ?  
C19 C20 H20A 118.8 . . ?  
C20 C21 C22 118.6(2) . . ?  
C20 C21 C32 121.9(3) . . ?  
C22 C21 C32 119.5(3) . . ?  
C21 C22 C17 120.2(3) . . ?  
C21 C22 H22A 119.9 . . ?  
C17 C22 H22A 119.9 . . ?  
N2 C23 C28 112.8(2) . . ?  
N2 C23 C24 113.3(3) . . ?  
C28 C23 C24 109.7(3) . . ?  
N2 C23 H23A 106.9 . . ?  
C28 C23 H23A 106.9 . . ?  
C24 C23 H23A 106.9 . . ?  
C23 C24 C25 110.5(3) . . ?  
C23 C24 H24A 109.6 . . ?  
C25 C24 H24A 109.6 . . ?  
C23 C24 H24B 109.6 . . ?  
C25 C24 H24B 109.6 . . ?  
H24A C24 H24B 108.1 . . ?  
C26 C25 C24 112.9(4) . . ?  
C26 C25 H25A 109.0 . . ?  
C24 C25 H25A 109.0 . . ?  
C26 C25 H25B 109.0 . . ?  
C24 C25 H25B 109.0 . . ?  
H25A C25 H25B 107.8 . . ?  
C28 C27 C26 125.9(4) . . ?  
C28 C27 H27A 117.1 . . ?  
C26 C27 H27A 117.1 . . ?  
C27 C28 C23 122.0(3) . . ?  
C27 C28 H28A 119.0 . . ?  
C23 C28 H28A 119.0 . . ?  
O2 C29 N2 121.1(3) . . ?  
O2 C29 C30 121.0(2) . . ?  
N2 C29 C30 117.9(2) . . ?  
C29 C30 H30A 109.5 . . ?  
C29 C30 H30B 109.5 . . ?  
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H30A C30 H30B 109.5 . . ?  
C29 C30 H30C 109.5 . . ?  
H30A C30 H30C 109.5 . . ?  
H30B C30 H30C 109.5 . . ?  
C19 C31 H31A 109.5 . . ?  
C19 C31 H31B 109.5 . . ?  
H31A C31 H31B 109.5 . . ?  
C19 C31 H31C 109.5 . . ?  
H31A C31 H31C 109.5 . . ?  
H31B C31 H31C 109.5 . . ?  
C21 C32 H32A 109.5 . . ?  
C21 C32 H32B 109.5 . . ?  
H32A C32 H32B 109.5 . . ?  
C21 C32 H32C 109.5 . . ?  
H32A C32 H32C 109.5 . . ?  
H32B C32 H32C 109.5 . . ?  
C27 C26 C25 110.7(3) . . ?  
C27 C26 H26A 109.5 . . ?  
C25 C26 H26A 109.5 . . ?  
C27 C26 H26B 109.5 . . ?  
C25 C26 H26B 109.5 . . ?  
H26A C26 H26B 108.1 . . ?  
   
_diffrn_measured_fraction_theta_max    0.938  
_diffrn_reflns_theta_full              32.61  
_diffrn_measured_fraction_theta_full   0.938  
_refine_diff_density_max    1.207  
_refine_diff_density_min   -0.681  
_refine_diff_density_rms    0.077  
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
 
The corresponding CIF file for anti-4.52 is shown below, between the lines of “+” symbols. 
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+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
data_dgc922s  
   
_audit_creation_method            SHELXL-97  
_chemical_name_systematic  
;  
 ?  
;  
_chemical_name_common             ?  
_chemical_melting_point           ?  
_chemical_formula_moiety          ?  
_chemical_formula_sum  
 'C16 H18 I N O3'  
_chemical_formula_weight          399.21  
   
loop_  
 _atom_type_symbol  
 _atom_type_description  
 _atom_type_scat_dispersion_real  
 _atom_type_scat_dispersion_imag  
 _atom_type_scat_source  
 'C'  'C'   0.0033   0.0016  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'H'  'H'   0.0000   0.0000  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'N'  'N'   0.0061   0.0033  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'O'  'O'   0.0106   0.0060  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'I'  'I'  -0.4742   1.8119  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
   
_symmetry_cell_setting            Monoclinic  
_symmetry_space_group_name_H-M    P2(1)/c  
   
loop_  
 _symmetry_equiv_pos_as_xyz  
 'x, y, z'  
 '-x, y+1/2, -z+1/2'  
 '-x, -y, -z'  
 'x, -y-1/2, z-1/2'  
   
_cell_length_a                    9.7112(15)  
_cell_length_b                    11.6237(17)  
_cell_length_c                    14.127(2)  
_cell_angle_alpha                 90.00  
_cell_angle_beta                  94.332(3)  
_cell_angle_gamma                 90.00  
_cell_volume                      1590.1(4)  
_cell_formula_units_Z             4  
_cell_measurement_temperature     203(2)  
_cell_measurement_reflns_used     5306  
_cell_measurement_theta_min       0.00  
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_cell_measurement_theta_max       0.00  
   
_exptl_crystal_description        ?  
_exptl_crystal_colour             ?  
_exptl_crystal_size_max           0.34  
_exptl_crystal_size_mid           0.25  
_exptl_crystal_size_min           0.21  
_exptl_crystal_density_meas       0  
_exptl_crystal_density_diffrn     1.668  
_exptl_crystal_density_method     'not measured'  
_exptl_crystal_F_000              792  
_exptl_absorpt_coefficient_mu     2.023  
_exptl_absorpt_correction_type    none  
_exptl_absorpt_correction_T_min   0.5462  
_exptl_absorpt_correction_T_max   0.6760  
_exptl_absorpt_process_details    ?  
   
_exptl_special_details  
;  
 ?  
;  
   
_diffrn_ambient_temperature       203(2)  
_diffrn_radiation_wavelength      0.71073  
_diffrn_radiation_type            MoK\a  
_diffrn_radiation_source          'fine-focus sealed tube'  
_diffrn_radiation_monochromator   graphite  
_diffrn_measurement_device_type   'CCD area detector'  
_diffrn_measurement_method        'phi and omega scans'  
_diffrn_detector_area_resol_mean  ?  
_diffrn_standards_number          ?  
_diffrn_standards_interval_count  ?  
_diffrn_standards_interval_time   ?  
_diffrn_standards_decay_%         ?  
_diffrn_reflns_number             15074  
_diffrn_reflns_av_R_equivalents   0.0444  
_diffrn_reflns_av_sigmaI/netI     0.0359  
_diffrn_reflns_limit_h_min        -12  
_diffrn_reflns_limit_h_max        12  
_diffrn_reflns_limit_k_min        -15  
_diffrn_reflns_limit_k_max        15  
_diffrn_reflns_limit_l_min        -18  
_diffrn_reflns_limit_l_max        18  
_diffrn_reflns_theta_min          2.10  
_diffrn_reflns_theta_max          27.50  
_reflns_number_total              3655  
_reflns_number_gt                 3144  
_reflns_threshold_expression      >2sigma(I)  
   
_computing_data_collection        'Bruker SMART'  
_computing_cell_refinement        'Bruker SMART'  
_computing_data_reduction         'Bruker SAINT'  
_computing_structure_solution     'SHELXS-97 (Sheldrick, 1990)'  
_computing_structure_refinement   'SHELXL-97 (Sheldrick, 1997)'  
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_computing_molecular_graphics     'Bruker SHELXTL'  
_computing_publication_material   'Bruker SHELXTL'  
   
_refine_special_details  
;  
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and  
 goodness of fit S are based on F^2^, conventional R-factors R are based  
 on F, with F set to zero for negative F^2^. The threshold expression of  
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and 
is  
 not relevant to the choice of reflections for refinement.  R-factors 
based  
 on F^2^ are statistically about twice as large as those based on F, and 
R-  
 factors based on ALL data will be even larger.  
;  
   
_refine_ls_structure_factor_coef  Fsqd  
_refine_ls_matrix_type            full  
_refine_ls_weighting_scheme       calc  
_refine_ls_weighting_details  
 'calc w=1/[\s^2^(Fo^2^)+(0.0780P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3'  
_atom_sites_solution_primary      direct  
_atom_sites_solution_secondary    difmap  
_atom_sites_solution_hydrogens    geom  
_refine_ls_hydrogen_treatment     mixed  
_refine_ls_extinction_method      none  
_refine_ls_extinction_coef        ?  
_refine_ls_number_reflns          3655  
_refine_ls_number_parameters      240  
_refine_ls_number_restraints      0  
_refine_ls_R_factor_all           0.0433  
_refine_ls_R_factor_gt            0.0362  
_refine_ls_wR_factor_ref          0.1128  
_refine_ls_wR_factor_gt           0.1071  
_refine_ls_goodness_of_fit_ref    0.996  
_refine_ls_restrained_S_all       0.996  
_refine_ls_shift/su_max           0.083  
_refine_ls_shift/su_mean          0.006  
   
loop_  
 _atom_site_label  
 _atom_site_type_symbol  
 _atom_site_fract_x  
 _atom_site_fract_y  
 _atom_site_fract_z  
 _atom_site_U_iso_or_equiv  
 _atom_site_adp_type  
 _atom_site_occupancy  
 _atom_site_symmetry_multiplicity  
 _atom_site_calc_flag  
 _atom_site_refinement_flags  
 _atom_site_disorder_assembly  
 _atom_site_disorder_group  
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I I 0.72654(2) 0.845623(19) 0.818067(16) 0.04560(12) Uani 1 1 d . . .  
N N 0.8461(2) 0.58283(19) 0.85798(15) 0.0260(5) Uani 1 1 d . . .  
O1 O 0.7107(2) 0.3853(2) 0.55234(14) 0.0362(5) Uani 1 1 d . . .  
C1 C 0.6255(3) 0.6898(3) 0.84230(19) 0.0316(6) Uani 1 1 d . . .  
O2 O 0.7856(3) 0.3469(2) 0.40915(19) 0.0590(8) Uani 1 1 d . . .  
C2 C 0.4822(3) 0.6924(3) 0.8437(2) 0.0413(7) Uani 1 1 d . . .  
H2 H 0.437(3) 0.762(3) 0.834(2) 0.031(8) Uiso 1 1 d . . .  
O3 O 1.0604(2) 0.60724(19) 0.92997(15) 0.0345(5) Uani 1 1 d . . .  
C3 C 0.4116(3) 0.5925(4) 0.8640(2) 0.0449(8) Uani 1 1 d . . .  
H3 H 0.318(5) 0.591(4) 0.874(3) 0.056(12) Uiso 1 1 d . . .  
C4 C 0.4839(3) 0.4920(3) 0.8833(3) 0.0431(8) Uani 1 1 d . . .  
H4 H 0.435(4) 0.431(4) 0.900(3) 0.047(11) Uiso 1 1 d . . .  
C5 C 0.6260(3) 0.4895(3) 0.8826(2) 0.0360(7) Uani 1 1 d . . .  
H5 H 0.674(4) 0.432(3) 0.891(3) 0.043(10) Uiso 1 1 d . . .  
C6 C 0.6994(3) 0.5884(2) 0.86170(18) 0.0281(6) Uani 1 1 d . . .  
C7 C 0.9011(3) 0.5290(3) 0.77395(19) 0.0295(6) Uani 1 1 d . . .  
H7 H 0.996(4) 0.539(3) 0.785(3) 0.042(10) Uiso 1 1 d . . .  
C8 C 0.8440(4) 0.5843(3) 0.6814(2) 0.0361(7) Uani 1 1 d . . .  
H8A H 0.870(5) 0.665(3) 0.678(3) 0.061(13) Uiso 1 1 d . . .  
H8B H 0.737(4) 0.581(3) 0.677(2) 0.031(8) Uiso 1 1 d . . .  
C9 C 0.8955(4) 0.5206(3) 0.5981(2) 0.0342(6) Uani 1 1 d . . .  
H9A H 0.860(4) 0.547(3) 0.545(3) 0.046(11) Uiso 1 1 d . . .  
H9B H 0.991(4) 0.523(4) 0.604(3) 0.055(11) Uiso 1 1 d . . .  
C10 C 0.8543(3) 0.3950(3) 0.5946(2) 0.0316(6) Uani 1 1 d . . .  
H10 H 0.907(4) 0.355(3) 0.551(3) 0.027(8) Uiso 1 1 d . . .  
C11 C 0.8571(3) 0.3412(2) 0.6908(2) 0.0329(6) Uani 1 1 d . . .  
H11 H 0.847(3) 0.250(3) 0.693(2) 0.030(8) Uiso 1 1 d . . .  
C12 C 0.8785(3) 0.4013(3) 0.7708(2) 0.0339(6) Uani 1 1 d . . .  
H12 H 0.889(4) 0.363(3) 0.833(3) 0.043(10) Uiso 1 1 d . . .  
C13 C 0.6926(4) 0.3610(3) 0.4594(2) 0.0362(7) Uani 1 1 d . . .  
C14 C 0.5431(4) 0.3552(4) 0.4269(3) 0.0536(10) Uani 1 1 d . . .  
H14A H 0.5141 0.4281 0.3985 0.080 Uiso 1 1 calc R . .  
H14B H 0.4896 0.3395 0.4807 0.080 Uiso 1 1 calc R . .  
H14C H 0.5282 0.2943 0.3803 0.080 Uiso 1 1 calc R . .  
C15 C 0.9352(3) 0.6154(2) 0.93288(19) 0.0265(5) Uani 1 1 d . . .  
C16 C 0.8715(4) 0.6607(3) 1.0199(2) 0.0347(7) Uani 1 1 d . . .  
H16A H 0.8341 0.5970 1.0543 0.052 Uiso 1 1 calc R . .  
H16B H 0.7980 0.7142 1.0007 0.052 Uiso 1 1 calc R . .  
H16C H 0.9416 0.6998 1.0606 0.052 Uiso 1 1 calc R . .  
   
loop_  
 _atom_site_aniso_label  
 _atom_site_aniso_U_11  
 _atom_site_aniso_U_22  
 _atom_site_aniso_U_33  
 _atom_site_aniso_U_23  
 _atom_site_aniso_U_13  
 _atom_site_aniso_U_12  
I 0.04962(18) 0.03439(16) 0.05196(18) 0.00805(8) -0.00157(11) 0.00553(8)  
N 0.0229(11) 0.0297(11) 0.0249(10) -0.0036(9) -0.0004(8) 0.0030(9)  
O1 0.0312(11) 0.0490(12) 0.0282(10) -0.0068(9) -0.0001(8) -0.0028(9)  
C1 0.0305(14) 0.0376(15) 0.0262(13) -0.0046(11) -0.0016(11) 0.0068(12)  
O2 0.0563(17) 0.086(2) 0.0353(13) -0.0149(12) 0.0063(12) -0.0039(14)  
C2 0.0335(16) 0.0545(19) 0.0356(16) -0.0071(14) 0.0003(13) 0.0133(15)  
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O3 0.0265(10) 0.0355(11) 0.0404(11) -0.0005(9) -0.0054(8) -0.0032(8)  
C3 0.0244(15) 0.067(2) 0.0436(18) -0.0138(16) 0.0041(13) -0.0011(15)  
C4 0.0322(16) 0.052(2) 0.0461(18) -0.0044(15) 0.0080(14) -0.0082(15)  
C5 0.0334(16) 0.0363(16) 0.0390(16) -0.0032(13) 0.0073(13) -0.0003(13)  
C6 0.0271(13) 0.0358(15) 0.0210(12) -0.0039(11) -0.0001(10) 0.0007(11)  
C7 0.0239(13) 0.0376(15) 0.0271(13) -0.0051(11) 0.0030(10) 0.0029(11)  
C8 0.053(2) 0.0283(15) 0.0287(14) 0.0001(11) 0.0114(13) -0.0030(13)  
C9 0.0396(17) 0.0368(16) 0.0265(14) -0.0006(12) 0.0050(12) -0.0062(13)  
C10 0.0279(14) 0.0387(16) 0.0285(13) -0.0074(12) 0.0047(11) -0.0013(12)  
C11 0.0312(15) 0.0300(15) 0.0370(15) 0.0003(11) 0.0000(12) 0.0000(11)  
C12 0.0372(16) 0.0328(15) 0.0314(14) 0.0020(12) 0.0011(12) 0.0083(12)  
C13 0.0431(18) 0.0355(16) 0.0296(15) -0.0011(11) 0.0000(13) -0.0056(13)  
C14 0.050(2) 0.066(3) 0.043(2) -0.0039(16) -0.0120(17) -0.0129(18)  
C15 0.0330(14) 0.0193(12) 0.0266(13) 0.0016(10) -0.0026(10) 0.0017(10)  
C16 0.0429(17) 0.0354(16) 0.0244(14) -0.0048(11) -0.0066(12) 0.0073(12)  
   
_geom_special_details  
;  
 All esds (except the esd in the dihedral angle between two l.s. planes)  
 are estimated using the full covariance matrix.  The cell esds are taken  
 into account individually in the estimation of esds in distances, angles  
 and torsion angles; correlations between esds in cell parameters are only  
 used when they are defined by crystal symmetry.  An approximate 
(isotropic)  
 treatment of cell esds is used for estimating esds involving l.s. planes.  
;  
   
loop_  
 _geom_bond_atom_site_label_1  
 _geom_bond_atom_site_label_2  
 _geom_bond_distance  
 _geom_bond_site_symmetry_2  
 _geom_bond_publ_flag  
I C1 2.101(3) . ?  
N C15 1.369(3) . ?  
N C6 1.432(3) . ?  
N C7 1.477(3) . ?  
O1 C13 1.341(4) . ?  
O1 C10 1.479(3) . ?  
C1 C2 1.394(4) . ?  
C1 C6 1.396(4) . ?  
O2 C13 1.202(4) . ?  
C2 C3 1.389(6) . ?  
C2 H2 0.92(3) . ?  
O3 C15 1.223(3) . ?  
C3 C4 1.379(6) . ?  
C3 H3 0.93(5) . ?  
C4 C5 1.381(4) . ?  
C4 H4 0.90(4) . ?  
C5 C6 1.396(4) . ?  
C5 H5 0.82(4) . ?  
C7 C12 1.500(4) . ?  
C7 C8 1.524(4) . ?  
C7 H7 0.93(4) . ?  
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C8 C9 1.507(4) . ?  
C8 H8A 0.97(4) . ?  
C8 H8B 1.03(3) . ?  
C9 C10 1.515(4) . ?  
C9 H9A 0.86(4) . ?  
C9 H9B 0.93(4) . ?  
C10 C11 1.494(4) . ?  
C10 H10 0.95(4) . ?  
C11 C12 1.332(4) . ?  
C11 H11 1.06(3) . ?  
C12 H12 0.98(4) . ?  
C13 C14 1.491(5) . ?  
C14 H14A 0.9700 . ?  
C14 H14B 0.9700 . ?  
C14 H14C 0.9700 . ?  
C15 C16 1.512(4) . ?  
C16 H16A 0.9700 . ?  
C16 H16B 0.9700 . ?  
C16 H16C 0.9700 . ?  
   
loop_  
 _geom_angle_atom_site_label_1  
 _geom_angle_atom_site_label_2  
 _geom_angle_atom_site_label_3  
 _geom_angle  
 _geom_angle_site_symmetry_1  
 _geom_angle_site_symmetry_3  
 _geom_angle_publ_flag  
C15 N C6 122.2(2) . . ?  
C15 N C7 119.5(2) . . ?  
C6 N C7 118.0(2) . . ?  
C13 O1 C10 117.4(2) . . ?  
C2 C1 C6 121.0(3) . . ?  
C2 C1 I 117.6(2) . . ?  
C6 C1 I 121.3(2) . . ?  
C1 C2 C3 119.6(3) . . ?  
C1 C2 H2 119(2) . . ?  
C3 C2 H2 122(2) . . ?  
C4 C3 C2 119.8(3) . . ?  
C4 C3 H3 116(3) . . ?  
C2 C3 H3 124(3) . . ?  
C3 C4 C5 120.7(3) . . ?  
C3 C4 H4 117(3) . . ?  
C5 C4 H4 122(3) . . ?  
C4 C5 C6 120.7(3) . . ?  
C4 C5 H5 125(3) . . ?  
C6 C5 H5 114(3) . . ?  
C5 C6 C1 118.3(3) . . ?  
C5 C6 N 119.7(3) . . ?  
C1 C6 N 122.0(3) . . ?  
N C7 C12 112.4(2) . . ?  
N C7 C8 112.4(2) . . ?  
C12 C7 C8 110.4(2) . . ?  
N C7 H7 103(2) . . ?  
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C12 C7 H7 106(2) . . ?  
C8 C7 H7 113(2) . . ?  
C9 C8 C7 110.0(3) . . ?  
C9 C8 H8A 110(3) . . ?  
C7 C8 H8A 112(3) . . ?  
C9 C8 H8B 109.1(18) . . ?  
C7 C8 H8B 109.2(18) . . ?  
H8A C8 H8B 107(4) . . ?  
C8 C9 C10 113.4(3) . . ?  
C8 C9 H9A 112(3) . . ?  
C10 C9 H9A 103(3) . . ?  
C8 C9 H9B 108(3) . . ?  
C10 C9 H9B 107(3) . . ?  
H9A C9 H9B 114(4) . . ?  
O1 C10 C11 106.7(2) . . ?  
O1 C10 C9 109.0(3) . . ?  
C11 C10 C9 112.7(2) . . ?  
O1 C10 H10 104(2) . . ?  
C11 C10 H10 114(2) . . ?  
C9 C10 H10 110.2(19) . . ?  
C12 C11 C10 123.0(3) . . ?  
C12 C11 H11 120.1(17) . . ?  
C10 C11 H11 116.8(17) . . ?  
C11 C12 C7 123.8(3) . . ?  
C11 C12 H12 121(2) . . ?  
C7 C12 H12 115(2) . . ?  
O2 C13 O1 123.9(3) . . ?  
O2 C13 C14 124.7(3) . . ?  
O1 C13 C14 111.3(3) . . ?  
C13 C14 H14A 109.5 . . ?  
C13 C14 H14B 109.5 . . ?  
H14A C14 H14B 109.5 . . ?  
C13 C14 H14C 109.5 . . ?  
H14A C14 H14C 109.5 . . ?  
H14B C14 H14C 109.5 . . ?  
O3 C15 N 121.6(3) . . ?  
O3 C15 C16 121.5(3) . . ?  
N C15 C16 116.8(3) . . ?  
C15 C16 H16A 109.5 . . ?  
C15 C16 H16B 109.5 . . ?  
H16A C16 H16B 109.5 . . ?  
C15 C16 H16C 109.5 . . ?  
H16A C16 H16C 109.5 . . ?  
H16B C16 H16C 109.5 . . ?  
   
_diffrn_measured_fraction_theta_max    1.000  
_diffrn_reflns_theta_full              27.50  
_diffrn_measured_fraction_theta_full   1.000  
_refine_diff_density_max    1.623  
_refine_diff_density_min   -0.526  
_refine_diff_density_rms    0.092  
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+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
 
The corresponding CIF file for (P)-5.31 is shown below, between the lines of “+” symbols. 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
data_dg7151s  
   
_audit_creation_method            SHELXL-97  
_chemical_name_systematic  
;  
 ?  
;  
_chemical_name_common             ?  
_chemical_melting_point           ?  
_chemical_formula_moiety          ?  
_chemical_formula_sum  
 'C20 H19 Br I N O4'  
_chemical_formula_weight          544.17  
   
loop_  
 _atom_type_symbol  
 _atom_type_description  
 _atom_type_scat_dispersion_real  
 _atom_type_scat_dispersion_imag  
 _atom_type_scat_source  
 'C'  'C'   0.0033   0.0016  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'H'  'H'   0.0000   0.0000  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'N'  'N'   0.0061   0.0033  
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 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'O'  'O'   0.0106   0.0060  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'Br'  'Br'  -0.2901   2.4595  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'I'  'I'  -0.4742   1.8119  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
   
_symmetry_cell_setting           Monoclinic  
_symmetry_space_group_name_H-M    'P 21'  
   
loop_  
 _symmetry_equiv_pos_as_xyz  
 'x, y, z'  
 '-x, y+1/2, -z'  
   
_cell_length_a                    16.9278(18)  
_cell_length_b                    7.4154(8)  
_cell_length_c                    35.492(4)  
_cell_angle_alpha                 90.00  
_cell_angle_beta                  95.125(2)  
_cell_angle_gamma                 90.00  
_cell_volume                      4437.4(8)  
_cell_formula_units_Z             8  
_cell_measurement_temperature     203(2)  
_cell_measurement_reflns_used     5106  
_cell_measurement_theta_min       2.43  
_cell_measurement_theta_max       23.59  
   
_exptl_crystal_description        block  
_exptl_crystal_colour             colorless  
_exptl_crystal_size_max           0.31  
_exptl_crystal_size_mid           0.28  
_exptl_crystal_size_min           0.14  
_exptl_crystal_density_meas       0  
_exptl_crystal_density_diffrn     1.629  
_exptl_crystal_density_method     'not measured'  
_exptl_crystal_F_000              2128  
_exptl_absorpt_coefficient_mu     3.267  
_exptl_absorpt_correction_type    Multi-scan  
_exptl_absorpt_correction_T_min   0.4308  
_exptl_absorpt_correction_T_max   0.6577  
_exptl_absorpt_process_details    'Bruker Sadabs'  
   
_exptl_special_details  
;  
 ?  
;  
   
_diffrn_ambient_temperature       203(2)  
_diffrn_radiation_wavelength      0.71073  
_diffrn_radiation_type            MoK\a  
_diffrn_radiation_source          'fine-focus sealed tube'  
_diffrn_radiation_monochromator   graphite  
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_diffrn_measurement_device_type   'CCD area detector'  
_diffrn_measurement_method        'phi and omega scans'  
_diffrn_detector_area_resol_mean  ?  
_diffrn_standards_number          ?  
_diffrn_standards_interval_count  ?  
_diffrn_standards_interval_time   ?  
_diffrn_standards_decay_%         ?  
_diffrn_reflns_number             24977  
_diffrn_reflns_av_R_equivalents   0.0000  
_diffrn_reflns_av_sigmaI/netI     0.0759  
_diffrn_reflns_limit_h_min        -23  
_diffrn_reflns_limit_h_max        23  
_diffrn_reflns_limit_k_min        -10  
_diffrn_reflns_limit_k_max        10  
_diffrn_reflns_limit_l_min        -49  
_diffrn_reflns_limit_l_max        49  
_diffrn_reflns_theta_min          1.73  
_diffrn_reflns_theta_max          30.00  
_reflns_number_total              24977  
_reflns_number_gt                 17531  
_reflns_threshold_expression      >2sigma(I)  
   
_computing_data_collection        'Bruker SMART'  
_computing_cell_refinement        'Bruker SMART'  
_computing_data_reduction         'Bruker SAINT'  
_computing_structure_solution     'SHELXS-97 (Sheldrick, 1990)'  
_computing_structure_refinement   'SHELXL-97 (Sheldrick, 1997)'  
_computing_molecular_graphics     'Bruker SHELXTL'  
_computing_publication_material   'Bruker SHELXTL'  
   
_refine_special_details  
;  
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and  
 goodness of fit S are based on F^2^, conventional R-factors R are based  
 on F, with F set to zero for negative F^2^. The threshold expression of  
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and 
is  
 not relevant to the choice of reflections for refinement.  R-factors 
based  
 on F^2^ are statistically about twice as large as those based on F, and 
R-  
 factors based on ALL data will be even larger.  
;  
   
_refine_ls_structure_factor_coef  Fsqd  
_refine_ls_matrix_type            full  
_refine_ls_weighting_scheme       calc  
_refine_ls_weighting_details  
 'calc w=1/[\s^2^(Fo^2^)+(0.0780P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3'  
_atom_sites_solution_primary      direct  
_atom_sites_solution_secondary    difmap  
_atom_sites_solution_hydrogens    geom  
_refine_ls_hydrogen_treatment   constr  
_refine_ls_extinction_method      none  
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_refine_ls_extinction_coef        ?  
_refine_ls_abs_structure_details  
 'Flack H D (1983), Acta Cryst. A39, 876-881'  
_refine_ls_abs_structure_Flack    0.021(10)  
_refine_ls_number_reflns          24977  
_refine_ls_number_parameters      964  
_refine_ls_number_restraints      1  
_refine_ls_R_factor_all           0.1007  
_refine_ls_R_factor_gt            0.0764  
_refine_ls_wR_factor_ref          0.1965  
_refine_ls_wR_factor_gt           0.1861  
_refine_ls_goodness_of_fit_ref    1.298  
_refine_ls_restrained_S_all       1.298  
_refine_ls_shift/su_max           0.001  
_refine_ls_shift/su_mean          0.000  
   
loop_  
 _atom_site_label  
 _atom_site_type_symbol  
 _atom_site_fract_x  
 _atom_site_fract_y  
 _atom_site_fract_z  
 _atom_site_U_iso_or_equiv  
 _atom_site_adp_type  
 _atom_site_occupancy  
 _atom_site_symmetry_multiplicity  
 _atom_site_calc_flag  
 _atom_site_refinement_flags  
 _atom_site_disorder_assembly  
 _atom_site_disorder_group  
N1 N 0.4459(3) -0.8211(8) 0.67220(15) 0.0333(12) Uani 1 1 d . . .  
Br1 Br 0.46294(5) -0.90311(11) 0.75773(2) 0.04295(18) Uani 1 1 d . . .  
I1 I 0.59485(4) -1.20797(8) 0.68950(2) 0.06564(19) Uani 1 1 d . . .  
C1 C 0.3791(4) -0.9787(9) 0.72141(19) 0.0353(15) Uani 1 1 d . . .  
O1 O 0.1931(4) -0.8804(13) 0.53197(17) 0.080(2) Uani 1 1 d . . .  
H1A H 0.1997 -0.8901 0.5092 0.120 Uiso 1 1 calc R . .  
N2 N 0.0611(3) -0.8642(8) 0.33039(17) 0.0334(12) Uani 1 1 d . . .  
Br2 Br 0.03187(4) -0.95229(11) 0.24549(2) 0.04380(19) Uani 1 1 d . . .  
I2 I -0.09332(4) -1.26463(9) 0.32113(2) 0.06561(19) Uani 1 1 d . . .  
C2 C 0.3166(4) -1.0704(10) 0.7343(2) 0.0377(16) Uani 1 1 d . . .  
H2A H 0.3162 -1.1001 0.7600 0.045 Uiso 1 1 calc R . .  
O2 O 0.3252(4) -0.8922(12) 0.53797(17) 0.070(2) Uani 1 1 d . . .  
Br3 Br 0.50809(5) 0.60120(11) -0.220050(19) 0.04235(18) Uani 1 1 d . . .  
I3 I 0.20534(3) 0.30057(11) -0.20836(2) 0.0715(2) Uani 1 1 d . . .  
N3 N 0.3934(3) 0.6393(8) -0.15808(17) 0.0328(12) Uani 1 1 d . . .  
C3 C 0.2533(4) -1.1190(9) 0.70822(18) 0.0310(14) Uani 1 1 d . . .  
O3 O 0.5616(3) -0.7871(9) 0.64411(17) 0.0540(14) Uani 1 1 d . . .  
Br4 Br -0.01832(5) 0.54571(12) 0.22264(2) 0.04402(19) Uani 1 1 d . . .  
I4 I 0.26564(5) 0.19256(11) 0.17671(2) 0.0807(2) Uani 1 1 d . . .  
N4 N 0.1071(3) 0.5805(8) 0.16504(16) 0.0343(12) Uani 1 1 d . . .  
C4 C 0.2571(4) -1.0731(10) 0.6710(2) 0.0376(16) Uani 1 1 d . . .  
H4A H 0.2146 -1.1067 0.6535 0.045 Uiso 1 1 calc R . .  
O4 O 0.2309(4) -0.3319(12) 0.56005(18) 0.072(2) Uani 1 1 d . . .  
O5 O 0.3288(5) -0.8939(15) 0.46327(18) 0.093(3) Uani 1 1 d . . .  
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H5A H 0.3211 -0.8940 0.4860 0.139 Uiso 1 1 calc R . .  
C5 C 0.3187(4) -0.9818(10) 0.65771(17) 0.0343(15) Uani 1 1 d . . .  
O6 O 0.1988(4) -0.9067(12) 0.45861(15) 0.070(2) Uani 1 1 d . . .  
C6 C 0.3840(4) -0.9307(9) 0.68312(19) 0.0357(15) Uani 1 1 d . . .  
C7 C 0.3196(5) -0.9393(11) 0.6165(2) 0.0407(16) Uani 1 1 d . . .  
H7A H 0.3693 -0.9232 0.6071 0.049 Uiso 1 1 calc R . .  
O7 O -0.0509(4) -0.8623(10) 0.36152(18) 0.0625(16) Uiso 1 1 d . . .  
O8 O 0.2807(4) -0.3663(10) 0.43923(18) 0.0647(18) Uani 1 1 d . . .  
C8 C 0.2568(6) -0.9228(13) 0.5924(2) 0.053(2) Uani 1 1 d . . .  
H8A H 0.2065 -0.9310 0.6016 0.064 Uiso 1 1 calc R . .  
O9 O 0.3685(4) 0.4467(10) 0.01055(15) 0.0589(17) Uani 1 1 d . . .  
H9A H 0.3292 0.4357 0.0228 0.088 Uiso 1 1 calc R . .  
C9 C 0.2611(6) -0.8919(14) 0.5519(2) 0.056(2) Uani 1 1 d . . .  
O10 O 0.2784(4) 0.4748(10) -0.03818(17) 0.0592(17) Uani 1 1 d . . .  
C10 C 0.5100(5) -0.8834(12) 0.6547(2) 0.0432(17) Uani 1 1 d . . .  
O11 O 0.2724(3) 0.6950(8) -0.18605(16) 0.0469(13) Uani 1 1 d . . .  
C11 C 0.5112(6) -1.0868(12) 0.6480(2) 0.054(2) Uani 1 1 d . . .  
H11A H 0.5265 -1.1119 0.6225 0.065 Uiso 1 1 calc R . .  
H11B H 0.4583 -1.1374 0.6500 0.065 Uiso 1 1 calc R . .  
O12 O 0.3141(4) 1.0482(11) -0.00855(17) 0.0623(17) Uani 1 1 d . . .  
C12 C 0.4406(5) -0.6258(9) 0.6784(2) 0.0432(18) Uani 1 1 d . . .  
H12A H 0.4935 -0.5719 0.6783 0.052 Uiso 1 1 calc R . .  
H12B H 0.4214 -0.6031 0.7032 0.052 Uiso 1 1 calc R . .  
O13 O 0.1636(3) 0.3801(10) 0.00132(14) 0.0539(17) Uani 1 1 d . . .  
H13B H 0.2033 0.4122 -0.0090 0.081 Uiso 1 1 calc R . .  
C13 C 0.4099(5) -0.4835(11) 0.6138(2) 0.0452(18) Uani 1 1 d . . .  
H13A H 0.4638 -0.4915 0.6096 0.054 Uiso 1 1 calc R . .  
O14 O 0.2480(3) 0.4152(9) 0.05253(14) 0.0460(13) Uani 1 1 d . . .  
C14 C 0.3576(6) -0.4180(14) 0.5864(3) 0.063(3) Uani 1 1 d . . .  
H14A H 0.3766 -0.3797 0.5636 0.076 Uiso 1 1 calc R . .  
O15 O 0.2276(3) 0.6595(9) 0.18960(18) 0.0544(15) Uani 1 1 d . . .  
C15 C 0.2804(5) -0.4051(12) 0.5901(2) 0.0453(18) Uani 1 1 d . . .  
O16 O 0.0655(3) 0.8223(10) -0.00750(15) 0.0575(16) Uani 1 1 d . . .  
C16 C 0.2502(5) -0.4572(12) 0.6239(2) 0.0456(18) Uani 1 1 d . . .  
H16A H 0.1961 -0.4452 0.6274 0.055 Uiso 1 1 calc R . .  
C17 C 0.3036(5) -0.5272(11) 0.6517(2) 0.0401(17) Uani 1 1 d . . .  
H17A H 0.2843 -0.5687 0.6742 0.048 Uiso 1 1 calc R . .  
C18 C 0.3853(6) -0.5393(10) 0.6482(2) 0.0471(19) Uani 1 1 d . . .  
C20 C 0.1851(4) -1.2258(12) 0.7200(2) 0.0449(18) Uani 1 1 d . . .  
H20A H 0.1472 -1.2460 0.6983 0.067 Uiso 1 1 calc R . .  
H20B H 0.1598 -1.1600 0.7393 0.067 Uiso 1 1 calc R . .  
H20C H 0.2041 -1.3408 0.7302 0.067 Uiso 1 1 calc R . .  
C21 C 0.1247(4) -0.9983(9) 0.27831(18) 0.0299(13) Uani 1 1 d . . .  
C22 C 0.1894(5) -1.0807(11) 0.26253(19) 0.0413(17) Uani 1 1 d . . .  
H22A H 0.1858 -1.1150 0.2369 0.050 Uiso 1 1 calc R . .  
C23 C 0.2582(4) -1.1096(11) 0.28583(18) 0.0353(15) Uani 1 1 d . . .  
C24 C 0.2606(4) -1.0760(9) 0.32355(19) 0.0325(14) Uani 1 1 d . . .  
H24A H 0.3059 -1.1089 0.3393 0.039 Uiso 1 1 calc R . .  
C25 C 0.1972(4) -0.9937(9) 0.33951(18) 0.0304(13) Uani 1 1 d . . .  
C26 C 0.1276(4) -0.9555(9) 0.31602(18) 0.0286(13) Uani 1 1 d . . .  
C27 C 0.1996(5) -0.9500(10) 0.38029(18) 0.0386(16) Uani 1 1 d . . .  
H27A H 0.1516 -0.9253 0.3907 0.046 Uiso 1 1 calc R . .  
C28 C 0.2679(5) -0.9440(15) 0.4031(2) 0.056(2) Uani 1 1 d . . .  
H28A H 0.3169 -0.9600 0.3930 0.068 Uiso 1 1 calc R . .  
  330 
C29 C 0.2648(5) -0.9123(15) 0.4440(2) 0.057(2) Uani 1 1 d . . .  
C30 C 0.0041(5) -0.9458(12) 0.3482(2) 0.0454(18) Uani 1 1 d . . .  
C31 C 0.0086(5) -1.1443(12) 0.3521(3) 0.054(2) Uani 1 1 d . . .  
H31A H 0.0100 -1.1778 0.3789 0.064 Uiso 1 1 calc R . .  
H31B H 0.0573 -1.1887 0.3423 0.064 Uiso 1 1 calc R . .  
C32 C 0.0622(5) -0.6621(10) 0.3260(2) 0.0439(18) Uani 1 1 d . . .  
H32A H 0.0084 -0.6150 0.3271 0.053 Uiso 1 1 calc R . .  
H32B H 0.0794 -0.6317 0.3011 0.053 Uiso 1 1 calc R . .  
C33 C 0.0958(5) -0.5545(12) 0.3915(3) 0.051(2) Uani 1 1 d . . .  
H33A H 0.0448 -0.5910 0.3968 0.061 Uiso 1 1 calc R . .  
C34 C 0.1472(6) -0.4823(13) 0.4205(3) 0.055(2) Uani 1 1 d . . .  
H34A H 0.1303 -0.4669 0.4448 0.066 Uiso 1 1 calc R . .  
C35 C 0.2236(6) -0.4334(12) 0.4132(2) 0.054(2) Uani 1 1 d . . .  
C36 C 0.2464(5) -0.4508(13) 0.3756(2) 0.0483(19) Uani 1 1 d . . .  
H36A H 0.2970 -0.4145 0.3696 0.058 Uiso 1 1 calc R . .  
C37 C 0.1929(5) -0.5215(10) 0.3489(2) 0.0419(17) Uani 1 1 d . . .  
H37A H 0.2079 -0.5360 0.3242 0.050 Uiso 1 1 calc R . .  
C38 C 0.1173(5) -0.5731(10) 0.3564(2) 0.0399(16) Uani 1 1 d . . .  
C39 C 0.2548(9) -0.368(2) 0.4805(4) 0.123(6) Uani 1 1 d . . .  
H39A H 0.2974 -0.3209 0.4978 0.185 Uiso 1 1 calc R . .  
H39B H 0.2431 -0.4911 0.4876 0.185 Uiso 1 1 calc R . .  
H39C H 0.2079 -0.2942 0.4816 0.185 Uiso 1 1 calc R . .  
C40 C 0.3311(5) -1.1939(14) 0.2702(2) 0.0497(19) Uani 1 1 d . . .  
H40A H 0.3737 -1.2034 0.2903 0.075 Uiso 1 1 calc R . .  
H40B H 0.3481 -1.1186 0.2501 0.075 Uiso 1 1 calc R . .  
H40C H 0.3178 -1.3130 0.2604 0.075 Uiso 1 1 calc R . .  
C41 C 0.5131(4) 0.4754(10) -0.17276(19) 0.0343(15) Uani 1 1 d . . .  
C42 C 0.5740(4) 0.3564(11) -0.1647(2) 0.0385(16) Uani 1 1 d . . .  
H42A H 0.6125 0.3397 -0.1818 0.046 Uiso 1 1 calc R . .  
C43 C 0.5784(5) 0.2606(11) -0.1311(2) 0.0438(18) Uani 1 1 d . . .  
C44 C 0.5216(4) 0.2962(11) -0.1052(2) 0.0369(15) Uani 1 1 d . . .  
H44A H 0.5242 0.2344 -0.0820 0.044 Uiso 1 1 calc R . .  
C45 C 0.4609(4) 0.4240(10) -0.11400(19) 0.0328(14) Uani 1 1 d . . .  
C46 C 0.4572(4) 0.5111(9) -0.14836(19) 0.0300(13) Uani 1 1 d . . .  
C47 C 0.4006(4) 0.4498(10) -0.08647(18) 0.0358(15) Uani 1 1 d . . .  
H47A H 0.3501 0.4881 -0.0964 0.043 Uiso 1 1 calc R . .  
C48 C 0.4107(5) 0.4244(12) -0.0493(2) 0.0416(17) Uani 1 1 d . . .  
H48A H 0.4606 0.3888 -0.0380 0.050 Uiso 1 1 calc R . .  
C49 C 0.3456(5) 0.4507(13) -0.0256(2) 0.0451(19) Uani 1 1 d . . .  
C50 C 0.3229(4) 0.5896(10) -0.17703(19) 0.0347(14) Uani 1 1 d . . .  
C51 C 0.3185(5) 0.3892(13) -0.1850(3) 0.054(2) Uani 1 1 d . . .  
H51A H 0.3325 0.3237 -0.1614 0.065 Uiso 1 1 calc R . .  
H51B H 0.3579 0.3587 -0.2026 0.065 Uiso 1 1 calc R . .  
C52 C 0.4104(4) 0.8337(11) -0.1500(2) 0.0394(16) Uani 1 1 d . . .  
H52A H 0.4671 0.8554 -0.1517 0.047 Uiso 1 1 calc R . .  
H52B H 0.3811 0.9067 -0.1696 0.047 Uiso 1 1 calc R . .  
C53 C 0.3113(5) 0.9637(10) -0.1090(2) 0.0426(17) Uani 1 1 d . . .  
H53A H 0.2741 0.9711 -0.1303 0.051 Uiso 1 1 calc R . .  
C54 C 0.2917(5) 1.0182(14) -0.0747(2) 0.052(2) Uani 1 1 d . . .  
H54A H 0.2428 1.0757 -0.0727 0.062 Uiso 1 1 calc R . .  
C55 C 0.3430(5) 0.9909(12) -0.0419(2) 0.050(2) Uani 1 1 d . . .  
C56 C 0.4186(5) 0.9314(12) -0.0449(3) 0.0492(19) Uani 1 1 d . . .  
H56A H 0.4555 0.9260 -0.0235 0.059 Uiso 1 1 calc R . .  
C57 C 0.4397(4) 0.8793(11) -0.0800(2) 0.0390(16) Uani 1 1 d . . .  
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H57A H 0.4907 0.8313 -0.0817 0.047 Uiso 1 1 calc R . .  
C58 C 0.3895(4) 0.8945(10) -0.1127(2) 0.0380(16) Uani 1 1 d . . .  
C59 C 0.3602(6) 1.0132(17) 0.0263(3) 0.070(3) Uani 1 1 d . . .  
H59A H 0.3326 1.0595 0.0471 0.105 Uiso 1 1 calc R . .  
H59B H 0.4113 1.0720 0.0262 0.105 Uiso 1 1 calc R . .  
H59C H 0.3678 0.8842 0.0294 0.105 Uiso 1 1 calc R . .  
C60 C 0.6421(5) 0.1225(14) -0.1215(3) 0.061(3) Uani 1 1 d . . .  
H60A H 0.6767 0.1162 -0.1418 0.092 Uiso 1 1 calc R . .  
H60B H 0.6179 0.0055 -0.1183 0.092 Uiso 1 1 calc R . .  
H60C H 0.6728 0.1566 -0.0982 0.092 Uiso 1 1 calc R . .  
C61 C -0.0161(4) 0.4190(10) 0.17626(19) 0.0328(14) Uani 1 1 d . . .  
C62 C -0.0752(4) 0.3050(13) 0.1650(2) 0.0417(17) Uani 1 1 d . . .  
H62A H -0.1181 0.2917 0.1799 0.050 Uiso 1 1 calc R . .  
C63 C -0.0743(5) 0.2051(11) 0.1313(2) 0.0464(18) Uani 1 1 d . . .  
C64 C -0.0087(4) 0.2239(10) 0.11075(19) 0.0349(14) Uani 1 1 d . . .  
H64A H -0.0060 0.1541 0.0888 0.042 Uiso 1 1 calc R . .  
C65 C 0.0539(4) 0.3437(9) 0.12153(17) 0.0308(13) Uani 1 1 d . . .  
C66 C 0.0481(4) 0.4458(9) 0.15481(17) 0.0294(13) Uani 1 1 d . . .  
C67 C 0.1179(4) 0.3735(9) 0.09753(17) 0.0284(13) Uani 1 1 d . . .  
H67A H 0.1663 0.4152 0.1094 0.034 Uiso 1 1 calc R . .  
C68 C 0.1144(4) 0.3471(10) 0.0596(2) 0.0382(16) Uani 1 1 d . . .  
H68A H 0.0671 0.3029 0.0470 0.046 Uiso 1 1 calc R . .  
C69 C 0.1795(4) 0.3837(11) 0.03830(19) 0.0362(15) Uani 1 1 d . . .  
C70 C 0.1772(4) 0.5495(12) 0.18471(19) 0.0398(16) Uani 1 1 d . . .  
C71 C 0.1874(5) 0.3649(13) 0.2036(2) 0.0480(19) Uani 1 1 d . . .  
H71A H 0.1354 0.3066 0.2034 0.058 Uiso 1 1 calc R . .  
H71B H 0.2079 0.3815 0.2301 0.058 Uiso 1 1 calc R . .  
C72 C 0.0876(5) 0.7669(11) 0.1522(2) 0.0465(18) Uani 1 1 d . . .  
H72A H 0.1280 0.8495 0.1638 0.056 Uiso 1 1 calc R . .  
H72B H 0.0365 0.8018 0.1609 0.056 Uiso 1 1 calc R . .  
C73 C 0.1475(4) 0.8342(11) 0.0922(2) 0.0423(17) Uani 1 1 d . . .  
H73A H 0.1954 0.8581 0.1068 0.051 Uiso 1 1 calc R . .  
C74 C 0.1460(4) 0.8508(11) 0.0524(2) 0.0410(17) Uani 1 1 d . . .  
H74A H 0.1913 0.8841 0.0405 0.049 Uiso 1 1 calc R . .  
C75 C 0.0730(5) 0.8147(11) 0.03180(19) 0.0409(16) Uani 1 1 d . . .  
C76 C 0.0075(4) 0.7684(12) 0.0492(2) 0.0474(19) Uani 1 1 d . . .  
H76A H -0.0406 0.7453 0.0346 0.057 Uiso 1 1 calc R . .  
C77 C 0.0112(4) 0.7552(11) 0.0875(2) 0.0430(17) Uani 1 1 d . . .  
H77A H -0.0348 0.7255 0.0991 0.052 Uiso 1 1 calc R . .  
C78 C 0.0836(4) 0.7858(10) 0.11037(18) 0.0369(15) Uani 1 1 d . . .  
C79 C 0.1317(6) 0.8756(15) -0.0266(3) 0.062(2) Uani 1 1 d . . .  
H79A H 0.1173 0.8748 -0.0537 0.093 Uiso 1 1 calc R . .  
H79B H 0.1751 0.7922 -0.0206 0.093 Uiso 1 1 calc R . .  
H79C H 0.1480 0.9961 -0.0187 0.093 Uiso 1 1 calc R . .  
C80 C -0.1399(5) 0.0774(14) 0.1178(3) 0.056(2) Uani 1 1 d . . .  
H80A H -0.1808 0.0798 0.1353 0.084 Uiso 1 1 calc R . .  
H80B H -0.1188 -0.0439 0.1166 0.084 Uiso 1 1 calc R . .  
H80C H -0.1624 0.1139 0.0929 0.084 Uiso 1 1 calc R . .  
C19 C 0.1411(11) -0.322(4) 0.5599(6) 0.172(8) Uiso 1 1 d . . .  
H19A H 0.1189 -0.2677 0.5365 0.258 Uiso 1 1 calc R . .  
H19B H 0.1272 -0.2504 0.5811 0.258 Uiso 1 1 calc R . .  
H19C H 0.1199 -0.4432 0.5619 0.258 Uiso 1 1 calc R . .  
   
loop_  
  332 
 _atom_site_aniso_label  
 _atom_site_aniso_U_11  
 _atom_site_aniso_U_22  
 _atom_site_aniso_U_33  
 _atom_site_aniso_U_23  
 _atom_site_aniso_U_13  
 _atom_site_aniso_U_12  
N1 0.039(3) 0.031(3) 0.029(3) -0.009(2) 0.002(2) -0.004(2)  
Br1 0.0494(4) 0.0421(4) 0.0351(3) 0.0014(3) -0.0094(3) -0.0030(3)  
I1 0.0577(3) 0.0408(3) 0.0975(5) 0.0162(3) 0.0020(3) 0.0066(3)  
C1 0.050(4) 0.022(3) 0.032(3) -0.006(3) -0.001(3) 0.003(3)  
O1 0.087(5) 0.116(7) 0.033(3) 0.004(4) -0.010(3) 0.040(5)  
N2 0.031(3) 0.025(3) 0.044(3) -0.001(2) 0.003(2) 0.004(2)  
Br2 0.0437(4) 0.0480(5) 0.0372(4) -0.0013(3) -0.0105(3) 0.0063(3)  
I2 0.0485(3) 0.0472(3) 0.0986(5) -0.0182(3) -0.0075(3) 0.0010(3)  
C2 0.046(4) 0.033(4) 0.034(3) -0.006(3) 0.000(3) 0.006(3)  
O2 0.063(4) 0.103(6) 0.043(3) -0.012(4) -0.009(3) -0.009(4)  
Br3 0.0483(4) 0.0487(5) 0.0312(3) 0.0068(3) 0.0100(3) 0.0005(3)  
I3 0.0467(3) 0.0721(4) 0.0923(5) -0.0326(4) -0.0132(3) -0.0051(3)  
N3 0.027(3) 0.033(3) 0.039(3) 0.001(2) 0.007(2) -0.001(2)  
C3 0.042(4) 0.024(3) 0.027(3) 0.000(2) -0.001(3) -0.002(3)  
O3 0.049(3) 0.052(4) 0.061(4) 0.013(3) 0.006(3) -0.002(3)  
Br4 0.0491(4) 0.0528(5) 0.0310(3) -0.0032(3) 0.0085(3) 0.0110(4)  
I4 0.0806(5) 0.0624(4) 0.1019(6) 0.0212(4) 0.0249(4) 0.0243(4)  
N4 0.035(3) 0.034(3) 0.032(3) 0.002(2) -0.006(2) 0.004(2)  
C4 0.046(4) 0.029(3) 0.037(4) -0.011(3) -0.004(3) 0.009(3)  
O4 0.063(4) 0.098(6) 0.052(4) 0.017(4) -0.007(3) 0.022(4)  
O5 0.084(5) 0.146(9) 0.043(3) 0.004(5) -0.022(3) -0.037(6)  
C5 0.050(4) 0.032(4) 0.020(3) -0.001(3) 0.000(3) 0.003(3)  
O6 0.084(5) 0.096(6) 0.028(3) 0.005(3) 0.001(3) 0.015(4)  
C6 0.047(4) 0.026(3) 0.034(3) -0.003(3) 0.003(3) 0.008(3)  
C7 0.045(4) 0.041(4) 0.036(3) -0.007(3) 0.005(3) 0.003(3)  
O8 0.076(4) 0.068(4) 0.049(3) -0.005(3) -0.001(3) -0.011(4)  
C8 0.064(5) 0.061(6) 0.031(4) -0.010(4) -0.012(3) 0.019(4)  
O9 0.056(3) 0.088(5) 0.036(3) -0.004(3) 0.020(3) -0.020(3)  
C9 0.073(6) 0.056(5) 0.039(4) -0.007(4) -0.003(4) 0.001(5)  
O10 0.049(3) 0.083(5) 0.048(3) 0.019(3) 0.022(3) 0.007(3)  
C10 0.049(4) 0.044(4) 0.036(4) 0.004(3) 0.003(3) 0.004(4)  
O11 0.032(3) 0.056(4) 0.052(3) 0.001(3) 0.001(2) 0.010(3)  
C11 0.075(6) 0.042(5) 0.047(5) -0.004(4) 0.013(4) 0.020(4)  
O12 0.059(4) 0.081(5) 0.045(3) -0.014(3) -0.004(3) 0.011(4)  
C12 0.074(5) 0.018(3) 0.034(4) 0.004(3) -0.011(3) -0.005(3)  
O13 0.038(3) 0.098(5) 0.027(2) -0.008(3) 0.008(2) -0.014(3)  
C13 0.048(4) 0.042(4) 0.046(4) 0.007(3) 0.006(3) 0.002(4)  
O14 0.029(2) 0.074(4) 0.035(3) -0.013(3) 0.004(2) -0.011(3)  
C14 0.068(6) 0.066(6) 0.055(5) 0.026(5) 0.006(4) 0.016(5)  
O15 0.038(3) 0.058(4) 0.067(4) -0.010(3) 0.000(3) -0.016(3)  
C15 0.044(4) 0.043(4) 0.048(4) 0.010(4) 0.002(3) 0.005(4)  
O16 0.051(3) 0.082(5) 0.037(3) 0.006(3) -0.009(2) -0.009(3)  
C16 0.040(4) 0.050(5) 0.048(4) 0.000(4) 0.010(3) -0.001(4)  
C17 0.048(4) 0.041(4) 0.031(3) -0.001(3) 0.005(3) 0.004(3)  
C18 0.073(6) 0.028(4) 0.039(4) -0.001(3) -0.003(4) 0.008(4)  
C20 0.043(4) 0.054(5) 0.038(4) 0.002(3) 0.004(3) -0.009(4)  
C21 0.029(3) 0.030(3) 0.030(3) 0.001(3) -0.006(2) 0.001(3)  
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C22 0.063(5) 0.039(4) 0.022(3) 0.000(3) 0.004(3) -0.017(3)  
C23 0.027(3) 0.051(4) 0.028(3) 0.008(3) 0.000(2) 0.001(3)  
C24 0.033(3) 0.032(3) 0.031(3) 0.010(3) -0.003(3) -0.003(3)  
C25 0.038(3) 0.029(3) 0.025(3) 0.005(2) 0.006(3) 0.001(3)  
C26 0.030(3) 0.024(3) 0.032(3) 0.005(3) 0.002(2) -0.005(2)  
C27 0.056(4) 0.035(4) 0.024(3) -0.003(3) -0.002(3) 0.008(3)  
C28 0.058(5) 0.084(7) 0.025(3) -0.006(4) -0.006(3) -0.006(5)  
C29 0.056(5) 0.079(7) 0.032(4) 0.009(4) -0.009(3) -0.012(5)  
C30 0.042(4) 0.053(5) 0.041(4) -0.011(4) 0.004(3) -0.001(4)  
C31 0.044(4) 0.043(5) 0.072(6) 0.009(4) -0.001(4) -0.003(4)  
C32 0.063(5) 0.027(4) 0.041(4) 0.007(3) -0.005(3) 0.007(3)  
C33 0.044(4) 0.050(5) 0.060(5) -0.002(4) 0.008(4) -0.001(4)  
C34 0.065(5) 0.052(5) 0.052(5) -0.004(4) 0.026(4) -0.001(4)  
C35 0.071(6) 0.043(5) 0.044(4) 0.000(4) -0.012(4) -0.008(4)  
C36 0.050(4) 0.051(5) 0.045(4) 0.005(4) 0.009(3) -0.001(4)  
C37 0.058(5) 0.036(4) 0.033(4) -0.003(3) 0.013(3) -0.007(3)  
C38 0.050(4) 0.028(4) 0.041(4) -0.008(3) 0.002(3) 0.001(3)  
C39 0.161(14) 0.110(12) 0.087(9) -0.005(9) -0.056(9) -0.032(11)  
C40 0.044(4) 0.059(5) 0.046(4) -0.007(4) 0.007(3) 0.008(4)  
C41 0.041(4) 0.036(4) 0.026(3) 0.004(3) 0.009(3) -0.008(3)  
C42 0.027(3) 0.052(5) 0.037(4) -0.001(3) 0.004(3) -0.001(3)  
C43 0.047(4) 0.043(5) 0.042(4) 0.011(3) 0.007(3) 0.011(3)  
C44 0.031(3) 0.036(4) 0.043(4) 0.008(3) 0.000(3) 0.005(3)  
C45 0.026(3) 0.034(4) 0.038(4) -0.001(3) 0.000(3) -0.003(3)  
C46 0.025(3) 0.028(3) 0.036(3) -0.003(3) -0.001(2) -0.004(2)  
C47 0.041(4) 0.042(4) 0.025(3) -0.001(3) 0.005(3) -0.002(3)  
C48 0.036(4) 0.053(5) 0.036(4) 0.003(3) 0.004(3) -0.005(3)  
C49 0.039(4) 0.063(5) 0.033(4) 0.015(3) 0.003(3) -0.014(4)  
C50 0.031(3) 0.040(4) 0.034(3) 0.003(3) 0.004(3) 0.000(3)  
C51 0.029(4) 0.052(5) 0.081(6) -0.016(5) 0.003(4) -0.013(4)  
C52 0.039(4) 0.048(5) 0.032(3) 0.005(3) 0.005(3) -0.003(3)  
C53 0.051(4) 0.028(4) 0.048(4) 0.006(3) 0.002(3) 0.000(3)  
C54 0.039(4) 0.062(6) 0.055(5) -0.012(4) 0.000(3) 0.001(4)  
C55 0.060(5) 0.045(5) 0.042(4) -0.005(3) -0.017(4) 0.010(4)  
C56 0.051(5) 0.046(5) 0.050(5) -0.006(4) 0.001(4) -0.005(4)  
C57 0.030(3) 0.048(4) 0.037(4) 0.003(3) -0.007(3) -0.004(3)  
C58 0.042(4) 0.029(3) 0.044(4) -0.005(3) 0.007(3) -0.016(3)  
C59 0.069(6) 0.090(8) 0.047(5) -0.017(5) -0.012(4) 0.032(6)  
C60 0.038(4) 0.056(6) 0.091(7) 0.023(5) 0.014(4) 0.024(4)  
C61 0.032(3) 0.035(4) 0.030(3) 0.001(3) 0.000(3) 0.006(3)  
C62 0.032(3) 0.059(5) 0.035(4) 0.002(3) 0.009(3) -0.003(4)  
C63 0.050(4) 0.032(4) 0.057(5) -0.005(4) 0.007(4) 0.001(3)  
C64 0.030(3) 0.038(4) 0.037(3) -0.004(3) 0.007(3) -0.004(3)  
C65 0.041(4) 0.025(3) 0.026(3) 0.000(2) 0.002(3) -0.006(3)  
C66 0.038(3) 0.028(3) 0.021(3) -0.004(2) -0.001(2) 0.004(3)  
C67 0.031(3) 0.030(3) 0.024(3) -0.003(2) 0.002(2) 0.003(3)  
C68 0.047(4) 0.034(4) 0.034(4) -0.005(3) 0.005(3) -0.007(3)  
C69 0.028(3) 0.048(4) 0.031(3) -0.005(3) -0.001(3) -0.002(3)  
C70 0.035(4) 0.053(5) 0.033(3) -0.012(3) 0.010(3) 0.006(3)  
C71 0.042(4) 0.058(5) 0.044(4) 0.014(4) 0.003(3) 0.007(4)  
C72 0.059(5) 0.039(5) 0.041(4) 0.001(3) 0.003(3) 0.000(4)  
C73 0.031(3) 0.051(5) 0.043(4) -0.002(3) -0.008(3) -0.003(3)  
C74 0.038(4) 0.045(4) 0.038(4) 0.005(3) -0.008(3) -0.008(3)  
C75 0.054(4) 0.039(4) 0.027(3) 0.005(3) -0.007(3) 0.002(4)  
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C76 0.040(4) 0.048(5) 0.051(4) 0.013(4) -0.014(3) 0.001(3)  
C77 0.027(3) 0.044(4) 0.057(5) 0.001(3) -0.001(3) 0.002(3)  
C78 0.049(4) 0.030(3) 0.030(3) 0.002(3) -0.008(3) 0.001(3)  
C79 0.078(6) 0.066(6) 0.044(5) 0.007(4) 0.015(4) 0.005(5)  
C80 0.034(4) 0.058(6) 0.078(6) -0.008(5) 0.012(4) -0.016(4)  
   
_geom_special_details  
;  
 All esds (except the esd in the dihedral angle between two l.s. planes)  
 are estimated using the full covariance matrix.  The cell esds are taken  
 into account individually in the estimation of esds in distances, angles  
 and torsion angles; correlations between esds in cell parameters are only  
 used when they are defined by crystal symmetry.  An approximate 
(isotropic)  
 treatment of cell esds is used for estimating esds involving l.s. planes.  
;  
   
loop_  
 _geom_bond_atom_site_label_1  
 _geom_bond_atom_site_label_2  
 _geom_bond_distance  
 _geom_bond_site_symmetry_2  
 _geom_bond_publ_flag  
N1 C10 1.377(10) . ?  
N1 C6 1.407(9) . ?  
N1 C12 1.469(9) . ?  
Br1 C1 1.914(7) . ?  
I1 C11 2.147(9) . ?  
C1 C2 1.371(11) . ?  
C1 C6 1.414(10) . ?  
O1 C9 1.299(11) . ?  
N2 C30 1.345(10) . ?  
N2 C26 1.444(9) . ?  
N2 C32 1.507(9) . ?  
Br2 C21 1.901(6) . ?  
I2 C31 2.156(9) . ?  
C2 C3 1.399(10) . ?  
O2 C9 1.231(12) . ?  
Br3 C41 1.915(7) . ?  
I3 C51 2.122(8) . ?  
N3 C50 1.368(9) . ?  
N3 C46 1.457(9) . ?  
N3 C52 1.493(10) . ?  
C3 C4 1.373(10) . ?  
C3 C20 1.489(10) . ?  
O3 C10 1.214(10) . ?  
Br4 C61 1.899(7) . ?  
I4 C71 2.127(9) . ?  
N4 C70 1.343(9) . ?  
N4 C66 1.436(9) . ?  
N4 C72 1.483(10) . ?  
C4 C5 1.361(11) . ?  
O4 C15 1.405(10) . ?  
O4 C19 1.521(19) . ?  
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O5 C29 1.236(10) . ?  
C5 C6 1.414(10) . ?  
C5 C7 1.498(10) . ?  
O6 C29 1.275(11) . ?  
C7 C8 1.308(11) . ?  
O7 C30 1.246(10) . ?  
O8 C35 1.370(10) . ?  
O8 C39 1.566(16) . ?  
C8 C9 1.466(12) . ?  
O9 C49 1.308(9) . ?  
O10 C49 1.198(10) . ?  
C10 C11 1.528(12) . ?  
O11 C50 1.182(9) . ?  
O12 C55 1.386(11) . ?  
O12 C59 1.427(11) . ?  
C12 C18 1.504(11) . ?  
O13 C69 1.316(8) . ?  
C13 C14 1.347(12) . ?  
C13 C18 1.386(11) . ?  
O14 C69 1.245(8) . ?  
C14 C15 1.328(12) . ?  
O15 C70 1.181(10) . ?  
C15 C16 1.400(11) . ?  
O16 C75 1.390(8) . ?  
O16 C79 1.418(10) . ?  
C16 C17 1.379(11) . ?  
C17 C18 1.403(12) . ?  
C21 C26 1.372(9) . ?  
C21 C22 1.414(11) . ?  
C22 C23 1.384(10) . ?  
C23 C24 1.359(10) . ?  
C23 C40 1.530(10) . ?  
C24 C25 1.397(10) . ?  
C25 C26 1.410(9) . ?  
C25 C27 1.480(9) . ?  
C27 C28 1.352(11) . ?  
C28 C29 1.475(11) . ?  
C30 C31 1.480(13) . ?  
C32 C38 1.513(11) . ?  
C33 C38 1.337(12) . ?  
C33 C34 1.392(13) . ?  
C34 C35 1.390(13) . ?  
C35 C36 1.427(12) . ?  
C36 C37 1.356(12) . ?  
C37 C38 1.385(11) . ?  
C41 C42 1.368(10) . ?  
C41 C46 1.364(9) . ?  
C42 C43 1.385(10) . ?  
C43 C44 1.412(10) . ?  
C43 C60 1.505(11) . ?  
C44 C45 1.412(9) . ?  
C45 C46 1.376(10) . ?  
C45 C47 1.487(10) . ?  
C47 C48 1.330(10) . ?  
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C48 C49 1.456(11) . ?  
C50 C51 1.513(12) . ?  
C52 C58 1.469(10) . ?  
C53 C54 1.354(11) . ?  
C53 C58 1.436(11) . ?  
C54 C55 1.403(11) . ?  
C55 C56 1.367(12) . ?  
C56 C57 1.381(12) . ?  
C57 C58 1.383(10) . ?  
C61 C62 1.344(11) . ?  
C61 C66 1.395(9) . ?  
C62 C63 1.407(11) . ?  
C63 C64 1.389(10) . ?  
C63 C80 1.506(11) . ?  
C64 C65 1.410(9) . ?  
C65 C66 1.414(9) . ?  
C65 C67 1.453(9) . ?  
C67 C68 1.358(9) . ?  
C68 C69 1.416(10) . ?  
C70 C71 1.528(12) . ?  
C72 C78 1.487(10) . ?  
C73 C78 1.357(10) . ?  
C73 C74 1.413(11) . ?  
C74 C75 1.406(10) . ?  
C75 C76 1.359(11) . ?  
C76 C77 1.358(11) . ?  
C77 C78 1.427(9) . ?  
   
loop_  
 _geom_angle_atom_site_label_1  
 _geom_angle_atom_site_label_2  
 _geom_angle_atom_site_label_3  
 _geom_angle  
 _geom_angle_site_symmetry_1  
 _geom_angle_site_symmetry_3  
 _geom_angle_publ_flag  
C10 N1 C6 124.5(6) . . ?  
C10 N1 C12 117.4(7) . . ?  
C6 N1 C12 118.1(6) . . ?  
C2 C1 C6 123.9(7) . . ?  
C2 C1 Br1 118.0(5) . . ?  
C6 C1 Br1 118.1(6) . . ?  
C30 N2 C26 124.8(6) . . ?  
C30 N2 C32 120.8(7) . . ?  
C26 N2 C32 114.3(6) . . ?  
C1 C2 C3 118.5(7) . . ?  
C50 N3 C46 122.5(6) . . ?  
C50 N3 C52 120.0(6) . . ?  
C46 N3 C52 117.3(5) . . ?  
C4 C3 C2 118.2(7) . . ?  
C4 C3 C20 120.5(6) . . ?  
C2 C3 C20 121.2(6) . . ?  
C70 N4 C66 125.1(6) . . ?  
C70 N4 C72 118.7(7) . . ?  
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C66 N4 C72 116.2(6) . . ?  
C5 C4 C3 124.1(7) . . ?  
C15 O4 C19 123.3(10) . . ?  
C4 C5 C6 119.4(6) . . ?  
C4 C5 C7 121.1(6) . . ?  
C6 C5 C7 119.4(7) . . ?  
N1 C6 C5 122.5(6) . . ?  
N1 C6 C1 121.2(6) . . ?  
C5 C6 C1 115.9(7) . . ?  
C8 C7 C5 125.4(8) . . ?  
C35 O8 C39 112.8(8) . . ?  
C7 C8 C9 123.2(9) . . ?  
O2 C9 O1 123.6(8) . . ?  
O2 C9 C8 121.1(8) . . ?  
O1 C9 C8 115.1(9) . . ?  
O3 C10 N1 124.1(8) . . ?  
O3 C10 C11 120.8(8) . . ?  
N1 C10 C11 115.1(7) . . ?  
C10 C11 I1 108.8(6) . . ?  
C55 O12 C59 118.5(7) . . ?  
N1 C12 C18 110.8(6) . . ?  
C14 C13 C18 120.9(8) . . ?  
C15 C14 C13 123.0(8) . . ?  
C14 C15 C16 120.1(8) . . ?  
C14 C15 O4 118.6(7) . . ?  
C16 C15 O4 121.2(7) . . ?  
C75 O16 C79 119.2(6) . . ?  
C17 C16 C15 116.9(7) . . ?  
C16 C17 C18 123.2(7) . . ?  
C13 C18 C17 115.9(7) . . ?  
C13 C18 C12 122.6(8) . . ?  
C17 C18 C12 121.2(8) . . ?  
C26 C21 C22 121.7(6) . . ?  
C26 C21 Br2 120.8(5) . . ?  
C22 C21 Br2 117.5(5) . . ?  
C23 C22 C21 118.1(6) . . ?  
C24 C23 C22 120.6(7) . . ?  
C24 C23 C40 118.5(6) . . ?  
C22 C23 C40 120.7(6) . . ?  
C23 C24 C25 121.6(6) . . ?  
C24 C25 C26 118.6(6) . . ?  
C24 C25 C27 122.5(6) . . ?  
C26 C25 C27 118.8(6) . . ?  
C21 C26 C25 119.0(6) . . ?  
C21 C26 N2 119.5(6) . . ?  
C25 C26 N2 121.4(6) . . ?  
C28 C27 C25 122.7(7) . . ?  
C27 C28 C29 119.4(8) . . ?  
O5 C29 O6 121.9(8) . . ?  
O5 C29 C28 117.1(9) . . ?  
O6 C29 C28 120.9(8) . . ?  
O7 C30 N2 123.2(8) . . ?  
O7 C30 C31 119.6(8) . . ?  
N2 C30 C31 117.3(7) . . ?  
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C30 C31 I2 109.3(6) . . ?  
N2 C32 C38 111.8(6) . . ?  
C38 C33 C34 121.6(8) . . ?  
C35 C34 C33 119.5(8) . . ?  
O8 C35 C34 125.5(8) . . ?  
O8 C35 C36 115.4(8) . . ?  
C34 C35 C36 119.0(8) . . ?  
C37 C36 C35 117.9(8) . . ?  
C36 C37 C38 122.9(7) . . ?  
C33 C38 C37 118.9(7) . . ?  
C33 C38 C32 120.6(8) . . ?  
C37 C38 C32 120.3(7) . . ?  
C42 C41 C46 123.0(6) . . ?  
C42 C41 Br3 118.1(5) . . ?  
C46 C41 Br3 118.9(5) . . ?  
C41 C42 C43 119.6(7) . . ?  
C42 C43 C44 118.4(7) . . ?  
C42 C43 C60 121.7(7) . . ?  
C44 C43 C60 119.8(7) . . ?  
C43 C44 C45 120.4(6) . . ?  
C46 C45 C44 119.0(6) . . ?  
C46 C45 C47 122.9(6) . . ?  
C44 C45 C47 118.0(6) . . ?  
C41 C46 C45 119.5(6) . . ?  
C41 C46 N3 121.2(6) . . ?  
C45 C46 N3 119.3(6) . . ?  
C48 C47 C45 126.9(7) . . ?  
C47 C48 C49 121.1(7) . . ?  
O10 C49 O9 123.8(8) . . ?  
O10 C49 C48 123.3(7) . . ?  
O9 C49 C48 112.9(7) . . ?  
O11 C50 N3 122.3(7) . . ?  
O11 C50 C51 125.2(7) . . ?  
N3 C50 C51 112.5(6) . . ?  
C50 C51 I3 113.9(6) . . ?  
C58 C52 N3 114.3(6) . . ?  
C54 C53 C58 119.4(7) . . ?  
C53 C54 C55 121.4(8) . . ?  
C56 C55 O12 124.8(7) . . ?  
C56 C55 C54 119.6(8) . . ?  
O12 C55 C54 115.1(7) . . ?  
C55 C56 C57 118.8(8) . . ?  
C56 C57 C58 123.1(7) . . ?  
C57 C58 C53 117.1(7) . . ?  
C57 C58 C52 123.5(7) . . ?  
C53 C58 C52 119.4(7) . . ?  
C62 C61 C66 121.5(6) . . ?  
C62 C61 Br4 119.8(5) . . ?  
C66 C61 Br4 118.7(5) . . ?  
C61 C62 C63 121.2(7) . . ?  
C64 C63 C62 117.7(7) . . ?  
C64 C63 C80 119.8(7) . . ?  
C62 C63 C80 122.5(7) . . ?  
C63 C64 C65 122.5(7) . . ?  
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C64 C65 C66 117.2(6) . . ?  
C64 C65 C67 121.2(6) . . ?  
C66 C65 C67 121.3(6) . . ?  
C61 C66 C65 119.7(6) . . ?  
C61 C66 N4 121.2(6) . . ?  
C65 C66 N4 119.0(6) . . ?  
C68 C67 C65 126.3(6) . . ?  
C67 C68 C69 122.3(7) . . ?  
O14 C69 O13 120.6(6) . . ?  
O14 C69 C68 124.1(6) . . ?  
O13 C69 C68 115.3(6) . . ?  
O15 C70 N4 123.5(8) . . ?  
O15 C70 C71 120.2(7) . . ?  
N4 C70 C71 116.2(7) . . ?  
C70 C71 I4 113.0(5) . . ?  
N4 C72 C78 112.5(6) . . ?  
C78 C73 C74 123.7(6) . . ?  
C75 C74 C73 116.1(7) . . ?  
C76 C75 O16 117.4(6) . . ?  
C76 C75 C74 121.8(6) . . ?  
O16 C75 C74 120.8(7) . . ?  
C77 C76 C75 120.4(7) . . ?  
C76 C77 C78 121.3(7) . . ?  
C73 C78 C77 116.8(6) . . ?  
C73 C78 C72 122.2(6) . . ?  
C77 C78 C72 120.9(7) . . ?  
   
_diffrn_measured_fraction_theta_max    0.997  
_diffrn_reflns_theta_full              30.00  
_diffrn_measured_fraction_theta_full   0.997  
_refine_diff_density_max    8.357  
_refine_diff_density_min   -1.927  
_refine_diff_density_rms    0.198  
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
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The corresponding CIF file for (S)-5.18f is shown below, between the lines of “+” symbols. 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
data_dg81908s  
   
_audit_creation_method            SHELXL-97  
_chemical_name_systematic  
;  
 ?  
;  
_chemical_name_common             ?  
_chemical_melting_point           ?  
_chemical_formula_moiety          'C24 H28 Br N O4'  
_chemical_formula_sum  
 'C24 H28 Br N O4'  
_chemical_formula_weight          474.38  
_chemical_absolute_configuration   ad  
loop_  
 _atom_type_symbol  
 _atom_type_description  
 _atom_type_scat_dispersion_real  
 _atom_type_scat_dispersion_imag  
 _atom_type_scat_source  
 'C'  'C'   0.0033   0.0016  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'H'  'H'   0.0000   0.0000  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'N'  'N'   0.0061   0.0033  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
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 'O'  'O'   0.0106   0.0060  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'Br'  'Br'  -0.2901   2.4595  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
   
_symmetry_cell_setting           monoclinic  
_symmetry_space_group_name_H-M    'P 21'  
   
loop_  
 _symmetry_equiv_pos_as_xyz  
 'x, y, z'  
 '-x, y+1/2, -z'  
   
_cell_length_a                    10.5601(18)  
_cell_length_b                    7.3873(13)  
_cell_length_c                    14.727(3)  
_cell_angle_alpha                 90.00  
_cell_angle_beta                  101.490(4)  
_cell_angle_gamma                 90.00  
_cell_volume                      1125.8(3)  
_cell_formula_units_Z             2  
_cell_measurement_temperature     203(2)  
_cell_measurement_reflns_used     2752  
_cell_measurement_theta_min       2.6  
_cell_measurement_theta_max       22.6  
   
_exptl_crystal_description       block  
_exptl_crystal_colour             colorless  
_exptl_crystal_size_max           0.21  
_exptl_crystal_size_mid           0.18  
_exptl_crystal_size_min           0.10  
_exptl_crystal_density_meas       0  
_exptl_crystal_density_diffrn     1.399  
_exptl_crystal_density_method     'not measured'  
_exptl_crystal_F_000              492  
_exptl_absorpt_coefficient_mu     1.855  
_exptl_absorpt_correction_type    Multi-scan  
_exptl_absorpt_correction_T_min   0.6967  
_exptl_absorpt_correction_T_max   0.8362  
_exptl_absorpt_process_details   'Bruker Sadabs'  
   
_exptl_special_details  
;  
 ?  
;  
   
_diffrn_ambient_temperature       203(2)  
_diffrn_radiation_wavelength      0.71073  
_diffrn_radiation_type            MoK\a  
_diffrn_radiation_source          'fine-focus sealed tube'  
_diffrn_radiation_monochromator   graphite  
_diffrn_measurement_device_type   'Bruker Smart Apex CCD'  
_diffrn_measurement_method        'omega scans'  
_diffrn_detector_area_resol_mean  ?  
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_diffrn_standards_number          ?  
_diffrn_standards_interval_count  ?  
_diffrn_standards_interval_time   ?  
_diffrn_standards_decay_%         ?  
_diffrn_reflns_number             14095  
_diffrn_reflns_av_R_equivalents   0.0458  
_diffrn_reflns_av_sigmaI/netI     0.0873  
_diffrn_reflns_limit_h_min        -15  
_diffrn_reflns_limit_h_max        15  
_diffrn_reflns_limit_k_min        -10  
_diffrn_reflns_limit_k_max        11  
_diffrn_reflns_limit_l_min        -21  
_diffrn_reflns_limit_l_max        21  
_diffrn_reflns_theta_min          1.97  
_diffrn_reflns_theta_max          32.35  
_reflns_number_total              7315  
_reflns_number_gt                 5348  
_reflns_threshold_expression      >2sigma(I)  
   
_computing_data_collection        'Bruker SMART'  
_computing_cell_refinement        'Bruker SMART'  
_computing_data_reduction         'Bruker SAINT'  
_computing_structure_solution     'SHELXS-97 (Sheldrick, 1990)'  
_computing_structure_refinement   'SHELXL-97 (Sheldrick, 1997)'  
_computing_molecular_graphics     'Bruker SHELXTL'  
_computing_publication_material   'Bruker SHELXTL'  
   
_refine_special_details  
;  
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and  
 goodness of fit S are based on F^2^, conventional R-factors R are based  
 on F, with F set to zero for negative F^2^. The threshold expression of  
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and 
is  
 not relevant to the choice of reflections for refinement.  R-factors 
based  
 on F^2^ are statistically about twice as large as those based on F, and 
R-  
 factors based on ALL data will be even larger.  
;  
   
_refine_ls_structure_factor_coef  Fsqd  
_refine_ls_matrix_type            full  
_refine_ls_weighting_scheme       calc  
_refine_ls_weighting_details  
 'calc w=1/[\s^2^(Fo^2^)+(0.0780P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3'  
_atom_sites_solution_primary      direct  
_atom_sites_solution_secondary    difmap  
_atom_sites_solution_hydrogens    geom  
_refine_ls_hydrogen_treatment     constr  
_refine_ls_extinction_method      none  
_refine_ls_extinction_coef        ?  
_refine_ls_abs_structure_details  
 'Flack H D (1983), Acta Cryst. A39, 876-881'  
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_refine_ls_abs_structure_Flack    0.008(9)  
_refine_ls_number_reflns          7315  
_refine_ls_number_parameters      277  
_refine_ls_number_restraints      1  
_refine_ls_R_factor_all           0.0747  
_refine_ls_R_factor_gt            0.0500  
_refine_ls_wR_factor_ref          0.1338  
_refine_ls_wR_factor_gt           0.1159  
_refine_ls_goodness_of_fit_ref    0.823  
_refine_ls_restrained_S_all       0.823  
_refine_ls_shift/su_max           0.001  
_refine_ls_shift/su_mean          0.000  
   
loop_  
 _atom_site_label  
 _atom_site_type_symbol  
 _atom_site_fract_x  
 _atom_site_fract_y  
 _atom_site_fract_z  
 _atom_site_U_iso_or_equiv  
 _atom_site_adp_type  
 _atom_site_occupancy  
 _atom_site_symmetry_multiplicity  
 _atom_site_calc_flag  
 _atom_site_refinement_flags  
 _atom_site_disorder_assembly  
 _atom_site_disorder_group  
Br Br 0.70134(3) 0.27425(5) 0.31693(2) 0.04584(12) Uani 1 1 d . . .  
N N 0.4912(2) 0.5276(3) 0.17956(16) 0.0266(5) Uani 1 1 d . . .  
O1 O -0.0922(2) 0.2666(7) 0.02915(15) 0.0580(7) Uani 1 1 d . . .  
C1 C 0.6143(3) 0.4885(4) 0.3422(2) 0.0289(6) Uani 1 1 d . . .  
O2 O 0.4508(2) 0.6082(3) 0.02853(14) 0.0365(5) Uani 1 1 d . . .  
C2 C 0.6505(3) 0.5530(5) 0.4312(2) 0.0356(7) Uani 1 1 d . . .  
H2A H 0.7046 0.4827 0.4761 0.043 Uiso 1 1 calc R . .  
C3 C 0.6082(3) 0.7203(5) 0.4555(2) 0.0354(7) Uani 1 1 d . . .  
O3 O 0.2397(2) 0.8903(5) 0.35234(17) 0.0590(8) Uani 1 1 d . . .  
O4 O 0.06552(17) 0.7986(4) 0.24937(12) 0.0332(5) Uani 1 1 d . . .  
C4 C 0.5253(3) 0.8181(4) 0.3885(2) 0.0306(7) Uani 1 1 d . . .  
H4A H 0.4961 0.9321 0.4038 0.037 Uiso 1 1 calc R . .  
C5 C 0.4840(2) 0.7515(4) 0.29883(17) 0.0249(5) Uani 1 1 d . . .  
C6 C 0.4054(3) 0.8677(4) 0.22364(19) 0.0251(5) Uani 1 1 d . . .  
H6A H 0.4128 0.9954 0.2445 0.030 Uiso 1 1 calc R . .  
C7 C 0.4701(3) 0.8490(4) 0.1398(2) 0.0309(6) Uani 1 1 d . . .  
H7A H 0.4232 0.9223 0.0885 0.037 Uiso 1 1 calc R . .  
H7B H 0.5590 0.8943 0.1559 0.037 Uiso 1 1 calc R . .  
C8 C 0.4714(3) 0.6552(4) 0.1097(2) 0.0271(6) Uani 1 1 d . . .  
C9 C 0.5282(3) 0.5836(4) 0.27343(18) 0.0254(5) Uani 1 1 d . . .  
C10 C 0.4512(3) 0.3402(4) 0.1522(2) 0.0334(6) Uani 1 1 d . . .  
H10A H 0.4814 0.2592 0.2047 0.040 Uiso 1 1 calc R . .  
H10B H 0.4928 0.3027 0.1014 0.040 Uiso 1 1 calc R . .  
C11 C 0.2248(3) 0.3299(5) 0.1842(2) 0.0410(8) Uani 1 1 d . . .  
H11A H 0.2603 0.3489 0.2472 0.049 Uiso 1 1 calc R . .  
C12 C 0.0892(3) 0.3118(5) 0.1555(2) 0.0438(9) Uani 1 1 d . . .  
H12A H 0.0347 0.3198 0.1987 0.053 Uiso 1 1 calc R . .  
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C13 C 0.0391(3) 0.2826(7) 0.0638(2) 0.0433(7) Uani 1 1 d . . .  
C14 C 0.1175(3) 0.2699(9) 0.0002(2) 0.0544(9) Uani 1 1 d . . .  
H14A H 0.0818 0.2479 -0.0625 0.065 Uiso 1 1 calc R . .  
C15 C 0.2488(3) 0.2895(7) 0.0292(2) 0.0465(8) Uani 1 1 d . . .  
H15A H 0.3018 0.2820 -0.0150 0.056 Uiso 1 1 calc R . .  
C16 C 0.3059(3) 0.3201(4) 0.1215(2) 0.0325(6) Uani 1 1 d . . .  
C17 C 0.2610(3) 0.8188(4) 0.19704(19) 0.0290(6) Uani 1 1 d . . .  
H17A H 0.2199 0.8958 0.1453 0.035 Uiso 1 1 calc R . .  
H17B H 0.2528 0.6929 0.1757 0.035 Uiso 1 1 calc R . .  
C18 C 0.1906(3) 0.8412(4) 0.2758(2) 0.0318(6) Uani 1 1 d . . .  
C19 C -0.0212(3) 0.8001(6) 0.3167(2) 0.0383(8) Uani 1 1 d . . .  
C20 C -0.1533(3) 0.7639(9) 0.2556(3) 0.0577(10) Uani 1 1 d . . .  
H20A H -0.1705 0.8536 0.2065 0.087 Uiso 1 1 calc R . .  
H20B H -0.2193 0.7710 0.2927 0.087 Uiso 1 1 calc R . .  
H20C H -0.1540 0.6440 0.2286 0.087 Uiso 1 1 calc R . .  
C21 C 0.0175(5) 0.6520(8) 0.3869(3) 0.0698(14) Uani 1 1 d . . .  
H21A H 0.0203 0.5375 0.3552 0.105 Uiso 1 1 calc R . .  
H21B H -0.0451 0.6447 0.4269 0.105 Uiso 1 1 calc R . .  
H21C H 0.1022 0.6785 0.4239 0.105 Uiso 1 1 calc R . .  
C22 C -0.0216(4) 0.9837(7) 0.3617(3) 0.0562(11) Uani 1 1 d . . .  
H22A H 0.0607 1.0037 0.4033 0.084 Uiso 1 1 calc R . .  
H22B H -0.0906 0.9887 0.3964 0.084 Uiso 1 1 calc R . .  
H22C H -0.0353 1.0767 0.3143 0.084 Uiso 1 1 calc R . .  
C23 C 0.6525(3) 0.7955(8) 0.5525(2) 0.0524(9) Uani 1 1 d . . .  
H23A H 0.5878 0.7700 0.5891 0.079 Uiso 1 1 calc R . .  
H23B H 0.6644 0.9253 0.5491 0.079 Uiso 1 1 calc R . .  
H23C H 0.7336 0.7392 0.5812 0.079 Uiso 1 1 calc R . .  
C24 C -0.1764(3) 0.2712(10) 0.0912(3) 0.0656(11) Uani 1 1 d . . .  
H24A H -0.1446 0.1914 0.1430 0.098 Uiso 1 1 calc R . .  
H24B H -0.2616 0.2315 0.0599 0.098 Uiso 1 1 calc R . .  
H24C H -0.1817 0.3938 0.1136 0.098 Uiso 1 1 calc R . .  
   
loop_  
 _atom_site_aniso_label  
 _atom_site_aniso_U_11  
 _atom_site_aniso_U_22  
 _atom_site_aniso_U_33  
 _atom_site_aniso_U_23  
 _atom_site_aniso_U_13  
 _atom_site_aniso_U_12  
Br 0.04299(18) 0.04097(18) 0.05117(19) 0.00253(18) 0.00365(13) 0.01911(17)  
N 0.0298(11) 0.0231(11) 0.0277(11) 0.0031(9) 0.0075(9) 0.0026(9)  
O1 0.0408(12) 0.089(2) 0.0403(12) -0.0045(19) -0.0005(10) -0.015(2)  
C1 0.0258(13) 0.0260(13) 0.0357(15) 0.0047(11) 0.0085(11) 0.0058(10)  
O2 0.0454(13) 0.0398(13) 0.0267(10) 0.0027(9) 0.0129(9) 0.0024(10)  
C2 0.0268(14) 0.0475(19) 0.0319(15) 0.0094(13) 0.0047(11) 0.0038(13)  
C3 0.0272(14) 0.048(2) 0.0300(14) -0.0005(12) 0.0039(11) -0.0002(12)  
O3 0.0294(12) 0.109(3) 0.0376(13) -0.0261(15) 0.0048(10) 0.0018(14)  
O4 0.0265(9) 0.0448(14) 0.0288(9) -0.0018(10) 0.0070(7) -0.0020(10)  
C4 0.0273(13) 0.0341(18) 0.0303(13) -0.0013(11) 0.0058(10) 0.0000(11)  
C5 0.0197(10) 0.0263(15) 0.0290(11) 0.0030(11) 0.0057(9) 0.0008(10)  
C6 0.0246(12) 0.0225(13) 0.0286(13) 0.0019(10) 0.0060(10) 0.0013(10)  
C7 0.0305(14) 0.0282(14) 0.0353(16) 0.0084(12) 0.0099(12) -0.0010(11)  
C8 0.0271(14) 0.0287(15) 0.0283(14) 0.0065(11) 0.0123(11) 0.0021(11)  
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C9 0.0232(12) 0.0272(14) 0.0266(12) 0.0037(10) 0.0072(10) -0.0013(10)  
C10 0.0373(15) 0.0260(13) 0.0369(15) 0.0000(12) 0.0074(12) 0.0040(12)  
C11 0.0460(18) 0.046(2) 0.0314(15) -0.0024(13) 0.0099(13) -0.0081(14)  
C12 0.0452(17) 0.051(3) 0.0401(16) -0.0013(15) 0.0197(14) -0.0060(15)  
C13 0.0417(15) 0.0466(18) 0.0397(15) -0.0023(19) 0.0033(12) -0.0063(19)  
C14 0.0514(18) 0.077(3) 0.0332(15) -0.006(2) 0.0034(13) -0.008(3)  
C15 0.0481(17) 0.056(2) 0.0358(15) -0.0091(19) 0.0091(13) -0.005(2)  
C16 0.0362(14) 0.0245(15) 0.0375(15) 0.0010(11) 0.0090(12) -0.0014(11)  
C17 0.0251(12) 0.0324(17) 0.0298(13) 0.0012(10) 0.0067(10) 0.0054(10)  
C18 0.0255(13) 0.0380(15) 0.0319(14) -0.0027(12) 0.0059(11) 0.0038(11)  
C19 0.0287(13) 0.054(2) 0.0341(14) 0.0080(15) 0.0124(11) 0.0027(15)  
C20 0.0361(16) 0.086(3) 0.0536(19) -0.003(3) 0.0159(14) -0.010(2)  
C21 0.067(3) 0.082(3) 0.070(3) 0.038(3) 0.035(2) 0.024(3)  
C22 0.044(2) 0.073(3) 0.055(2) -0.014(2) 0.0184(18) 0.011(2)  
C23 0.0485(18) 0.067(3) 0.0367(16) -0.006(2) -0.0029(13) 0.004(2)  
C24 0.0377(17) 0.099(3) 0.061(2) -0.012(3) 0.0104(15) -0.013(3)  
   
_geom_special_details  
;  
 All esds (except the esd in the dihedral angle between two l.s. planes)  
 are estimated using the full covariance matrix.  The cell esds are taken  
 into account individually in the estimation of esds in distances, angles  
 and torsion angles; correlations between esds in cell parameters are only  
 used when they are defined by crystal symmetry.  An approximate 
(isotropic)  
 treatment of cell esds is used for estimating esds involving l.s. planes.  
;  
   
loop_  
 _geom_bond_atom_site_label_1  
 _geom_bond_atom_site_label_2  
 _geom_bond_distance  
 _geom_bond_site_symmetry_2  
 _geom_bond_publ_flag  
Br C1 1.903(3) . ?  
N C8 1.380(4) . ?  
N C9 1.421(4) . ?  
N C10 1.480(4) . ?  
O1 C13 1.384(4) . ?  
O1 C24 1.397(4) . ?  
C1 C2 1.375(4) . ?  
C1 C9 1.407(4) . ?  
O2 C8 1.222(4) . ?  
C2 C3 1.385(5) . ?  
C2 H2A 0.9400 . ?  
C3 C4 1.385(4) . ?  
C3 C23 1.516(5) . ?  
O3 C18 1.200(4) . ?  
O4 C18 1.338(3) . ?  
O4 C19 1.477(3) . ?  
C4 C5 1.395(4) . ?  
C4 H4A 0.9400 . ?  
C5 C9 1.402(4) . ?  
C5 C6 1.512(4) . ?  
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C6 C7 1.533(4) . ?  
C6 C17 1.539(4) . ?  
C6 H6A 0.9900 . ?  
C7 C8 1.499(4) . ?  
C7 H7A 0.9800 . ?  
C7 H7B 0.9800 . ?  
C10 C16 1.518(4) . ?  
C10 H10A 0.9800 . ?  
C10 H10B 0.9800 . ?  
C11 C16 1.381(4) . ?  
C11 C12 1.416(5) . ?  
C11 H11A 0.9400 . ?  
C12 C13 1.366(5) . ?  
C12 H12A 0.9400 . ?  
C13 C14 1.370(5) . ?  
C14 C15 1.375(5) . ?  
C14 H14A 0.9400 . ?  
C15 C16 1.392(4) . ?  
C15 H15A 0.9400 . ?  
C17 C18 1.506(4) . ?  
C17 H17A 0.9800 . ?  
C17 H17B 0.9800 . ?  
C19 C21 1.504(6) . ?  
C19 C22 1.510(6) . ?  
C19 C20 1.525(5) . ?  
C20 H20A 0.9700 . ?  
C20 H20B 0.9700 . ?  
C20 H20C 0.9700 . ?  
C21 H21A 0.9700 . ?  
C21 H21B 0.9700 . ?  
C21 H21C 0.9700 . ?  
C22 H22A 0.9700 . ?  
C22 H22B 0.9700 . ?  
C22 H22C 0.9700 . ?  
C23 H23A 0.9700 . ?  
C23 H23B 0.9700 . ?  
C23 H23C 0.9700 . ?  
C24 H24A 0.9700 . ?  
C24 H24B 0.9700 . ?  
C24 H24C 0.9700 . ?  
   
loop_  
 _geom_angle_atom_site_label_1  
 _geom_angle_atom_site_label_2  
 _geom_angle_atom_site_label_3  
 _geom_angle  
 _geom_angle_site_symmetry_1  
 _geom_angle_site_symmetry_3  
 _geom_angle_publ_flag  
C8 N C9 119.9(2) . . ?  
C8 N C10 116.3(2) . . ?  
C9 N C10 123.1(2) . . ?  
C13 O1 C24 118.6(3) . . ?  
C2 C1 C9 122.0(3) . . ?  
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C2 C1 Br 114.9(2) . . ?  
C9 C1 Br 122.9(2) . . ?  
C1 C2 C3 120.9(3) . . ?  
C1 C2 H2A 119.6 . . ?  
C3 C2 H2A 119.6 . . ?  
C4 C3 C2 118.1(3) . . ?  
C4 C3 C23 120.8(3) . . ?  
C2 C3 C23 121.0(3) . . ?  
C18 O4 C19 120.8(2) . . ?  
C3 C4 C5 121.6(3) . . ?  
C3 C4 H4A 119.2 . . ?  
C5 C4 H4A 119.2 . . ?  
C4 C5 C9 120.4(2) . . ?  
C4 C5 C6 121.0(3) . . ?  
C9 C5 C6 118.1(2) . . ?  
C5 C6 C7 105.7(2) . . ?  
C5 C6 C17 115.1(2) . . ?  
C7 C6 C17 110.6(2) . . ?  
C5 C6 H6A 108.4 . . ?  
C7 C6 H6A 108.4 . . ?  
C17 C6 H6A 108.4 . . ?  
C8 C7 C6 110.8(2) . . ?  
C8 C7 H7A 109.5 . . ?  
C6 C7 H7A 109.5 . . ?  
C8 C7 H7B 109.5 . . ?  
C6 C7 H7B 109.5 . . ?  
H7A C7 H7B 108.1 . . ?  
O2 C8 N 120.4(3) . . ?  
O2 C8 C7 123.3(3) . . ?  
N C8 C7 116.2(2) . . ?  
C5 C9 C1 116.8(3) . . ?  
C5 C9 N 118.4(2) . . ?  
C1 C9 N 124.6(3) . . ?  
N C10 C16 112.9(2) . . ?  
N C10 H10A 109.0 . . ?  
C16 C10 H10A 109.0 . . ?  
N C10 H10B 109.0 . . ?  
C16 C10 H10B 109.0 . . ?  
H10A C10 H10B 107.8 . . ?  
C16 C11 C12 121.4(3) . . ?  
C16 C11 H11A 119.3 . . ?  
C12 C11 H11A 119.3 . . ?  
C13 C12 C11 118.6(3) . . ?  
C13 C12 H12A 120.7 . . ?  
C11 C12 H12A 120.7 . . ?  
C12 C13 C14 121.2(3) . . ?  
C12 C13 O1 122.7(3) . . ?  
C14 C13 O1 116.1(3) . . ?  
C13 C14 C15 119.4(3) . . ?  
C13 C14 H14A 120.3 . . ?  
C15 C14 H14A 120.3 . . ?  
C14 C15 C16 122.3(3) . . ?  
C14 C15 H15A 118.9 . . ?  
C16 C15 H15A 118.9 . . ?  
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C11 C16 C15 117.1(3) . . ?  
C11 C16 C10 121.4(3) . . ?  
C15 C16 C10 121.5(3) . . ?  
C18 C17 C6 113.2(2) . . ?  
C18 C17 H17A 108.9 . . ?  
C6 C17 H17A 108.9 . . ?  
C18 C17 H17B 108.9 . . ?  
C6 C17 H17B 108.9 . . ?  
H17A C17 H17B 107.7 . . ?  
O3 C18 O4 124.1(3) . . ?  
O3 C18 C17 124.7(3) . . ?  
O4 C18 C17 111.2(2) . . ?  
O4 C19 C21 109.7(3) . . ?  
O4 C19 C22 110.9(3) . . ?  
C21 C19 C22 112.1(4) . . ?  
O4 C19 C20 102.6(2) . . ?  
C21 C19 C20 111.7(4) . . ?  
C22 C19 C20 109.5(4) . . ?  
C19 C20 H20A 109.5 . . ?  
C19 C20 H20B 109.5 . . ?  
H20A C20 H20B 109.5 . . ?  
C19 C20 H20C 109.5 . . ?  
H20A C20 H20C 109.5 . . ?  
H20B C20 H20C 109.5 . . ?  
C19 C21 H21A 109.5 . . ?  
C19 C21 H21B 109.5 . . ?  
H21A C21 H21B 109.5 . . ?  
C19 C21 H21C 109.5 . . ?  
H21A C21 H21C 109.5 . . ?  
H21B C21 H21C 109.5 . . ?  
C19 C22 H22A 109.5 . . ?  
C19 C22 H22B 109.5 . . ?  
H22A C22 H22B 109.5 . . ?  
C19 C22 H22C 109.5 . . ?  
H22A C22 H22C 109.5 . . ?  
H22B C22 H22C 109.5 . . ?  
C3 C23 H23A 109.5 . . ?  
C3 C23 H23B 109.5 . . ?  
H23A C23 H23B 109.5 . . ?  
C3 C23 H23C 109.5 . . ?  
H23A C23 H23C 109.5 . . ?  
H23B C23 H23C 109.5 . . ?  
O1 C24 H24A 109.5 . . ?  
O1 C24 H24B 109.5 . . ?  
H24A C24 H24B 109.5 . . ?  
O1 C24 H24C 109.5 . . ?  
H24A C24 H24C 109.5 . . ?  
H24B C24 H24C 109.5 . . ?  
   
_diffrn_measured_fraction_theta_max    0.943  
_diffrn_reflns_theta_full              30.00  
_diffrn_measured_fraction_theta_full   1.000  
_refine_diff_density_max    0.776  
_refine_diff_density_min   -0.254  
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_refine_diff_density_rms    0.073  
 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
 
The corresponding CIF file for (S)-5.18f is shown below, between the lines of “+” symbols. 
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++ 
data_dgc915s  
   
_audit_creation_method            SHELXL-97  
_chemical_name_systematic  
;  
 ?  
;  
_chemical_name_common             ?  
_chemical_melting_point           ?  
_chemical_formula_moiety          ?  
_chemical_formula_sum  
 'C27 H33 N O5'  
_chemical_formula_weight          451.54  
   
loop_  
 _atom_type_symbol  
 _atom_type_description  
 _atom_type_scat_dispersion_real  
 _atom_type_scat_dispersion_imag  
 _atom_type_scat_source  
 'C'  'C'   0.0033   0.0016  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'H'  'H'   0.0000   0.0000  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
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 'N'  'N'   0.0061   0.0033  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
 'O'  'O'   0.0106   0.0060  
 'International Tables Vol C Tables 4.2.6.8 and 6.1.1.4'  
   
_symmetry_cell_setting            Monoclinic  
_symmetry_space_group_name_H-M    P2(1)/c  
   
loop_  
 _symmetry_equiv_pos_as_xyz  
 'x, y, z'  
 '-x, y+1/2, -z+1/2'  
 '-x, -y, -z'  
 'x, -y-1/2, z-1/2'  
   
_cell_length_a                    12.012(3)  
_cell_length_b                    9.305(2)  
_cell_length_c                    22.056(5)  
_cell_angle_alpha                 90.00  
_cell_angle_beta                  101.822(5)  
_cell_angle_gamma                 90.00  
_cell_volume                      2412.9(10)  
_cell_formula_units_Z             4  
_cell_measurement_temperature     203(2)  
_cell_measurement_reflns_used     1240  
_cell_measurement_theta_min       2.29  
_cell_measurement_theta_max       20.23  
   
_exptl_crystal_description        ?  
_exptl_crystal_colour             ?  
_exptl_crystal_size_max           0.25  
_exptl_crystal_size_mid           0.21  
_exptl_crystal_size_min           0.21  
_exptl_crystal_density_meas       0  
_exptl_crystal_density_diffrn     1.243  
_exptl_crystal_density_method     'not measured'  
_exptl_crystal_F_000              968  
_exptl_absorpt_coefficient_mu     0.085  
_exptl_absorpt_correction_type    none  
_exptl_absorpt_correction_T_min   0.9790  
_exptl_absorpt_correction_T_max   0.9824  
_exptl_absorpt_process_details    ?  
   
_exptl_special_details  
;  
 ?  
;  
   
_diffrn_ambient_temperature       203(2)  
_diffrn_radiation_wavelength      0.71073  
_diffrn_radiation_type            MoK\a  
_diffrn_radiation_source          'fine-focus sealed tube'  
_diffrn_radiation_monochromator   graphite  
_diffrn_measurement_device_type   'CCD area detector'  
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_diffrn_measurement_method        'phi and omega scans'  
_diffrn_detector_area_resol_mean  ?  
_diffrn_standards_number          ?  
_diffrn_standards_interval_count  ?  
_diffrn_standards_interval_time   ?  
_diffrn_standards_decay_%         ?  
_diffrn_reflns_number             18592  
_diffrn_reflns_av_R_equivalents   0.0893  
_diffrn_reflns_av_sigmaI/netI     0.0730  
_diffrn_reflns_limit_h_min        -14  
_diffrn_reflns_limit_h_max        14  
_diffrn_reflns_limit_k_min        -11  
_diffrn_reflns_limit_k_max        11  
_diffrn_reflns_limit_l_min        -26  
_diffrn_reflns_limit_l_max        26  
_diffrn_reflns_theta_min          1.73  
_diffrn_reflns_theta_max          25.00  
_reflns_number_total              4245  
_reflns_number_gt                 2609  
_reflns_threshold_expression      >2sigma(I)  
   
_computing_data_collection        'Bruker SMART'  
_computing_cell_refinement        'Bruker SMART'  
_computing_data_reduction         'Bruker SAINT'  
_computing_structure_solution     'SHELXS-97 (Sheldrick, 1990)'  
_computing_structure_refinement   'SHELXL-97 (Sheldrick, 1997)'  
_computing_molecular_graphics     'Bruker SHELXTL'  
_computing_publication_material   'Bruker SHELXTL'  
   
_refine_special_details  
;  
 Refinement of F^2^ against ALL reflections.  The weighted R-factor wR and  
 goodness of fit S are based on F^2^, conventional R-factors R are based  
 on F, with F set to zero for negative F^2^. The threshold expression of  
 F^2^ > 2sigma(F^2^) is used only for calculating R-factors(gt) etc. and 
is  
 not relevant to the choice of reflections for refinement.  R-factors 
based  
 on F^2^ are statistically about twice as large as those based on F, and 
R-  
 factors based on ALL data will be even larger.  
;  
   
_refine_ls_structure_factor_coef  Fsqd  
_refine_ls_matrix_type            full  
_refine_ls_weighting_scheme       calc  
_refine_ls_weighting_details  
 'calc w=1/[\s^2^(Fo^2^)+(0.0780P)^2^+0.0000P] where P=(Fo^2^+2Fc^2^)/3'  
_atom_sites_solution_primary      direct  
_atom_sites_solution_secondary    difmap  
_atom_sites_solution_hydrogens    geom  
_refine_ls_hydrogen_treatment     mixed  
_refine_ls_extinction_method      none  
_refine_ls_extinction_coef        ?  
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_refine_ls_number_reflns          4245  
_refine_ls_number_parameters      298  
_refine_ls_number_restraints      0  
_refine_ls_R_factor_all           0.1066  
_refine_ls_R_factor_gt            0.0570  
_refine_ls_wR_factor_ref          0.1537  
_refine_ls_wR_factor_gt           0.1323  
_refine_ls_goodness_of_fit_ref    0.922  
_refine_ls_restrained_S_all       0.922  
_refine_ls_shift/su_max           0.004  
_refine_ls_shift/su_mean          0.001  
   
loop_  
 _atom_site_label  
 _atom_site_type_symbol  
 _atom_site_fract_x  
 _atom_site_fract_y  
 _atom_site_fract_z  
 _atom_site_U_iso_or_equiv  
 _atom_site_adp_type  
 _atom_site_occupancy  
 _atom_site_symmetry_multiplicity  
 _atom_site_calc_flag  
 _atom_site_refinement_flags  
 _atom_site_disorder_assembly  
 _atom_site_disorder_group  
O1 O -0.22651(16) 0.3973(2) 0.00797(9) 0.0462(5) Uani 1 1 d . . .  
O2 O 0.31427(17) 0.5545(2) 0.19965(9) 0.0491(5) Uani 1 1 d . . .  
O3 O 0.25520(15) 0.67436(18) 0.27684(8) 0.0388(5) Uani 1 1 d . . .  
O4 O 0.00988(16) 0.04730(18) 0.13943(8) 0.0433(5) Uani 1 1 d . . .  
O5 O -0.44740(17) -0.2070(2) -0.03796(9) 0.0547(6) Uani 1 1 d . . .  
N N -0.05503(18) 0.2520(2) 0.08834(10) 0.0334(5) Uani 1 1 d . . .  
C1 C -0.0617(2) 0.4062(3) 0.08769(12) 0.0328(6) Uani 1 1 d . . .  
C2 C -0.1456(2) 0.4783(3) 0.04508(12) 0.0369(7) Uani 1 1 d . . .  
C3 C -0.1466(2) 0.6276(3) 0.04417(13) 0.0421(7) Uani 1 1 d . . .  
H3A H -0.2018 0.6764 0.0151 0.051 Uiso 1 1 calc R . .  
C4 C -0.0676(2) 0.7047(3) 0.08535(13) 0.0418(7) Uani 1 1 d . . .  
H4A H -0.0689 0.8057 0.0841 0.050 Uiso 1 1 calc R . .  
C5 C 0.0132(2) 0.6352(3) 0.12821(12) 0.0377(7) Uani 1 1 d . . .  
H5A H 0.0664 0.6889 0.1565 0.045 Uiso 1 1 calc R . .  
C6 C 0.0171(2) 0.4862(3) 0.13032(12) 0.0328(6) Uani 1 1 d . . .  
C7 C 0.0992(2) 0.4007(3) 0.17657(11) 0.0320(6) Uani 1 1 d . . .  
H7A H 0.1608 0.3667 0.1564 0.038 Uiso 1 1 calc R . .  
C8 C 0.1533(2) 0.4678(3) 0.23841(12) 0.0347(6) Uani 1 1 d . . .  
H8A H 0.0941 0.5217 0.2542 0.042 Uiso 1 1 calc R . .  
C9 C 0.1916(2) 0.3356(3) 0.28256(12) 0.0388(7) Uani 1 1 d . . .  
H9A H 0.1628 0.3498 0.3211 0.047 Uiso 1 1 calc R . .  
C10 C 0.1290(2) 0.2056(3) 0.24734(12) 0.0390(7) Uani 1 1 d . . .  
H10A H 0.1819 0.1458 0.2300 0.047 Uiso 1 1 calc R . .  
H10B H 0.0939 0.1465 0.2751 0.047 Uiso 1 1 calc R . .  
C11 C 0.0389(2) 0.2694(3) 0.19611(12) 0.0329(6) Uani 1 1 d . . .  
H11A H -0.0266 0.3014 0.2136 0.039 Uiso 1 1 calc R . .  
C12 C -0.0031(2) 0.1778(3) 0.14021(12) 0.0339(6) Uani 1 1 d . . .  
C13 C -0.2767(3) 0.4521(4) -0.05124(13) 0.0577(9) Uani 1 1 d . . .  
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H13A H -0.3327 0.3843 -0.0725 0.087 Uiso 1 1 calc R . .  
H13B H -0.2183 0.4666 -0.0752 0.087 Uiso 1 1 calc R . .  
H13C H -0.3136 0.5431 -0.0466 0.087 Uiso 1 1 calc R . .  
C14 C 0.2500(2) 0.5691(3) 0.23468(12) 0.0356(7) Uani 1 1 d . . .  
C15 C 0.3441(2) 0.7869(3) 0.28372(13) 0.0426(7) Uani 1 1 d . . .  
C16 C 0.3324(3) 0.8701(3) 0.22387(14) 0.0634(10) Uani 1 1 d . . .  
H16A H 0.2566 0.9108 0.2129 0.095 Uiso 1 1 calc R . .  
H16B H 0.3448 0.8060 0.1912 0.095 Uiso 1 1 calc R . .  
H16C H 0.3882 0.9467 0.2291 0.095 Uiso 1 1 calc R . .  
C17 C 0.3152(3) 0.8801(3) 0.33495(15) 0.0591(9) Uani 1 1 d . . .  
H17A H 0.2406 0.9227 0.3210 0.089 Uiso 1 1 calc R . .  
H17B H 0.3716 0.9556 0.3453 0.089 Uiso 1 1 calc R . .  
H17C H 0.3149 0.8214 0.3713 0.089 Uiso 1 1 calc R . .  
C18 C 0.4605(3) 0.7192(4) 0.30403(16) 0.0624(9) Uani 1 1 d . . .  
H18A H 0.4777 0.6613 0.2705 0.094 Uiso 1 1 calc R . .  
H18B H 0.4611 0.6588 0.3399 0.094 Uiso 1 1 calc R . .  
H18C H 0.5173 0.7941 0.3146 0.094 Uiso 1 1 calc R . .  
C19 C 0.3190(3) 0.3109(3) 0.29993(15) 0.0571(9) Uani 1 1 d . . .  
H19A H 0.3346 0.2283 0.3272 0.086 Uiso 1 1 calc R . .  
H19B H 0.3556 0.3952 0.3210 0.086 Uiso 1 1 calc R . .  
H19C H 0.3483 0.2934 0.2627 0.086 Uiso 1 1 calc R . .  
C20 C -0.0737(2) 0.1724(3) 0.02922(12) 0.0373(7) Uani 1 1 d . . .  
H20A H -0.0081 0.1092 0.0299 0.045 Uiso 1 1 calc R . .  
H20B H -0.0750 0.2419 -0.0043 0.045 Uiso 1 1 calc R . .  
C21 C -0.1798(2) 0.0825(3) 0.01355(12) 0.0331(6) Uani 1 1 d . . .  
C22 C -0.2446(2) 0.0429(3) 0.05583(12) 0.0364(7) Uani 1 1 d . . .  
H22A H -0.2265 0.0807 0.0962 0.044 Uiso 1 1 calc R . .  
C23 C -0.3355(2) -0.0509(3) 0.04038(13) 0.0395(7) Uani 1 1 d . . .  
H23A H -0.3785 -0.0758 0.0700 0.047 Uiso 1 1 calc R . .  
C24 C -0.3628(2) -0.1075(3) -0.01862(13) 0.0409(7) Uani 1 1 d . . .  
C25 C -0.3014(3) -0.0661(3) -0.06232(13) 0.0452(7) Uani 1 1 d . . .  
H25A H -0.3209 -0.1020 -0.1030 0.054 Uiso 1 1 calc R . .  
C26 C -0.2114(2) 0.0280(3) -0.04609(13) 0.0428(7) Uani 1 1 d . . .  
H26A H -0.1704 0.0558 -0.0762 0.051 Uiso 1 1 calc R . .  
C27 C -0.5024(3) -0.2664(3) 0.00774(15) 0.0612(9) Uani 1 1 d . . .  
H27A H -0.5600 -0.3344 -0.0117 0.092 Uiso 1 1 calc R . .  
H27B H -0.5379 -0.1900 0.0270 0.092 Uiso 1 1 calc R . .  
H27C H -0.4467 -0.3153 0.0390 0.092 Uiso 1 1 calc R . .  
   
loop_  
 _atom_site_aniso_label  
 _atom_site_aniso_U_11  
 _atom_site_aniso_U_22  
 _atom_site_aniso_U_33  
 _atom_site_aniso_U_23  
 _atom_site_aniso_U_13  
 _atom_site_aniso_U_12  
O1 0.0456(12) 0.0463(12) 0.0423(12) 0.0093(10) -0.0013(10) -0.0040(10)  
O2 0.0518(13) 0.0552(13) 0.0449(12) -0.0080(10) 0.0211(11) -0.0135(10)  
O3 0.0422(11) 0.0328(10) 0.0419(11) -0.0041(9) 0.0101(9) -0.0055(9)  
O4 0.0518(12) 0.0261(11) 0.0502(12) 0.0010(9) 0.0060(10) 0.0013(9)  
O5 0.0514(13) 0.0547(13) 0.0549(14) -0.0032(11) 0.0037(11) -0.0171(11)  
N 0.0376(13) 0.0282(12) 0.0343(13) -0.0011(10) 0.0075(10) 0.0004(10)  
C1 0.0377(16) 0.0267(14) 0.0380(16) 0.0032(12) 0.0172(13) 0.0009(12)  
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C2 0.0385(16) 0.0382(17) 0.0356(16) 0.0026(13) 0.0116(14) -0.0007(13)  
C3 0.0469(18) 0.0362(17) 0.0447(18) 0.0120(14) 0.0128(15) 0.0091(14)  
C4 0.0526(19) 0.0308(15) 0.0460(18) 0.0046(14) 0.0197(15) 0.0040(14)  
C5 0.0469(17) 0.0276(15) 0.0413(17) -0.0007(13) 0.0155(14) 0.0009(13)  
C6 0.0355(15) 0.0306(15) 0.0359(16) 0.0027(12) 0.0161(13) -0.0003(12)  
C7 0.0370(15) 0.0272(14) 0.0339(15) 0.0009(12) 0.0125(12) 0.0013(12)  
C8 0.0386(16) 0.0317(15) 0.0360(15) -0.0027(12) 0.0127(13) -0.0009(12)  
C9 0.0503(18) 0.0359(16) 0.0314(15) 0.0022(13) 0.0109(13) -0.0017(13)  
C10 0.0438(17) 0.0334(15) 0.0395(16) 0.0056(13) 0.0080(13) -0.0006(13)  
C11 0.0372(15) 0.0291(14) 0.0344(15) 0.0003(12) 0.0121(12) -0.0028(12)  
C12 0.0337(15) 0.0283(16) 0.0411(17) 0.0025(13) 0.0111(13) -0.0013(12)  
C13 0.056(2) 0.074(2) 0.0400(18) 0.0129(17) 0.0038(16) -0.0061(18)  
C14 0.0393(16) 0.0337(15) 0.0336(15) -0.0005(13) 0.0065(13) 0.0008(13)  
C15 0.0415(17) 0.0340(16) 0.0507(18) 0.0016(14) 0.0057(14) -0.0109(13)  
C16 0.084(3) 0.0424(18) 0.062(2) 0.0060(17) 0.0126(19) -0.0152(18)  
C17 0.068(2) 0.0463(19) 0.064(2) -0.0157(17) 0.0151(18) -0.0147(17)  
C18 0.0432(19) 0.068(2) 0.073(2) -0.0077(19) 0.0040(17) -0.0072(17)  
C19 0.059(2) 0.0464(19) 0.059(2) 0.0090(16) -0.0053(17) 0.0006(16)  
C20 0.0403(16) 0.0342(15) 0.0384(16) -0.0023(13) 0.0102(13) 0.0009(13)  
C21 0.0364(15) 0.0282(14) 0.0343(15) 0.0009(12) 0.0067(13) 0.0050(12)  
C22 0.0423(16) 0.0342(15) 0.0330(15) -0.0019(12) 0.0082(13) 0.0010(13)  
C23 0.0396(16) 0.0402(16) 0.0397(17) 0.0037(14) 0.0105(13) -0.0001(14)  
C24 0.0374(16) 0.0357(16) 0.0458(18) 0.0040(14) 0.0000(14) 0.0001(13)  
C25 0.0502(19) 0.0495(18) 0.0337(16) -0.0053(14) 0.0033(14) -0.0022(15)  
C26 0.0481(18) 0.0450(17) 0.0361(17) 0.0015(14) 0.0102(14) -0.0009(15)  
C27 0.053(2) 0.058(2) 0.071(2) 0.0070(18) 0.0108(18) -0.0134(17)  
   
_geom_special_details  
;  
 All esds (except the esd in the dihedral angle between two l.s. planes)  
 are estimated using the full covariance matrix.  The cell esds are taken  
 into account individually in the estimation of esds in distances, angles  
 and torsion angles; correlations between esds in cell parameters are only  
 used when they are defined by crystal symmetry.  An approximate 
(isotropic)  
 treatment of cell esds is used for estimating esds involving l.s. planes.  
;  
   
loop_  
 _geom_bond_atom_site_label_1  
 _geom_bond_atom_site_label_2  
 _geom_bond_distance  
 _geom_bond_site_symmetry_2  
 _geom_bond_publ_flag  
O1 C2 1.363(3) . ?  
O1 C13 1.417(3) . ?  
O2 C14 1.207(3) . ?  
O3 C14 1.343(3) . ?  
O3 C15 1.481(3) . ?  
O4 C12 1.225(3) . ?  
O5 C24 1.376(3) . ?  
O5 C27 1.425(3) . ?  
N C12 1.372(3) . ?  
N C1 1.438(3) . ?  
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N C20 1.476(3) . ?  
C1 C2 1.400(4) . ?  
C1 C6 1.404(4) . ?  
C2 C3 1.390(4) . ?  
C3 C4 1.373(4) . ?  
C3 H3A 0.9400 . ?  
C4 C5 1.370(4) . ?  
C4 H4A 0.9400 . ?  
C5 C6 1.388(4) . ?  
C5 H5A 0.9400 . ?  
C6 C7 1.494(4) . ?  
C7 C8 1.520(3) . ?  
C7 C11 1.527(3) . ?  
C7 H7A 0.9900 . ?  
C8 C14 1.511(4) . ?  
C8 C9 1.578(4) . ?  
C8 H8A 0.9900 . ?  
C9 C19 1.516(4) . ?  
C9 C10 1.547(4) . ?  
C9 H9A 0.9900 . ?  
C10 C11 1.516(4) . ?  
C10 H10A 0.9800 . ?  
C10 H10B 0.9800 . ?  
C11 C12 1.499(4) . ?  
C11 H11A 0.9900 . ?  
C13 H13A 0.9700 . ?  
C13 H13B 0.9700 . ?  
C13 H13C 0.9700 . ?  
C15 C16 1.512(4) . ?  
C15 C18 1.516(4) . ?  
C15 C17 1.520(4) . ?  
C16 H16A 0.9700 . ?  
C16 H16B 0.9700 . ?  
C16 H16C 0.9700 . ?  
C17 H17A 0.9700 . ?  
C17 H17B 0.9700 . ?  
C17 H17C 0.9700 . ?  
C18 H18A 0.9700 . ?  
C18 H18B 0.9700 . ?  
C18 H18C 0.9700 . ?  
C19 H19A 0.9700 . ?  
C19 H19B 0.9700 . ?  
C19 H19C 0.9700 . ?  
C20 C21 1.504(4) . ?  
C20 H20A 0.9800 . ?  
C20 H20B 0.9800 . ?  
C21 C22 1.381(4) . ?  
C21 C26 1.388(4) . ?  
C22 C23 1.385(4) . ?  
C22 H22A 0.9400 . ?  
C23 C24 1.380(4) . ?  
C23 H23A 0.9400 . ?  
C24 C25 1.383(4) . ?  
C25 C26 1.380(4) . ?  
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C25 H25A 0.9400 . ?  
C26 H26A 0.9400 . ?  
C27 H27A 0.9700 . ?  
C27 H27B 0.9700 . ?  
C27 H27C 0.9700 . ?  
   
loop_  
 _geom_angle_atom_site_label_1  
 _geom_angle_atom_site_label_2  
 _geom_angle_atom_site_label_3  
 _geom_angle  
 _geom_angle_site_symmetry_1  
 _geom_angle_site_symmetry_3  
 _geom_angle_publ_flag  
C2 O1 C13 118.1(2) . . ?  
C14 O3 C15 121.1(2) . . ?  
C24 O5 C27 117.5(2) . . ?  
C12 N C1 121.7(2) . . ?  
C12 N C20 116.4(2) . . ?  
C1 N C20 119.6(2) . . ?  
C2 C1 C6 119.3(2) . . ?  
C2 C1 N 121.1(2) . . ?  
C6 C1 N 119.6(2) . . ?  
O1 C2 C3 122.8(3) . . ?  
O1 C2 C1 117.7(2) . . ?  
C3 C2 C1 119.4(3) . . ?  
C4 C3 C2 120.6(3) . . ?  
C4 C3 H3A 119.7 . . ?  
C2 C3 H3A 119.7 . . ?  
C5 C4 C3 120.4(3) . . ?  
C5 C4 H4A 119.8 . . ?  
C3 C4 H4A 119.8 . . ?  
C4 C5 C6 120.6(3) . . ?  
C4 C5 H5A 119.7 . . ?  
C6 C5 H5A 119.7 . . ?  
C5 C6 C1 119.6(2) . . ?  
C5 C6 C7 124.6(2) . . ?  
C1 C6 C7 115.8(2) . . ?  
C6 C7 C8 119.7(2) . . ?  
C6 C7 C11 109.5(2) . . ?  
C8 C7 C11 102.4(2) . . ?  
C6 C7 H7A 108.2 . . ?  
C8 C7 H7A 108.2 . . ?  
C11 C7 H7A 108.2 . . ?  
C14 C8 C7 113.5(2) . . ?  
C14 C8 C9 112.9(2) . . ?  
C7 C8 C9 104.5(2) . . ?  
C14 C8 H8A 108.6 . . ?  
C7 C8 H8A 108.6 . . ?  
C9 C8 H8A 108.6 . . ?  
C19 C9 C10 111.7(2) . . ?  
C19 C9 C8 115.2(2) . . ?  
C10 C9 C8 104.4(2) . . ?  
C19 C9 H9A 108.4 . . ?  
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C10 C9 H9A 108.4 . . ?  
C8 C9 H9A 108.4 . . ?  
C11 C10 C9 105.5(2) . . ?  
C11 C10 H10A 110.6 . . ?  
C9 C10 H10A 110.6 . . ?  
C11 C10 H10B 110.6 . . ?  
C9 C10 H10B 110.6 . . ?  
H10A C10 H10B 108.8 . . ?  
C12 C11 C10 117.3(2) . . ?  
C12 C11 C7 108.8(2) . . ?  
C10 C11 C7 102.5(2) . . ?  
C12 C11 H11A 109.3 . . ?  
C10 C11 H11A 109.3 . . ?  
C7 C11 H11A 109.3 . . ?  
O4 C12 N 121.6(2) . . ?  
O4 C12 C11 123.6(2) . . ?  
N C12 C11 114.7(2) . . ?  
O1 C13 H13A 109.5 . . ?  
O1 C13 H13B 109.5 . . ?  
H13A C13 H13B 109.5 . . ?  
O1 C13 H13C 109.5 . . ?  
H13A C13 H13C 109.5 . . ?  
H13B C13 H13C 109.5 . . ?  
O2 C14 O3 125.4(2) . . ?  
O2 C14 C8 124.4(2) . . ?  
O3 C14 C8 110.2(2) . . ?  
O3 C15 C16 109.6(2) . . ?  
O3 C15 C18 109.8(2) . . ?  
C16 C15 C18 112.7(3) . . ?  
O3 C15 C17 102.1(2) . . ?  
C16 C15 C17 111.3(3) . . ?  
C18 C15 C17 110.8(3) . . ?  
C15 C16 H16A 109.5 . . ?  
C15 C16 H16B 109.5 . . ?  
H16A C16 H16B 109.5 . . ?  
C15 C16 H16C 109.5 . . ?  
H16A C16 H16C 109.5 . . ?  
H16B C16 H16C 109.5 . . ?  
C15 C17 H17A 109.5 . . ?  
C15 C17 H17B 109.5 . . ?  
H17A C17 H17B 109.5 . . ?  
C15 C17 H17C 109.5 . . ?  
H17A C17 H17C 109.5 . . ?  
H17B C17 H17C 109.5 . . ?  
C15 C18 H18A 109.5 . . ?  
C15 C18 H18B 109.5 . . ?  
H18A C18 H18B 109.5 . . ?  
C15 C18 H18C 109.5 . . ?  
H18A C18 H18C 109.5 . . ?  
H18B C18 H18C 109.5 . . ?  
C9 C19 H19A 109.5 . . ?  
C9 C19 H19B 109.5 . . ?  
H19A C19 H19B 109.5 . . ?  
C9 C19 H19C 109.5 . . ?  
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H19A C19 H19C 109.5 . . ?  
H19B C19 H19C 109.5 . . ?  
N C20 C21 116.7(2) . . ?  
N C20 H20A 108.1 . . ?  
C21 C20 H20A 108.1 . . ?  
N C20 H20B 108.1 . . ?  
C21 C20 H20B 108.1 . . ?  
H20A C20 H20B 107.3 . . ?  
C22 C21 C26 117.4(2) . . ?  
C22 C21 C20 124.1(2) . . ?  
C26 C21 C20 118.4(2) . . ?  
C21 C22 C23 121.8(3) . . ?  
C21 C22 H22A 119.1 . . ?  
C23 C22 H22A 119.1 . . ?  
C24 C23 C22 119.7(3) . . ?  
C24 C23 H23A 120.1 . . ?  
C22 C23 H23A 120.1 . . ?  
O5 C24 C23 124.5(3) . . ?  
O5 C24 C25 115.9(3) . . ?  
C23 C24 C25 119.6(3) . . ?  
C26 C25 C24 119.8(3) . . ?  
C26 C25 H25A 120.1 . . ?  
C24 C25 H25A 120.1 . . ?  
C25 C26 C21 121.7(3) . . ?  
C25 C26 H26A 119.2 . . ?  
C21 C26 H26A 119.2 . . ?  
O5 C27 H27A 109.5 . . ?  
O5 C27 H27B 109.5 . . ?  
H27A C27 H27B 109.5 . . ?  
O5 C27 H27C 109.5 . . ?  
H27A C27 H27C 109.5 . . ?  
H27B C27 H27C 109.5 . . ?  
   
_diffrn_measured_fraction_theta_max    1.000  
_diffrn_reflns_theta_full              25.00  
_diffrn_measured_fraction_theta_full   1.000  
_refine_diff_density_max    0.171  
_refine_diff_density_min   -0.163  
_refine_diff_density_rms    0.040  
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